<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
 xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:owl="http://www.w3.org/2002/07/owl#"
 xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"
 xml:base="http://www.reactome.org/biopax/91/168249#">
<owl:Ontology rdf:about="">
 <owl:imports rdf:resource="http://www.biopax.org/release/biopax-level3.owl#" />
</owl:Ontology>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction367">
 <bp:evidence rdf:resource="#Evidence449" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1084">
 <bp:evidence rdf:resource="#Evidence1276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC6A binds alpha-mannan in fungal cell walls</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction366">
 <bp:evidence rdf:resource="#Evidence447" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1085">
 <bp:evidence rdf:resource="#Evidence1277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC4D binds mycobacterial trehalose-6,6&apos;-dimycolate (TDM)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction369">
 <bp:evidence rdf:resource="#Evidence451" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1082">
 <bp:evidence rdf:resource="#Evidence1274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN and FYN phosphorylate FCER1G in CLEC6A:FCERG and CLEC4E:FCERG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction368">
 <bp:evidence rdf:resource="#Evidence450" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1083">
 <bp:evidence rdf:resource="#Evidence1275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC4C binds HIV and HCV glycoproteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1080">
 <bp:evidence rdf:resource="#Evidence1272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1081">
 <bp:evidence rdf:resource="#Evidence1273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC4E binds alpha-mannan and trehalose-6-6&apos;-dimycolate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction370">
 <bp:evidence rdf:resource="#Evidence452" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction372">
 <bp:evidence rdf:resource="#Evidence454" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction371">
 <bp:evidence rdf:resource="#Evidence453" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction374">
 <bp:evidence rdf:resource="#Evidence457" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1088">
 <bp:evidence rdf:resource="#Evidence1280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK phosphorylates PLCG2 in p-6Y-SYK:p-Y65,Y76-FCER1G:PLCG2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction373">
 <bp:evidence rdf:resource="#Evidence455" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1089">
 <bp:evidence rdf:resource="#Evidence1281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK binds to p-Y65,Y76-FCER1G</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction376">
 <bp:evidence rdf:resource="#Evidence459" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1086">
 <bp:evidence rdf:resource="#Evidence1278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLCG1 binds p-6Y-SYK:p-Y65,Y76-FCER1G</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction375">
 <bp:evidence rdf:resource="#Evidence458" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1087">
 <bp:evidence rdf:resource="#Evidence1279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLCG2 translocates from cytosol to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction356">
 <bp:evidence rdf:resource="#Evidence433" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1095">
 <bp:evidence rdf:resource="#Evidence1288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 binds ICAM3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction355">
 <bp:evidence rdf:resource="#Evidence432" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1096">
 <bp:evidence rdf:resource="#Evidence1289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK phosphorylates p21 RAF1 on S338</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction358">
 <bp:evidence rdf:resource="#Evidence437" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1093">
 <bp:evidence rdf:resource="#Evidence1286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protein kinase A (PKA) and RPS6KA5 (MSK1) phosphorylates p65 (RELA) subunit</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction357">
 <bp:evidence rdf:resource="#Evidence436" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1094">
 <bp:evidence rdf:resource="#Evidence1287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAF1 binds p21 RAS:GTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1091">
 <bp:evidence rdf:resource="#Evidence1283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC4A binds HIV and HCV glycoproteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction359">
 <bp:evidence rdf:resource="#Evidence438" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1092">
 <bp:evidence rdf:resource="#Evidence1285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CBP and p300 binds NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1090">
 <bp:evidence rdf:resource="#Evidence1282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC10A binds Tn-MUC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction361">
 <bp:evidence rdf:resource="#Evidence440" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction360">
 <bp:evidence rdf:resource="#Evidence439" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction363">
 <bp:evidence rdf:resource="#Evidence443" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1099">
 <bp:evidence rdf:resource="#Evidence1292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 binds ManLAM</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction362">
 <bp:evidence rdf:resource="#Evidence442" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction365">
 <bp:evidence rdf:resource="#Evidence445" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1097">
 <bp:evidence rdf:resource="#Evidence1290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 binds ICAM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction364">
 <bp:evidence rdf:resource="#Evidence444" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1098">
 <bp:evidence rdf:resource="#Evidence1291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFKs phosphorylates RAF1 on Y340,Y341</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction345">
 <bp:evidence rdf:resource="#Evidence418" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1/or p-IRAK2:p-IRAK4:MyD88:activated TLR7/8 or 9  </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1062">
 <bp:evidence rdf:resource="#Evidence1250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of WASP and N-WASP by CDC42</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction344">
 <bp:evidence rdf:resource="#Evidence417" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 interacts with the activated TLR receptor 7, 8 or 9 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1063">
 <bp:evidence rdf:resource="#Evidence1251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Branching and elongation of mother and daughter filaments</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction347">
 <bp:evidence rdf:resource="#Evidence420" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps within the complex pIRAK4:MyD88:activated TLR7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1060">
 <bp:evidence rdf:resource="#Evidence1248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Detachment of WASP/WAVE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction346">
 <bp:evidence rdf:resource="#Evidence419" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR7/8 or 9 receptor:MyD88 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1061">
 <bp:evidence rdf:resource="#Evidence1249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of LIMK1 by Hsp90</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction349">
 <bp:evidence rdf:resource="#Evidence425" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction348">
 <bp:evidence rdf:resource="#Evidence421" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction350">
 <bp:evidence rdf:resource="#Evidence426" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1068">
 <bp:evidence rdf:resource="#Evidence1257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PLCgamma to membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1069">
 <bp:evidence rdf:resource="#Evidence1258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K binds to p-6Y-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction352">
 <bp:evidence rdf:resource="#Evidence429" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1066">
 <bp:evidence rdf:resource="#Evidence1255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAG stimulates protein kinase C-delta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction351">
 <bp:evidence rdf:resource="#Evidence427" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1067">
 <bp:evidence rdf:resource="#Evidence1256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction354">
 <bp:evidence rdf:resource="#Evidence431" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1064">
 <bp:evidence rdf:resource="#Evidence1253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Production of AA by iPLA2 upon FCGR activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction353">
 <bp:evidence rdf:resource="#Evidence430" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1065">
 <bp:evidence rdf:resource="#Evidence1254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and activation of PLCG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction334">
 <bp:evidence rdf:resource="#Evidence406" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to MyD88: activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1073">
 <bp:evidence rdf:resource="#Evidence1262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction333">
 <bp:evidence rdf:resource="#Evidence404" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-ter TLR7 dimer binds TLR7, TLR8 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1074">
 <bp:evidence rdf:resource="#Evidence1263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrolysis of PC to PA by PLD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction336">
 <bp:evidence rdf:resource="#Evidence408" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR 7/8 or 9 : MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1071">
 <bp:evidence rdf:resource="#Evidence1260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active PLCG1 hydrolyses PIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction335">
 <bp:evidence rdf:resource="#Evidence407" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1072">
 <bp:evidence rdf:resource="#Evidence1261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Conversion of PA into DAG by PAP-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction338">
 <bp:evidence rdf:resource="#Evidence410" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction337">
 <bp:evidence rdf:resource="#Evidence409" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1/or IRAK2 binds to the activated IRAK4 :MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1070">
 <bp:evidence rdf:resource="#Evidence1259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of PLCG from FCGR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction339">
 <bp:evidence rdf:resource="#Evidence412" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF7 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1079">
 <bp:evidence rdf:resource="#Evidence1269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGER-1,2,3 bind AGEs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction341">
 <bp:evidence rdf:resource="#Evidence414" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of p-IRF7:p-IRF7 to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1077">
 <bp:evidence rdf:resource="#Evidence1267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Advanced glycosylation end product-specific receptor (AGER/RAGE) is a multiligand receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction340">
 <bp:evidence rdf:resource="#Evidence413" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 interacts with IRF7 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1078">
 <bp:evidence rdf:resource="#Evidence1268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The TRTK-12 fragment of F-actin capping protein alpha binds the AGER ligand S100B</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction343">
 <bp:evidence rdf:resource="#Evidence416" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 ubiquitinqtes IRF7 within the activated TLR7/8 or 9 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1075">
 <bp:evidence rdf:resource="#Evidence1264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction342">
 <bp:evidence rdf:resource="#Evidence415" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1076">
 <bp:evidence rdf:resource="#Evidence1266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AGER binds ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction323">
 <bp:evidence rdf:resource="#Evidence392" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral dsRNA binds the Toll-Like Receptor 3 (TLR3)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction322">
 <bp:evidence rdf:resource="#Evidence391" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral dsRNA:TLR3:TRIF complex recruits RIP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction325">
 <bp:evidence rdf:resource="#Evidence396" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S446-IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction324">
 <bp:evidence rdf:resource="#Evidence395" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASL is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction327">
 <bp:evidence rdf:resource="#Evidence398" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated IKBKB phosphorylates IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction326">
 <bp:evidence rdf:resource="#Evidence397" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASL recruits IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction329">
 <bp:evidence rdf:resource="#Evidence400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S446-IRF5 dimer translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction328">
 <bp:evidence rdf:resource="#Evidence399" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC15A4 binds TASL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction330">
 <bp:evidence rdf:resource="#Evidence401" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-ter TLR7 dimer binds HCQ</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction332">
 <bp:evidence rdf:resource="#Evidence403" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-ter TLR7 dimer binds imiquimod</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction331">
 <bp:evidence rdf:resource="#Evidence402" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR8 dimer binds TLR7, TLR8 ligands</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction319">
 <bp:evidence rdf:resource="#Evidence387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated TAK1 dissociates from the TLR3 receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction312">
 <bp:evidence rdf:resource="#Evidence379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR3-induced ripoptosome assembly</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction311">
 <bp:evidence rdf:resource="#Evidence378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-8 processing within TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction314">
 <bp:evidence rdf:resource="#Evidence382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of recruited TAK1 within the activated TLR3 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction313">
 <bp:evidence rdf:resource="#Evidence380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP3 binds TICAM1 within TLR3 complex to mediate necroptosis </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction316">
 <bp:evidence rdf:resource="#Evidence384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral dsRNA:TLR3:TICAM1 complex recruits TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction315">
 <bp:evidence rdf:resource="#Evidence383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon TLR3 stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction318">
 <bp:evidence rdf:resource="#Evidence386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiqitination of TRAF6 bound to viral dsRNS:TLR3:TICAM1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction317">
 <bp:evidence rdf:resource="#Evidence385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR3:TRIF:K63pUb-TRAF6 recruits TAK1complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction321">
 <bp:evidence rdf:resource="#Evidence390" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKG subunit of IKK complex binds K63pUb- RIP1 within the TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction320">
 <bp:evidence rdf:resource="#Evidence389" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63-linked ubiquitination of RIP1 bound to the activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction309">
 <bp:evidence rdf:resource="#Evidence375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) is phosphorylated within the activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction308">
 <bp:evidence rdf:resource="#Evidence374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerized phospho-IRF3/IRF7 is transported to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence691">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence690">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction301">
 <bp:evidence rdf:resource="#Evidence366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 binds K63-pUb-TANK:K63-pUb-TRAF3:TRIF:activated TLR3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence695">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction300">
 <bp:evidence rdf:resource="#Evidence365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3/IRF7 recruitment to p-TBK1/p-IKK epsilon bound to the activated TLR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence694">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction303">
 <bp:evidence rdf:resource="#Evidence368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK binds K63-poly-Ub-TRAF3:TICAM1:activated TLR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence693">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction302">
 <bp:evidence rdf:resource="#Evidence367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK is ubiquitinated within TANK:K63polyUb-TRAF3:TICAM1:TLR3:viral dsRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence692">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction305">
 <bp:evidence rdf:resource="#Evidence371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is ubiquitinated within TBK1:K63polyUb-TANK:K63polyUb-TRAF3:TRIF:activated TLR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence699">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction304">
 <bp:evidence rdf:resource="#Evidence369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of phosphorylated IRF3/IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence698">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction307">
 <bp:evidence rdf:resource="#Evidence373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) is ubiquitinated within the activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence697">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction306">
 <bp:evidence rdf:resource="#Evidence372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OPTN binds TBK1 within the activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence696">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction310">
 <bp:evidence rdf:resource="#Evidence376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF3 binds to TRIF:activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence680">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence684">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence683">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence682">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence681">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence688">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence687">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence686">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence685">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence689">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep626">
 <bp:stepProcess rdf:resource="#BiochemicalReaction517" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep627">
 <bp:stepProcess rdf:resource="#BiochemicalReaction518" />
 <bp:stepProcess rdf:resource="#Catalysis245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep628">
 <bp:stepProcess rdf:resource="#BiochemicalReaction519" />
 <bp:stepProcess rdf:resource="#Catalysis246" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep629">
 <bp:stepProcess rdf:resource="#BiochemicalReaction520" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep622">
 <bp:stepProcess rdf:resource="#BiochemicalReaction513" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep623">
 <bp:stepProcess rdf:resource="#BiochemicalReaction514" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep624">
 <bp:stepProcess rdf:resource="#BiochemicalReaction515" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep625">
 <bp:stepProcess rdf:resource="#Catalysis244" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction516" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence673">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence672">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence671">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence670">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence677">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence676">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence675">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence674">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence679">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence678">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep620">
 <bp:stepProcess rdf:resource="#Catalysis243" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction511" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep621">
 <bp:stepProcess rdf:resource="#BiochemicalReaction512" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep637">
 <bp:stepProcess rdf:resource="#Catalysis249" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction526" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep638">
 <bp:stepProcess rdf:resource="#BiochemicalReaction527" />
 <bp:stepProcess rdf:resource="#Catalysis250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep639">
 <bp:stepProcess rdf:resource="#Pathway113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep633">
 <bp:stepProcess rdf:resource="#BiochemicalReaction524" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep634">
 <bp:stepProcess rdf:resource="#Pathway111" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep635">
 <bp:stepProcess rdf:resource="#Pathway112" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep636">
 <bp:stepProcess rdf:resource="#BiochemicalReaction525" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence662">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence661">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence660">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence666">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence665">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence664">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence663">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence669">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence668">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence667">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep630">
 <bp:stepProcess rdf:resource="#Catalysis247" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction521" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep631">
 <bp:stepProcess rdf:resource="#BiochemicalReaction522" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep632">
 <bp:stepProcess rdf:resource="#Catalysis248" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction523" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep648">
 <bp:stepProcess rdf:resource="#BiochemicalReaction534" />
 <bp:stepProcess rdf:resource="#Catalysis254" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep649">
 <bp:stepProcess rdf:resource="#Catalysis255" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction535" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep644">
 <bp:stepProcess rdf:resource="#BiochemicalReaction532" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep645">
 <bp:stepProcess rdf:resource="#Pathway114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep646">
 <bp:stepProcess rdf:resource="#Pathway115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep647">
 <bp:stepProcess rdf:resource="#BiochemicalReaction533" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence651">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence650">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence655">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence654">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence653">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence652">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence659">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence658">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence657">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence656">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep640">
 <bp:stepProcess rdf:resource="#BiochemicalReaction528" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep641">
 <bp:stepProcess rdf:resource="#BiochemicalReaction529" />
 <bp:stepProcess rdf:resource="#Catalysis251" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep642">
 <bp:stepProcess rdf:resource="#BiochemicalReaction530" />
 <bp:stepProcess rdf:resource="#Catalysis252" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep643">
 <bp:stepProcess rdf:resource="#BiochemicalReaction531" />
 <bp:stepProcess rdf:resource="#Catalysis253" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep659">
 <bp:stepProcess rdf:resource="#Pathway118" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep655">
 <bp:stepProcess rdf:resource="#BiochemicalReaction540" />
 <bp:stepProcess rdf:resource="#Catalysis259" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep656">
 <bp:stepProcess rdf:resource="#Catalysis260" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction541" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep657">
 <bp:stepProcess rdf:resource="#Pathway117" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep658">
 <bp:stepProcess rdf:resource="#BiochemicalReaction542" />
 <bp:stepProcess rdf:resource="#Catalysis261" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence640">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence644">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence643">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence642">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence641">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence648">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence647">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence646">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence645">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence649">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep651">
 <bp:stepProcess rdf:resource="#BiochemicalReaction537" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep652">
 <bp:stepProcess rdf:resource="#Pathway116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep653">
 <bp:stepProcess rdf:resource="#Catalysis257" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction538" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep654">
 <bp:stepProcess rdf:resource="#BiochemicalReaction539" />
 <bp:stepProcess rdf:resource="#Catalysis258" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep650">
 <bp:stepProcess rdf:resource="#Catalysis256" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction536" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence633">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence632">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence631">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence630">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence637">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence636">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence635">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence634">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence639">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence638">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction399">
 <bp:evidence rdf:resource="#Evidence484" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence622">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence621">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence620">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence626">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence625">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence624">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence623">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence629">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence628">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence627">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep604">
 <bp:stepProcess rdf:resource="#BiochemicalReaction497" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep605">
 <bp:stepProcess rdf:resource="#BiochemicalReaction498" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep606">
 <bp:stepProcess rdf:resource="#Catalysis238" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction499" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep607">
 <bp:stepProcess rdf:resource="#Catalysis239" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction500" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep600">
 <bp:stepProcess rdf:resource="#BiochemicalReaction496" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep601">
 <bp:stepProcess rdf:resource="#Pathway106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep602">
 <bp:stepProcess rdf:resource="#Pathway107" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep603">
 <bp:stepProcess rdf:resource="#Pathway108" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction389">
 <bp:evidence rdf:resource="#Evidence474" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction388">
 <bp:evidence rdf:resource="#Evidence473" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep608">
 <bp:stepProcess rdf:resource="#BiochemicalReaction501" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence611">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep609">
 <bp:stepProcess rdf:resource="#BiochemicalReaction502" />
 <bp:stepProcess rdf:resource="#Catalysis240" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence610">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction392">
 <bp:evidence rdf:resource="#Evidence477" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence615">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction391">
 <bp:evidence rdf:resource="#Evidence476" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence614">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction394">
 <bp:evidence rdf:resource="#Evidence479" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence613">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction393">
 <bp:evidence rdf:resource="#Evidence478" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence612">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction396">
 <bp:evidence rdf:resource="#Evidence481" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence619">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction395">
 <bp:evidence rdf:resource="#Evidence480" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence618">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction398">
 <bp:evidence rdf:resource="#Evidence483" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence617">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction397">
 <bp:evidence rdf:resource="#Evidence482" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence616">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction390">
 <bp:evidence rdf:resource="#Evidence475" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep615">
 <bp:stepProcess rdf:resource="#BiochemicalReaction506" />
 <bp:stepProcess rdf:resource="#Catalysis241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep616">
 <bp:stepProcess rdf:resource="#BiochemicalReaction507" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep617">
 <bp:stepProcess rdf:resource="#BiochemicalReaction508" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep618">
 <bp:stepProcess rdf:resource="#BiochemicalReaction509" />
 <bp:stepProcess rdf:resource="#Catalysis242" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep611">
 <bp:stepProcess rdf:resource="#BiochemicalReaction503" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep612">
 <bp:stepProcess rdf:resource="#BiochemicalReaction504" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep613">
 <bp:stepProcess rdf:resource="#Pathway110" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep614">
 <bp:stepProcess rdf:resource="#BiochemicalReaction505" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction378">
 <bp:evidence rdf:resource="#Evidence461" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction377">
 <bp:evidence rdf:resource="#Evidence460" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction379">
 <bp:evidence rdf:resource="#Evidence462" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence600">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep619">
 <bp:stepProcess rdf:resource="#BiochemicalReaction510" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction381">
 <bp:evidence rdf:resource="#Evidence464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence604">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction380">
 <bp:evidence rdf:resource="#Evidence463" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence603">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction383">
 <bp:evidence rdf:resource="#Evidence467" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence602">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction382">
 <bp:evidence rdf:resource="#Evidence465" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1/or IRAK2:TRAF6-oligomer from the p-IRAK4 :oligo-Myd88:activated TLR7/8 or 9 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence601">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction385">
 <bp:evidence rdf:resource="#Evidence470" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence608">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction384">
 <bp:evidence rdf:resource="#Evidence468" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence607">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction387">
 <bp:evidence rdf:resource="#Evidence472" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence606">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction386">
 <bp:evidence rdf:resource="#Evidence471" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence605">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence609">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep610">
 <bp:stepProcess rdf:resource="#Pathway109" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis260">
 <bp:controlled rdf:resource="#BiochemicalReaction541" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep589">
 <bp:stepProcess rdf:resource="#Pathway104" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis267">
 <bp:controlled rdf:resource="#BiochemicalReaction548" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis268">
 <bp:controlled rdf:resource="#BiochemicalReaction549" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis265">
 <bp:controlled rdf:resource="#BiochemicalReaction546" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis266">
 <bp:controlled rdf:resource="#BiochemicalReaction547" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis263">
 <bp:controlled rdf:resource="#BiochemicalReaction544" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence710">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis264">
 <bp:controlled rdf:resource="#BiochemicalReaction545" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis261">
 <bp:controlled rdf:resource="#BiochemicalReaction542" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis262">
 <bp:controlled rdf:resource="#BiochemicalReaction543" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence714">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence713">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence712">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep580">
 <bp:stepProcess rdf:resource="#BiochemicalReaction478" />
 <bp:stepProcess rdf:resource="#Catalysis230" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence711">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence718">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence717">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis258">
 <bp:controlled rdf:resource="#BiochemicalReaction539" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence716">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis259">
 <bp:controlled rdf:resource="#BiochemicalReaction540" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence715">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep585">
 <bp:stepProcess rdf:resource="#BiochemicalReaction483" />
 <bp:stepProcess rdf:resource="#Catalysis231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep586">
 <bp:stepProcess rdf:resource="#BiochemicalReaction484" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep587">
 <bp:stepProcess rdf:resource="#BiochemicalReaction485" />
 <bp:stepProcess rdf:resource="#Catalysis232" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep588">
 <bp:stepProcess rdf:resource="#BiochemicalReaction486" />
 <bp:stepProcess rdf:resource="#Catalysis233" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence719">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep581">
 <bp:stepProcess rdf:resource="#BiochemicalReaction479" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep582">
 <bp:stepProcess rdf:resource="#BiochemicalReaction480" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep583">
 <bp:stepProcess rdf:resource="#BiochemicalReaction481" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep584">
 <bp:stepProcess rdf:resource="#BiochemicalReaction482" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis256">
 <bp:controlled rdf:resource="#BiochemicalReaction536" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis257">
 <bp:controlled rdf:resource="#BiochemicalReaction538" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis254">
 <bp:controlled rdf:resource="#BiochemicalReaction534" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis255">
 <bp:controlled rdf:resource="#BiochemicalReaction535" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis252">
 <bp:controlled rdf:resource="#BiochemicalReaction530" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis253">
 <bp:controlled rdf:resource="#BiochemicalReaction531" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis250">
 <bp:controlled rdf:resource="#BiochemicalReaction527" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis251">
 <bp:controlled rdf:resource="#BiochemicalReaction529" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence703">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence702">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep590">
 <bp:stepProcess rdf:resource="#BiochemicalReaction487" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence701">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep591">
 <bp:stepProcess rdf:resource="#BiochemicalReaction488" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence700">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis249">
 <bp:controlled rdf:resource="#BiochemicalReaction526" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence707">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence706">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis247">
 <bp:controlled rdf:resource="#BiochemicalReaction521" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence705">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis248">
 <bp:controlled rdf:resource="#BiochemicalReaction523" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence704">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep596">
 <bp:stepProcess rdf:resource="#BiochemicalReaction492" />
 <bp:stepProcess rdf:resource="#Catalysis236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep597">
 <bp:stepProcess rdf:resource="#BiochemicalReaction493" />
 <bp:stepProcess rdf:resource="#Catalysis237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep598">
 <bp:stepProcess rdf:resource="#BiochemicalReaction494" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence709">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep599">
 <bp:stepProcess rdf:resource="#BiochemicalReaction495" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence708">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep592">
 <bp:stepProcess rdf:resource="#Catalysis234" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction489" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep593">
 <bp:stepProcess rdf:resource="#BiochemicalReaction490" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep594">
 <bp:stepProcess rdf:resource="#BiochemicalReaction491" />
 <bp:stepProcess rdf:resource="#Catalysis235" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep595">
 <bp:stepProcess rdf:resource="#Pathway105" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis245">
 <bp:controlled rdf:resource="#BiochemicalReaction518" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis246">
 <bp:controlled rdf:resource="#BiochemicalReaction519" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis243">
 <bp:controlled rdf:resource="#BiochemicalReaction511" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis244">
 <bp:controlled rdf:resource="#BiochemicalReaction516" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis241">
 <bp:controlled rdf:resource="#BiochemicalReaction506" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis242">
 <bp:controlled rdf:resource="#BiochemicalReaction509" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis240">
 <bp:controlled rdf:resource="#BiochemicalReaction502" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis238">
 <bp:controlled rdf:resource="#BiochemicalReaction499" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis239">
 <bp:controlled rdf:resource="#BiochemicalReaction500" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis236">
 <bp:controlled rdf:resource="#BiochemicalReaction492" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis237">
 <bp:controlled rdf:resource="#BiochemicalReaction493" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis234">
 <bp:controlled rdf:resource="#BiochemicalReaction489" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis235">
 <bp:controlled rdf:resource="#BiochemicalReaction491" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis232">
 <bp:controlled rdf:resource="#BiochemicalReaction485" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis233">
 <bp:controlled rdf:resource="#BiochemicalReaction486" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis230">
 <bp:controlled rdf:resource="#BiochemicalReaction478" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis231">
 <bp:controlled rdf:resource="#BiochemicalReaction483" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis229">
 <bp:controlled rdf:resource="#BiochemicalReaction476" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis227">
 <bp:controlled rdf:resource="#BiochemicalReaction466" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis228">
 <bp:controlled rdf:resource="#BiochemicalReaction473" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis225">
 <bp:controlled rdf:resource="#BiochemicalReaction463" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis226">
 <bp:controlled rdf:resource="#BiochemicalReaction464" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep549">
 <bp:stepProcess rdf:resource="#BiochemicalReaction452" />
 <bp:stepProcess rdf:resource="#Catalysis215" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep545">
 <bp:stepProcess rdf:resource="#Pathway98" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep546">
 <bp:stepProcess rdf:resource="#Catalysis212" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction449" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep547">
 <bp:stepProcess rdf:resource="#BiochemicalReaction450" />
 <bp:stepProcess rdf:resource="#Catalysis213" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep548">
 <bp:stepProcess rdf:resource="#BiochemicalReaction451" />
 <bp:stepProcess rdf:resource="#Catalysis214" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1396">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1190" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1395">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1189" />
 <bp:stepProcess rdf:resource="#Catalysis476" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1398">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1192" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1397">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1191" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1392">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1187" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1391">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1186" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1394">
 <bp:stepProcess rdf:resource="#Pathway207" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1393">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep541">
 <bp:stepProcess rdf:resource="#Catalysis209" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction445" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep542">
 <bp:stepProcess rdf:resource="#BiochemicalReaction446" />
 <bp:stepProcess rdf:resource="#Catalysis210" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep543">
 <bp:stepProcess rdf:resource="#Catalysis211" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction447" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep544">
 <bp:stepProcess rdf:resource="#BiochemicalReaction448" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1399">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1193" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep540">
 <bp:stepProcess rdf:resource="#BiochemicalReaction444" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis292">
 <bp:controlled rdf:resource="#BiochemicalReaction602" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis293">
 <bp:controlled rdf:resource="#BiochemicalReaction603" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis290">
 <bp:controlled rdf:resource="#BiochemicalReaction599" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis291">
 <bp:controlled rdf:resource="#BiochemicalReaction600" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep556">
 <bp:stepProcess rdf:resource="#BiochemicalReaction457" />
 <bp:stepProcess rdf:resource="#Catalysis220" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep557">
 <bp:stepProcess rdf:resource="#Catalysis221" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction458" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep558">
 <bp:stepProcess rdf:resource="#Catalysis222" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction459" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep559">
 <bp:stepProcess rdf:resource="#BiochemicalReaction460" />
 <bp:stepProcess rdf:resource="#Catalysis223" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis298">
 <bp:controlled rdf:resource="#BiochemicalReaction611" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1390">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1185" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis299">
 <bp:controlled rdf:resource="#BiochemicalReaction612" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis296">
 <bp:controlled rdf:resource="#BiochemicalReaction607" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis297">
 <bp:controlled rdf:resource="#BiochemicalReaction610" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis294">
 <bp:controlled rdf:resource="#BiochemicalReaction605" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis295">
 <bp:controlled rdf:resource="#BiochemicalReaction606" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1385">
 <bp:stepProcess rdf:resource="#Pathway205" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1384">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1181" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1387">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1182" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1386">
 <bp:stepProcess rdf:resource="#Pathway206" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1178" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1380">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1177" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1180" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1382">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep552">
 <bp:stepProcess rdf:resource="#Pathway100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep553">
 <bp:stepProcess rdf:resource="#Catalysis217" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction454" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep554">
 <bp:stepProcess rdf:resource="#Catalysis218" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction455" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep555">
 <bp:stepProcess rdf:resource="#Catalysis219" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction456" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1389">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1388">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1183" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep550">
 <bp:stepProcess rdf:resource="#Pathway99" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep551">
 <bp:stepProcess rdf:resource="#Catalysis216" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction453" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis281">
 <bp:controlled rdf:resource="#BiochemicalReaction581" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis282">
 <bp:controlled rdf:resource="#BiochemicalReaction583" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis280">
 <bp:controlled rdf:resource="#BiochemicalReaction578" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep567">
 <bp:stepProcess rdf:resource="#BiochemicalReaction467" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep568">
 <bp:stepProcess rdf:resource="#BiochemicalReaction468" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep569">
 <bp:stepProcess rdf:resource="#BiochemicalReaction469" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis289">
 <bp:controlled rdf:resource="#BiochemicalReaction598" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis287">
 <bp:controlled rdf:resource="#BiochemicalReaction596" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis288">
 <bp:controlled rdf:resource="#BiochemicalReaction597" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis285">
 <bp:controlled rdf:resource="#BiochemicalReaction591" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis286">
 <bp:controlled rdf:resource="#BiochemicalReaction593" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis283">
 <bp:controlled rdf:resource="#BiochemicalReaction588" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis284">
 <bp:controlled rdf:resource="#BiochemicalReaction590" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1374">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1172" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1373">
 <bp:stepProcess rdf:resource="#Catalysis474" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1171" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1376">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1173" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1375">
 <bp:stepProcess rdf:resource="#Pathway204" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1370">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1168" />
 <bp:stepProcess rdf:resource="#Catalysis473" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1372">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1170" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1371">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1169" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep563">
 <bp:stepProcess rdf:resource="#Catalysis225" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction463" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep564">
 <bp:stepProcess rdf:resource="#BiochemicalReaction464" />
 <bp:stepProcess rdf:resource="#Catalysis226" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep565">
 <bp:stepProcess rdf:resource="#BiochemicalReaction465" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep566">
 <bp:stepProcess rdf:resource="#Catalysis227" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction466" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1378">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1175" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep560">
 <bp:stepProcess rdf:resource="#Pathway101" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1377">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1174" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep561">
 <bp:stepProcess rdf:resource="#BiochemicalReaction461" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep562">
 <bp:stepProcess rdf:resource="#BiochemicalReaction462" />
 <bp:stepProcess rdf:resource="#Catalysis224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1379">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1176" />
 <bp:stepProcess rdf:resource="#Catalysis475" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis270">
 <bp:controlled rdf:resource="#BiochemicalReaction552" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis271">
 <bp:controlled rdf:resource="#BiochemicalReaction553" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep578">
 <bp:stepProcess rdf:resource="#Catalysis229" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction476" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep579">
 <bp:stepProcess rdf:resource="#BiochemicalReaction477" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis278">
 <bp:controlled rdf:resource="#BiochemicalReaction573" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis279">
 <bp:controlled rdf:resource="#BiochemicalReaction574" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis276">
 <bp:controlled rdf:resource="#BiochemicalReaction565" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis277">
 <bp:controlled rdf:resource="#BiochemicalReaction566" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis274">
 <bp:controlled rdf:resource="#BiochemicalReaction561" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis275">
 <bp:controlled rdf:resource="#BiochemicalReaction564" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis272">
 <bp:controlled rdf:resource="#BiochemicalReaction555" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis273">
 <bp:controlled rdf:resource="#BiochemicalReaction559" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1162" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1362">
 <bp:stepProcess rdf:resource="#Pathway202" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1365">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1164" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1364">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1163" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis269">
 <bp:controlled rdf:resource="#BiochemicalReaction551" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1361">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1161" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1360">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1160" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep574">
 <bp:stepProcess rdf:resource="#BiochemicalReaction472" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep575">
 <bp:stepProcess rdf:resource="#BiochemicalReaction473" />
 <bp:stepProcess rdf:resource="#Catalysis228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep576">
 <bp:stepProcess rdf:resource="#BiochemicalReaction474" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep577">
 <bp:stepProcess rdf:resource="#BiochemicalReaction475" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep570">
 <bp:stepProcess rdf:resource="#Pathway102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1367">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep571">
 <bp:stepProcess rdf:resource="#BiochemicalReaction470" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1366">
 <bp:stepProcess rdf:resource="#Pathway203" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep572">
 <bp:stepProcess rdf:resource="#BiochemicalReaction471" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1369">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1167" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep573">
 <bp:stepProcess rdf:resource="#Pathway103" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1368">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1166" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1004">
 <bp:evidence rdf:resource="#Evidence1187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cathelicidin LL-37 binds to bacterial cell wall</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1352">
 <bp:stepProcess rdf:resource="#Pathway200" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1005">
 <bp:evidence rdf:resource="#Evidence1188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HTN1,HTN3 or HTN5 binds the bacterial anionic surface </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1351">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1153" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1002">
 <bp:evidence rdf:resource="#Evidence1185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGLYRP2 binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1354">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1155" />
 <bp:stepProcess rdf:resource="#Catalysis472" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1003">
 <bp:evidence rdf:resource="#Evidence1186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGLYRP2 hydrolyzes bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1353">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1154" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1000">
 <bp:evidence rdf:resource="#Evidence1183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DCD forms oligomeric complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1001">
 <bp:evidence rdf:resource="#Evidence1184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INTL1 binds bacterial glycans</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1152" />
 <bp:stepProcess rdf:resource="#Catalysis471" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1359">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1159" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1008">
 <bp:evidence rdf:resource="#Evidence1191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHGA-derived peptide binds the bacterial cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1356">
 <bp:stepProcess rdf:resource="#Pathway201" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1009">
 <bp:evidence rdf:resource="#Evidence1193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A7 or S100A7A binds Zn2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1156" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1006">
 <bp:evidence rdf:resource="#Evidence1189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DCD is processed into DCD(63-110)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1358">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1158" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1007">
 <bp:evidence rdf:resource="#Evidence1190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNASEs bind bacterial LPS, PGN</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1357">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1157" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1015">
 <bp:evidence rdf:resource="#Evidence1199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BPIF binds bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1341">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1145" />
 <bp:stepProcess rdf:resource="#Catalysis466" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1016">
 <bp:evidence rdf:resource="#Evidence1200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REG3A binds bacterial phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1340">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1144" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1013">
 <bp:evidence rdf:resource="#Evidence1197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LCN2:2,5DHBA binds Fe3+</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1147" />
 <bp:stepProcess rdf:resource="#Catalysis467" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1014">
 <bp:evidence rdf:resource="#Evidence1198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DCD(63-110) is processed to DCD(63-109)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1342">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1146" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1011">
 <bp:evidence rdf:resource="#Evidence1195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lactoferrin scavenges iron ions</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1012">
 <bp:evidence rdf:resource="#Evidence1196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A8:S100A9 binds Mn2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1010">
 <bp:evidence rdf:resource="#Evidence1194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A8:S100A9 binds Zn2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1349">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1151" />
 <bp:stepProcess rdf:resource="#Catalysis470" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1348">
 <bp:stepProcess rdf:resource="#Catalysis469" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1150" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1019">
 <bp:evidence rdf:resource="#Evidence1203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNLY is transferred to the phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1345">
 <bp:stepProcess rdf:resource="#Pathway199" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1344">
 <bp:stepProcess rdf:resource="#Pathway198" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1017">
 <bp:evidence rdf:resource="#Evidence1201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYZ binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1347">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1149" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1018">
 <bp:evidence rdf:resource="#Evidence1202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEAP2 binds bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1346">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1148" />
 <bp:stepProcess rdf:resource="#Catalysis468" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1330">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1135" />
 <bp:stepProcess rdf:resource="#Catalysis462" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1332">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1137" />
 <bp:stepProcess rdf:resource="#Catalysis463" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1331">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1338">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1142" />
 <bp:stepProcess rdf:resource="#Catalysis465" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1337">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1141" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1339">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1143" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1138" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1333">
 <bp:stepProcess rdf:resource="#Pathway197" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1336">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1140" />
 <bp:stepProcess rdf:resource="#Catalysis464" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1335">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1139" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1321">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1320">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1125" />
 <bp:stepProcess rdf:resource="#Catalysis458" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1327">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1132" />
 <bp:stepProcess rdf:resource="#Catalysis460" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1326">
 <bp:stepProcess rdf:resource="#Catalysis459" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1329">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1134" />
 <bp:stepProcess rdf:resource="#Catalysis461" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1328">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1133" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1323">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1322">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1325">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1130" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1324">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1319">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1124" />
 <bp:stepProcess rdf:resource="#Catalysis457" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis223">
 <bp:controlled rdf:resource="#BiochemicalReaction460" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1040">
 <bp:evidence rdf:resource="#Evidence1228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of CRKII:DOCK180:ELMO complex to FCGR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis224">
 <bp:controlled rdf:resource="#BiochemicalReaction462" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1041">
 <bp:evidence rdf:resource="#Evidence1229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-ERK phosphorylates WAVEs and ABI</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis221">
 <bp:controlled rdf:resource="#BiochemicalReaction458" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis222">
 <bp:controlled rdf:resource="#BiochemicalReaction459" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis220">
 <bp:controlled rdf:resource="#BiochemicalReaction457" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1048">
 <bp:evidence rdf:resource="#Evidence1236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of cofilin by LIMK-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1049">
 <bp:evidence rdf:resource="#Evidence1237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PAK1 phosphorylates LIMK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis218">
 <bp:controlled rdf:resource="#BiochemicalReaction455" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1046">
 <bp:evidence rdf:resource="#Evidence1234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1:GTP and PIP3 bind WAVE Regulatory Complex (WRC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1115" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis219">
 <bp:controlled rdf:resource="#BiochemicalReaction456" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1047">
 <bp:evidence rdf:resource="#Evidence1235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Extension of pseudopodia by myosin-X in a PI3K dependent manner</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis216">
 <bp:controlled rdf:resource="#BiochemicalReaction453" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1044">
 <bp:evidence rdf:resource="#Evidence1232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1 by CRKII:DOCK180:ELMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis217">
 <bp:controlled rdf:resource="#BiochemicalReaction454" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1045">
 <bp:evidence rdf:resource="#Evidence1233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WASPs or WAVEs activate the ARP2/3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis214">
 <bp:controlled rdf:resource="#BiochemicalReaction451" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1042">
 <bp:evidence rdf:resource="#Evidence1230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Src phosphorylate WASP,N-WASP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis215">
 <bp:controlled rdf:resource="#BiochemicalReaction452" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1043">
 <bp:evidence rdf:resource="#Evidence1231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">(WASPs, WAVE):G-actin:ARP2/3 binds F-actin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1316">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1315">
 <bp:stepProcess rdf:resource="#Catalysis456" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1318">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1317">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1312">
 <bp:stepProcess rdf:resource="#Catalysis454" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1117" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1311">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1314">
 <bp:stepProcess rdf:resource="#Catalysis455" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1119" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1118" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1309">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1308">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1113" />
 <bp:stepProcess rdf:resource="#Catalysis453" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis212">
 <bp:controlled rdf:resource="#BiochemicalReaction449" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1051">
 <bp:evidence rdf:resource="#Evidence1239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RAC1 and CDC42 activate PAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis213">
 <bp:controlled rdf:resource="#BiochemicalReaction450" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1052">
 <bp:evidence rdf:resource="#Evidence1240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis210">
 <bp:controlled rdf:resource="#BiochemicalReaction446" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis211">
 <bp:controlled rdf:resource="#BiochemicalReaction447" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1050">
 <bp:evidence rdf:resource="#Evidence1238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of VAV1 to p-6Y-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis209">
 <bp:controlled rdf:resource="#BiochemicalReaction445" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1059">
 <bp:evidence rdf:resource="#Evidence1247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">An unknown GEF exchanges GTP for GDP on CDC42:GDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis207">
 <bp:controlled rdf:resource="#BiochemicalReaction441" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1057">
 <bp:evidence rdf:resource="#Evidence1245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transphosphorylation of pLIMK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis208">
 <bp:controlled rdf:resource="#BiochemicalReaction442" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1058">
 <bp:evidence rdf:resource="#Evidence1246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Role of myosins in phagosome formation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis205">
 <bp:controlled rdf:resource="#BiochemicalReaction438" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1055">
 <bp:evidence rdf:resource="#Evidence1243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1 by VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis206">
 <bp:controlled rdf:resource="#BiochemicalReaction440" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1056">
 <bp:evidence rdf:resource="#Evidence1244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">WIP binds WASP,N-WASP, activating them</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis203">
 <bp:controlled rdf:resource="#BiochemicalReaction435" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1053">
 <bp:evidence rdf:resource="#Evidence1241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ABL phosphorylates WAVEs</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis204">
 <bp:controlled rdf:resource="#BiochemicalReaction437" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1054">
 <bp:evidence rdf:resource="#Evidence1242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1305">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1111" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1304">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1110" />
 <bp:stepProcess rdf:resource="#Catalysis452" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1307">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1112" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1306">
 <bp:stepProcess rdf:resource="#Pathway196" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1301">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1107" />
 <bp:stepProcess rdf:resource="#Catalysis450" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1300">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1106" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1303">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1109" />
 <bp:stepProcess rdf:resource="#Catalysis451" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1302">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1108" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis201">
 <bp:controlled rdf:resource="#BiochemicalReaction430" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis202">
 <bp:controlled rdf:resource="#BiochemicalReaction434" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis200">
 <bp:controlled rdf:resource="#BiochemicalReaction425" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1026">
 <bp:evidence rdf:resource="#Evidence1210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGLYRP1 binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1027">
 <bp:evidence rdf:resource="#Evidence1211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REG3A,REG3G binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1024">
 <bp:evidence rdf:resource="#Evidence1208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">EPPIN protein complex binds bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1025">
 <bp:evidence rdf:resource="#Evidence1209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLA2G2A binds bacterial phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1022">
 <bp:evidence rdf:resource="#Evidence1206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PGLYRP3,4 binds bacterial peptidoglycan</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1023">
 <bp:evidence rdf:resource="#Evidence1207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNASEs bind bacterial phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1020">
 <bp:evidence rdf:resource="#Evidence1204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNLY binds the bacterial cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1021">
 <bp:evidence rdf:resource="#Evidence1205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRTN3 cleaves CAMP(31-170) to generate CAMP(134-170)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1028">
 <bp:evidence rdf:resource="#Evidence1212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYZ hydrolyzes peptidoglycans in the bacterial cell wall</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1029">
 <bp:evidence rdf:resource="#Evidence1213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HTN5, (HTN1, HTN3) binds fungal SSA1/SSA2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1030">
 <bp:evidence rdf:resource="#Evidence1214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ELANE, CTSG or PRTN3 binds bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1037">
 <bp:evidence rdf:resource="#Evidence1224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SYK by Src kinases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1038">
 <bp:evidence rdf:resource="#Evidence1225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of SYK to phosphorylated ITAMs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1035">
 <bp:evidence rdf:resource="#Evidence1222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sequestering and phosphorylation Fc gamma receptors in the lipid rafts</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1036">
 <bp:evidence rdf:resource="#Evidence1223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-linking of FCGRIIA with IgG-coated Ag</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1033">
 <bp:evidence rdf:resource="#Evidence1218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRAMP1 transports divalent metal ions across phagosomal membranes of macrophages</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1034">
 <bp:evidence rdf:resource="#Evidence1221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-linking of FCGRIIIA with IgG-coated Ag</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1031">
 <bp:evidence rdf:resource="#Evidence1215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GNLY binds the bacterial cell surface in the phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1032">
 <bp:evidence rdf:resource="#Evidence1217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATP7A transports cytosolic Cu2+ to phagosomal lumen</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1039">
 <bp:evidence rdf:resource="#Evidence1226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-linking of FCGRIA with IgG-coated Ag</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction488">
 <bp:evidence rdf:resource="#Evidence592" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex upon TLR7/8 or 9 stimulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction487">
 <bp:evidence rdf:resource="#Evidence591" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization initiated from endosomal compartments</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction489">
 <bp:evidence rdf:resource="#Evidence593" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 at endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction491">
 <bp:evidence rdf:resource="#Evidence595" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon TLR stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction490">
 <bp:evidence rdf:resource="#Evidence594" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3  upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction493">
 <bp:evidence rdf:resource="#Evidence598" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1 upon TLR7/8 or 9 activation&lt;br&gt;</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction492">
 <bp:evidence rdf:resource="#Evidence597" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino upon TLR7/8 or 9 activation </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction495">
 <bp:evidence rdf:resource="#Evidence600" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1 upon stimulation of TLR7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction494">
 <bp:evidence rdf:resource="#Evidence599" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction497">
 <bp:evidence rdf:resource="#Evidence605" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction496">
 <bp:evidence rdf:resource="#Evidence601" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1510">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1296" />
 <bp:stepProcess rdf:resource="#Catalysis519" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1512">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1298" />
 <bp:stepProcess rdf:resource="#Catalysis520" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1511">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1297" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1507">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1293" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1506">
 <bp:stepProcess rdf:resource="#Catalysis517" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1292" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1509">
 <bp:stepProcess rdf:resource="#Catalysis518" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1295" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1508">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1294" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction477">
 <bp:evidence rdf:resource="#Evidence580" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction476">
 <bp:evidence rdf:resource="#Evidence579" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction479">
 <bp:evidence rdf:resource="#Evidence582" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction478">
 <bp:evidence rdf:resource="#Evidence581" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction480">
 <bp:evidence rdf:resource="#Evidence583" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction482">
 <bp:evidence rdf:resource="#Evidence585" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction481">
 <bp:evidence rdf:resource="#Evidence584" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction484">
 <bp:evidence rdf:resource="#Evidence587" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction483">
 <bp:evidence rdf:resource="#Evidence586" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction486">
 <bp:evidence rdf:resource="#Evidence589" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction485">
 <bp:evidence rdf:resource="#Evidence588" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1503">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1289" />
 <bp:stepProcess rdf:resource="#Catalysis516" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1502">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1505">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1291" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1504">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1290" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1501">
 <bp:stepProcess rdf:resource="#Catalysis515" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1287" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1500">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1286" />
 <bp:stepProcess rdf:resource="#Catalysis514" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction466">
 <bp:evidence rdf:resource="#Evidence567" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1183">
 <bp:evidence rdf:resource="#Evidence1389" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,4S-IRF3 is dimerized</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction465">
 <bp:evidence rdf:resource="#Evidence566" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1184">
 <bp:evidence rdf:resource="#Evidence1390" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment TBK1 to dsDNA:ZBP1 followed by its activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction468">
 <bp:evidence rdf:resource="#Evidence569" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1181">
 <bp:evidence rdf:resource="#Evidence1385" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AIM2 binds dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction467">
 <bp:evidence rdf:resource="#Evidence568" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1182">
 <bp:evidence rdf:resource="#Evidence1388" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction469">
 <bp:evidence rdf:resource="#Evidence570" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1/or IRAK2:TRAF6-oligomer from the p-IRAK4 :oligo-Myd88:activated TLR7/8 or 9 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1180">
 <bp:evidence rdf:resource="#Evidence1384" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING dimerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction471">
 <bp:evidence rdf:resource="#Evidence573" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1189">
 <bp:evidence rdf:resource="#Evidence1396" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKK Complex phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction470">
 <bp:evidence rdf:resource="#Evidence572" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction473">
 <bp:evidence rdf:resource="#Evidence576" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1187">
 <bp:evidence rdf:resource="#Evidence1393" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IRF3 to activated ZBP1:TBK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction472">
 <bp:evidence rdf:resource="#Evidence575" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1188">
 <bp:evidence rdf:resource="#Evidence1394" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZBP1 binds cytosolic DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction475">
 <bp:evidence rdf:resource="#Evidence578" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1185">
 <bp:evidence rdf:resource="#Evidence1391" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 binds amlexanox</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction474">
 <bp:evidence rdf:resource="#Evidence577" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1186">
 <bp:evidence rdf:resource="#Evidence1392" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerized phospho-IRF3 migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction455">
 <bp:evidence rdf:resource="#Evidence555" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1194">
 <bp:evidence rdf:resource="#Evidence1402" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DHX36 binds DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction454">
 <bp:evidence rdf:resource="#Evidence554" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1195">
 <bp:evidence rdf:resource="#Evidence1403" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DHX36 or DHX9 binds MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction457">
 <bp:evidence rdf:resource="#Evidence557" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1192">
 <bp:evidence rdf:resource="#Evidence1399" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZBP1(DAI) recruits RIP1 and RIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction456">
 <bp:evidence rdf:resource="#Evidence556" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1193">
 <bp:evidence rdf:resource="#Evidence1400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNA-PK binds microbial dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction459">
 <bp:evidence rdf:resource="#Evidence559" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1190">
 <bp:evidence rdf:resource="#Evidence1397" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP1 facilitates IKK complex phosphorylation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction458">
 <bp:evidence rdf:resource="#Evidence558" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1191">
 <bp:evidence rdf:resource="#Evidence1398" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFkB complex translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction460">
 <bp:evidence rdf:resource="#Evidence560" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction462">
 <bp:evidence rdf:resource="#Evidence563" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1198">
 <bp:evidence rdf:resource="#Evidence1406" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFkB complex translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction461">
 <bp:evidence rdf:resource="#Evidence562" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1199">
 <bp:evidence rdf:resource="#Evidence1407" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA polymerase III transcribes microbial dsDNA to dsRNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction464">
 <bp:evidence rdf:resource="#Evidence565" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1196">
 <bp:evidence rdf:resource="#Evidence1404" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-IRF7:p-IRF7 translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction463">
 <bp:evidence rdf:resource="#Evidence564" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1197">
 <bp:evidence rdf:resource="#Evidence1405" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DHX9 binds DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction444">
 <bp:evidence rdf:resource="#Evidence541" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction443">
 <bp:evidence rdf:resource="#Evidence538" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction446">
 <bp:evidence rdf:resource="#Evidence543" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction445">
 <bp:evidence rdf:resource="#Evidence542" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction448">
 <bp:evidence rdf:resource="#Evidence545" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction447">
 <bp:evidence rdf:resource="#Evidence544" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction449">
 <bp:evidence rdf:resource="#Evidence547" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction451">
 <bp:evidence rdf:resource="#Evidence549" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction450">
 <bp:evidence rdf:resource="#Evidence548" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction453">
 <bp:evidence rdf:resource="#Evidence552" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction452">
 <bp:evidence rdf:resource="#Evidence550" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction433">
 <bp:evidence rdf:resource="#Evidence524" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR7/8 or 9 receptor:MyD88 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction432">
 <bp:evidence rdf:resource="#Evidence523" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1/or p-IRAK2:p-IRAK4:MyD88:activated TLR7/8 or 9  </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction435">
 <bp:evidence rdf:resource="#Evidence526" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction434">
 <bp:evidence rdf:resource="#Evidence525" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps within the complex pIRAK4:MyD88:activated TLR7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction437">
 <bp:evidence rdf:resource="#Evidence531" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction436">
 <bp:evidence rdf:resource="#Evidence530" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction439">
 <bp:evidence rdf:resource="#Evidence534" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction438">
 <bp:evidence rdf:resource="#Evidence532" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction440">
 <bp:evidence rdf:resource="#Evidence535" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction442">
 <bp:evidence rdf:resource="#Evidence537" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction441">
 <bp:evidence rdf:resource="#Evidence536" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction429">
 <bp:evidence rdf:resource="#Evidence520" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction422">
 <bp:evidence rdf:resource="#Evidence512" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction421">
 <bp:evidence rdf:resource="#Evidence511" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to MyD88: activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction424">
 <bp:evidence rdf:resource="#Evidence514" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1/or IRAK2 binds to the activated IRAK4 :MyD88:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction423">
 <bp:evidence rdf:resource="#Evidence513" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR 7/8 or 9 : MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction426">
 <bp:evidence rdf:resource="#Evidence517" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF7 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction425">
 <bp:evidence rdf:resource="#Evidence515" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:activated TLR 7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction428">
 <bp:evidence rdf:resource="#Evidence519" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of p-IRF7:p-IRF7 to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction427">
 <bp:evidence rdf:resource="#Evidence518" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 interacts with IRF7 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction431">
 <bp:evidence rdf:resource="#Evidence522" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 interacts with the activated TLR receptor 7, 8 or 9 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction430">
 <bp:evidence rdf:resource="#Evidence521" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 ubiquitinqtes IRF7 within the activated TLR7/8 or 9 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction419">
 <bp:evidence rdf:resource="#Evidence508" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-ter TLR9 dimer binds HCQ</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction418">
 <bp:evidence rdf:resource="#Evidence507" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Engulfed CpG DNA binds to endosomal C-ter TLR9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction411">
 <bp:evidence rdf:resource="#Evidence500" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASL is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction410">
 <bp:evidence rdf:resource="#Evidence498" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rab5-mediated recruitment of class III PI3K to TLR9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction413">
 <bp:evidence rdf:resource="#Evidence502" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TASL recruits IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction412">
 <bp:evidence rdf:resource="#Evidence501" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-S446-IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction415">
 <bp:evidence rdf:resource="#Evidence504" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC15A4 binds TASL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction414">
 <bp:evidence rdf:resource="#Evidence503" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated IKBKB phosphorylates IRF5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction417">
 <bp:evidence rdf:resource="#Evidence506" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Engulfed CpG DNA binds to endosomal N-ter TLR9 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction416">
 <bp:evidence rdf:resource="#Evidence505" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S446-IRF5 dimer translocates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction420">
 <bp:evidence rdf:resource="#Evidence509" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Engulfed CpG DNA binds to endosomal full-length TLR9</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep505">
 <bp:stepProcess rdf:resource="#BiochemicalReaction417" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep506">
 <bp:stepProcess rdf:resource="#BiochemicalReaction418" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep507">
 <bp:stepProcess rdf:resource="#BiochemicalReaction419" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep508">
 <bp:stepProcess rdf:resource="#BiochemicalReaction420" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep501">
 <bp:stepProcess rdf:resource="#BiochemicalReaction413" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence790">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep502">
 <bp:stepProcess rdf:resource="#Catalysis197" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction414" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep503">
 <bp:stepProcess rdf:resource="#BiochemicalReaction415" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep504">
 <bp:stepProcess rdf:resource="#BiochemicalReaction416" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence794">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence793">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence792">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence791">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep509">
 <bp:stepProcess rdf:resource="#Pathway90" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence798">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence797">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence796">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence795">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence799">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep500">
 <bp:stepProcess rdf:resource="#BiochemicalReaction412" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep516">
 <bp:stepProcess rdf:resource="#BiochemicalReaction426" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep517">
 <bp:stepProcess rdf:resource="#BiochemicalReaction427" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep518">
 <bp:stepProcess rdf:resource="#BiochemicalReaction428" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep519">
 <bp:stepProcess rdf:resource="#BiochemicalReaction429" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep512">
 <bp:stepProcess rdf:resource="#BiochemicalReaction423" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep513">
 <bp:stepProcess rdf:resource="#BiochemicalReaction424" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep514">
 <bp:stepProcess rdf:resource="#Catalysis200" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction425" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep515">
 <bp:stepProcess rdf:resource="#Pathway91" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence783">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence782">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence781">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence780">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence787">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence786">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence785">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence784">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence789">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence788">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep510">
 <bp:stepProcess rdf:resource="#BiochemicalReaction421" />
 <bp:stepProcess rdf:resource="#Catalysis198" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep511">
 <bp:stepProcess rdf:resource="#BiochemicalReaction422" />
 <bp:stepProcess rdf:resource="#Catalysis199" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep527">
 <bp:stepProcess rdf:resource="#Pathway93" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep528">
 <bp:stepProcess rdf:resource="#Pathway94" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep529">
 <bp:stepProcess rdf:resource="#BiochemicalReaction436" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep523">
 <bp:stepProcess rdf:resource="#BiochemicalReaction433" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep524">
 <bp:stepProcess rdf:resource="#Catalysis202" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction434" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep525">
 <bp:stepProcess rdf:resource="#Catalysis203" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction435" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep526">
 <bp:stepProcess rdf:resource="#Pathway92" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence772">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence771">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence770">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence776">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence775">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence774">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence773">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence779">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence778">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence777">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep520">
 <bp:stepProcess rdf:resource="#BiochemicalReaction430" />
 <bp:stepProcess rdf:resource="#Catalysis201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep521">
 <bp:stepProcess rdf:resource="#BiochemicalReaction431" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep522">
 <bp:stepProcess rdf:resource="#BiochemicalReaction432" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis193">
 <bp:controlled rdf:resource="#BiochemicalReaction402" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep538">
 <bp:stepProcess rdf:resource="#Pathway96" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis194">
 <bp:controlled rdf:resource="#BiochemicalReaction404" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep539">
 <bp:stepProcess rdf:resource="#Pathway97" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1109">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis191">
 <bp:controlled rdf:resource="#BiochemicalReaction398" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis192">
 <bp:controlled rdf:resource="#BiochemicalReaction399" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep534">
 <bp:stepProcess rdf:resource="#BiochemicalReaction440" />
 <bp:stepProcess rdf:resource="#Catalysis206" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis190">
 <bp:controlled rdf:resource="#BiochemicalReaction396" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep535">
 <bp:stepProcess rdf:resource="#Catalysis207" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction441" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep536">
 <bp:stepProcess rdf:resource="#Catalysis208" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction442" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep537">
 <bp:stepProcess rdf:resource="#BiochemicalReaction443" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence761">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence760">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis199">
 <bp:controlled rdf:resource="#BiochemicalReaction422" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis197">
 <bp:controlled rdf:resource="#BiochemicalReaction414" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence765">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis198">
 <bp:controlled rdf:resource="#BiochemicalReaction421" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence764">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis195">
 <bp:controlled rdf:resource="#BiochemicalReaction405" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence763">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis196">
 <bp:controlled rdf:resource="#BiochemicalReaction406" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence762">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence769">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence768">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence767">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence766">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1100">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep530">
 <bp:stepProcess rdf:resource="#Catalysis204" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction437" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1102">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep531">
 <bp:stepProcess rdf:resource="#Catalysis205" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction438" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1101">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep532">
 <bp:stepProcess rdf:resource="#Pathway95" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1104">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep533">
 <bp:stepProcess rdf:resource="#BiochemicalReaction439" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1103">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1106">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1105">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1108">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1107">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence750">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence754">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence753">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence752">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence751">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence758">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence757">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence756">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence755">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence759">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction7">
 <bp:evidence rdf:resource="#Evidence10" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Full-length TLR3/7/8/9 binds to UNC93B1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction8">
 <bp:evidence rdf:resource="#Evidence12" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Flagellin binds to TLR5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction9">
 <bp:evidence rdf:resource="#Evidence15" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction3">
 <bp:evidence rdf:resource="#Evidence6" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Folded full-length TLR7/8/9 dissociates from the GP96:CNPY3 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction4">
 <bp:evidence rdf:resource="#Evidence7" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">UNC93B1 delivers endosomal full-length TLRs to endolysosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction5">
 <bp:evidence rdf:resource="#Evidence8" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR folding by chaperones GP96 and CNPY3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction6">
 <bp:evidence rdf:resource="#Evidence9" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR processing at low pH</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1">
 <bp:evidence rdf:resource="#Evidence4" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endosomal TLRs pass through the Golgi</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction2">
 <bp:evidence rdf:resource="#Evidence5" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR9 processing at neutral pH</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence743">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence742">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence741">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence740">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence747">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence746">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence745">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence744">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence749">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence748">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence732">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence731">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence730">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence736">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence735">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence734">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence733">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence739">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence738">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence737">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction499">
 <bp:evidence rdf:resource="#Evidence607" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction498">
 <bp:evidence rdf:resource="#Evidence606" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence721">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence720">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence725">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence724">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence723">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence722">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence729">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence728">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence727">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence726">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep468">
 <bp:stepProcess rdf:resource="#Pathway85" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep469">
 <bp:stepProcess rdf:resource="#BiochemicalReaction385" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis146">
 <bp:controlled rdf:resource="#BiochemicalReaction286" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis147">
 <bp:controlled rdf:resource="#BiochemicalReaction291" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis144">
 <bp:controlled rdf:resource="#BiochemicalReaction281" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis145">
 <bp:controlled rdf:resource="#BiochemicalReaction284" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis142">
 <bp:controlled rdf:resource="#BiochemicalReaction272" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence831">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis143">
 <bp:controlled rdf:resource="#BiochemicalReaction274" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence830">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis140">
 <bp:controlled rdf:resource="#BiochemicalReaction270" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis141">
 <bp:controlled rdf:resource="#BiochemicalReaction271" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence835">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence834">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence833">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1030">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence832">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis139">
 <bp:controlled rdf:resource="#BiochemicalReaction268" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence839">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1032">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence838">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1031">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis137">
 <bp:controlled rdf:resource="#BiochemicalReaction266" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence837">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1034">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis138">
 <bp:controlled rdf:resource="#BiochemicalReaction267" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence836">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1033">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep464">
 <bp:stepProcess rdf:resource="#BiochemicalReaction382" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1036">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep465">
 <bp:stepProcess rdf:resource="#Pathway84" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1035">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep466">
 <bp:stepProcess rdf:resource="#BiochemicalReaction383" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1038">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep467">
 <bp:stepProcess rdf:resource="#BiochemicalReaction384" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1037">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep460">
 <bp:stepProcess rdf:resource="#BiochemicalReaction378" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep461">
 <bp:stepProcess rdf:resource="#BiochemicalReaction379" />
 <bp:stepProcess rdf:resource="#Catalysis186" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1039">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep462">
 <bp:stepProcess rdf:resource="#BiochemicalReaction380" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep463">
 <bp:stepProcess rdf:resource="#BiochemicalReaction381" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep479">
 <bp:stepProcess rdf:resource="#BiochemicalReaction395" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis135">
 <bp:controlled rdf:resource="#BiochemicalReaction264" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis136">
 <bp:controlled rdf:resource="#BiochemicalReaction265" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis133">
 <bp:controlled rdf:resource="#BiochemicalReaction262" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis134">
 <bp:controlled rdf:resource="#BiochemicalReaction263" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis131">
 <bp:controlled rdf:resource="#BiochemicalReaction260" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence820">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis132">
 <bp:controlled rdf:resource="#BiochemicalReaction261" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis130">
 <bp:controlled rdf:resource="#BiochemicalReaction259" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence824">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence823">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence822">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1041">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep470">
 <bp:stepProcess rdf:resource="#BiochemicalReaction386" />
 <bp:stepProcess rdf:resource="#Catalysis187" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence821">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1040">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis128">
 <bp:controlled rdf:resource="#BiochemicalReaction257" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence828">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1043">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis129">
 <bp:controlled rdf:resource="#BiochemicalReaction258" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence827">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1042">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis126">
 <bp:controlled rdf:resource="#BiochemicalReaction254" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence826">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1045">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis127">
 <bp:controlled rdf:resource="#BiochemicalReaction255" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence825">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1044">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep475">
 <bp:stepProcess rdf:resource="#BiochemicalReaction391" />
 <bp:stepProcess rdf:resource="#Catalysis189" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1047">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep476">
 <bp:stepProcess rdf:resource="#BiochemicalReaction392" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1046">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep477">
 <bp:stepProcess rdf:resource="#BiochemicalReaction393" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1049">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep478">
 <bp:stepProcess rdf:resource="#BiochemicalReaction394" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence829">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1048">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep471">
 <bp:stepProcess rdf:resource="#BiochemicalReaction387" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep472">
 <bp:stepProcess rdf:resource="#BiochemicalReaction388" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep473">
 <bp:stepProcess rdf:resource="#BiochemicalReaction389" />
 <bp:stepProcess rdf:resource="#Catalysis188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep474">
 <bp:stepProcess rdf:resource="#BiochemicalReaction390" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway2">
 <bp:pathwayOrder rdf:resource="#PathwayStep392" />
 <bp:pathwayOrder rdf:resource="#PathwayStep688" />
 <bp:pathwayOrder rdf:resource="#PathwayStep601" />
 <bp:pathwayOrder rdf:resource="#PathwayStep2" />
 <bp:pathwayOrder rdf:resource="#PathwayStep10" />
 <bp:pathwayOrder rdf:resource="#PathwayStep877" />
 <bp:pathwayOrder rdf:resource="#PathwayStep97" />
 <bp:pathwayOrder rdf:resource="#PathwayStep295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep496" />
 <bp:pathwayComponent rdf:resource="#Pathway3" />
 <bp:pathwayComponent rdf:resource="#Pathway4" />
 <bp:pathwayComponent rdf:resource="#Pathway88" />
 <bp:pathwayComponent rdf:resource="#Pathway152" />
 <bp:pathwayComponent rdf:resource="#Pathway53" />
 <bp:pathwayComponent rdf:resource="#Pathway121" />
 <bp:pathwayComponent rdf:resource="#Pathway19" />
 <bp:pathwayComponent rdf:resource="#Pathway70" />
 <bp:pathwayComponent rdf:resource="#Pathway106" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence2" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll-like Receptor Cascades</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In human, ten members of the Toll-like receptor (TLR) family (TLR1-TLR10) have been identified (TLR11 has been found in mouse, but not in human). All TLRs have a similar Toll/IL-1 receptor (TIR) domain in their cytoplasmic region and an Ig-like domain in the extracellular region, where each is enriched with a varying number of leucine-rich repeats (LRRs). Each TLR can recognize specific microbial pathogen components. The binding pathogenic component to TLR initializes signaling pathways that lead to induction of Interferon alpha/beta and inflammatory cytokines. There are two main signaling pathways. The first is a MyD88-dependent pathway that is common to all TLRs, except TLR3; the second is a TRIF(TICAM1)-dependent pathway that is peculiar to TLR3 and TLR4. TLR4-mediated signaling pathway via TRIF requires adapter molecule TRAM (TRIF-related adapter molecule or TICAM2). TRAM is thought to bridge between the activated TLR4 complex and TRIF.(Takeda    Akira 2004; Akira 2003; Takeda    Akira 2005; Kawai 2005; Heine    Ulmer 2005). This pathway is organized as trafficking and processing of TLR, various TLR cascades (TLR10,TLR3,TLR5,TLR7/8,TLR9,TLR4,TLR2) and their regulation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway3">
 <bp:pathwayOrder rdf:resource="#PathwayStep4" />
 <bp:pathwayOrder rdf:resource="#PathwayStep5" />
 <bp:pathwayOrder rdf:resource="#PathwayStep3" />
 <bp:pathwayOrder rdf:resource="#PathwayStep8" />
 <bp:pathwayOrder rdf:resource="#PathwayStep9" />
 <bp:pathwayOrder rdf:resource="#PathwayStep6" />
 <bp:pathwayOrder rdf:resource="#PathwayStep7" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction2" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction7" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction3" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction4" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction5" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction6" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence3" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trafficking and processing of endosomal TLR</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mammalian TLR3, TLR7, TLR8, TLR9 are endosomal receptors that sense nucleic acids that have been released from endocytosed/phagocytosed bacteria, viruses or parasites. These TLRs have a ligand-recognition domain that faces the lumen of the endosome (which is topologically equivalent to the outside of the cell), a transmembrane domain, and a signaling domain that faces the cytosol. Under normal conditions, self nucleic acids are not recognized by TLRs due to multiple levels of regulation including receptor compartmentalization, trafficking and proteolytic processing (Barton GM et al 2006, Ewald SE et al 2008). At steady state TLR3, TLR7, TLR8, TLR9 reside primarily in the endoplasmic reticulum (ER), however, their activation by specific ligands only occurs within acidified endolysosomal compartments (Hacker H et al 1998, Funami K et al 2004, Gibbard RJ et al 2006). Several chaperon proteins associate with TLRs in the ER to provide efficient translocation to endolysosome. Upon reaching endolysosomal compartments the ectodomains of TLR7 and TLR9 are proteolytically cleaved by cysteine endoproteases. Both full-length and cleaved C-terminus of TLR9 bind CpG-oligodeoxynucleotides, however it has been proposed that only the processed receptor is functional.  Although similar cleavage of TLR3 has been reported by Ewald et al 2011, other studies demonstrated that the N-terminal region of TLR3 ectodomain was implicated in ligand binding, thus TLR3 may function as a full-length receptor (Liu L et al 2008, Tokisue T et al 2008).  There are no data on TLR8 processing, although the cell biology of TLR8 is probably similar to TLR9 and TLR7 (Gibbard RJ et al 2006, Wei T et al 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway4">
 <bp:pathwayOrder rdf:resource="#PathwayStep12" />
 <bp:pathwayOrder rdf:resource="#PathwayStep11" />
 <bp:pathwayComponent rdf:resource="#Pathway5" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction8" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence11" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 5 (TLR5) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR5 is the receptor for flagellin, the protein that forms bacterial flagella. Unlike most other Pathogen-Associated Molecular Patterns (PAMPs), flagellin does not undergo any posttranslational modifications that would distinguish it from cellular proteins. However, flagellin is extremely conserved at its amino- and carboxyl-termini, which presumably explains why it was selected as a ligand for innate immune recognition. TLR5 is expressed on epithelial cells as well as on macrophages and dendritic cells. Expression of TLR5 on intestinal epithelium is polarized such that TLR5 is expressed only on the basolateral side of the cell, as pathogenic but not commensal microbes cross the epithelial barrier. This ensures that innate immune responses are confined to pathogenic but not commensal microbes (Paul 2004; Hayashi et al. 2001; Gewirtz et al. 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway5">
 <bp:pathwayOrder rdf:resource="#PathwayStep90" />
 <bp:pathwayOrder rdf:resource="#PathwayStep41" />
 <bp:pathwayOrder rdf:resource="#PathwayStep96" />
 <bp:pathwayOrder rdf:resource="#PathwayStep40" />
 <bp:pathwayOrder rdf:resource="#PathwayStep89" />
 <bp:pathwayOrder rdf:resource="#PathwayStep44" />
 <bp:pathwayOrder rdf:resource="#PathwayStep88" />
 <bp:pathwayOrder rdf:resource="#PathwayStep43" />
 <bp:pathwayOrder rdf:resource="#PathwayStep87" />
 <bp:pathwayOrder rdf:resource="#PathwayStep20" />
 <bp:pathwayOrder rdf:resource="#PathwayStep42" />
 <bp:pathwayOrder rdf:resource="#PathwayStep86" />
 <bp:pathwayOrder rdf:resource="#PathwayStep13" />
 <bp:pathwayOrder rdf:resource="#PathwayStep19" />
 <bp:pathwayOrder rdf:resource="#PathwayStep18" />
 <bp:pathwayOrder rdf:resource="#PathwayStep39" />
 <bp:pathwayComponent rdf:resource="#Pathway6" />
 <bp:pathwayComponent rdf:resource="#Pathway7" />
 <bp:pathwayComponent rdf:resource="#Pathway9" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction71" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction70" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction73" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction72" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction13" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction35" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction79" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction34" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction14" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction36" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction33" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction32" />
 <bp:pathwayComponent rdf:resource="#Pathway18" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence13" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mammalian myeloid differentiation factor 88 (MyD88) is Toll/interleukin (IL)-1 (TIR)-domain containing adapter  protein which plays crucial role in TLR signaling. All TLRs, with only one exception of TLR3, can initiate downstream  signaling trough MyD88. In the MyD88 - dependent pathway, once the adaptor is bound to TLR  it leads to recruitment of IL1 receptor associated kinase family  IRAK which is followed by activation of tumour necrosis factor receptor-associated factor 6 (TRAF6) . TRAF6 is an ubiquitin E3 ligase which in turn induces TGF-beta activating kinase 1 (TAK1) auto phosphorylation. Once activated TAK1 can ultimately mediate the induction of the transcription factor NF-kB or the mitogen-activated protein kinases  (MAPK), such as JNK, p38 and ERK. This results in the translocation of the activated NF-kB and MAPKs to the nucleus and the initiation of appropriate gene transcription leading to the production of many proinflammatory cytokines and antimicrobial peptides.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway6">
 <bp:pathwayOrder rdf:resource="#PathwayStep16" />
 <bp:pathwayOrder rdf:resource="#PathwayStep15" />
 <bp:pathwayOrder rdf:resource="#PathwayStep14" />
 <bp:pathwayOrder rdf:resource="#PathwayStep17" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction12" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction11" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction10" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction9" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence14" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway7">
 <bp:pathwayOrder rdf:resource="#PathwayStep23" />
 <bp:pathwayOrder rdf:resource="#PathwayStep22" />
 <bp:pathwayOrder rdf:resource="#PathwayStep21" />
 <bp:pathwayOrder rdf:resource="#PathwayStep38" />
 <bp:pathwayOrder rdf:resource="#PathwayStep37" />
 <bp:pathwayOrder rdf:resource="#PathwayStep36" />
 <bp:pathwayOrder rdf:resource="#PathwayStep35" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction15" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction31" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction30" />
 <bp:pathwayComponent rdf:resource="#Pathway8" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction28" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction16" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction29" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence21" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway8">
 <bp:pathwayOrder rdf:resource="#PathwayStep30" />
 <bp:pathwayOrder rdf:resource="#PathwayStep34" />
 <bp:pathwayOrder rdf:resource="#PathwayStep33" />
 <bp:pathwayOrder rdf:resource="#PathwayStep32" />
 <bp:pathwayOrder rdf:resource="#PathwayStep31" />
 <bp:pathwayOrder rdf:resource="#PathwayStep27" />
 <bp:pathwayOrder rdf:resource="#PathwayStep26" />
 <bp:pathwayOrder rdf:resource="#PathwayStep25" />
 <bp:pathwayOrder rdf:resource="#PathwayStep24" />
 <bp:pathwayOrder rdf:resource="#PathwayStep29" />
 <bp:pathwayOrder rdf:resource="#PathwayStep28" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction24" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction23" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction26" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction25" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction20" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction22" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction21" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction17" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction27" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction19" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction18" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence24" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway9">
 <bp:pathwayOrder rdf:resource="#PathwayStep45" />
 <bp:pathwayOrder rdf:resource="#PathwayStep55" />
 <bp:pathwayOrder rdf:resource="#PathwayStep77" />
 <bp:pathwayOrder rdf:resource="#PathwayStep49" />
 <bp:pathwayComponent rdf:resource="#Pathway11" />
 <bp:pathwayComponent rdf:resource="#Pathway12" />
 <bp:pathwayComponent rdf:resource="#Pathway10" />
 <bp:pathwayComponent rdf:resource="#Pathway17" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence45" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis124">
 <bp:controlled rdf:resource="#BiochemicalReaction250" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis125">
 <bp:controlled rdf:resource="#BiochemicalReaction253" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis122">
 <bp:controlled rdf:resource="#BiochemicalReaction248" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis123">
 <bp:controlled rdf:resource="#BiochemicalReaction249" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis120">
 <bp:controlled rdf:resource="#BiochemicalReaction245" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis121">
 <bp:controlled rdf:resource="#BiochemicalReaction246" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway1">
 <bp:pathwayOrder rdf:resource="#PathwayStep1408" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1154" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1096" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep973" />
 <bp:pathwayOrder rdf:resource="#PathwayStep984" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1037" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1443" />
 <bp:pathwayOrder rdf:resource="#PathwayStep891" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1269" />
 <bp:pathwayComponent rdf:resource="#Pathway2" />
 <bp:pathwayComponent rdf:resource="#Pathway209" />
 <bp:pathwayComponent rdf:resource="#Pathway190" />
 <bp:pathwayComponent rdf:resource="#Pathway180" />
 <bp:pathwayComponent rdf:resource="#Pathway191" />
 <bp:pathwayComponent rdf:resource="#Pathway171" />
 <bp:pathwayComponent rdf:resource="#Pathway163" />
 <bp:pathwayComponent rdf:resource="#Pathway153" />
 <bp:pathwayComponent rdf:resource="#Pathway164" />
 <bp:pathwayComponent rdf:resource="#Pathway186" />
 <bp:pathwayComponent rdf:resource="#Pathway198" />
 <bp:pathwayComponent rdf:resource="#Pathway177" />
 <bp:pathwayComponent rdf:resource="#Pathway178" />
 <bp:pathwayComponent rdf:resource="#Pathway211" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Innate Immune System</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Innate immunity encompases the nonspecific part of immunity tha are part of an individual&apos;s natural biologic makeup</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence813">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1050">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence812">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis119">
 <bp:controlled rdf:resource="#BiochemicalReaction238" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep480">
 <bp:stepProcess rdf:resource="#BiochemicalReaction396" />
 <bp:stepProcess rdf:resource="#Catalysis190" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence811">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1052">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep481">
 <bp:stepProcess rdf:resource="#BiochemicalReaction397" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence810">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1051">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis117">
 <bp:controlled rdf:resource="#BiochemicalReaction236" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence817">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1054">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis118">
 <bp:controlled rdf:resource="#BiochemicalReaction237" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence816">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1053">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis115">
 <bp:controlled rdf:resource="#BiochemicalReaction221" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence815">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1056">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis116">
 <bp:controlled rdf:resource="#BiochemicalReaction223" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence814">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1055">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep486">
 <bp:stepProcess rdf:resource="#BiochemicalReaction401" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1058">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep487">
 <bp:stepProcess rdf:resource="#Catalysis193" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction402" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1057">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep488">
 <bp:stepProcess rdf:resource="#BiochemicalReaction403" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence819">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep489">
 <bp:stepProcess rdf:resource="#Catalysis194" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction404" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence818">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1059">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep482">
 <bp:stepProcess rdf:resource="#Catalysis191" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction398" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep483">
 <bp:stepProcess rdf:resource="#Catalysis192" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction399" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep484">
 <bp:stepProcess rdf:resource="#Pathway86" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep485">
 <bp:stepProcess rdf:resource="#BiochemicalReaction400" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis113">
 <bp:controlled rdf:resource="#BiochemicalReaction219" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis114">
 <bp:controlled rdf:resource="#BiochemicalReaction220" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis111">
 <bp:controlled rdf:resource="#BiochemicalReaction216" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis112">
 <bp:controlled rdf:resource="#BiochemicalReaction217" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis110">
 <bp:controlled rdf:resource="#BiochemicalReaction215" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1070">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence802">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1061">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep490">
 <bp:stepProcess rdf:resource="#Pathway87" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence801">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1060">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis108">
 <bp:controlled rdf:resource="#BiochemicalReaction213" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep491">
 <bp:stepProcess rdf:resource="#Catalysis195" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction405" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence800">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1063">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis109">
 <bp:controlled rdf:resource="#BiochemicalReaction214" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep492">
 <bp:stepProcess rdf:resource="#BiochemicalReaction406" />
 <bp:stepProcess rdf:resource="#Catalysis196" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1062">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis106">
 <bp:controlled rdf:resource="#BiochemicalReaction211" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence806">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1065">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis107">
 <bp:controlled rdf:resource="#BiochemicalReaction212" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence805">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1064">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis104">
 <bp:controlled rdf:resource="#BiochemicalReaction209" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence804">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1067">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis105">
 <bp:controlled rdf:resource="#BiochemicalReaction210" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence803">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1066">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep497">
 <bp:stepProcess rdf:resource="#BiochemicalReaction410" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1069">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep498">
 <bp:stepProcess rdf:resource="#Pathway89" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence809">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1068">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep499">
 <bp:stepProcess rdf:resource="#BiochemicalReaction411" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence808">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence807">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep493">
 <bp:stepProcess rdf:resource="#BiochemicalReaction407" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep494">
 <bp:stepProcess rdf:resource="#BiochemicalReaction408" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep495">
 <bp:stepProcess rdf:resource="#BiochemicalReaction409" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep496">
 <bp:stepProcess rdf:resource="#Pathway88" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep428">
 <bp:stepProcess rdf:resource="#BiochemicalReaction352" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis182">
 <bp:controlled rdf:resource="#BiochemicalReaction373" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep429">
 <bp:stepProcess rdf:resource="#BiochemicalReaction353" />
 <bp:stepProcess rdf:resource="#Catalysis165" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis183">
 <bp:controlled rdf:resource="#BiochemicalReaction375" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis180">
 <bp:controlled rdf:resource="#BiochemicalReaction371" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis181">
 <bp:controlled rdf:resource="#BiochemicalReaction372" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep424">
 <bp:stepProcess rdf:resource="#BiochemicalReaction349" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep425">
 <bp:stepProcess rdf:resource="#BiochemicalReaction350" />
 <bp:stepProcess rdf:resource="#Catalysis163" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep426">
 <bp:stepProcess rdf:resource="#BiochemicalReaction351" />
 <bp:stepProcess rdf:resource="#Catalysis164" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep427">
 <bp:stepProcess rdf:resource="#Pathway77" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis188">
 <bp:controlled rdf:resource="#BiochemicalReaction389" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis189">
 <bp:controlled rdf:resource="#BiochemicalReaction391" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis186">
 <bp:controlled rdf:resource="#BiochemicalReaction379" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis187">
 <bp:controlled rdf:resource="#BiochemicalReaction386" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis184">
 <bp:controlled rdf:resource="#BiochemicalReaction376" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis185">
 <bp:controlled rdf:resource="#BiochemicalReaction377" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep96">
 <bp:stepProcess rdf:resource="#BiochemicalReaction79" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep95">
 <bp:stepProcess rdf:resource="#BiochemicalReaction78" />
 <bp:stepProcess rdf:resource="#Catalysis42" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep94">
 <bp:stepProcess rdf:resource="#Catalysis41" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction77" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep93">
 <bp:stepProcess rdf:resource="#BiochemicalReaction76" />
 <bp:stepProcess rdf:resource="#Catalysis40" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep99">
 <bp:stepProcess rdf:resource="#BiochemicalReaction80" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep98">
 <bp:stepProcess rdf:resource="#Pathway20" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep97">
 <bp:stepProcess rdf:resource="#Pathway19" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep420">
 <bp:stepProcess rdf:resource="#BiochemicalReaction348" />
 <bp:stepProcess rdf:resource="#Catalysis162" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep421">
 <bp:stepProcess rdf:resource="#Pathway74" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep422">
 <bp:stepProcess rdf:resource="#Pathway75" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep423">
 <bp:stepProcess rdf:resource="#Pathway76" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep439">
 <bp:stepProcess rdf:resource="#BiochemicalReaction361" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis171">
 <bp:controlled rdf:resource="#BiochemicalReaction362" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis172">
 <bp:controlled rdf:resource="#BiochemicalReaction363" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis170">
 <bp:controlled rdf:resource="#BiochemicalReaction360" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep435">
 <bp:stepProcess rdf:resource="#BiochemicalReaction357" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep436">
 <bp:stepProcess rdf:resource="#Catalysis168" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction358" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep437">
 <bp:stepProcess rdf:resource="#Catalysis169" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction359" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep438">
 <bp:stepProcess rdf:resource="#BiochemicalReaction360" />
 <bp:stepProcess rdf:resource="#Catalysis170" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis179">
 <bp:controlled rdf:resource="#BiochemicalReaction370" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis177">
 <bp:controlled rdf:resource="#BiochemicalReaction368" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis178">
 <bp:controlled rdf:resource="#BiochemicalReaction369" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis175">
 <bp:controlled rdf:resource="#BiochemicalReaction366" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis176">
 <bp:controlled rdf:resource="#BiochemicalReaction367" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis173">
 <bp:controlled rdf:resource="#BiochemicalReaction364" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis174">
 <bp:controlled rdf:resource="#BiochemicalReaction365" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1001">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1000">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep431">
 <bp:stepProcess rdf:resource="#BiochemicalReaction355" />
 <bp:stepProcess rdf:resource="#Catalysis167" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1003">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep432">
 <bp:stepProcess rdf:resource="#BiochemicalReaction356" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1002">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep433">
 <bp:stepProcess rdf:resource="#Pathway78" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1005">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep434">
 <bp:stepProcess rdf:resource="#Pathway79" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1004">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1007">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1006">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1009">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep430">
 <bp:stepProcess rdf:resource="#BiochemicalReaction354" />
 <bp:stepProcess rdf:resource="#Catalysis166" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1008">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis160">
 <bp:controlled rdf:resource="#BiochemicalReaction343" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis161">
 <bp:controlled rdf:resource="#BiochemicalReaction347" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep446">
 <bp:stepProcess rdf:resource="#BiochemicalReaction366" />
 <bp:stepProcess rdf:resource="#Catalysis175" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep447">
 <bp:stepProcess rdf:resource="#Pathway82" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep448">
 <bp:stepProcess rdf:resource="#BiochemicalReaction367" />
 <bp:stepProcess rdf:resource="#Catalysis176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep449">
 <bp:stepProcess rdf:resource="#Catalysis177" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction368" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis168">
 <bp:controlled rdf:resource="#BiochemicalReaction358" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis169">
 <bp:controlled rdf:resource="#BiochemicalReaction359" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis166">
 <bp:controlled rdf:resource="#BiochemicalReaction354" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis167">
 <bp:controlled rdf:resource="#BiochemicalReaction355" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep81">
 <bp:stepProcess rdf:resource="#BiochemicalReaction65" />
 <bp:stepProcess rdf:resource="#Catalysis36" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis164">
 <bp:controlled rdf:resource="#BiochemicalReaction351" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep80">
 <bp:stepProcess rdf:resource="#Catalysis35" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction64" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis165">
 <bp:controlled rdf:resource="#BiochemicalReaction353" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis162">
 <bp:controlled rdf:resource="#BiochemicalReaction348" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis163">
 <bp:controlled rdf:resource="#BiochemicalReaction350" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep74">
 <bp:stepProcess rdf:resource="#BiochemicalReaction59" />
 <bp:stepProcess rdf:resource="#Catalysis31" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1495">
 <bp:stepProcess rdf:resource="#Catalysis511" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1281" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep73">
 <bp:stepProcess rdf:resource="#BiochemicalReaction58" />
 <bp:stepProcess rdf:resource="#Catalysis30" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1494">
 <bp:stepProcess rdf:resource="#Catalysis510" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1280" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep72">
 <bp:stepProcess rdf:resource="#BiochemicalReaction57" />
 <bp:stepProcess rdf:resource="#Catalysis29" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1497">
 <bp:stepProcess rdf:resource="#Catalysis512" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1283" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep71">
 <bp:stepProcess rdf:resource="#BiochemicalReaction56" />
 <bp:stepProcess rdf:resource="#Catalysis28" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1496">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1282" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep78">
 <bp:stepProcess rdf:resource="#BiochemicalReaction62" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1010">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1491">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1278" />
 <bp:stepProcess rdf:resource="#Catalysis509" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep77">
 <bp:stepProcess rdf:resource="#Pathway17" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1490">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1277" />
 <bp:stepProcess rdf:resource="#Catalysis508" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep76">
 <bp:stepProcess rdf:resource="#Catalysis33" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction61" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis159">
 <bp:controlled rdf:resource="#BiochemicalReaction338" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1012">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1493">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1279" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep75">
 <bp:stepProcess rdf:resource="#Catalysis32" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction60" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1011">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1492">
 <bp:stepProcess rdf:resource="#Pathway215" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep442">
 <bp:stepProcess rdf:resource="#Catalysis172" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction363" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1014">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep443">
 <bp:stepProcess rdf:resource="#BiochemicalReaction364" />
 <bp:stepProcess rdf:resource="#Catalysis173" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1013">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep444">
 <bp:stepProcess rdf:resource="#BiochemicalReaction365" />
 <bp:stepProcess rdf:resource="#Catalysis174" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1016">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep79">
 <bp:stepProcess rdf:resource="#Catalysis34" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction63" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep445">
 <bp:stepProcess rdf:resource="#Pathway81" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1015">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1018">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1499">
 <bp:stepProcess rdf:resource="#Catalysis513" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1285" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1017">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1498">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1284" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep440">
 <bp:stepProcess rdf:resource="#Pathway80" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep441">
 <bp:stepProcess rdf:resource="#Catalysis171" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction362" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1019">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis150">
 <bp:controlled rdf:resource="#BiochemicalReaction296" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep457">
 <bp:stepProcess rdf:resource="#Catalysis183" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction375" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep458">
 <bp:stepProcess rdf:resource="#BiochemicalReaction376" />
 <bp:stepProcess rdf:resource="#Catalysis184" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep459">
 <bp:stepProcess rdf:resource="#BiochemicalReaction377" />
 <bp:stepProcess rdf:resource="#Catalysis185" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis157">
 <bp:controlled rdf:resource="#BiochemicalReaction334" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis158">
 <bp:controlled rdf:resource="#BiochemicalReaction335" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis155">
 <bp:controlled rdf:resource="#BiochemicalReaction320" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis156">
 <bp:controlled rdf:resource="#BiochemicalReaction327" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep92">
 <bp:stepProcess rdf:resource="#BiochemicalReaction75" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis153">
 <bp:controlled rdf:resource="#BiochemicalReaction314" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep91">
 <bp:stepProcess rdf:resource="#BiochemicalReaction74" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis154">
 <bp:controlled rdf:resource="#BiochemicalReaction315" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep90">
 <bp:stepProcess rdf:resource="#Pathway18" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis151">
 <bp:controlled rdf:resource="#BiochemicalReaction299" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis152">
 <bp:controlled rdf:resource="#BiochemicalReaction311" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep85">
 <bp:stepProcess rdf:resource="#BiochemicalReaction69" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1484">
 <bp:stepProcess rdf:resource="#Catalysis505" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1271" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep84">
 <bp:stepProcess rdf:resource="#BiochemicalReaction68" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1483">
 <bp:stepProcess rdf:resource="#Catalysis504" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1270" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep83">
 <bp:stepProcess rdf:resource="#BiochemicalReaction67" />
 <bp:stepProcess rdf:resource="#Catalysis37" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1486">
 <bp:stepProcess rdf:resource="#Catalysis507" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep82">
 <bp:stepProcess rdf:resource="#BiochemicalReaction66" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1485">
 <bp:stepProcess rdf:resource="#Catalysis506" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1272" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep89">
 <bp:stepProcess rdf:resource="#BiochemicalReaction73" />
 <bp:stepProcess rdf:resource="#Catalysis39" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1021">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1480">
 <bp:stepProcess rdf:resource="#Pathway214" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep88">
 <bp:stepProcess rdf:resource="#BiochemicalReaction72" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1020">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep87">
 <bp:stepProcess rdf:resource="#BiochemicalReaction71" />
 <bp:stepProcess rdf:resource="#Catalysis38" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis148">
 <bp:controlled rdf:resource="#BiochemicalReaction293" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1023">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1482">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1269" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep86">
 <bp:stepProcess rdf:resource="#BiochemicalReaction70" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis149">
 <bp:controlled rdf:resource="#BiochemicalReaction294" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1022">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1481">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1268" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep453">
 <bp:stepProcess rdf:resource="#BiochemicalReaction372" />
 <bp:stepProcess rdf:resource="#Catalysis181" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1025">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep454">
 <bp:stepProcess rdf:resource="#Catalysis182" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction373" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1024">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep455">
 <bp:stepProcess rdf:resource="#Pathway83" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1027">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep456">
 <bp:stepProcess rdf:resource="#BiochemicalReaction374" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1026">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1029">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1488">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1275" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep450">
 <bp:stepProcess rdf:resource="#BiochemicalReaction369" />
 <bp:stepProcess rdf:resource="#Catalysis178" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1028">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1487">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep451">
 <bp:stepProcess rdf:resource="#BiochemicalReaction370" />
 <bp:stepProcess rdf:resource="#Catalysis179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep452">
 <bp:stepProcess rdf:resource="#Catalysis180" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction371" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1489">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1276" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction408">
 <bp:evidence rdf:resource="#Evidence495" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1 upon stimulation of TLR7/8 or 9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction407">
 <bp:evidence rdf:resource="#Evidence494" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6 upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction409">
 <bp:evidence rdf:resource="#Evidence496" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction400">
 <bp:evidence rdf:resource="#Evidence486" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization initiated from endosomal compartments</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction402">
 <bp:evidence rdf:resource="#Evidence488" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2 at endosome membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction401">
 <bp:evidence rdf:resource="#Evidence487" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex upon TLR7/8 or 9 stimulation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction404">
 <bp:evidence rdf:resource="#Evidence490" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon TLR stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction403">
 <bp:evidence rdf:resource="#Evidence489" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3  upon TLR7/8 or 9 activation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction406">
 <bp:evidence rdf:resource="#Evidence493" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1 upon TLR7/8 or 9 activation&lt;br&gt;</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction405">
 <bp:evidence rdf:resource="#Evidence492" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino upon TLR7/8 or 9 activation </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep52">
 <bp:stepProcess rdf:resource="#BiochemicalReaction42" />
 <bp:stepProcess rdf:resource="#Catalysis17" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1125">
 <bp:evidence rdf:resource="#Evidence1321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 oligomer autoubiquitinates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1473">
 <bp:stepProcess rdf:resource="#Catalysis501" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1261" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep51">
 <bp:stepProcess rdf:resource="#BiochemicalReaction41" />
 <bp:stepProcess rdf:resource="#Catalysis16" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1126">
 <bp:evidence rdf:resource="#Evidence1322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIKA2 binds K63polyUb-TRAF6 oligomer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1472">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1260" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep50">
 <bp:stepProcess rdf:resource="#BiochemicalReaction40" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1123">
 <bp:evidence rdf:resource="#Evidence1319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC-delta is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1475">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1263" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1124">
 <bp:evidence rdf:resource="#Evidence1320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63polyUb-TRAF6 ubiquitinates TAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1474">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep56">
 <bp:stepProcess rdf:resource="#Pathway13" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1121">
 <bp:evidence rdf:resource="#Evidence1317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MALT1 binds BCL10</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep55">
 <bp:stepProcess rdf:resource="#Pathway12" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1122">
 <bp:evidence rdf:resource="#Evidence1318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MALT1 oligomers</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep54">
 <bp:stepProcess rdf:resource="#BiochemicalReaction44" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1471">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1259" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep53">
 <bp:stepProcess rdf:resource="#BiochemicalReaction43" />
 <bp:stepProcess rdf:resource="#Catalysis18" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1120">
 <bp:evidence rdf:resource="#Evidence1316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">1,3-beta-D-glucan:p-Y15-CLEC7A:SYK phosphorylates PLCG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1470">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1258" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep59">
 <bp:stepProcess rdf:resource="#BiochemicalReaction47" />
 <bp:stepProcess rdf:resource="#Catalysis20" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep58">
 <bp:stepProcess rdf:resource="#BiochemicalReaction46" />
 <bp:stepProcess rdf:resource="#Catalysis19" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep57">
 <bp:stepProcess rdf:resource="#BiochemicalReaction45" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1129">
 <bp:evidence rdf:resource="#Evidence1325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y753,Y759-PLCG2 translocates from cytosol to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1477">
 <bp:stepProcess rdf:resource="#Catalysis502" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1265" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1476">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1264" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1127">
 <bp:evidence rdf:resource="#Evidence1323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A binds 1,3-beta-D-glucan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1479">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1267" />
 <bp:stepProcess rdf:resource="#Catalysis503" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1128">
 <bp:evidence rdf:resource="#Evidence1324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CARD9 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1478">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1266" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep70">
 <bp:stepProcess rdf:resource="#BiochemicalReaction55" />
 <bp:stepProcess rdf:resource="#Catalysis27" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep63">
 <bp:stepProcess rdf:resource="#Catalysis22" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction50" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1136">
 <bp:evidence rdf:resource="#Evidence1332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB1:RELA translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1462">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1250" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep62">
 <bp:stepProcess rdf:resource="#Pathway14" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1137">
 <bp:evidence rdf:resource="#Evidence1333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC-delta phosphorylates CARD9</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1461">
 <bp:stepProcess rdf:resource="#Catalysis495" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1249" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep61">
 <bp:stepProcess rdf:resource="#BiochemicalReaction49" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1134">
 <bp:evidence rdf:resource="#Evidence1330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of NEMO by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1464">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1252" />
 <bp:stepProcess rdf:resource="#Catalysis497" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep60">
 <bp:stepProcess rdf:resource="#BiochemicalReaction48" />
 <bp:stepProcess rdf:resource="#Catalysis21" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1135">
 <bp:evidence rdf:resource="#Evidence1331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">beta-TRCP ubiquitinates IkB-alpha in p-S32,33-IkB-alpha:NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1463">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1251" />
 <bp:stepProcess rdf:resource="#Catalysis496" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep67">
 <bp:stepProcess rdf:resource="#Pathway15" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1132">
 <bp:evidence rdf:resource="#Evidence1328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-Y753,Y759-PLCG2 hydrolyses PIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep66">
 <bp:stepProcess rdf:resource="#BiochemicalReaction53" />
 <bp:stepProcess rdf:resource="#Catalysis25" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1133">
 <bp:evidence rdf:resource="#Evidence1329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKC-delta translocates to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep65">
 <bp:stepProcess rdf:resource="#Catalysis24" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction52" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1130">
 <bp:evidence rdf:resource="#Evidence1326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCL10 binds CARD9</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1460">
 <bp:stepProcess rdf:resource="#Catalysis494" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1248" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep64">
 <bp:stepProcess rdf:resource="#Catalysis23" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction51" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1131">
 <bp:evidence rdf:resource="#Evidence1327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63polyUb-TAK1 autophosphorylates</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1469">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1257" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep69">
 <bp:stepProcess rdf:resource="#Pathway16" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep68">
 <bp:stepProcess rdf:resource="#BiochemicalReaction54" />
 <bp:stepProcess rdf:resource="#Catalysis26" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1466">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1254" />
 <bp:stepProcess rdf:resource="#Catalysis499" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1465">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1253" />
 <bp:stepProcess rdf:resource="#Catalysis498" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1138">
 <bp:evidence rdf:resource="#Evidence1335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-8 binds MALT</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1468">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1256" />
 <bp:stepProcess rdf:resource="#Catalysis500" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1139">
 <bp:evidence rdf:resource="#Evidence1336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IL1B gene is transcribed</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1467">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1255" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep30">
 <bp:stepProcess rdf:resource="#BiochemicalReaction23" />
 <bp:stepProcess rdf:resource="#Catalysis8" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1103">
 <bp:evidence rdf:resource="#Evidence1298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active NIK phosphorylates IKKA dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1451">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1240" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1104">
 <bp:evidence rdf:resource="#Evidence1299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF-beta-TRCP binds p-7S-p100 in active NIK:p-S176,180-IKKA dimer:p-7S-p100:RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1450">
 <bp:stepProcess rdf:resource="#Catalysis490" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1239" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1101">
 <bp:evidence rdf:resource="#Evidence1294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p300 acetylates RELA subunit</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1453">
 <bp:stepProcess rdf:resource="#Catalysis491" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1242" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1102">
 <bp:evidence rdf:resource="#Evidence1295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 activate GTPase RAS</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1452">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1241" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep34">
 <bp:stepProcess rdf:resource="#BiochemicalReaction27" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep33">
 <bp:stepProcess rdf:resource="#BiochemicalReaction26" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1100">
 <bp:evidence rdf:resource="#Evidence1293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S276-RELA binds RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep32">
 <bp:stepProcess rdf:resource="#BiochemicalReaction25" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep31">
 <bp:stepProcess rdf:resource="#BiochemicalReaction24" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep38">
 <bp:stepProcess rdf:resource="#Catalysis11" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction31" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1459">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1247" />
 <bp:stepProcess rdf:resource="#Catalysis493" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep37">
 <bp:stepProcess rdf:resource="#Catalysis10" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction30" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1458">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1246" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep36">
 <bp:stepProcess rdf:resource="#BiochemicalReaction29" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1109">
 <bp:evidence rdf:resource="#Evidence1304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF-beta-TRCP ubiquitinates p-7S-p100:RELB in active NIK:p-176,S180-IKKA dimer:p-7S-p100:SCF-beta-TRCP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep35">
 <bp:stepProcess rdf:resource="#Catalysis9" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction28" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1107">
 <bp:evidence rdf:resource="#Evidence1302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active NIK:p-S176,180-IKKA dimer phosphorylates p100:RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1455">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1244" />
 <bp:stepProcess rdf:resource="#Catalysis492" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1108">
 <bp:evidence rdf:resource="#Evidence1303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p52:RELB translocates from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1454">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1243" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1105">
 <bp:evidence rdf:resource="#Evidence1300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p100:RELB binds active NIK:p-IKKA dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1457">
 <bp:stepProcess rdf:resource="#Pathway213" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep39">
 <bp:stepProcess rdf:resource="#BiochemicalReaction32" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1106">
 <bp:evidence rdf:resource="#Evidence1301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of NIK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1456">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1245" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep41">
 <bp:stepProcess rdf:resource="#BiochemicalReaction34" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1114">
 <bp:evidence rdf:resource="#Evidence1310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1440">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep40">
 <bp:stepProcess rdf:resource="#Catalysis12" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction33" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1115">
 <bp:evidence rdf:resource="#Evidence1311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Calcineurin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1112">
 <bp:evidence rdf:resource="#Evidence1308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of CaN:CaM:NFAT to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1442">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1233" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1113">
 <bp:evidence rdf:resource="#Evidence1309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcineurin binds and dephosphorylates NFAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1441">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1232" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep45">
 <bp:stepProcess rdf:resource="#Pathway10" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1110">
 <bp:evidence rdf:resource="#Evidence1305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome processes p-7S-p100:RELB to form p52:RELB</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep44">
 <bp:stepProcess rdf:resource="#Pathway9" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1111">
 <bp:evidence rdf:resource="#Evidence1306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CCL17 and CCL22 genes are transcribed</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep43">
 <bp:stepProcess rdf:resource="#BiochemicalReaction36" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep42">
 <bp:stepProcess rdf:resource="#BiochemicalReaction35" />
 <bp:stepProcess rdf:resource="#Catalysis13" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep49">
 <bp:stepProcess rdf:resource="#Pathway11" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1448">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep48">
 <bp:stepProcess rdf:resource="#BiochemicalReaction39" />
 <bp:stepProcess rdf:resource="#Catalysis15" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1447">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1236" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep47">
 <bp:stepProcess rdf:resource="#BiochemicalReaction38" />
 <bp:stepProcess rdf:resource="#Catalysis14" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep46">
 <bp:stepProcess rdf:resource="#BiochemicalReaction37" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1449">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1238" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1118">
 <bp:evidence rdf:resource="#Evidence1314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1444">
 <bp:stepProcess rdf:resource="#Pathway212" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1119">
 <bp:evidence rdf:resource="#Evidence1315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SRC kinase phosphorylates CLEC7A:1,3-beta-D-glucan</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1443">
 <bp:stepProcess rdf:resource="#Pathway211" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1116">
 <bp:evidence rdf:resource="#Evidence1312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium binds calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1446">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1235" />
 <bp:stepProcess rdf:resource="#Catalysis489" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1117">
 <bp:evidence rdf:resource="#Evidence1313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1445">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1234" />
 <bp:stepProcess rdf:resource="#Catalysis488" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis102">
 <bp:controlled rdf:resource="#BiochemicalReaction207" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1161">
 <bp:evidence rdf:resource="#Evidence1362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of beta-catenin at Ser552</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis103">
 <bp:controlled rdf:resource="#BiochemicalReaction208" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1162">
 <bp:evidence rdf:resource="#Evidence1364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING binds cyclic GMP-AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis100">
 <bp:controlled rdf:resource="#BiochemicalReaction204" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis101">
 <bp:controlled rdf:resource="#BiochemicalReaction206" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1160">
 <bp:evidence rdf:resource="#Evidence1361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRR FLII-interacting protein 1 associates with beta-catenin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1081">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1080">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1072">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1169">
 <bp:evidence rdf:resource="#Evidence1372" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING recruits TBK1 and STAT6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1071">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1074">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1167">
 <bp:evidence rdf:resource="#Evidence1370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S407,Y641-STAT6 dimer migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1431">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1222" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1073">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1168">
 <bp:evidence rdf:resource="#Evidence1371" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 phosphorylates STAT6 at Ser407</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1430">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1221" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep12">
 <bp:stepProcess rdf:resource="#Pathway5" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1076">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1165">
 <bp:evidence rdf:resource="#Evidence1368" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is phosphorylated within STING:TBK1:STAT6 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep11">
 <bp:stepProcess rdf:resource="#BiochemicalReaction8" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1075">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1166">
 <bp:evidence rdf:resource="#Evidence1369" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S407,Y641-STAT6 is dimerized</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep10">
 <bp:stepProcess rdf:resource="#Pathway4" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1078">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1163">
 <bp:evidence rdf:resource="#Evidence1365" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX41 binds bacterial c-di-AMP, c-di-GMP  </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1077">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1164">
 <bp:evidence rdf:resource="#Evidence1366" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cGAS binds cytosolic DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep16">
 <bp:stepProcess rdf:resource="#BiochemicalReaction11" />
 <bp:stepProcess rdf:resource="#Catalysis3" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1437">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep15">
 <bp:stepProcess rdf:resource="#BiochemicalReaction10" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1079">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1436">
 <bp:stepProcess rdf:resource="#Catalysis487" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep14">
 <bp:stepProcess rdf:resource="#BiochemicalReaction9" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1439">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1230" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep13">
 <bp:stepProcess rdf:resource="#Pathway6" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1438">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1229" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1433">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1224" />
 <bp:stepProcess rdf:resource="#Catalysis485" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep19">
 <bp:stepProcess rdf:resource="#BiochemicalReaction14" />
 <bp:stepProcess rdf:resource="#Catalysis5" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1432">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1223" />
 <bp:stepProcess rdf:resource="#Catalysis484" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep18">
 <bp:stepProcess rdf:resource="#BiochemicalReaction13" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1435">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1226" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep17">
 <bp:stepProcess rdf:resource="#BiochemicalReaction12" />
 <bp:stepProcess rdf:resource="#Catalysis4" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1434">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1225" />
 <bp:stepProcess rdf:resource="#Catalysis486" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1429">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1220" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1172">
 <bp:evidence rdf:resource="#Evidence1375" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX41 binds viral dsDNA </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1173">
 <bp:evidence rdf:resource="#Evidence1377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,4S-IRF3 is dimerized</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1170">
 <bp:evidence rdf:resource="#Evidence1373" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S407-STAT6 is phosphorylated at Tyr641</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1171">
 <bp:evidence rdf:resource="#Evidence1374" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cGAS produces cyclic GMP-AMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1090">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1092">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1091">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1083">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1082">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1085">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1178">
 <bp:evidence rdf:resource="#Evidence1382" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IFI16 binds cytosolic dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1420">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1211" />
 <bp:stepProcess rdf:resource="#Catalysis478" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1084">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1179">
 <bp:evidence rdf:resource="#Evidence1383" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING binds c-di-GMP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep23">
 <bp:stepProcess rdf:resource="#Pathway8" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1087">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1176">
 <bp:evidence rdf:resource="#Evidence1380" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3 is phosphorylated by TBK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep22">
 <bp:stepProcess rdf:resource="#BiochemicalReaction16" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1086">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1177">
 <bp:evidence rdf:resource="#Evidence1381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING recruits TBK1 and IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep21">
 <bp:stepProcess rdf:resource="#BiochemicalReaction15" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1089">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1174">
 <bp:evidence rdf:resource="#Evidence1378" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is phosphorylated within STING:TBK1:IRF3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep20">
 <bp:stepProcess rdf:resource="#Pathway7" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1088">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1175">
 <bp:evidence rdf:resource="#Evidence1379" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerized phospho-IRF3 migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep27">
 <bp:stepProcess rdf:resource="#BiochemicalReaction20" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1426">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1217" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep26">
 <bp:stepProcess rdf:resource="#BiochemicalReaction19" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1425">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1216" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep25">
 <bp:stepProcess rdf:resource="#Catalysis6" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction18" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1428">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1219" />
 <bp:stepProcess rdf:resource="#Catalysis483" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep24">
 <bp:stepProcess rdf:resource="#BiochemicalReaction17" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1427">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1218" />
 <bp:stepProcess rdf:resource="#Catalysis482" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1422">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1213" />
 <bp:stepProcess rdf:resource="#Catalysis479" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1421">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1212" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep29">
 <bp:stepProcess rdf:resource="#BiochemicalReaction22" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1424">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1215" />
 <bp:stepProcess rdf:resource="#Catalysis481" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep28">
 <bp:stepProcess rdf:resource="#Catalysis7" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction21" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1423">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1214" />
 <bp:stepProcess rdf:resource="#Catalysis480" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1419">
 <bp:stepProcess rdf:resource="#Pathway210" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1418">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1210" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1140">
 <bp:evidence rdf:resource="#Evidence1337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-8 cleaves IL1B precursor</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1094">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1147">
 <bp:evidence rdf:resource="#Evidence1344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome processes K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complex to form NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1093">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1148">
 <bp:evidence rdf:resource="#Evidence1347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DTX4 ubiquitinates p-S172-TBK1 within NLRP4:DTX4:STING:TBK1:IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1096">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1145">
 <bp:evidence rdf:resource="#Evidence1342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S177,S181-IKKB:IKKA:pUb-NEMO phosphorylates IkB-alpha:NF-kB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1095">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1146">
 <bp:evidence rdf:resource="#Evidence1343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SYK binds p-Y15-CLEC7A:1,3-beta-D-glucan</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1098">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1143">
 <bp:evidence rdf:resource="#Evidence1340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BCL10 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1097">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1144">
 <bp:evidence rdf:resource="#Evidence1341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MALT1 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1141">
 <bp:evidence rdf:resource="#Evidence1338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ASC binds Caspase-8 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1099">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1142">
 <bp:evidence rdf:resource="#Evidence1339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63polyUb-p-3T,1S-TAK1 phosphorylates IKK-beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1415">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1207" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1414">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1206" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1417">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1209" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1416">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1208" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1411">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1203" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1410">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1202" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1149">
 <bp:evidence rdf:resource="#Evidence1348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING binds TRIM32 or TRIM56 </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1413">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1205" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1412">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1204" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1408">
 <bp:stepProcess rdf:resource="#Pathway209" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1407">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1200" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1409">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1201" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1150">
 <bp:evidence rdf:resource="#Evidence1349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX41 ubiquitination by TRIM21</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1151">
 <bp:evidence rdf:resource="#Evidence1350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DTX4 ubiquitinates p-S172-TBK1 within NLRP4:DTX4:dsDNA:ZBP1:TBK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1158">
 <bp:evidence rdf:resource="#Evidence1359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin migrates to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1159">
 <bp:evidence rdf:resource="#Evidence1360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-catenin enhances association of IRF3 with CBP/p300 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1156">
 <bp:evidence rdf:resource="#Evidence1356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP4 and DTX4 associate with p-S172-TBK1 within STING:TBK1:IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1157">
 <bp:evidence rdf:resource="#Evidence1358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRR FLII-interacting protein 1 binds dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1154">
 <bp:evidence rdf:resource="#Evidence1354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TREX1 binds retroviral-derived DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1155">
 <bp:evidence rdf:resource="#Evidence1355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral DNA cleavage by TREX1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1152">
 <bp:evidence rdf:resource="#Evidence1351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING ubiquitination by TRIM32 or TRIM56</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1153">
 <bp:evidence rdf:resource="#Evidence1352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP4 and DTX4 associate with p-S172-TBK1 within dsDNA:ZBP1:TBK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1404">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1197" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1403">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1196" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1406">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1199" />
 <bp:stepProcess rdf:resource="#Catalysis477" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1405">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1198" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1400">
 <bp:stepProcess rdf:resource="#Pathway208" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1402">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1195" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1401">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1194" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction125">
 <bp:evidence rdf:resource="#Evidence157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction124">
 <bp:evidence rdf:resource="#Evidence156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction127">
 <bp:evidence rdf:resource="#Evidence159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction126">
 <bp:evidence rdf:resource="#Evidence158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction129">
 <bp:evidence rdf:resource="#Evidence161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction128">
 <bp:evidence rdf:resource="#Evidence160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction130">
 <bp:evidence rdf:resource="#Evidence162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction132">
 <bp:evidence rdf:resource="#Evidence165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP3 binds TRIF to mediate necroptosis</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction131">
 <bp:evidence rdf:resource="#Evidence164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR4-induced ripoptosome assembly</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction134">
 <bp:evidence rdf:resource="#Evidence168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerized phospho-IRF3/IRF7 is transported to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction133">
 <bp:evidence rdf:resource="#Evidence166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-8 processing within TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction114">
 <bp:evidence rdf:resource="#Evidence145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction113">
 <bp:evidence rdf:resource="#Evidence143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction116">
 <bp:evidence rdf:resource="#Evidence148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction115">
 <bp:evidence rdf:resource="#Evidence146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction118">
 <bp:evidence rdf:resource="#Evidence150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction117">
 <bp:evidence rdf:resource="#Evidence149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction119">
 <bp:evidence rdf:resource="#Evidence151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction121">
 <bp:evidence rdf:resource="#Evidence153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction120">
 <bp:evidence rdf:resource="#Evidence152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction123">
 <bp:evidence rdf:resource="#Evidence155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction122">
 <bp:evidence rdf:resource="#Evidence154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence493">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence492">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence491">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence490">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction103">
 <bp:evidence rdf:resource="#Evidence132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence497">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction102">
 <bp:evidence rdf:resource="#Evidence131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence496">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction105">
 <bp:evidence rdf:resource="#Evidence134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence495">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction104">
 <bp:evidence rdf:resource="#Evidence133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence494">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction107">
 <bp:evidence rdf:resource="#Evidence137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction106">
 <bp:evidence rdf:resource="#Evidence136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction109">
 <bp:evidence rdf:resource="#Evidence139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence499">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction108">
 <bp:evidence rdf:resource="#Evidence138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence498">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction110">
 <bp:evidence rdf:resource="#Evidence140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction112">
 <bp:evidence rdf:resource="#Evidence142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction111">
 <bp:evidence rdf:resource="#Evidence141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence482">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence481">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence480">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence486">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence485">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence484">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence483">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence489">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence488">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence487">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction101">
 <bp:evidence rdf:resource="#Evidence130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction100">
 <bp:evidence rdf:resource="#Evidence129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence471">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence470">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence475">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence474">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence473">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence472">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence479">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence478">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence477">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence476">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence460">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence464">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence463">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence462">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence461">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence468">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence467">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence466">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence465">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence469">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence453">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence452">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence451">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence450">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence457">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence456">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence455">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence454">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence459">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence458">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence442">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence441">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence440">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence446">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence445">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence444">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence443">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence449">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence448">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence447">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence431">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence430">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence435">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence434">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence433">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence432">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence439">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence438">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence437">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence436">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1209">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence420">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence424">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence423">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence422">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence421">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence428">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence427">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence426">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence425">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence429">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1201">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1200">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1203">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1202">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1205">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1204">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1206">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep406">
 <bp:stepProcess rdf:resource="#Catalysis158" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep407">
 <bp:stepProcess rdf:resource="#BiochemicalReaction336" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1219">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep408">
 <bp:stepProcess rdf:resource="#BiochemicalReaction337" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep409">
 <bp:stepProcess rdf:resource="#Catalysis159" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction338" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep402">
 <bp:stepProcess rdf:resource="#BiochemicalReaction332" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep403">
 <bp:stepProcess rdf:resource="#BiochemicalReaction333" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep404">
 <bp:stepProcess rdf:resource="#Pathway72" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep405">
 <bp:stepProcess rdf:resource="#BiochemicalReaction334" />
 <bp:stepProcess rdf:resource="#Catalysis157" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence413">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence412">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence411">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence410">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction194">
 <bp:evidence rdf:resource="#Evidence238" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence417">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction193">
 <bp:evidence rdf:resource="#Evidence237" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence416">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction196">
 <bp:evidence rdf:resource="#Evidence241" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence415">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction195">
 <bp:evidence rdf:resource="#Evidence239" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence414">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction198">
 <bp:evidence rdf:resource="#Evidence243" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction197">
 <bp:evidence rdf:resource="#Evidence242" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence419">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1210">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction199">
 <bp:evidence rdf:resource="#Evidence244" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence418">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1212">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1211">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep400">
 <bp:stepProcess rdf:resource="#BiochemicalReaction330" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1214">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep401">
 <bp:stepProcess rdf:resource="#BiochemicalReaction331" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1213">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction190">
 <bp:evidence rdf:resource="#Evidence232" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:TIRAP:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1216">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1215">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction192">
 <bp:evidence rdf:resource="#Evidence234" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1218">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction191">
 <bp:evidence rdf:resource="#Evidence233" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1217">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep417">
 <bp:stepProcess rdf:resource="#BiochemicalReaction345" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep418">
 <bp:stepProcess rdf:resource="#BiochemicalReaction346" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep419">
 <bp:stepProcess rdf:resource="#Catalysis161" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction347" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep413">
 <bp:stepProcess rdf:resource="#BiochemicalReaction341" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep414">
 <bp:stepProcess rdf:resource="#BiochemicalReaction342" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep415">
 <bp:stepProcess rdf:resource="#Catalysis160" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction343" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep416">
 <bp:stepProcess rdf:resource="#BiochemicalReaction344" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction179">
 <bp:evidence rdf:resource="#Evidence221" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence402">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence401">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence400">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction183">
 <bp:evidence rdf:resource="#Evidence225" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence406">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction182">
 <bp:evidence rdf:resource="#Evidence224" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence405">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction185">
 <bp:evidence rdf:resource="#Evidence227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:Mal</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence404">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction184">
 <bp:evidence rdf:resource="#Evidence226" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4 interacts with MAL (TIRAP)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence403">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction187">
 <bp:evidence rdf:resource="#Evidence229" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 or IRAK2 binds to the activated IRAK4 :activated TLR:MyD88:TIRAP complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction186">
 <bp:evidence rdf:resource="#Evidence228" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP binds PIP2-rich regions in the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence409">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction189">
 <bp:evidence rdf:resource="#Evidence231" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence408">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1221">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction188">
 <bp:evidence rdf:resource="#Evidence230" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP is phosphorylated by BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence407">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1220">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1223">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep410">
 <bp:stepProcess rdf:resource="#Pathway73" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1222">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep411">
 <bp:stepProcess rdf:resource="#BiochemicalReaction339" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1225">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep412">
 <bp:stepProcess rdf:resource="#BiochemicalReaction340" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1224">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1227">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1226">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction181">
 <bp:evidence rdf:resource="#Evidence223" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1229">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction180">
 <bp:evidence rdf:resource="#Evidence222" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1228">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction169">
 <bp:evidence rdf:resource="#Evidence211" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction168">
 <bp:evidence rdf:resource="#Evidence209" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction172">
 <bp:evidence rdf:resource="#Evidence214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction171">
 <bp:evidence rdf:resource="#Evidence213" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction174">
 <bp:evidence rdf:resource="#Evidence216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction173">
 <bp:evidence rdf:resource="#Evidence215" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction176">
 <bp:evidence rdf:resource="#Evidence218" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction175">
 <bp:evidence rdf:resource="#Evidence217" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction178">
 <bp:evidence rdf:resource="#Evidence220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction177">
 <bp:evidence rdf:resource="#Evidence219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction170">
 <bp:evidence rdf:resource="#Evidence212" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction158">
 <bp:evidence rdf:resource="#Evidence195" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAM:TLR4:LY96:LPS:CD14 recruits TRIF (TICAM1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction157">
 <bp:evidence rdf:resource="#Evidence194" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63-linked ubiquitination of RIP1 bound to the activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction159">
 <bp:evidence rdf:resource="#Evidence197" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Secreted CD14 binds LPS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction161">
 <bp:evidence rdf:resource="#Evidence199" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD14:LPS binds CR3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction160">
 <bp:evidence rdf:resource="#Evidence198" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GPI-bound CD14 binds LPS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction163">
 <bp:evidence rdf:resource="#Evidence203" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction162">
 <bp:evidence rdf:resource="#Evidence201" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR receptor:TIRAP:MyD88 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction165">
 <bp:evidence rdf:resource="#Evidence205" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction164">
 <bp:evidence rdf:resource="#Evidence204" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction167">
 <bp:evidence rdf:resource="#Evidence208" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction166">
 <bp:evidence rdf:resource="#Evidence206" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction147">
 <bp:evidence rdf:resource="#Evidence182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is ubiquitinated within TBK1:K63polyUb-TANK:K63polyUb-TRAF3:TRIF:activated TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction146">
 <bp:evidence rdf:resource="#Evidence181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) is ubiquitinated within the activated TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction149">
 <bp:evidence rdf:resource="#Evidence185" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated TAK1 leaves activated TLR receptor complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction148">
 <bp:evidence rdf:resource="#Evidence183" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3/IRF7 recruitment to p-TBK1/p-IKK epsilon bound to the activated TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction150">
 <bp:evidence rdf:resource="#Evidence186" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR4:TICAM1:K63pUb-TRAF6 recruits TAK1complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction152">
 <bp:evidence rdf:resource="#Evidence188" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR4:TICAM1 recruits TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction151">
 <bp:evidence rdf:resource="#Evidence187" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of TAK1 complex bound to activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction154">
 <bp:evidence rdf:resource="#Evidence190" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon TLR stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction153">
 <bp:evidence rdf:resource="#Evidence189" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of TRAF6 bound to the activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction156">
 <bp:evidence rdf:resource="#Evidence193" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIF:activated TLR3/TLR4 complex recruits RIP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction155">
 <bp:evidence rdf:resource="#Evidence192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKG subunit of IKK complex binds polyubiquinated RIP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction136">
 <bp:evidence rdf:resource="#Evidence170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) is phosphorylated within the activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction135">
 <bp:evidence rdf:resource="#Evidence169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK binds K63-poly-Ub-TRAF3:TICAM1:activated TLR4 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction138">
 <bp:evidence rdf:resource="#Evidence172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of phosphorylated IRF3/IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction137">
 <bp:evidence rdf:resource="#Evidence171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRF-3/IRF7 and their release from the activated TLR complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction139">
 <bp:evidence rdf:resource="#Evidence173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IKK&#949; (IKBKE) to K63polyUb-TANK:K63polyUb-TRAF3:TRIF:activated TLR4 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction141">
 <bp:evidence rdf:resource="#Evidence175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK is ubiquitinated within TANK:K63polyUb-TRAF3:TRIF:activated TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction140">
 <bp:evidence rdf:resource="#Evidence174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TBK1 to K63polyUb-TANK:K63polyUb-TRAF3:TRIF:activated TLR4 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction143">
 <bp:evidence rdf:resource="#Evidence177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto-ubiquitination of TRAF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction142">
 <bp:evidence rdf:resource="#Evidence176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is phosphorylated within the activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction145">
 <bp:evidence rdf:resource="#Evidence180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OPTN binds TBK1 within the activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction144">
 <bp:evidence rdf:resource="#Evidence178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF3 binds TICAM1:activated TLR4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction925">
 <bp:evidence rdf:resource="#Evidence1102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1:ADP-heptose binds TIFA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction924">
 <bp:evidence rdf:resource="#Evidence1101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIFA oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction927">
 <bp:evidence rdf:resource="#Evidence1104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of TRAF6 bound to ALPK1:ADP-heptose:TIFA oligomer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction926">
 <bp:evidence rdf:resource="#Evidence1103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1 binds ADP-heptose</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep347">
 <bp:stepProcess rdf:resource="#BiochemicalReaction284" />
 <bp:stepProcess rdf:resource="#Catalysis145" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction929">
 <bp:evidence rdf:resource="#Evidence1106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 within the ALPK1:ADP-heptose:p-T9-TIFA:pUb-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 :MAP3K7 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep348">
 <bp:stepProcess rdf:resource="#BiochemicalReaction285" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction928">
 <bp:evidence rdf:resource="#Evidence1105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1:ADP-heptose:TIFA oligomer recruits TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep349">
 <bp:stepProcess rdf:resource="#BiochemicalReaction286" />
 <bp:stepProcess rdf:resource="#Catalysis146" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction921">
 <bp:evidence rdf:resource="#Evidence1098" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 oligomerizes within the ALPK1:ADP-heptose:TIFA oligomer complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction920">
 <bp:evidence rdf:resource="#Evidence1096" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">viral dsRNA:IFIH1, viral dsRNA:K63polyUb-DDX58 bind MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction923">
 <bp:evidence rdf:resource="#Evidence1100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1 phosphorylates TIFA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction922">
 <bp:evidence rdf:resource="#Evidence1099" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ALPK1:ADP-heptose:p-T9-TIFA oligomer:K63pUb-TRAF6 oligomer recruits MAP3K7 (TAK1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1151">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1150">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1152">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1154">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep343">
 <bp:stepProcess rdf:resource="#BiochemicalReaction280" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1157">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep344">
 <bp:stepProcess rdf:resource="#BiochemicalReaction281" />
 <bp:stepProcess rdf:resource="#Catalysis144" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1156">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep345">
 <bp:stepProcess rdf:resource="#BiochemicalReaction282" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1159">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep346">
 <bp:stepProcess rdf:resource="#BiochemicalReaction283" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1158">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep340">
 <bp:stepProcess rdf:resource="#BiochemicalReaction278" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep341">
 <bp:stepProcess rdf:resource="#BiochemicalReaction279" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep342">
 <bp:stepProcess rdf:resource="#Pathway64" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction914">
 <bp:evidence rdf:resource="#Evidence1090" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TANK to TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis490">
 <bp:controlled rdf:resource="#BiochemicalReaction1239" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction913">
 <bp:evidence rdf:resource="#Evidence1089" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of p-IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis491">
 <bp:controlled rdf:resource="#BiochemicalReaction1242" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction916">
 <bp:evidence rdf:resource="#Evidence1092" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1, IKBKE form homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction915">
 <bp:evidence rdf:resource="#Evidence1091" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-IRF7 dimer interacts with coactivator CBP/p300</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep358">
 <bp:stepProcess rdf:resource="#BiochemicalReaction295" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction918">
 <bp:evidence rdf:resource="#Evidence1094" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of Interferon-alpha and beta mediated by VAF/pIRF7:CBP/p300</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep359">
 <bp:stepProcess rdf:resource="#Pathway65" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction917">
 <bp:evidence rdf:resource="#Evidence1093" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IRF7 to TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction919">
 <bp:evidence rdf:resource="#Evidence1095" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX58 is K63 polyubiquitinated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis498">
 <bp:controlled rdf:resource="#BiochemicalReaction1253" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis499">
 <bp:controlled rdf:resource="#BiochemicalReaction1254" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis496">
 <bp:controlled rdf:resource="#BiochemicalReaction1251" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis497">
 <bp:controlled rdf:resource="#BiochemicalReaction1252" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction910">
 <bp:evidence rdf:resource="#Evidence1086" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TBK1/IKK epsilon complex to TANK:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis494">
 <bp:controlled rdf:resource="#BiochemicalReaction1248" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis495">
 <bp:controlled rdf:resource="#BiochemicalReaction1249" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction912">
 <bp:evidence rdf:resource="#Evidence1088" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of p-IRF7:p-IRF7 to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis492">
 <bp:controlled rdf:resource="#BiochemicalReaction1244" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction911">
 <bp:evidence rdf:resource="#Evidence1087" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TRAF6/TRAF2 to MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis493">
 <bp:controlled rdf:resource="#BiochemicalReaction1247" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1160">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1162">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1161">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1163">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1166">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis489">
 <bp:controlled rdf:resource="#BiochemicalReaction1235" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1165">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep354">
 <bp:stepProcess rdf:resource="#Catalysis147" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction291" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1168">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep355">
 <bp:stepProcess rdf:resource="#BiochemicalReaction292" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1167">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep356">
 <bp:stepProcess rdf:resource="#BiochemicalReaction293" />
 <bp:stepProcess rdf:resource="#Catalysis148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep357">
 <bp:stepProcess rdf:resource="#BiochemicalReaction294" />
 <bp:stepProcess rdf:resource="#Catalysis149" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1169">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep350">
 <bp:stepProcess rdf:resource="#BiochemicalReaction287" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep351">
 <bp:stepProcess rdf:resource="#BiochemicalReaction288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep352">
 <bp:stepProcess rdf:resource="#BiochemicalReaction289" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep353">
 <bp:stepProcess rdf:resource="#BiochemicalReaction290" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction903">
 <bp:evidence rdf:resource="#Evidence1078" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of caspase-8 and -10 to FADD complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction902">
 <bp:evidence rdf:resource="#Evidence1077" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerzation of procaspase-8, procaspase-10</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis480">
 <bp:controlled rdf:resource="#BiochemicalReaction1214" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction905">
 <bp:evidence rdf:resource="#Evidence1080" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Processing of caspases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction904">
 <bp:evidence rdf:resource="#Evidence1079" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAVS interacts with RIPK1 and FADD</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep369">
 <bp:stepProcess rdf:resource="#Pathway66" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction907">
 <bp:evidence rdf:resource="#Evidence1083" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">VAF/pIRF7:CBP/p300 binds the promoters of type-I IFN genes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction906">
 <bp:evidence rdf:resource="#Evidence1082" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of TBK1/IKBKE</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction909">
 <bp:evidence rdf:resource="#Evidence1085" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction908">
 <bp:evidence rdf:resource="#Evidence1084" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of VAF (virus-activated factor) complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis487">
 <bp:controlled rdf:resource="#BiochemicalReaction1227" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis488">
 <bp:controlled rdf:resource="#BiochemicalReaction1234" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis485">
 <bp:controlled rdf:resource="#BiochemicalReaction1224" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis486">
 <bp:controlled rdf:resource="#BiochemicalReaction1225" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis483">
 <bp:controlled rdf:resource="#BiochemicalReaction1219" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis484">
 <bp:controlled rdf:resource="#BiochemicalReaction1223" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction901">
 <bp:evidence rdf:resource="#Evidence1076" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1180">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis481">
 <bp:controlled rdf:resource="#BiochemicalReaction1215" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction900">
 <bp:evidence rdf:resource="#Evidence1074" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAVS:TOMM70 recruits HSP90:TBK1:IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis482">
 <bp:controlled rdf:resource="#BiochemicalReaction1218" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1171">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1170">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1173">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep360">
 <bp:stepProcess rdf:resource="#Catalysis150" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction296" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1172">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1175">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1174">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1177">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis478">
 <bp:controlled rdf:resource="#BiochemicalReaction1211" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1176">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis479">
 <bp:controlled rdf:resource="#BiochemicalReaction1213" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep365">
 <bp:stepProcess rdf:resource="#BiochemicalReaction301" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1179">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep366">
 <bp:stepProcess rdf:resource="#BiochemicalReaction302" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1178">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep367">
 <bp:stepProcess rdf:resource="#BiochemicalReaction303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep368">
 <bp:stepProcess rdf:resource="#BiochemicalReaction304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep361">
 <bp:stepProcess rdf:resource="#BiochemicalReaction297" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep362">
 <bp:stepProcess rdf:resource="#BiochemicalReaction298" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep363">
 <bp:stepProcess rdf:resource="#BiochemicalReaction299" />
 <bp:stepProcess rdf:resource="#Catalysis151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep364">
 <bp:stepProcess rdf:resource="#BiochemicalReaction300" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis476">
 <bp:controlled rdf:resource="#BiochemicalReaction1189" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis477">
 <bp:controlled rdf:resource="#BiochemicalReaction1199" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis474">
 <bp:controlled rdf:resource="#BiochemicalReaction1171" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis475">
 <bp:controlled rdf:resource="#BiochemicalReaction1176" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis472">
 <bp:controlled rdf:resource="#BiochemicalReaction1155" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis473">
 <bp:controlled rdf:resource="#BiochemicalReaction1168" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1191">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis470">
 <bp:controlled rdf:resource="#BiochemicalReaction1151" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1190">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis471">
 <bp:controlled rdf:resource="#BiochemicalReaction1152" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1182">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1181">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep370">
 <bp:stepProcess rdf:resource="#BiochemicalReaction305" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1184">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep371">
 <bp:stepProcess rdf:resource="#BiochemicalReaction306" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1183">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1186">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis469">
 <bp:controlled rdf:resource="#BiochemicalReaction1150" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1185">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1188">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis467">
 <bp:controlled rdf:resource="#BiochemicalReaction1147" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1187">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis468">
 <bp:controlled rdf:resource="#BiochemicalReaction1148" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep376">
 <bp:stepProcess rdf:resource="#Pathway67" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep377">
 <bp:stepProcess rdf:resource="#BiochemicalReaction311" />
 <bp:stepProcess rdf:resource="#Catalysis152" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1189">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep378">
 <bp:stepProcess rdf:resource="#BiochemicalReaction312" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep379">
 <bp:stepProcess rdf:resource="#BiochemicalReaction313" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep372">
 <bp:stepProcess rdf:resource="#BiochemicalReaction307" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep373">
 <bp:stepProcess rdf:resource="#BiochemicalReaction308" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep374">
 <bp:stepProcess rdf:resource="#BiochemicalReaction309" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep375">
 <bp:stepProcess rdf:resource="#BiochemicalReaction310" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep307">
 <bp:stepProcess rdf:resource="#Pathway57" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep308">
 <bp:stepProcess rdf:resource="#Pathway58" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep309">
 <bp:stepProcess rdf:resource="#BiochemicalReaction252" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep303">
 <bp:stepProcess rdf:resource="#BiochemicalReaction248" />
 <bp:stepProcess rdf:resource="#Catalysis122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep304">
 <bp:stepProcess rdf:resource="#Catalysis123" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction249" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep305">
 <bp:stepProcess rdf:resource="#BiochemicalReaction250" />
 <bp:stepProcess rdf:resource="#Catalysis124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep306">
 <bp:stepProcess rdf:resource="#BiochemicalReaction251" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1202">
 <bp:evidence rdf:resource="#Evidence1411" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAP12 interacts with NKG2C</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1203">
 <bp:evidence rdf:resource="#Evidence1412" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR2DS5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1200">
 <bp:evidence rdf:resource="#Evidence1408" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MRE11 binds cytosolic DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1201">
 <bp:evidence rdf:resource="#Evidence1410" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and TREM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1111">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1110">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1113">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep300">
 <bp:stepProcess rdf:resource="#BiochemicalReaction246" />
 <bp:stepProcess rdf:resource="#Catalysis121" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1112">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep301">
 <bp:stepProcess rdf:resource="#Pathway56" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1115">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1208">
 <bp:evidence rdf:resource="#Evidence1417" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and TREM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep302">
 <bp:stepProcess rdf:resource="#BiochemicalReaction247" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1114">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1209">
 <bp:evidence rdf:resource="#Evidence1418" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and NKG2D</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1117">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1206">
 <bp:evidence rdf:resource="#Evidence1415" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR3DS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1116">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1207">
 <bp:evidence rdf:resource="#Evidence1416" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR2DS1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1119">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1204">
 <bp:evidence rdf:resource="#Evidence1413" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and MDL-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1118">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1205">
 <bp:evidence rdf:resource="#Evidence1414" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of SIGLEC14/15/16 and DAP12</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep318">
 <bp:stepProcess rdf:resource="#BiochemicalReaction260" />
 <bp:stepProcess rdf:resource="#Catalysis131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep319">
 <bp:stepProcess rdf:resource="#Pathway60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep314">
 <bp:stepProcess rdf:resource="#Pathway59" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep315">
 <bp:stepProcess rdf:resource="#Catalysis128" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction257" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep316">
 <bp:stepProcess rdf:resource="#Catalysis129" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction258" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep317">
 <bp:stepProcess rdf:resource="#BiochemicalReaction259" />
 <bp:stepProcess rdf:resource="#Catalysis130" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1213">
 <bp:evidence rdf:resource="#Evidence1423" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and activation of VAV2/VAV3 by SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1214">
 <bp:evidence rdf:resource="#Evidence1424" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PLC-gamma by p-BTK/p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1211">
 <bp:evidence rdf:resource="#Evidence1421" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of BTK by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1212">
 <bp:evidence rdf:resource="#Evidence1422" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Release of p-PLCG1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1120">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1210">
 <bp:evidence rdf:resource="#Evidence1419" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR2DS4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1122">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1121">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep310">
 <bp:stepProcess rdf:resource="#BiochemicalReaction253" />
 <bp:stepProcess rdf:resource="#Catalysis125" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1124">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep311">
 <bp:stepProcess rdf:resource="#Catalysis126" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction254" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1123">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep312">
 <bp:stepProcess rdf:resource="#BiochemicalReaction255" />
 <bp:stepProcess rdf:resource="#Catalysis127" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1126">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1219">
 <bp:evidence rdf:resource="#Evidence1429" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep313">
 <bp:stepProcess rdf:resource="#BiochemicalReaction256" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1128">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1217">
 <bp:evidence rdf:resource="#Evidence1427" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p85 regulatory unit of PI3K binds p-6Y-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1127">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1218">
 <bp:evidence rdf:resource="#Evidence1428" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of DAP12</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1215">
 <bp:evidence rdf:resource="#Evidence1425" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K phosphorylates PIP2 to PIP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1129">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1216">
 <bp:evidence rdf:resource="#Evidence1426" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of VAV and BTK to p-SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep329">
 <bp:stepProcess rdf:resource="#Pathway62" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep325">
 <bp:stepProcess rdf:resource="#BiochemicalReaction265" />
 <bp:stepProcess rdf:resource="#Catalysis136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep326">
 <bp:stepProcess rdf:resource="#BiochemicalReaction266" />
 <bp:stepProcess rdf:resource="#Catalysis137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep327">
 <bp:stepProcess rdf:resource="#Catalysis138" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction267" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep328">
 <bp:stepProcess rdf:resource="#Catalysis139" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction268" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1131">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1130">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1133">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1132">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep321">
 <bp:stepProcess rdf:resource="#Pathway61" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1135">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep322">
 <bp:stepProcess rdf:resource="#BiochemicalReaction262" />
 <bp:stepProcess rdf:resource="#Catalysis133" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1134">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep323">
 <bp:stepProcess rdf:resource="#BiochemicalReaction263" />
 <bp:stepProcess rdf:resource="#Catalysis134" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1137">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep324">
 <bp:stepProcess rdf:resource="#BiochemicalReaction264" />
 <bp:stepProcess rdf:resource="#Catalysis135" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1139">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1138">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep320">
 <bp:stepProcess rdf:resource="#BiochemicalReaction261" />
 <bp:stepProcess rdf:resource="#Catalysis132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep336">
 <bp:stepProcess rdf:resource="#BiochemicalReaction275" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep337">
 <bp:stepProcess rdf:resource="#BiochemicalReaction276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep338">
 <bp:stepProcess rdf:resource="#BiochemicalReaction277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep339">
 <bp:stepProcess rdf:resource="#Pathway63" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1140">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1141">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1143">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep332">
 <bp:stepProcess rdf:resource="#BiochemicalReaction271" />
 <bp:stepProcess rdf:resource="#Catalysis141" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1146">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep333">
 <bp:stepProcess rdf:resource="#BiochemicalReaction272" />
 <bp:stepProcess rdf:resource="#Catalysis142" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1145">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep334">
 <bp:stepProcess rdf:resource="#BiochemicalReaction273" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1148">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep335">
 <bp:stepProcess rdf:resource="#BiochemicalReaction274" />
 <bp:stepProcess rdf:resource="#Catalysis143" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1149">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep330">
 <bp:stepProcess rdf:resource="#BiochemicalReaction269" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep331">
 <bp:stepProcess rdf:resource="#BiochemicalReaction270" />
 <bp:stepProcess rdf:resource="#Catalysis140" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis421">
 <bp:controlled rdf:resource="#BiochemicalReaction1037" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis422">
 <bp:controlled rdf:resource="#BiochemicalReaction1041" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis420">
 <bp:controlled rdf:resource="#BiochemicalReaction1035" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis418">
 <bp:controlled rdf:resource="#BiochemicalReaction1032" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1246">
 <bp:evidence rdf:resource="#Evidence1459" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TAK1 kinase complex to oligo-K63-pUb-TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis419">
 <bp:controlled rdf:resource="#BiochemicalReaction1033" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1247">
 <bp:evidence rdf:resource="#Evidence1460" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of NEMO by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis416">
 <bp:controlled rdf:resource="#BiochemicalReaction1021" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1244">
 <bp:evidence rdf:resource="#Evidence1456" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of beta and gamma subunits by LYN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis417">
 <bp:controlled rdf:resource="#BiochemicalReaction1028" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1245">
 <bp:evidence rdf:resource="#Evidence1457" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of SYK to p-FCERI gamma subunit</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis414">
 <bp:controlled rdf:resource="#BiochemicalReaction1003" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1242">
 <bp:evidence rdf:resource="#Evidence1454" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LAT by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis415">
 <bp:controlled rdf:resource="#BiochemicalReaction1014" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1243">
 <bp:evidence rdf:resource="#Evidence1455" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Allergen dependent IgE bound FCERI aggregation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis412">
 <bp:controlled rdf:resource="#BiochemicalReaction985" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1240">
 <bp:evidence rdf:resource="#Evidence1452" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3K associates with phosphorylated GAB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis413">
 <bp:controlled rdf:resource="#BiochemicalReaction986" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1241">
 <bp:evidence rdf:resource="#Evidence1453" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IgE binds FCERI</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1248">
 <bp:evidence rdf:resource="#Evidence1461" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">beta-TRCP ubiquitinates IkB-alpha in p-S32,33-IkB-alpha:NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1249">
 <bp:evidence rdf:resource="#Evidence1462" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of CARMA1 by PKC-theta</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis410">
 <bp:controlled rdf:resource="#BiochemicalReaction968" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction994">
 <bp:evidence rdf:resource="#Evidence1177" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNP1-3 bind CD4</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis411">
 <bp:controlled rdf:resource="#BiochemicalReaction977" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction993">
 <bp:evidence rdf:resource="#Evidence1176" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNP1-4 are stored in primary neutrophil granules</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1250">
 <bp:evidence rdf:resource="#Evidence1463" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB1:RELA translocates from the cytosol to the nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction996">
 <bp:evidence rdf:resource="#Evidence1179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pro-HNP1-4 are cleaved to biologically active defensin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction995">
 <bp:evidence rdf:resource="#Evidence1178" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-defensin alpha 5 is secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction998">
 <bp:evidence rdf:resource="#Evidence1181" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REG3A oligomerize to form a pore complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction997">
 <bp:evidence rdf:resource="#Evidence1180" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PI3 binds the bacterial surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction999">
 <bp:evidence rdf:resource="#Evidence1182" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">BPI binds LPS on the bacterial surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis407">
 <bp:controlled rdf:resource="#BiochemicalReaction961" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1257">
 <bp:evidence rdf:resource="#Evidence1470" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PKC-theta</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis408">
 <bp:controlled rdf:resource="#BiochemicalReaction964" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1258">
 <bp:evidence rdf:resource="#Evidence1471" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oligomerization of BCL10 and MALT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis405">
 <bp:controlled rdf:resource="#BiochemicalReaction951" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1255">
 <bp:evidence rdf:resource="#Evidence1468" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TRAF6 to CBM complex by binding to MALT1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis406">
 <bp:controlled rdf:resource="#BiochemicalReaction952" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1256">
 <bp:evidence rdf:resource="#Evidence1469" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26S proteasome processes K48PolyUb-K21,22-p-S32,36-IkBA:NF-kB complex to form NF-kB complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis403">
 <bp:controlled rdf:resource="#BiochemicalReaction933" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1253">
 <bp:evidence rdf:resource="#Evidence1466" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto-ubiquitination of TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis404">
 <bp:controlled rdf:resource="#BiochemicalReaction947" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1254">
 <bp:evidence rdf:resource="#Evidence1467" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IKK-beta by TAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis401">
 <bp:controlled rdf:resource="#BiochemicalReaction930" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1251">
 <bp:evidence rdf:resource="#Evidence1464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PKC-theta</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis402">
 <bp:controlled rdf:resource="#BiochemicalReaction932" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1252">
 <bp:evidence rdf:resource="#Evidence1465" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-S177,S181-IKKB:IKKA:pUb-NEMO phosphorylates IkB-alpha:NF-kB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis409">
 <bp:controlled rdf:resource="#BiochemicalReaction967" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1259">
 <bp:evidence rdf:resource="#Evidence1472" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PKC theta to plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction983">
 <bp:evidence rdf:resource="#Evidence1165" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-defensins bind microbial membranes causing disruption</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis400">
 <bp:controlled rdf:resource="#BiochemicalReaction929" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction982">
 <bp:evidence rdf:resource="#Evidence1164" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta defensin 103 activates TLR1:TLR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction985">
 <bp:evidence rdf:resource="#Evidence1168" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ADP-Ribosylation of HNP-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction984">
 <bp:evidence rdf:resource="#Evidence1166" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pre-pro-defensins are cleaved to remove the signal peptide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction987">
 <bp:evidence rdf:resource="#Evidence1170" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNP1-4 are released into phagocytic vacuoles</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction986">
 <bp:evidence rdf:resource="#Evidence1169" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-HD5 is cleaved by trypsin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction989">
 <bp:evidence rdf:resource="#Evidence1172" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNP1-3 bind gp120</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction988">
 <bp:evidence rdf:resource="#Evidence1171" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pro-defensin alpha 5 is stored in Paneth cell granules</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1224">
 <bp:evidence rdf:resource="#Evidence1434" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1 by VAV2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1225">
 <bp:evidence rdf:resource="#Evidence1435" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS mediated nucleotide exchange of RAS (SHC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1222">
 <bp:evidence rdf:resource="#Evidence1432" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GADS:SLP-76 to p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1223">
 <bp:evidence rdf:resource="#Evidence1433" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SLP-76 by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction990">
 <bp:evidence rdf:resource="#Evidence1173" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-defensin dimers multimerize to form a pore complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1220">
 <bp:evidence rdf:resource="#Evidence1430" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of SYK to p-DAP12</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1221">
 <bp:evidence rdf:resource="#Evidence1431" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2:SOS to p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction992">
 <bp:evidence rdf:resource="#Evidence1175" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-defensin dimers adsorb onto microbial membrane anionic phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction991">
 <bp:evidence rdf:resource="#Evidence1174" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-defensins form biologically active dimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1228">
 <bp:evidence rdf:resource="#Evidence1438" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and IREM2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1229">
 <bp:evidence rdf:resource="#Evidence1439" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of DAP12</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1226">
 <bp:evidence rdf:resource="#Evidence1436" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PLC-gamma to SLP-76 and p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1227">
 <bp:evidence rdf:resource="#Evidence1437" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of LAT by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction979">
 <bp:evidence rdf:resource="#Evidence1161" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-defensins 4A and 103 bind CCR2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction972">
 <bp:evidence rdf:resource="#Evidence1151" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N2O3 enters bacteria</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction971">
 <bp:evidence rdf:resource="#Evidence1150" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrogen peroxide enters the bacterium</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction974">
 <bp:evidence rdf:resource="#Evidence1153" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HNO2 produces N2O3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction973">
 <bp:evidence rdf:resource="#Evidence1152" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peroxynitrite and carbon dioxide react to nitrosoperoxycarbonate</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction976">
 <bp:evidence rdf:resource="#Evidence1156" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DCD peptide binds bacterial membrane phospholipids</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction975">
 <bp:evidence rdf:resource="#Evidence1154" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitrite ion and HNO2 form a conjugated acid-base pair</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction978">
 <bp:evidence rdf:resource="#Evidence1159" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Binding of defensins to lipid II</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction977">
 <bp:evidence rdf:resource="#Evidence1157" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Trypsin cleaves REG3A or REG3G to generate REG3A,G(38-175)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1235">
 <bp:evidence rdf:resource="#Evidence1447" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of NTAL by p-SYK/Lyn</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1236">
 <bp:evidence rdf:resource="#Evidence1448" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2:SOS to p-10Y-NTAL</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1233">
 <bp:evidence rdf:resource="#Evidence1443" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SIRP beta binds TYROBP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1234">
 <bp:evidence rdf:resource="#Evidence1446" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PIP2 to PIP3 by PI3K</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1231">
 <bp:evidence rdf:resource="#Evidence1441" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and CLM7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1232">
 <bp:evidence rdf:resource="#Evidence1442" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and NKp44</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction981">
 <bp:evidence rdf:resource="#Evidence1163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-defensins are secreted</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction980">
 <bp:evidence rdf:resource="#Evidence1162" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta-defensins 1, 4A and 103 bind CCR6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1230">
 <bp:evidence rdf:resource="#Evidence1440" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of DAP12 and KIR2DS2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1239">
 <bp:evidence rdf:resource="#Evidence1451" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of GAB2 by SYK/FYN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1237">
 <bp:evidence rdf:resource="#Evidence1449" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GAB2 to PM and FCERI by binding to GRB2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1238">
 <bp:evidence rdf:resource="#Evidence1450" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of PDK1 to Plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction969">
 <bp:evidence rdf:resource="#Evidence1148" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peroxynitrite enters the bacterium</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction968">
 <bp:evidence rdf:resource="#Evidence1147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Membrane-bound myeloperoxidase (MPO) produces hypochlorous acid (HOCl)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction961">
 <bp:evidence rdf:resource="#Evidence1140" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myeloperoxidase (MPO) catalyzes oxidation of nitrite to nitrogen dioxide</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis465">
 <bp:controlled rdf:resource="#BiochemicalReaction1142" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1282">
 <bp:evidence rdf:resource="#Evidence1497" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of VAV to p-SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction960">
 <bp:evidence rdf:resource="#Evidence1139" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid (HOCL) reacts with Lys-monochloramine</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis466">
 <bp:controlled rdf:resource="#BiochemicalReaction1145" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1283">
 <bp:evidence rdf:resource="#Evidence1498" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SLP-76 by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction963">
 <bp:evidence rdf:resource="#Evidence1142" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Chloride ion and N-acyl group react to chloramide</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis463">
 <bp:controlled rdf:resource="#BiochemicalReaction1137" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1280">
 <bp:evidence rdf:resource="#Evidence1495" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction962">
 <bp:evidence rdf:resource="#Evidence1141" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid and nitrite react to nitryl chloride (NO2Cl)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis464">
 <bp:controlled rdf:resource="#BiochemicalReaction1140" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1281">
 <bp:evidence rdf:resource="#Evidence1496" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of PAK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction965">
 <bp:evidence rdf:resource="#Evidence1144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid (HOCl) reacts with unsaturated lipid to form lipid chlorohydrins</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis461">
 <bp:controlled rdf:resource="#BiochemicalReaction1134" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction964">
 <bp:evidence rdf:resource="#Evidence1143" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lactoperoxidase (LPO) produces OSCN-</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis462">
 <bp:controlled rdf:resource="#BiochemicalReaction1135" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction967">
 <bp:evidence rdf:resource="#Evidence1146" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myeloperoxidase (MPO) produces hypochlorous acid (HOCl)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction966">
 <bp:evidence rdf:resource="#Evidence1145" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid (HOCL) reacts with Lys residue to form Lys-monochloramine</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis460">
 <bp:controlled rdf:resource="#BiochemicalReaction1132" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1193">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep380">
 <bp:stepProcess rdf:resource="#Pathway68" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1192">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep381">
 <bp:stepProcess rdf:resource="#BiochemicalReaction314" />
 <bp:stepProcess rdf:resource="#Catalysis153" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1195">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1288">
 <bp:evidence rdf:resource="#Evidence1503" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and activation of VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep382">
 <bp:stepProcess rdf:resource="#BiochemicalReaction315" />
 <bp:stepProcess rdf:resource="#Catalysis154" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1194">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1289">
 <bp:evidence rdf:resource="#Evidence1504" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of RAC1 by VAV</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1197">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis458">
 <bp:controlled rdf:resource="#BiochemicalReaction1125" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1286">
 <bp:evidence rdf:resource="#Evidence1501" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation and activation of MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1196">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis459">
 <bp:controlled rdf:resource="#BiochemicalReaction1131" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1287">
 <bp:evidence rdf:resource="#Evidence1502" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SHC by SYK kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction970">
 <bp:evidence rdf:resource="#Evidence1149" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric oxide and O2 react to NO2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1199">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis456">
 <bp:controlled rdf:resource="#BiochemicalReaction1120" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1284">
 <bp:evidence rdf:resource="#Evidence1499" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1198">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis457">
 <bp:controlled rdf:resource="#BiochemicalReaction1124" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1285">
 <bp:evidence rdf:resource="#Evidence1500" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep387">
 <bp:stepProcess rdf:resource="#Pathway69" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep388">
 <bp:stepProcess rdf:resource="#BiochemicalReaction320" />
 <bp:stepProcess rdf:resource="#Catalysis155" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep389">
 <bp:stepProcess rdf:resource="#BiochemicalReaction321" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep383">
 <bp:stepProcess rdf:resource="#BiochemicalReaction316" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep384">
 <bp:stepProcess rdf:resource="#BiochemicalReaction317" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep385">
 <bp:stepProcess rdf:resource="#BiochemicalReaction318" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep386">
 <bp:stepProcess rdf:resource="#BiochemicalReaction319" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction958">
 <bp:evidence rdf:resource="#Evidence1137" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cys-sulfenyl chloride is converted to Cys-sulfenic acid</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction957">
 <bp:evidence rdf:resource="#Evidence1136" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myeloperoxidase (MPO) binds to the bacterial cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction959">
 <bp:evidence rdf:resource="#Evidence1138" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OSCN- reacts with Cys residues</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction950">
 <bp:evidence rdf:resource="#Evidence1128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N2O3 diffuses to phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis454">
 <bp:controlled rdf:resource="#BiochemicalReaction1117" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1293">
 <bp:evidence rdf:resource="#Evidence1508" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of GRB2:SOS complex with p-SHC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis455">
 <bp:controlled rdf:resource="#BiochemicalReaction1119" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1294">
 <bp:evidence rdf:resource="#Evidence1509" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GADS:SLP-76 to p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction952">
 <bp:evidence rdf:resource="#Evidence1130" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Intraphagosomal pH is lowered to 5 by V-ATPase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis452">
 <bp:controlled rdf:resource="#BiochemicalReaction1110" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1291">
 <bp:evidence rdf:resource="#Evidence1506" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of GRB2:SOS to p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction951">
 <bp:evidence rdf:resource="#Evidence1129" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NRAMP1 transports divalent metal ions across phagosomal membranes of macrophages</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis453">
 <bp:controlled rdf:resource="#BiochemicalReaction1113" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1292">
 <bp:evidence rdf:resource="#Evidence1507" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction954">
 <bp:evidence rdf:resource="#Evidence1132" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S-nitrosylation of cysteine residues in proteins by N2O3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis450">
 <bp:controlled rdf:resource="#BiochemicalReaction1107" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction953">
 <bp:evidence rdf:resource="#Evidence1131" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Superoxide and nitric oxide react to peroxynitrite in the phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis451">
 <bp:controlled rdf:resource="#BiochemicalReaction1109" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1290">
 <bp:evidence rdf:resource="#Evidence1505" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction956">
 <bp:evidence rdf:resource="#Evidence1135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hypochlorous acid (HOCL) oxidizes Cys residues to form Cys-sulfenyl chloride</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction955">
 <bp:evidence rdf:resource="#Evidence1134" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HOCl-induced glycosaminoglycan fragmentation</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep390">
 <bp:stepProcess rdf:resource="#BiochemicalReaction322" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep391">
 <bp:stepProcess rdf:resource="#BiochemicalReaction323" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep392">
 <bp:stepProcess rdf:resource="#Pathway70" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis449">
 <bp:controlled rdf:resource="#BiochemicalReaction1103" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep393">
 <bp:stepProcess rdf:resource="#Pathway71" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis447">
 <bp:controlled rdf:resource="#BiochemicalReaction1098" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1297">
 <bp:evidence rdf:resource="#Evidence1512" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PLC-gamma to SLP-76 and p-5Y-LAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis448">
 <bp:controlled rdf:resource="#BiochemicalReaction1101" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1298">
 <bp:evidence rdf:resource="#Evidence1513" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MEK7 by MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis445">
 <bp:controlled rdf:resource="#BiochemicalReaction1093" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1295">
 <bp:evidence rdf:resource="#Evidence1510" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SOS mediated nucleotide exchange of RAS (SHC)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis446">
 <bp:controlled rdf:resource="#BiochemicalReaction1096" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1296">
 <bp:evidence rdf:resource="#Evidence1511" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of MEK4 by MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep398">
 <bp:stepProcess rdf:resource="#BiochemicalReaction328" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep399">
 <bp:stepProcess rdf:resource="#BiochemicalReaction329" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep394">
 <bp:stepProcess rdf:resource="#BiochemicalReaction324" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep395">
 <bp:stepProcess rdf:resource="#BiochemicalReaction325" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep396">
 <bp:stepProcess rdf:resource="#BiochemicalReaction326" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep397">
 <bp:stepProcess rdf:resource="#Catalysis156" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction327" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction947">
 <bp:evidence rdf:resource="#Evidence1125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HV1-mediated H+ transfer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction946">
 <bp:evidence rdf:resource="#Evidence1124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydroxyl radical reacts with the base and sugar moiety of DNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction949">
 <bp:evidence rdf:resource="#Evidence1127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Glutathione scavenges nitrosyl</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction948">
 <bp:evidence rdf:resource="#Evidence1126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric oxide oxidizes to nitrosyl ion</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis443">
 <bp:controlled rdf:resource="#BiochemicalReaction1082" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1260">
 <bp:evidence rdf:resource="#Evidence1473" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of BCL10:MALT1 with CARMA1 to form CBM complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis444">
 <bp:controlled rdf:resource="#BiochemicalReaction1088" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1261">
 <bp:evidence rdf:resource="#Evidence1474" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of TAK1 complex bound to pUb-TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction941">
 <bp:evidence rdf:resource="#Evidence1119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydroperoxyl enters the bacterium</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis441">
 <bp:controlled rdf:resource="#BiochemicalReaction1075" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction940">
 <bp:evidence rdf:resource="#Evidence1118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric oxide enters the bacterium</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis442">
 <bp:controlled rdf:resource="#BiochemicalReaction1080" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction943">
 <bp:evidence rdf:resource="#Evidence1121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydroxyl-initiated lipid peroxidation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction942">
 <bp:evidence rdf:resource="#Evidence1120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Superoxide and nitric oxide react to peroxynitrite</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis440">
 <bp:controlled rdf:resource="#BiochemicalReaction1074" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction945">
 <bp:evidence rdf:resource="#Evidence1123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peroxynitrite oxidizes Cys residues</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction944">
 <bp:evidence rdf:resource="#Evidence1122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Peroxynitrite oxidizes Peptide-Methionine residues</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1268">
 <bp:evidence rdf:resource="#Evidence1482" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TEC kinases to p-SLP-76</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1269">
 <bp:evidence rdf:resource="#Evidence1483" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of CaN:CaM:NFAT to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis438">
 <bp:controlled rdf:resource="#BiochemicalReaction1071" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1266">
 <bp:evidence rdf:resource="#Evidence1479" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IgE binds omalizumab</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis439">
 <bp:controlled rdf:resource="#BiochemicalReaction1072" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1267">
 <bp:evidence rdf:resource="#Evidence1480" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis436">
 <bp:controlled rdf:resource="#BiochemicalReaction1066" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1264">
 <bp:evidence rdf:resource="#Evidence1477" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oligomerization of p-CARMA1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis437">
 <bp:controlled rdf:resource="#BiochemicalReaction1067" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1265">
 <bp:evidence rdf:resource="#Evidence1478" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of LYN kinase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis434">
 <bp:controlled rdf:resource="#BiochemicalReaction1064" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1262">
 <bp:evidence rdf:resource="#Evidence1475" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RasGRP interacts with DAG and Ca2+</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis435">
 <bp:controlled rdf:resource="#BiochemicalReaction1065" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1263">
 <bp:evidence rdf:resource="#Evidence1476" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Oligomerization of TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction936">
 <bp:evidence rdf:resource="#Evidence1114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric oxide diffuses into the phagosome</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction935">
 <bp:evidence rdf:resource="#Evidence1113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Superoxide anion dismutates to H2O2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction938">
 <bp:evidence rdf:resource="#Evidence1116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Superoxide anion reacts with Fe-S cluster</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction937">
 <bp:evidence rdf:resource="#Evidence1115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrogen peroxide and Fe2+ react to hydroxyl, hydroxide and Fe3+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction939">
 <bp:evidence rdf:resource="#Evidence1117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">H2O2 oxidizes Cys residues to form Cys-sulfenic acid</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis432">
 <bp:controlled rdf:resource="#BiochemicalReaction1057" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1271">
 <bp:evidence rdf:resource="#Evidence1485" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of TEC kinases by p-SYK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis433">
 <bp:controlled rdf:resource="#BiochemicalReaction1059" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1272">
 <bp:evidence rdf:resource="#Evidence1486" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrolysis of PIP2 by PLCG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction930">
 <bp:evidence rdf:resource="#Evidence1107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains upon ALPK1:ADP-heptose stimulation </bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis430">
 <bp:controlled rdf:resource="#BiochemicalReaction1054" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis431">
 <bp:controlled rdf:resource="#BiochemicalReaction1055" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1270">
 <bp:evidence rdf:resource="#Evidence1484" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcineurin binds and dephosphorylates NFAT</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction932">
 <bp:evidence rdf:resource="#Evidence1110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nitric Oxide Synthase (NOS) produces Nitric Oxide (NO)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction931">
 <bp:evidence rdf:resource="#Evidence1109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NO and NO2 react to N2O3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction934">
 <bp:evidence rdf:resource="#Evidence1112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protonation of superoxide</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction933">
 <bp:evidence rdf:resource="#Evidence1111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOX2 generates superoxide anion from oxygen</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis429">
 <bp:controlled rdf:resource="#BiochemicalReaction1053" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1279">
 <bp:evidence rdf:resource="#Evidence1494" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of PAK to the membrane by binding active RAC1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis427">
 <bp:controlled rdf:resource="#BiochemicalReaction1049" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1277">
 <bp:evidence rdf:resource="#Evidence1491" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3R:I(1,4,5)P3 tetramer transports Ca2+ from ER lumen to cytosol</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis428">
 <bp:controlled rdf:resource="#BiochemicalReaction1052" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1278">
 <bp:evidence rdf:resource="#Evidence1492" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of PLC-gamma</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis425">
 <bp:controlled rdf:resource="#BiochemicalReaction1047" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1275">
 <bp:evidence rdf:resource="#Evidence1489" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of Calcineurin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis426">
 <bp:controlled rdf:resource="#BiochemicalReaction1048" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1276">
 <bp:evidence rdf:resource="#Evidence1490" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Calcium binds calmodulin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis423">
 <bp:controlled rdf:resource="#BiochemicalReaction1042" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1273">
 <bp:evidence rdf:resource="#Evidence1487" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Autophosphorylation of BTK/ITK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis424">
 <bp:controlled rdf:resource="#BiochemicalReaction1044" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction1274">
 <bp:evidence rdf:resource="#Evidence1488" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IP3 binds to the IP3 receptor, opening the endoplasmic reticulum Ca2+ channel</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction246">
 <bp:evidence rdf:resource="#Evidence301" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction245">
 <bp:evidence rdf:resource="#Evidence300" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction248">
 <bp:evidence rdf:resource="#Evidence304" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction247">
 <bp:evidence rdf:resource="#Evidence303" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction249">
 <bp:evidence rdf:resource="#Evidence305" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction251">
 <bp:evidence rdf:resource="#Evidence307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction250">
 <bp:evidence rdf:resource="#Evidence306" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction253">
 <bp:evidence rdf:resource="#Evidence311" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction252">
 <bp:evidence rdf:resource="#Evidence310" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction255">
 <bp:evidence rdf:resource="#Evidence313" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction254">
 <bp:evidence rdf:resource="#Evidence312" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction235">
 <bp:evidence rdf:resource="#Evidence287" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction234">
 <bp:evidence rdf:resource="#Evidence286" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction237">
 <bp:evidence rdf:resource="#Evidence289" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction236">
 <bp:evidence rdf:resource="#Evidence288" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction239">
 <bp:evidence rdf:resource="#Evidence291" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR4:LY96:LPS:CD14 recruits TRAM (TICAM2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction238">
 <bp:evidence rdf:resource="#Evidence290" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction240">
 <bp:evidence rdf:resource="#Evidence292" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transfer of LPS onto TLR4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction242">
 <bp:evidence rdf:resource="#Evidence294" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endocytosis of TRAM (TICAM2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction241">
 <bp:evidence rdf:resource="#Evidence293" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Endocytosis of TLR4:LY96:LPS:CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction244">
 <bp:evidence rdf:resource="#Evidence299" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction243">
 <bp:evidence rdf:resource="#Evidence295" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Association of LBP with LPS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction224">
 <bp:evidence rdf:resource="#Evidence275" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction223">
 <bp:evidence rdf:resource="#Evidence274" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction226">
 <bp:evidence rdf:resource="#Evidence277" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4:TIRAP interacts with BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction225">
 <bp:evidence rdf:resource="#Evidence276" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction228">
 <bp:evidence rdf:resource="#Evidence279" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction227">
 <bp:evidence rdf:resource="#Evidence278" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of p-IRAK2:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction229">
 <bp:evidence rdf:resource="#Evidence280" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction231">
 <bp:evidence rdf:resource="#Evidence282" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction230">
 <bp:evidence rdf:resource="#Evidence281" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:TIRAP:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction233">
 <bp:evidence rdf:resource="#Evidence284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to p-IRAK2  </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction232">
 <bp:evidence rdf:resource="#Evidence283" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with TIRAP:activated TLR2/4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction213">
 <bp:evidence rdf:resource="#Evidence263" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction212">
 <bp:evidence rdf:resource="#Evidence262" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction215">
 <bp:evidence rdf:resource="#Evidence265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction214">
 <bp:evidence rdf:resource="#Evidence264" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction217">
 <bp:evidence rdf:resource="#Evidence267" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction216">
 <bp:evidence rdf:resource="#Evidence266" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction219">
 <bp:evidence rdf:resource="#Evidence270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction218">
 <bp:evidence rdf:resource="#Evidence269" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction220">
 <bp:evidence rdf:resource="#Evidence271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction222">
 <bp:evidence rdf:resource="#Evidence273" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction221">
 <bp:evidence rdf:resource="#Evidence272" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction209">
 <bp:evidence rdf:resource="#Evidence257" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence592">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence591">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence590">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction202">
 <bp:evidence rdf:resource="#Evidence249" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence596">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction201">
 <bp:evidence rdf:resource="#Evidence248" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence595">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction204">
 <bp:evidence rdf:resource="#Evidence251" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence594">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction203">
 <bp:evidence rdf:resource="#Evidence250" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence593">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction206">
 <bp:evidence rdf:resource="#Evidence254" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction205">
 <bp:evidence rdf:resource="#Evidence252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence599">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction208">
 <bp:evidence rdf:resource="#Evidence256" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence598">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction207">
 <bp:evidence rdf:resource="#Evidence255" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence597">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction211">
 <bp:evidence rdf:resource="#Evidence261" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction210">
 <bp:evidence rdf:resource="#Evidence259" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence581">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence580">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence585">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence584">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence583">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence582">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence589">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence588">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence587">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence586">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction200">
 <bp:evidence rdf:resource="#Evidence245" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis1">
 <bp:controlled rdf:resource="#BiochemicalReaction2" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis2">
 <bp:controlled rdf:resource="#BiochemicalReaction6" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis3">
 <bp:controlled rdf:resource="#BiochemicalReaction11" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis4">
 <bp:controlled rdf:resource="#BiochemicalReaction12" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence570">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence574">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence573">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence572">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence571">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence578">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence577">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence576">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence575">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence579">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence563">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence562">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence561">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence560">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence567">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence566">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence565">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence564">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence569">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence568">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence32">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1319">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence33">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1318">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence30">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence31">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence552">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence551">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence38">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence550">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence39">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence36">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence556">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence37">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence555">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence34">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence554">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence35">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence553">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence559">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence558">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence557">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1311">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1310">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1313">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1312">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1315">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1314">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1317">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1316">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence21">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence22">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1329">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence20">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence29">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence541">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence540">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence27">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence28">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence25">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence545">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence26">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence544">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence23">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence543">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence24">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence542">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence549">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence548">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence547">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence546">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1320">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1322">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1321">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1324">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1323">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1326">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1325">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1328">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1327">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence10">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence11">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence18">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence530">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence19">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence16">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence17">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence14">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence534">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence15">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence533">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence12">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence532">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence13">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence531">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence538">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence537">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence536">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence535">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1331">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence539">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1330">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1333">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1332">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1335">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1334">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1337">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1336">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1339">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1338">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence523">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence522">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence521">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence520">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence527">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence526">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence525">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence524">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1340">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence529">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1342">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence528">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1341">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1344">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1343">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1346">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1345">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1348">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1347">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1349">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction289">
 <bp:evidence rdf:resource="#Evidence353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence512">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence511">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence510">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction293">
 <bp:evidence rdf:resource="#Evidence357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence516">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction292">
 <bp:evidence rdf:resource="#Evidence356" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence515">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction295">
 <bp:evidence rdf:resource="#Evidence359" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SARM binds viral dsRNA:TLR3:TICAM1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence514">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction294">
 <bp:evidence rdf:resource="#Evidence358" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence513">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction297">
 <bp:evidence rdf:resource="#Evidence362" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK&#949; (IKBKE) binds K63-pUb-TANK:K63-pUb-TRAF3:TRIF:activated TLR3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction296">
 <bp:evidence rdf:resource="#Evidence361" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto-ubiquitination of TRAF3 within activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence519">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction299">
 <bp:evidence rdf:resource="#Evidence364" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRF-3/IRF7 and their release from the activated TLR3 complex </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence518">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction298">
 <bp:evidence rdf:resource="#Evidence363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 is phosphorylated within the activated TLR3 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence517">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction291">
 <bp:evidence rdf:resource="#Evidence355" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction290">
 <bp:evidence rdf:resource="#Evidence354" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction279">
 <bp:evidence rdf:resource="#Evidence342" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction278">
 <bp:evidence rdf:resource="#Evidence341" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence501">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence500">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction282">
 <bp:evidence rdf:resource="#Evidence346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence505">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction281">
 <bp:evidence rdf:resource="#Evidence345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence504">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction284">
 <bp:evidence rdf:resource="#Evidence348" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence503">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction283">
 <bp:evidence rdf:resource="#Evidence347" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence502">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction286">
 <bp:evidence rdf:resource="#Evidence350" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence509">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction285">
 <bp:evidence rdf:resource="#Evidence349" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence508">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction288">
 <bp:evidence rdf:resource="#Evidence352" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence507">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction287">
 <bp:evidence rdf:resource="#Evidence351" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence506">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction280">
 <bp:evidence rdf:resource="#Evidence344" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction268">
 <bp:evidence rdf:resource="#Evidence329" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction267">
 <bp:evidence rdf:resource="#Evidence328" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction269">
 <bp:evidence rdf:resource="#Evidence331" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction271">
 <bp:evidence rdf:resource="#Evidence333" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction270">
 <bp:evidence rdf:resource="#Evidence332" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction273">
 <bp:evidence rdf:resource="#Evidence335" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction272">
 <bp:evidence rdf:resource="#Evidence334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction275">
 <bp:evidence rdf:resource="#Evidence337" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction274">
 <bp:evidence rdf:resource="#Evidence336" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction277">
 <bp:evidence rdf:resource="#Evidence339" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Viral dsRNA:TLR3 recruits TRIF (TICAM1)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction276">
 <bp:evidence rdf:resource="#Evidence338" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1308">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1307">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1309">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction257">
 <bp:evidence rdf:resource="#Evidence316" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction256">
 <bp:evidence rdf:resource="#Evidence314" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction259">
 <bp:evidence rdf:resource="#Evidence318" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction258">
 <bp:evidence rdf:resource="#Evidence317" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction260">
 <bp:evidence rdf:resource="#Evidence319" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction262">
 <bp:evidence rdf:resource="#Evidence323" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction261">
 <bp:evidence rdf:resource="#Evidence321" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction264">
 <bp:evidence rdf:resource="#Evidence325" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction263">
 <bp:evidence rdf:resource="#Evidence324" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction266">
 <bp:evidence rdf:resource="#Evidence327" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction265">
 <bp:evidence rdf:resource="#Evidence326" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1300">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1302">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1301">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1304">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1303">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1306">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1305">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis380">
 <bp:controlled rdf:resource="#BiochemicalReaction837" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis381">
 <bp:controlled rdf:resource="#BiochemicalReaction838" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep226">
 <bp:stepProcess rdf:resource="#BiochemicalReaction185" />
 <bp:stepProcess rdf:resource="#Catalysis87" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep227">
 <bp:stepProcess rdf:resource="#BiochemicalReaction186" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep228">
 <bp:stepProcess rdf:resource="#BiochemicalReaction187" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep229">
 <bp:stepProcess rdf:resource="#Catalysis88" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction188" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis388">
 <bp:controlled rdf:resource="#BiochemicalReaction878" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis389">
 <bp:controlled rdf:resource="#BiochemicalReaction880" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis386">
 <bp:controlled rdf:resource="#BiochemicalReaction875" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis387">
 <bp:controlled rdf:resource="#BiochemicalReaction876" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis384">
 <bp:controlled rdf:resource="#BiochemicalReaction871" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis385">
 <bp:controlled rdf:resource="#BiochemicalReaction872" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis382">
 <bp:controlled rdf:resource="#BiochemicalReaction839" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis383">
 <bp:controlled rdf:resource="#BiochemicalReaction853" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1270">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1272">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1271">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1274">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1273">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis379">
 <bp:controlled rdf:resource="#BiochemicalReaction836" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1276">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1275">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep222">
 <bp:stepProcess rdf:resource="#BiochemicalReaction181" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1278">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep223">
 <bp:stepProcess rdf:resource="#BiochemicalReaction182" />
 <bp:stepProcess rdf:resource="#Catalysis85" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1277">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep224">
 <bp:stepProcess rdf:resource="#BiochemicalReaction183" />
 <bp:stepProcess rdf:resource="#Catalysis86" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep225">
 <bp:stepProcess rdf:resource="#BiochemicalReaction184" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1279">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep220">
 <bp:stepProcess rdf:resource="#BiochemicalReaction179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep221">
 <bp:stepProcess rdf:resource="#Catalysis84" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction180" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis370">
 <bp:controlled rdf:resource="#BiochemicalReaction797" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep237">
 <bp:stepProcess rdf:resource="#BiochemicalReaction194" />
 <bp:stepProcess rdf:resource="#Catalysis93" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction195" />
 <bp:stepProcess rdf:resource="#Catalysis94" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep239">
 <bp:stepProcess rdf:resource="#Pathway45" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis377">
 <bp:controlled rdf:resource="#BiochemicalReaction832" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis378">
 <bp:controlled rdf:resource="#BiochemicalReaction833" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis375">
 <bp:controlled rdf:resource="#BiochemicalReaction811" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis376">
 <bp:controlled rdf:resource="#BiochemicalReaction824" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis373">
 <bp:controlled rdf:resource="#BiochemicalReaction801" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis374">
 <bp:controlled rdf:resource="#BiochemicalReaction810" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis371">
 <bp:controlled rdf:resource="#BiochemicalReaction799" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1290">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis372">
 <bp:controlled rdf:resource="#BiochemicalReaction800" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1281">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1280">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1283">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1282">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1285">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1284">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis368">
 <bp:controlled rdf:resource="#BiochemicalReaction795" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1287">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis369">
 <bp:controlled rdf:resource="#BiochemicalReaction796" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1286">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep233">
 <bp:stepProcess rdf:resource="#Catalysis92" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction192" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1289">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep234">
 <bp:stepProcess rdf:resource="#Pathway43" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1288">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep235">
 <bp:stepProcess rdf:resource="#Pathway44" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep236">
 <bp:stepProcess rdf:resource="#BiochemicalReaction193" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep230">
 <bp:stepProcess rdf:resource="#Catalysis89" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction189" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep231">
 <bp:stepProcess rdf:resource="#Catalysis90" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction190" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep232">
 <bp:stepProcess rdf:resource="#Catalysis91" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction191" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep248">
 <bp:stepProcess rdf:resource="#Catalysis98" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction202" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep249">
 <bp:stepProcess rdf:resource="#Catalysis99" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction203" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis366">
 <bp:controlled rdf:resource="#BiochemicalReaction792" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis367">
 <bp:controlled rdf:resource="#BiochemicalReaction793" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis364">
 <bp:controlled rdf:resource="#BiochemicalReaction772" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis365">
 <bp:controlled rdf:resource="#BiochemicalReaction775" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis362">
 <bp:controlled rdf:resource="#BiochemicalReaction756" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis363">
 <bp:controlled rdf:resource="#BiochemicalReaction762" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis360">
 <bp:controlled rdf:resource="#BiochemicalReaction746" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis361">
 <bp:controlled rdf:resource="#BiochemicalReaction752" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1292">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1291">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1294">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1293">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis359">
 <bp:controlled rdf:resource="#BiochemicalReaction725" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1296">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1295">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis357">
 <bp:controlled rdf:resource="#BiochemicalReaction723" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1298">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis358">
 <bp:controlled rdf:resource="#BiochemicalReaction724" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1297">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep244">
 <bp:stepProcess rdf:resource="#BiochemicalReaction200" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep245">
 <bp:stepProcess rdf:resource="#Pathway46" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1299">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep246">
 <bp:stepProcess rdf:resource="#Pathway47" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep247">
 <bp:stepProcess rdf:resource="#BiochemicalReaction201" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep240">
 <bp:stepProcess rdf:resource="#BiochemicalReaction196" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep241">
 <bp:stepProcess rdf:resource="#BiochemicalReaction197" />
 <bp:stepProcess rdf:resource="#Catalysis95" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction198" />
 <bp:stepProcess rdf:resource="#Catalysis96" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep243">
 <bp:stepProcess rdf:resource="#Catalysis97" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction199" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep259">
 <bp:stepProcess rdf:resource="#Pathway50" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis355">
 <bp:controlled rdf:resource="#BiochemicalReaction708" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis356">
 <bp:controlled rdf:resource="#BiochemicalReaction710" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis353">
 <bp:controlled rdf:resource="#BiochemicalReaction706" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis354">
 <bp:controlled rdf:resource="#BiochemicalReaction707" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis351">
 <bp:controlled rdf:resource="#BiochemicalReaction703" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis352">
 <bp:controlled rdf:resource="#BiochemicalReaction704" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis350">
 <bp:controlled rdf:resource="#BiochemicalReaction702" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep250">
 <bp:stepProcess rdf:resource="#BiochemicalReaction204" />
 <bp:stepProcess rdf:resource="#Catalysis100" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis348">
 <bp:controlled rdf:resource="#BiochemicalReaction700" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis349">
 <bp:controlled rdf:resource="#BiochemicalReaction701" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis346">
 <bp:controlled rdf:resource="#BiochemicalReaction698" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis347">
 <bp:controlled rdf:resource="#BiochemicalReaction699" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep255">
 <bp:stepProcess rdf:resource="#Catalysis103" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction208" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep256">
 <bp:stepProcess rdf:resource="#BiochemicalReaction209" />
 <bp:stepProcess rdf:resource="#Catalysis104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep257">
 <bp:stepProcess rdf:resource="#Pathway49" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep258">
 <bp:stepProcess rdf:resource="#BiochemicalReaction210" />
 <bp:stepProcess rdf:resource="#Catalysis105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep251">
 <bp:stepProcess rdf:resource="#BiochemicalReaction205" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep252">
 <bp:stepProcess rdf:resource="#Pathway48" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep253">
 <bp:stepProcess rdf:resource="#Catalysis101" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction206" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep254">
 <bp:stepProcess rdf:resource="#Catalysis102" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction207" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1230">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1232">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1231">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1234">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1233">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1236">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1235">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1238">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1237">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1239">
</bp:Evidence>

<bp:Provenance rdf:ID="Provenance1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Reactome</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.reactome.org</bp:comment>
</bp:Provenance>

<bp:Evidence rdf:ID="Evidence1241">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1240">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1243">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1242">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1245">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1244">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1247">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1246">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1249">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1248">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep208">
 <bp:stepProcess rdf:resource="#BiochemicalReaction168" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep209">
 <bp:stepProcess rdf:resource="#Pathway42" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep204">
 <bp:stepProcess rdf:resource="#Catalysis79" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction165" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep205">
 <bp:stepProcess rdf:resource="#BiochemicalReaction166" />
 <bp:stepProcess rdf:resource="#Catalysis80" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep206">
 <bp:stepProcess rdf:resource="#Pathway41" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep207">
 <bp:stepProcess rdf:resource="#BiochemicalReaction167" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1250">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1252">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1251">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1254">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1253">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep200">
 <bp:stepProcess rdf:resource="#BiochemicalReaction162" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1256">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep201">
 <bp:stepProcess rdf:resource="#Pathway40" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1255">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction163" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1258">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep203">
 <bp:stepProcess rdf:resource="#BiochemicalReaction164" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1257">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1259">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep219">
 <bp:stepProcess rdf:resource="#BiochemicalReaction178" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis391">
 <bp:controlled rdf:resource="#BiochemicalReaction890" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis392">
 <bp:controlled rdf:resource="#BiochemicalReaction896" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis390">
 <bp:controlled rdf:resource="#BiochemicalReaction889" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep215">
 <bp:stepProcess rdf:resource="#BiochemicalReaction174" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep216">
 <bp:stepProcess rdf:resource="#BiochemicalReaction175" />
 <bp:stepProcess rdf:resource="#Catalysis83" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep217">
 <bp:stepProcess rdf:resource="#BiochemicalReaction176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep218">
 <bp:stepProcess rdf:resource="#BiochemicalReaction177" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis399">
 <bp:controlled rdf:resource="#BiochemicalReaction927" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis397">
 <bp:controlled rdf:resource="#BiochemicalReaction919" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis398">
 <bp:controlled rdf:resource="#BiochemicalReaction923" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis395">
 <bp:controlled rdf:resource="#BiochemicalReaction906" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis396">
 <bp:controlled rdf:resource="#BiochemicalReaction909" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis393">
 <bp:controlled rdf:resource="#BiochemicalReaction899" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis394">
 <bp:controlled rdf:resource="#BiochemicalReaction905" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence1261">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1260">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1262">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1264">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep211">
 <bp:stepProcess rdf:resource="#Catalysis81" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction170" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1267">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep212">
 <bp:stepProcess rdf:resource="#BiochemicalReaction171" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1266">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep213">
 <bp:stepProcess rdf:resource="#BiochemicalReaction172" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1269">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep214">
 <bp:stepProcess rdf:resource="#BiochemicalReaction173" />
 <bp:stepProcess rdf:resource="#Catalysis82" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1268">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep210">
 <bp:stepProcess rdf:resource="#BiochemicalReaction169" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis300">
 <bp:controlled rdf:resource="#BiochemicalReaction614" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis301">
 <bp:controlled rdf:resource="#BiochemicalReaction615" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis9">
 <bp:controlled rdf:resource="#BiochemicalReaction28" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis5">
 <bp:controlled rdf:resource="#BiochemicalReaction14" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis6">
 <bp:controlled rdf:resource="#BiochemicalReaction18" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis7">
 <bp:controlled rdf:resource="#BiochemicalReaction21" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis8">
 <bp:controlled rdf:resource="#BiochemicalReaction23" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis344">
 <bp:controlled rdf:resource="#BiochemicalReaction696" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis345">
 <bp:controlled rdf:resource="#BiochemicalReaction697" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis342">
 <bp:controlled rdf:resource="#BiochemicalReaction694" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis343">
 <bp:controlled rdf:resource="#BiochemicalReaction695" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis340">
 <bp:controlled rdf:resource="#BiochemicalReaction691" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis341">
 <bp:controlled rdf:resource="#BiochemicalReaction693" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep260">
 <bp:stepProcess rdf:resource="#Catalysis106" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction211" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis339">
 <bp:controlled rdf:resource="#BiochemicalReaction690" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep261">
 <bp:stepProcess rdf:resource="#Catalysis107" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction212" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis337">
 <bp:controlled rdf:resource="#BiochemicalReaction686" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis338">
 <bp:controlled rdf:resource="#BiochemicalReaction689" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis335">
 <bp:controlled rdf:resource="#BiochemicalReaction684" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis336">
 <bp:controlled rdf:resource="#BiochemicalReaction685" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep266">
 <bp:stepProcess rdf:resource="#Catalysis112" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction217" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep267">
 <bp:stepProcess rdf:resource="#Pathway51" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep268">
 <bp:stepProcess rdf:resource="#BiochemicalReaction218" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep269">
 <bp:stepProcess rdf:resource="#Catalysis113" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction219" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep262">
 <bp:stepProcess rdf:resource="#Catalysis108" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction213" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep263">
 <bp:stepProcess rdf:resource="#Catalysis109" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction214" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep264">
 <bp:stepProcess rdf:resource="#BiochemicalReaction215" />
 <bp:stepProcess rdf:resource="#Catalysis110" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep265">
 <bp:stepProcess rdf:resource="#Catalysis111" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction216" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis333">
 <bp:controlled rdf:resource="#BiochemicalReaction681" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis334">
 <bp:controlled rdf:resource="#BiochemicalReaction682" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis331">
 <bp:controlled rdf:resource="#BiochemicalReaction678" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis332">
 <bp:controlled rdf:resource="#BiochemicalReaction679" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis330">
 <bp:controlled rdf:resource="#BiochemicalReaction677" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep270">
 <bp:stepProcess rdf:resource="#BiochemicalReaction220" />
 <bp:stepProcess rdf:resource="#Catalysis114" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep271">
 <bp:stepProcess rdf:resource="#Catalysis115" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction221" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis328">
 <bp:controlled rdf:resource="#BiochemicalReaction675" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction222" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis329">
 <bp:controlled rdf:resource="#BiochemicalReaction676" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis326">
 <bp:controlled rdf:resource="#BiochemicalReaction670" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis327">
 <bp:controlled rdf:resource="#BiochemicalReaction672" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis324">
 <bp:controlled rdf:resource="#BiochemicalReaction667" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis325">
 <bp:controlled rdf:resource="#BiochemicalReaction669" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep277">
 <bp:stepProcess rdf:resource="#BiochemicalReaction227" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep278">
 <bp:stepProcess rdf:resource="#BiochemicalReaction228" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep279">
 <bp:stepProcess rdf:resource="#BiochemicalReaction229" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep273">
 <bp:stepProcess rdf:resource="#Catalysis116" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction223" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep274">
 <bp:stepProcess rdf:resource="#BiochemicalReaction224" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep275">
 <bp:stepProcess rdf:resource="#BiochemicalReaction225" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep276">
 <bp:stepProcess rdf:resource="#BiochemicalReaction226" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis322">
 <bp:controlled rdf:resource="#BiochemicalReaction660" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis323">
 <bp:controlled rdf:resource="#BiochemicalReaction662" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis320">
 <bp:controlled rdf:resource="#BiochemicalReaction653" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis321">
 <bp:controlled rdf:resource="#BiochemicalReaction657" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep280">
 <bp:stepProcess rdf:resource="#BiochemicalReaction230" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis319">
 <bp:controlled rdf:resource="#BiochemicalReaction652" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction231" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction232" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis317">
 <bp:controlled rdf:resource="#BiochemicalReaction645" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep283">
 <bp:stepProcess rdf:resource="#BiochemicalReaction233" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis318">
 <bp:controlled rdf:resource="#BiochemicalReaction646" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis315">
 <bp:controlled rdf:resource="#BiochemicalReaction631" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis316">
 <bp:controlled rdf:resource="#BiochemicalReaction644" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis313">
 <bp:controlled rdf:resource="#BiochemicalReaction628" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis314">
 <bp:controlled rdf:resource="#BiochemicalReaction629" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep288">
 <bp:stepProcess rdf:resource="#Catalysis118" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction237" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep289">
 <bp:stepProcess rdf:resource="#Catalysis119" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction238" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep284">
 <bp:stepProcess rdf:resource="#Pathway52" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep285">
 <bp:stepProcess rdf:resource="#BiochemicalReaction234" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction235" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep287">
 <bp:stepProcess rdf:resource="#Catalysis117" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction236" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis311">
 <bp:controlled rdf:resource="#BiochemicalReaction625" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis312">
 <bp:controlled rdf:resource="#BiochemicalReaction627" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis310">
 <bp:controlled rdf:resource="#BiochemicalReaction624" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep291">
 <bp:stepProcess rdf:resource="#BiochemicalReaction240" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis308">
 <bp:controlled rdf:resource="#BiochemicalReaction622" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep292">
 <bp:stepProcess rdf:resource="#BiochemicalReaction241" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis309">
 <bp:controlled rdf:resource="#BiochemicalReaction623" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep293">
 <bp:stepProcess rdf:resource="#BiochemicalReaction242" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis306">
 <bp:controlled rdf:resource="#BiochemicalReaction620" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction243" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis307">
 <bp:controlled rdf:resource="#BiochemicalReaction621" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis304">
 <bp:controlled rdf:resource="#BiochemicalReaction618" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis305">
 <bp:controlled rdf:resource="#BiochemicalReaction619" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis302">
 <bp:controlled rdf:resource="#BiochemicalReaction616" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep290">
 <bp:stepProcess rdf:resource="#BiochemicalReaction239" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis303">
 <bp:controlled rdf:resource="#BiochemicalReaction617" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep299">
 <bp:stepProcess rdf:resource="#BiochemicalReaction245" />
 <bp:stepProcess rdf:resource="#Catalysis120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep295">
 <bp:stepProcess rdf:resource="#Pathway53" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep296">
 <bp:stepProcess rdf:resource="#Pathway54" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep297">
 <bp:stepProcess rdf:resource="#Pathway55" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction244" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence273">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence272">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence271">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence270">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence277">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence276">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence275">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence274">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence279">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence278">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence262">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence261">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence260">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence266">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence265">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence264">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence263">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence269">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence268">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence267">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence251">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence250">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence255">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence254">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence253">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence252">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence259">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence258">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence257">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence256">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence240">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence244">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence243">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence242">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence241">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence248">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence247">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence246">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence245">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence249">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence233">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence232">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence231">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence230">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence237">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence236">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence235">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence234">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence239">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence238">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence222">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction796">
 <bp:evidence rdf:resource="#Evidence953" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor D cleaves C3b-bound Factor B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence221">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction795">
 <bp:evidence rdf:resource="#Evidence952" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor D cleaves C3(H2O)-bound Factor B</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence220">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction798">
 <bp:evidence rdf:resource="#Evidence955" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Classical C3 convertase (C4b:C2a complex)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction797">
 <bp:evidence rdf:resource="#Evidence954" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Conversion of C2 into C2a and C2b</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence226">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence225">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction799">
 <bp:evidence rdf:resource="#Evidence956" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Conversion of C4 into C4a and C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence224">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence223">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence229">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence228">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence227">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence211">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction785">
 <bp:evidence rdf:resource="#Evidence940" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3 convertases spontaneously dissociate</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence210">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction784">
 <bp:evidence rdf:resource="#Evidence939" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD46 binds C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction787">
 <bp:evidence rdf:resource="#Evidence943" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b binds to cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction786">
 <bp:evidence rdf:resource="#Evidence941" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b binding protein displaces C2a</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence215">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction789">
 <bp:evidence rdf:resource="#Evidence946" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3b binds to cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence214">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction788">
 <bp:evidence rdf:resource="#Evidence945" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor B binds to C3(H2O)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence213">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence212">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence219">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence218">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence217">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction790">
 <bp:evidence rdf:resource="#Evidence947" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Spontaneous hydrolysis of C3 thioester</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence216">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction792">
 <bp:evidence rdf:resource="#Evidence949" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3(H2O):Factor Bb cleaves C3 to C3b and C3a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction791">
 <bp:evidence rdf:resource="#Evidence948" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Properdin stabilizes C3b:Bb bound to cell surfaces</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction794">
 <bp:evidence rdf:resource="#Evidence951" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor B binds to surface-associated C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction793">
 <bp:evidence rdf:resource="#Evidence950" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of alternative pathway C5 convertase</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence200">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction774">
 <bp:evidence rdf:resource="#Evidence929" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD59 inhibits MAC formation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction773">
 <bp:evidence rdf:resource="#Evidence928" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CFHR dimers bind C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction776">
 <bp:evidence rdf:resource="#Evidence931" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Hydrolysis of internal thioester in C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction775">
 <bp:evidence rdf:resource="#Evidence930" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Thrombin, ELANE cleave C5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence204">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction778">
 <bp:evidence rdf:resource="#Evidence933" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H binds to membrane-associated C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence203">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction777">
 <bp:evidence rdf:resource="#Evidence932" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C1-Inh binds Antigen: antibody: C1 complex activated C1r, C1s</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence202">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence201">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction779">
 <bp:evidence rdf:resource="#Evidence934" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I complex formation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence208">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence207">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence206">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence205">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction781">
 <bp:evidence rdf:resource="#Evidence936" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD46 binds C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction780">
 <bp:evidence rdf:resource="#Evidence935" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b binding protein binds Protein S</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction783">
 <bp:evidence rdf:resource="#Evidence938" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C1-Inh binds and inactivates C1r, C1s</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence209">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction782">
 <bp:evidence rdf:resource="#Evidence937" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Vitronectin (VTN) binds to C5b:C6:C7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1439">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1430">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1432">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1431">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1434">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1433">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1436">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1435">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1438">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1437">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1441">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway100">
 <bp:pathwayOrder rdf:resource="#PathwayStep553" />
 <bp:pathwayOrder rdf:resource="#PathwayStep554" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction455" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction454" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence553" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1440">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway101">
 <bp:pathwayOrder rdf:resource="#PathwayStep567" />
 <bp:pathwayOrder rdf:resource="#PathwayStep568" />
 <bp:pathwayOrder rdf:resource="#PathwayStep563" />
 <bp:pathwayOrder rdf:resource="#PathwayStep564" />
 <bp:pathwayOrder rdf:resource="#PathwayStep565" />
 <bp:pathwayOrder rdf:resource="#PathwayStep566" />
 <bp:pathwayOrder rdf:resource="#PathwayStep561" />
 <bp:pathwayOrder rdf:resource="#PathwayStep562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction462" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction461" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction464" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction466" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction465" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction468" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction467" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence561" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1443">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway102">
 <bp:pathwayOrder rdf:resource="#PathwayStep585" />
 <bp:pathwayOrder rdf:resource="#PathwayStep586" />
 <bp:pathwayOrder rdf:resource="#PathwayStep587" />
 <bp:pathwayOrder rdf:resource="#PathwayStep588" />
 <bp:pathwayOrder rdf:resource="#PathwayStep571" />
 <bp:pathwayOrder rdf:resource="#PathwayStep572" />
 <bp:pathwayOrder rdf:resource="#PathwayStep573" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction471" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction470" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction484" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction483" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction486" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction485" />
 <bp:pathwayComponent rdf:resource="#Pathway103" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence571" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1442">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway103">
 <bp:pathwayOrder rdf:resource="#PathwayStep580" />
 <bp:pathwayOrder rdf:resource="#PathwayStep578" />
 <bp:pathwayOrder rdf:resource="#PathwayStep579" />
 <bp:pathwayOrder rdf:resource="#PathwayStep574" />
 <bp:pathwayOrder rdf:resource="#PathwayStep575" />
 <bp:pathwayOrder rdf:resource="#PathwayStep576" />
 <bp:pathwayOrder rdf:resource="#PathwayStep577" />
 <bp:pathwayOrder rdf:resource="#PathwayStep581" />
 <bp:pathwayOrder rdf:resource="#PathwayStep582" />
 <bp:pathwayOrder rdf:resource="#PathwayStep583" />
 <bp:pathwayOrder rdf:resource="#PathwayStep584" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction480" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction482" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction481" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction473" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction472" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction475" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction477" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction476" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction479" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction478" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence574" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1445">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway104">
 <bp:pathwayOrder rdf:resource="#PathwayStep590" />
 <bp:pathwayOrder rdf:resource="#PathwayStep591" />
 <bp:pathwayOrder rdf:resource="#PathwayStep592" />
 <bp:pathwayOrder rdf:resource="#PathwayStep593" />
 <bp:pathwayOrder rdf:resource="#PathwayStep594" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction491" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction490" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction488" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction487" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction489" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence590" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1444">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway105">
 <bp:pathwayOrder rdf:resource="#PathwayStep596" />
 <bp:pathwayOrder rdf:resource="#PathwayStep597" />
 <bp:pathwayOrder rdf:resource="#PathwayStep598" />
 <bp:pathwayOrder rdf:resource="#PathwayStep599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction493" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction492" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction495" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction494" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence596" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1447">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway106">
 <bp:pathwayOrder rdf:resource="#PathwayStep602" />
 <bp:pathwayOrder rdf:resource="#PathwayStep687" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction568" />
 <bp:pathwayComponent rdf:resource="#Pathway107" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence602" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 10 (TLR10) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Little is known about TLR10 ligands. It has been established that the receptor homodimerizes upon binding and signals in an MyD88-dependent manner (Hasan U et al 2005; Nyman T et al 2008). It may also heterodimerize with TLRs 1 and 2. It is expressed in a restricted fashion as a highly N-glycosylated protein detectable in B cells and dendritic cells.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1446">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway107">
 <bp:pathwayOrder rdf:resource="#PathwayStep629" />
 <bp:pathwayOrder rdf:resource="#PathwayStep633" />
 <bp:pathwayOrder rdf:resource="#PathwayStep677" />
 <bp:pathwayOrder rdf:resource="#PathwayStep634" />
 <bp:pathwayOrder rdf:resource="#PathwayStep678" />
 <bp:pathwayOrder rdf:resource="#PathwayStep679" />
 <bp:pathwayOrder rdf:resource="#PathwayStep603" />
 <bp:pathwayOrder rdf:resource="#PathwayStep608" />
 <bp:pathwayOrder rdf:resource="#PathwayStep609" />
 <bp:pathwayOrder rdf:resource="#PathwayStep630" />
 <bp:pathwayOrder rdf:resource="#PathwayStep631" />
 <bp:pathwayOrder rdf:resource="#PathwayStep686" />
 <bp:pathwayOrder rdf:resource="#PathwayStep610" />
 <bp:pathwayOrder rdf:resource="#PathwayStep632" />
 <bp:pathwayOrder rdf:resource="#PathwayStep676" />
 <bp:pathwayOrder rdf:resource="#PathwayStep680" />
 <bp:pathwayComponent rdf:resource="#Pathway109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction521" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction520" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction501" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction523" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction567" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction522" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction558" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction502" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction524" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction559" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction561" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction560" />
 <bp:pathwayComponent rdf:resource="#Pathway120" />
 <bp:pathwayComponent rdf:resource="#Pathway111" />
 <bp:pathwayComponent rdf:resource="#Pathway108" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence603" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mammalian myeloid differentiation factor 88 (MyD88) is Toll/interleukin (IL)-1 (TIR)-domain containing adapter  protein which plays crucial role in TLR signaling. All TLRs, with only one exception of TLR3, can initiate downstream  signaling trough MyD88. In the MyD88 - dependent pathway, once the adaptor is bound to TLR  it leads to recruitment of IL1 receptor associated kinase family  IRAK which is followed by activation of tumour necrosis factor receptor-associated factor 6 (TRAF6) . TRAF6 is an ubiquitin E3 ligase which in turn induces TGF-beta activating kinase 1 (TAK1) auto phosphorylation. Once activated TAK1 can ultimately mediate the induction of the transcription factor NF-kB or the mitogen-activated protein kinases  (MAPK), such as JNK, p38 and ERK. This results in the translocation of the activated NF-kB and MAPKs to the nucleus and the initiation of appropriate gene transcription leading to the production of many proinflammatory cytokines and antimicrobial peptides.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1449">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway108">
 <bp:pathwayOrder rdf:resource="#PathwayStep604" />
 <bp:pathwayOrder rdf:resource="#PathwayStep605" />
 <bp:pathwayOrder rdf:resource="#PathwayStep606" />
 <bp:pathwayOrder rdf:resource="#PathwayStep607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction497" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction499" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction498" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction500" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence604" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1448">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1450">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1452">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1451">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1454">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1453">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1456">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1455">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1458">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1457">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1459">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1461">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1460">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1463">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1462">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1465">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1464">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1467">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1466">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1469">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1468">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1407">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1406">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1409">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1408">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1401">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1400">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1403">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1402">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1405">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1404">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1418">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1417">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1419">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1410">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1412">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1411">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1414">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1413">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1416">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1415">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1429">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1428">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1421">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1420">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1423">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1422">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1425">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1424">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1427">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1426">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep109">
 <bp:stepProcess rdf:resource="#Catalysis46" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction86" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep105">
 <bp:stepProcess rdf:resource="#Catalysis44" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction83" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep106">
 <bp:stepProcess rdf:resource="#Pathway24" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep107">
 <bp:stepProcess rdf:resource="#BiochemicalReaction84" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep108">
 <bp:stepProcess rdf:resource="#Catalysis45" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction85" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway170">
 <bp:pathwayOrder rdf:resource="#PathwayStep1035" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1036" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction866" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction867" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1035" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The IPAF inflammasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The IPAF (NLRC4) inflammasome can be activated by several stimuli, most notably by Gram-negative bacteria with either type III or type IV secretion systems that result in cytosolic flagellin, which is recognized by the IPAF inflammasome (Miao et al. 2006). IPAF also recognizes the rod-component of the type III secretion system which shares a sequence motif with flagellin that is essential for detection (Miao et al. 2010). Detection of Legionella and/or flagellin may also involve NAIP5 (Zamboni et al. 2006, Lightfield et al. 2008). IPAF contains a CARD domain and can interact directly with procaspase-1 (Poyet et al. 2001) but ASC increases the maximal activation of caspase-1 in response to S. typhimurium (Mariathasan et al. 2004), S. flexneri, and P. aeruginosa suggesting a possible collaboration with a PYD-containing NLRP for responses to these pathogens (Schroder    Tschopp, 2010). IPAF mediated caspase-1 activation can lead to a particular type of cell death called &apos;pyroptosis&apos; (see Schroder    Tschopp 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1391">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway171">
 <bp:pathwayOrder rdf:resource="#PathwayStep1055" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1068" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1056" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1040" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1073" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1095" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1094" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1041" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1074" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1080" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1039" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1038" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction869" />
 <bp:pathwayComponent rdf:resource="#Pathway172" />
 <bp:pathwayComponent rdf:resource="#Pathway173" />
 <bp:pathwayComponent rdf:resource="#Pathway174" />
 <bp:pathwayComponent rdf:resource="#Pathway175" />
 <bp:pathwayComponent rdf:resource="#Pathway176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction870" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction919" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction884" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction920" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction868" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction900" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1038" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DDX58/IFIH1-mediated induction of interferon-alpha/beta</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIG-I-like helicases (RLHs) the retinoic acid inducible gene-I (RIG-I, DDX58) and melanoma differentiation associated gene 5 (MDA5, IFIH1) are RNA helicases that recognize viral double-stranded RNA (dsRNA) present within the cytoplasm (Yoneyama M    Fujita T 2007, 2008). Upon viral infection dsRNA is generated by positive-strand RNA virus families such as Flaviviridae and Coronaviridae, negative-strand RNA virus families including Orthomyxoviridae and Paramyxoviridae, and DNA virus families such as Herpesviridae and Adenoviridae (Weber F et al. 2006; Son KN et al. 2015). Functionally RIG-I (DDX58) and MDA5 (IFIH1) positively regulate the IFN genes in a similar fashion, however they differ in their response to different viral species. DDX58 (RIG-I) is essential for detecting influenza virus, Sendai virus, VSV and Japanese encephalitis virus (JEV), whereas IFIH1 (MDA5) is essential in sensing encephalomyocarditis virus (EMCV), Mengo virus and Theiler&apos;s virus, all of which belong to the picornavirus family. RIG-I and MDA5 signalling results in the activation of IKK epsilon and (TKK binding kinase 1) TBK1, two serine/threonine kinases that phosphorylate interferon regulatory factor 3 and 7 (IRF3 and IRF7). Upon phosphorylation, IRF3 and IRF7 translocate to the nucleus and subsequently induce interferon alpha (IFNA) and interferon beta (IFNB) gene transcription (Yoneyama M et al. 2004; Yoneyama M    Fujita T 2007, 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1390">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway172">
 <bp:pathwayOrder rdf:resource="#PathwayStep1044" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1043" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1054" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1046" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1045" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1051" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1050" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1042" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1053" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1052" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1048" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1047" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1049" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction873" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction872" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction883" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction875" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction874" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction877" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction876" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction879" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction878" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction880" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction871" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction882" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction881" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1042" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulators of DDX58/IFIH1 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">As with other cytokine systems, production of type I IFN is a transient process, and can be hazardous to the host if unregulated, resulting in chronic cellular toxicity or inflammatory and autoimmune diseases. RIG-I-mediated production of IFN can, in turn, increase the transcription of RIG-I itself, thus setting into motion an IFN amplification loop, which if left unchecked, could become deleterious to the host. This module mainly focuses on the endogenous negative regulation of the RIG-I-like receptor (RLR) family proteins RIG-I (DDX58) and MDA5 (IFIH1).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1393">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway173">
 <bp:pathwayOrder rdf:resource="#PathwayStep1066" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1065" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1057" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1067" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1062" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1061" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1064" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1063" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1060" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1059" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1058" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction891" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction890" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction893" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction892" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction895" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction894" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction886" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction885" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction888" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction887" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction889" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1057" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF3-dependent IRF activation pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAVS via its TRAF-interaction motif (TIM) directly interacts with TRAF3 and recruits TRAF3 to the signaling complex. TRAF3 acts as a scaffold for the assembly of a signaling complex composed of IKK epsilon/TBK1, leading to the activation of transcription factors IRF3/IRF7.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1392">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway174">
 <bp:pathwayOrder rdf:resource="#PathwayStep1072" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1071" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1070" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1069" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction897" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction896" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction899" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction898" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1069" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated NF-kB activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The TRAF6/TAK1 signal activates a canonical IKK complex, resulting in the activation of NF-kappaB as well as MAPK cascades leading to the activation of AP-1. Although TRAF6/TAK1 has been implicated in Tool like receptor (TLR) mediated cytokine production, the involvement of these molecules in the regulation of type I IFN induction mediated by RIG-I (DDX58)/MDA5 (IFIH1) pathway is largely unknown. According to the study done by Yoshida et al. the DDX58:MAVS pathway requires TRAF6 and MAP3K, MEKK1 to activate NF-kappaB and MAP Kinases for optimal induction of type I IFNs.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1395">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway175">
 <bp:pathwayOrder rdf:resource="#PathwayStep1077" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1076" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1079" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1078" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1075" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction903" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction902" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction905" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction904" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction901" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1075" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fas-AssociatedDeathDomain (FADD) and receptor interacting protein 1 (RIP1) are death domain containing molecules that interact with the C-terminal portion of MAVS (IPS-1) and induce NF-kB through interaction and activation of initiator caspases (caspase-8 and -10). Caspases are usually involved in apoptosis and inflammation but they also exhibit nonapoptotic functions. These nonapoptotic caspase functions involve prodomain-mediated activation of NF-kB. Processed caspases (caspase-8/10) encoding the DED (death effector domain) strongly activate NF-kB. The exact mechanism by which caspases mediate NF-kB activation is unclear, but the prodomains of caspase-8/10 may act as a scaffolding and allow the recruitment of the IKK complex in association with other signaling molecules.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1394">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway176">
 <bp:pathwayOrder rdf:resource="#PathwayStep1091" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1090" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1082" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1093" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1081" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1092" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1088" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1087" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1089" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1084" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1083" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1086" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1085" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction914" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction913" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction916" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction915" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction907" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction918" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction906" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction917" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction909" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction908" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction910" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction912" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction911" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1081" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated IRF7 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 is crucial for both DDX58 (RIG-I)- and IFIH1 (MDA5)-mediated antiviral responses. The absence of TRAF6 resulted in enhanced viral replication and a significant reduction in the production of type I IFNs and IL6 after infection with RNA virus. Activation of NF-kB and IRF7, but not that of IRF3, was significantly impaired during RIG-like helicases (RLHs) signaling in the absence of TRAF6. TRAF6-induced activation of IRF is likely to be specific for IRF7, while TRAF3 is thought to activate both IRF3 and IRF7. These results strongly suggest that the TRAF6- and TRAF3-dependent pathways are likely to bifurcate at mitochondrial antiviral-signaling protein MAVS (IPS-1), but to converge later at IRF7 in order to co-operatively induce sufficient production of type I IFNs during RLH signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1397">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway177">
 <bp:pathwayOrder rdf:resource="#PathwayStep1099" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1098" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1100" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1097" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1102" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction925" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction924" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction927" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction926" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction929" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction928" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction930" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction921" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction923" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction922" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1097" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-protein kinase 1 signaling pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Immune recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRR) often activates proinflammatory nuclear factor kappa B (NF-&#954;B) signalling. Lipopolysaccharide (LPS) is a well-known PAMP produced by gram-negative bacteria. LPS is recognized by toll like receptor 4 (TLR4) and is a strong activator of NF-&#954;B inflammatory responses (Akashi S et al. 2003). LPS is also recognized in the cytosol by mouse caspase-11 and related human caspase-4 and caspase-5, which stimulate pyroptosis, a proinflammatory form of cell death (Kayagaki N et al. 2011; Shi J et al. 2015). Key metabolic intermediates in LPS biosynthesis, d-glycero-&#946;-d-manno-heptose 1,7-bisphosphate (HBP) and ADP L-glycero-&#946;-d-manno-heptose (ADP-heptose) were reported to activate the NF-&#954;B pathway and trigger the innate immune responses (Milivojevic M et al. 2017; Zimmermann S et al. 2017; Zhou P et al. 2018; Garc&#237;a-Weber D; 2018). ADP-heptose but not HBP can enter host cells autonomously (Zhou P et al. 2018). During infection, ADP-heptose or HBP translocate into the host cytosol where their presence is sensed by alpha-protein kinase 1 (ALPK1) (Zimmermann S et al. 2017; Zhou P et al. 2018). ADP-heptose directly binds and activates ALPK1 (Garcia-Weber D et al. 2018; Zhou P et al. 2018); instead, HBP is converted by host-derived adenylyltransferases, such as nicotinamide nucleotide adenylyltransferases, to ADP-heptose 7-P, a substrate which can then activate ALPK1 (Zhou P et al. 2018). The ADP-heptose binding to ALPK1 is thought to trigger conformational changes and stimulate the kinase domain of ALPK1 (Zhou P et al. 2018). ALPK1 kinase activity in turn leads to the phosphorylation-dependent oligomerization of the tumor necrosis factor (TNF-&#945;) receptor&#8211;associated factor (TRAF)&#8211;interacting protein with the forkhead-associated domain (TIFA) (Zimmermann S et al. 2017; Zhou P et al. 2018). This process activates TRAF6 oligomerization and ubiquitination, and the recruitment of transforming growth factor &#946;-activated kinase 1 (TAK1)-binding protein 2 (TAB2), a component of the TAK1 (MAP3K7) complex (Ea CK et al. 2004; Gaudet RG et al. 2017). This TIFA oligomer signaling platform was given the term: TIFAsome. TIFAsome-activated TAK1 induces NF-&#954;B nuclear translocation and proinflammatory gene expression. The ALPK1-TIFA signaling pathway has been identified in human embryonic kidney cells, intestinal epithelial cells, gastric cells and cervical cancer cells (Gaudet RG et al. 2015, 2017; Stein SC et al. 2017; Gall A et al. 2017; Zimmermann S et al. 2017; Milivojevic M et al. 2017; Zhou P et al. 2018). In vivo studies demonstrate that ADP-heptose and Burkholderia cenocepacia trigger massive inflammatory responses with increased production of several NF-&#954;B-dependent cytokines and chemokines in wild type (WT), but not in Alpk1-/- mice (Zhou P et al. 2018). This Reactome module describes ALPK1 as a cytosolic innate immune receptor for bacterial ADP-heptose.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1396">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep101">
 <bp:stepProcess rdf:resource="#Pathway22" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway178">
 <bp:pathwayOrder rdf:resource="#PathwayStep1110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1111" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1151" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1115" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1122" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1128" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1124" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1126" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction947" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction969" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction946" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction949" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction948" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction941" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction940" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction943" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction942" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction945" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction944" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction970" />
 <bp:pathwayComponent rdf:resource="#Pathway179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction936" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction935" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction938" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction937" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction939" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction950" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction972" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction971" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction952" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction974" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction951" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction973" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction932" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction954" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction931" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction953" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction975" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction934" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction933" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROS and RNS production in phagocytes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The first line of defense against infectious agents involves an active recruitment of phagocytes to the site of infection. Recruited cells include polymorhonuclear (PMN) leukocytes (i.e., neutrophils) and monocytes/macrophages, which function together as innate immunity sentinels (Underhill DM    Ozinsky A 2002; Stuart LM    Ezekowitz RA 2005; Flannagan RS et al. 2012). Dendritic cells are also present, serving as important players in antigen presentation for ensuing adaptive responses (Savina A    Amigorena S 2007). These cell types are able to bind and engulf invading microbes into a membrane-enclosed vacuole - the phagosome, in a process termed phagocytosis. Phagocytosis can be defined as the receptor-mediated engulfment of particles greater than 0.5 micron in diameter. It is initiated by the cross-linking of host cell membrane receptors following engagement with their cognate ligands on the target surface (Underhill DM    Ozinsky A 2002; Stuart LM    Ezekowitz RA 2005; Flannagan RS et al. 2012). When engulfed by phagocytes, microorganisms are exposed to a number of host defense microbicidal events within the resulting phagosome. These include the production of reactive oxygen and nitrogen species (ROS and RNS, RONS) by specialized enzymes (Fang FC et al. 2004; Kohchi C et al. 2009; Gostner JM et al. 2013; Vatansever F et al. 2013). NADPH oxidase (NOX) complex consume oxygen to produce superoxide radical anion (O2.-) and hydrogen peroxide (H2O2) (Robinson et al. 2004). Induced NO synthase (iNOS) is involved in the production of NO, which is the primary source of all RNS in biological systems (Evans TG et al. 1996). The phagocyte NADPH oxidase and iNOS are expressed in both PMN and mononuclear phagocytes and both cell types have the capacity for phagosomal burst activity. However, the magnitude of ROS generation in neutrophils far exceeds that observed in macrophages (VanderVen BC et al. 2009). Macrophages are thought to produce considerably more RNS than neutrophils (Fang FC et al. 2004; Nathan    Shiloh 2000). The presence of RONS characterized by a relatively low reactivity, such as H2O2, O2&#729;&#8722; or NO, has no deleterious effect on biological environment (Attia SM 2010; Weidinger A    and Kozlov AV 2015). Their activity is controlled by endogenous antioxidants (both enzymatic and non-enzymatic) that are induced by oxidative stress. However the relatively low reactive species can initiate a cascade of reactions to generate more damaging &#8220;secondary&#8221; species such as hydroxyl radical (&#8226;OH), singlet oxygen or peroxinitrite (Robinson JM 2008; Fang FC et al. 2004). These &quot;secondary&quot; RONS are extremely toxic causing irreversible damage to all classes of biomolecules (Weidinger A    and Kozlov AV 2015; Fang FC et al. 2004; Kohchi C et al. 2009; Gostner JM et al. 2013; Vatansever F et al. 2013). Although macrophages and neutrophils use similar mechanisms for the internalization of targets, there are differences in how they perform phagocytosis and in the final outcome of the process (Tapper H    Grinstein S 1997; Vierira OV et al. 2002). Once formed, the phagosome undergoes an extensive maturation process whereby it develops into a microbicidal organelle able to eliminate the invading pathogen. Maturation involves re-modeling both the membrane of the phagosome and its luminal contents (Vierira OV et al. 2002). In macrophages, phagosome formation and maturation follows a series of strictly coordinated membrane fission/fusion events between the phagosome and compartments of the endo/lysosomal network gradually transforming the nascent phagosome into a phagolysosome, a degradative organelle endowed with potent microbicidal properties (Zimmerli S et al. 1996; Vierira OV et al. 2002). Neutrophils instead contain a large number of preformed granules such as azurophilic and specific granules that can rapidly fuse with phagosomes delivering antimicrobial substances (Karlsson A    Dahlgren C 2002; Naucler C et al. 2002; Nordenfelt P and Tapper H 2011). Phagosomal pH dynamics may also contribute to the maturation process by regulating membrane traffic events. The microbicidal activity of macrophages is characterized by progressive acidification of the lumen (down to pH 4&#8211;5) by the proton pumping vATPase. A low pH is a prerequisite for optimal enzymatic activity of most late endosomal/lysosomal hydrolases reported in macrophages. Neutrophil phagosome pH regulation differs significantly from what is observed in macrophages (Nordenfelt P and Tapper H 2011; Winterbourn CC et al. 2016). The massive activation of the oxidative burst is thought to result in early alkalization of neutrophil phagosomes which is linked to proton consumption during the generation of hydrogen peroxide (Segal AW et al. 1981; Levine AP et al. 2015). Other studies showed that neutrophil phagosome maintained neutral pH values before the pH gradually decreased (Jankowski A et al. 2002). Neutrophil phagosomes also exhibited a high proton leak, which was initiated upon activation of the NADPH oxidase, and this activation counteracted phagosomal acidification (Jankowski A et al. 2002). The Reactome module describes ROS and RNS production by phagocytic cells. The module includes cell-type specific events, for example, myeloperoxidase (MPO)-mediated production of hypochlorous acid in neutrophils. It also highlights differences between phagosomal pH dynamics in neutrophils and macrophages. The module describes microbicidal activity of selective RONS such as hydroxyl radical or peroxynitrite. However, detection of any of these species in the phagosomal environment is subject to many uncertainties (N&#252;sse O 2011; Erard M et al. 2018). The mechanisms by which reactive oxygen/nitrogen species kill pathogens in phagocytic immune cells are still not fully understood. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1399">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep102">
 <bp:stepProcess rdf:resource="#Pathway23" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway179">
 <bp:pathwayOrder rdf:resource="#PathwayStep1143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1142" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1133" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1144" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction958" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction957" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction968" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction959" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction961" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction960" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction963" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction962" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction965" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction964" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction956" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction967" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction955" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction966" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1133" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Events associated with phagocytolytic activity of PMN cells</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">When neutrophils engulf bacteria they enclose them in small vacuoles (phagosomes) into which superoxide is released by activated NADPH oxidase (NOX2) on the internalized neutrophil membrane. The directional nature of NOX2 activity creates a charge imbalance that must be counteracted to prevent depolarization of the membrane and the shutdown of activity (Winterbourn CC et al. 2016). Also, protons are produced in the cytosol and consumed in the external compartment (for example, the phagosome) through the dismutation of superoxide. Both situations are largely overcome by a balancing flow of protons transported by voltage-gated proton channels, primarily VSOP/HV1, which are activated in parallel with the oxidase (Demaurex N    El Chemaly A 2010; El Chemaly A et al. 2010; Petheo GL et al. 2010; Kovacs I et al. 2014; Henderson LM et al. 1987, 1988). The pH of the phagosome is regulated by these activities. In contrast to the phagosomes of macrophages, in which pH drops following particle ingestion, neutrophil phagosomes remain alkaline during the period that the oxidase is active. Until recently, their pH has been accepted to lie between 7.5 and 8. However, in a 2015 study using a probe that is more sensitive at higher pH, an average pH closer to 9 was measured in individual phagosomes (Levine AP et al. 2015). The superoxide dismutates to hydrogen peroxide, which is used by myeloperoxidase (MPO) to generate other oxidants, including the highly microbicidal species such as hypochlorous acid (Winterbourn CC et al. 2013, 2016).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1398">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep103">
 <bp:stepProcess rdf:resource="#BiochemicalReaction81" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep104">
 <bp:stepProcess rdf:resource="#Catalysis43" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction82" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep100">
 <bp:stepProcess rdf:resource="#Pathway21" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence9">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep116">
 <bp:stepProcess rdf:resource="#Catalysis49" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction91" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep117">
 <bp:stepProcess rdf:resource="#Catalysis50" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction92" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence7">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep118">
 <bp:stepProcess rdf:resource="#BiochemicalReaction93" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence8">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep119">
 <bp:stepProcess rdf:resource="#Pathway27" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway180">
 <bp:pathwayOrder rdf:resource="#PathwayStep1181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1197" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1155" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1199" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1210" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1213" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1157" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1179" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1212" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1214" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1191" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1186" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1188" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1183" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1205" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1207" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1201" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1004" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1026" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1005" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1027" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1002" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1024" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1003" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1025" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1000" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1022" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1001" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1023" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1020" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1021" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1008" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1006" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1028" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1007" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1029" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1030" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction976" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction998" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction997" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction977" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction999" />
 <bp:pathwayComponent rdf:resource="#Pathway181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1015" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1016" />
 <bp:pathwayComponent rdf:resource="#Pathway184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1014" />
 <bp:pathwayComponent rdf:resource="#Pathway185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1031" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1019" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1017" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1018" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1155" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antimicrobial peptides</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antimicrobial peptides (AMPs) are small molecular weight proteins with broad spectrum of antimicrobial activity against bacteria, viruses, and fungi (Zasloff M 2002; Radek K    Gallo R 2007). The majority of known AMPs are cationic peptides with common structural characteristics where domains of hydrophobic and cationic amino acids are spatially arranged into an amphipathic design, which facilitates their interaction with bacterial membranes (Shai Y 2002; Yeaman MR    Yount NY 2003; Brown KL    Hancock RE 2006; Dennison SR et al. 2005; Zelezetsky I    Tossi A 2006). It is generally excepted that the electrostatic interaction facilitates the initial binding of the positively charged peptides to the negatively charged bacterial membrane. Moreover, the structural amphiphilicity of AMPs is thought to promote their integration into lipid bilayers of pathogenic cells, leading to membrane disintegration and finally to the microbial cell death. In addition to cationic AMPs a few anionic antimicrobial peptides have been found in humans, however their mechanism of action remains to be clarified (Lai Y et al. 2007; Harris F et al. 2009; Paulmann M et al. 2012). Besides the direct neutralizing effects on bacteria AMPs may modulate cells of the adaptive immunity (neutrophils, T-cells, macrophages) to control inflammation and/or to increase bacterial clearance. AMPs have also been referred to as cationic host defense peptides, anionic antimicrobial peptides/proteins, cationic amphipathic peptides, cationic AMPs, host defense peptides and alpha-helical antimicrobial peptides (Brown KL    Hancock RE 2006; Harris F et al. 2009; Groenink J et al. 1999; Bradshaw J 2003; Riedl S et al. 2011; Huang Y et al. 2010). The Reactome module describes the interaction events of various types of human AMPs, such as cathelicidin, histatins and neutrophil serine proteases, with conserved patterns of microbial membranes at the host-pathogen interface. The module includes also proteolytic processing events for dermcidin (DCD) and cathelicidin (CAMP) that become functional upon cleavage. In addition, the module highlights an AMP-associated ability of the host to control metal quota at inflammation sites to influence host-pathogen interactions.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway181">
 <bp:pathwayOrder rdf:resource="#PathwayStep1165" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1166" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1158" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1159" />
 <bp:pathwayComponent rdf:resource="#Pathway182" />
 <bp:pathwayComponent rdf:resource="#Pathway183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction984" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction978" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1158" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Defensins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The defensins are a family of antimicrobial cationic peptide molecules which in mammals have a characteristic  beta-sheet-rich fold and framework of six disulphide-linked cysteines (Selsted    Ouellette 2005, Ganz 2003). Human defensin peptides have two subfamilies, alpha- and beta-defensins, differing in the length of peptide chain between the six cysteines and the order of disulphide bond pairing between them. A third subfamily, the theta defensins, is derived from alpha-defensins prematurely truncated by a stop codon between the third and fourth cysteine residues. The translated products are shortened to nonapeptides, covalently dimerized by disulfide linkages, and cyclized via new peptide bonds between the first and ninth residues. Humans have one pseudogene but no translated representatives of the theta class. In solution most alpha and beta defensins are monomers but can form dimers and higher order structures.   The primary cellular sources of defensins are neutrophils, epithelial cells and intestinal Paneth cells.Those expressed in neutrophils and the gut are predominantly constitutive, while those in epithelial tissues such as skin are often inducible by proinflammatory stimuli such as LPS or TNF-alpha.  Defensins are translated as precursor polypeptides that include a typical signal peptide or prepiece that is cleaved in the Golgi body, and a propiece, cleaved by differing mechanisms to produce the mature defensin. Mature defensin peptides can be further processed by removal of individual N-terminal residues (Yang et al. 2004). This may be a mechanism to broaden the activity profile of defensins (Ghosh et al. 2002).  Defensins have direct antimicrobial effects and kill a wide range of Gram-positive and negative bacteria, fungi and some viruses. The primary antimicrobial action of defensins is permeabilization of microbial target membranes but several additional mechanisms have been suggested (Brogden 2005, Wilmes et al. 2011). Defensins and related antimicrobial peptides such as cathelicidin bridge the innate and acquired immune responses. In addition to their antimicrobial properties, cathelicidin and several defensins show receptor-mediated chemotactic activity for immune cells such as monocytes, T cells or immature DCs, induce cytokine production by monocytes and epithelial cells, modulate angiogenesis and stimulate wound healing (Yang et al. 1999, 2000, 2004, Rehaume    Hancock 2008, Yeung et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway182">
 <bp:pathwayOrder rdf:resource="#PathwayStep1164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction979" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction981" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction980" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction983" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction982" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1160" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Beta defensins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Humans have 38 beta-defensin genes plus 9-10 pseudogenes (details available on the HGNC website at http://www.genenames.org/genefamilies/DEFB). Many beta-defensins are encoded by recently duplicated genes giving rise to identical transcripts. Nomenclature is confusing and currently in transition. Uniprot recommended names are used throughout this pathway. Many beta-defensins show expression that correlates with infection (Sahl et al. 2005, Pazgier et al. 2006). All so far characterized beta-defensins, i.e. beta-defensin 1 (hBD1), 4A (hBD2), 103 (hBD3), 104 (hBD4), 106 (hBD6), 118 (hBD18) and 128 (hBD28) have antimicrobial properties (Pazgier et al. 2006). For beta-defensins 4A, 103 and 118 (hBD2, 3, and 18) this has been shown to correlate with membrane permeabilization effects (Antcheva et al. 2004, Sahl et al. 2005, Yenugu et al. 2004). Electrostatic interaction and disruption of microbial membranes is widely believed to the primary mechanism of action for beta-defensins. Two models explain how membrane disruption takes place, the &apos;pore model&apos; which postulates that beta-defensins form transmembrane pores in a similar manner to alpha-defensins, and the &apos;carpet model&apos;, which suggests that beta-defensins act as detergents. Beta-defensins contain 6 conserved cysteine residues that in beta-defensins 1, 4A and 103 (hBD1-3) are experimentally confirmed to be cross-linked 1-5, 2-4, 3-6. The canonical sequence for beta-defensins is x2-10Cx5-6(G/A)xCX3-4Cx9-13Cx4-7CCxn. Structurally they are similar to alpha-defensins but with much shorter pre-regions. Though dimerization of some beta-defensins has been reported this is not the case for all and it is unclear whether it is required for function. The majority of functional studies have focused on beta-defensin 103 (hBD3), which has the most significant antimicrobial activity at physiological salt concentrations (Harder et al. 2001). Beta-defensin 103  is highly cationic with a net charge of +11 e0.  It exhibits broad-spectrum antimicrobial activity against gram-positive bacteria and some gram-negative bacteria (Harder et al. 2001), though some species are highly resistant (Sahly et al. 2003). Sensitivity correlates with lipid composition of the membrane, with more negatively-charged lipids correlating with larger beta-defensin 103-induced changes in membrane capacitance (Bohling et al. 2006). Though membrane disruption is widely believed to be the primary mechanism of action of beta-defensins they have other antimicrobial properties, such as inhibition of cell wall biosynthesis (Sass et al. 2010), and chemoattractant effects (Yang et al. 1999, Niyonsaba et al. 2002, 2004). The chemotactic activity of beta-defensins 1, 4A and 103 (hBD1-3) for memory T cells and immature DCs is mediated through binding to the chemokine receptor CCR6 and probably another unidentified Gi-coupled receptor (Yang et al. 1999, 2000).    Like defensins, the human cathelicidin LL37 peptide is rich in positively-charged  residues (Lehrer    Ganz 2002). Expression of certain beta-defensins can be induced in response to various signals, such as bacteria, pathogen-associated molecular patterns (PAMPs), or proinflammatory cytokines (Ganz 2003, Yang et al. 2004). Like the alpha-defensins, copy number variation has been reported for DEFB4, DEFB103 and DEFB104 with individuals having 2-12 copies per diploid genome. In contrast DEFB1 does not show such variation but exhibits a number of SNPs (Hollox et al. 2003, Linzmier    Ganz 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway183">
 <bp:pathwayOrder rdf:resource="#PathwayStep1176" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1167" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1177" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1171" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1173" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1169" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1168" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction990" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction992" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction991" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction994" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction993" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction985" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction996" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction995" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction987" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction986" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction989" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction988" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha-defensins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Humans have 7 alpha defensin genes plus 5 pseudogenes (see HGNC at http://www.genenames.org/genefamilies/DEFA). Alpha-defensins have six cysteines linked 1-6, 2-4, 3-5. The canonical sequence of alpha-defensins in humans is x1-2CXCRx2-3Cx3Ex3GxCx3Gx5CCx1-4, where x represents any amino acid residue.  Human alpha-defensins 1-4 are often called human neutrophil peptides (HNP1-4) as they were initially identified in neutrophil primary (azurophilic) granules. Alpha-defensins 5 and 6 (HD5, HD6) are products of Paneth cells. HNP-1 and -3 peptides are 30 residues long, differing only in the first amino acid. They are encoded by the genes DEFA1 and DEFA3 respectively. These exhibit copy number polymorphism, with some individuals having  4-14 copies per diploid  genome, while 10-37% of individuals have no copies of DEFA3 (Aldred et al. 2005, Linzmier    Ganz 2005, Ballana et al. 2007). HNP-4, encoded by DEFA4, is 33 amino acids long of which 22 differ from the other HNPs (Wilde et al. 1989). It is a minor component of neutrophil granules compared to HNP1-3. In contrast to DEFA1 and DEFA3, the genes for HNP-4, HD-5 and HD-6 are only found as two copies per diploid genome (Linzmeier    Ganz 2005). HNP-2 is 29 amino acids in length and is the proteolytic product of cleavage of the N-terminal amino acid from either HNP-1 and/or HNP-3 (Selsted et al. 1985). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway184">
 <bp:pathwayOrder rdf:resource="#PathwayStep1194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1195" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1013" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1011" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1012" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1010" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1009" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1192" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Metal sequestration by antimicrobial proteins</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Metals are necessary for all forms of life including microorganisms, evidenced by the fact that metal cations are constituents of approximately 40% of all proteins crystallized to date (Waldron KJ et al. 2009; Foster AW et al. 2014; Guengerich FP 2014, 2015). The ability of microorganisms to maintain the intracellular metal quota is essential and allows microorganisms to adapt to a variety of environments. Accordingly, the ability of the host to control metal quota at inflammation sites can influence host-pathogen interactions. The host may restrict microbial growth either by excluding essential metals from the microbes, by delivery of excess metals to cause toxicity, or by complexing metals in microorganisms (Becker KW    Skaar EP 2014).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway185">
 <bp:pathwayOrder rdf:resource="#PathwayStep1217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1216" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1033" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1032" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1216" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ion influx/efflux at host-pathogen interface</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Essential metal ions act as co-factors that enable enzymes to catalyse a wider range of chemical transformations than would be achievable using solely organic catalysts. The precise metal requirements of organisms vary between species, environmental niches, metabolic states and circadian rhythms.  Metals are required cofactors for numerous processes that are essential to both pathogen and host. They are coordinated in enzymes responsible for DNA replication and transcription, relief from oxidative stress, and cellular respiration. However, excess transition metals can be toxic due to their ability to cause spontaneous redox cycling and disrupt normal metabolic processes. Vertebrates have evolved intricate mechanisms to limit the availability of some crucial metals while concurrently flooding sites of infection with antimicrobial concentrations of other metals.   Both pathogens and hosts have complex regulatory systems for metal homeostasis. Understanding these provides strategies for fighting pathogens, either by excluding essential metals from the microbes, by delivery of excess metals to cause toxicity, or by complexing metals in microorganisms.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway186">
 <bp:pathwayOrder rdf:resource="#PathwayStep1251" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1226" />
 <bp:pathwayComponent rdf:resource="#Pathway187" />
 <bp:pathwayComponent rdf:resource="#Pathway188" />
 <bp:pathwayComponent rdf:resource="#Pathway189" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1219" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fcgamma receptor (FCGR) dependent phagocytosis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phagocytosis is one of the important innate immune responses that function to eliminate invading infectious agents. Monocytes, macrophages, and neutrophils are the professional phagocytic cells. Phagocytosis is a complex process involving the recognition of invading foreign particles by specific types of phagocytic receptors and the subsequent internalization of the particles. Fc gamma receptors (FCGRs) are among the best studied phagocytic receptors that bind to Fc portion of immunoglobulin G (IgG). Through their antigen binding F(ab) end, antibodies bind to specific antigen while their constant (Fc) region binds to FCGRs on phagocytes. The clustering of FCGRs by IgG antibodies on the phagocyte initiates a variety of signals, which lead, through the reorganisation of actin cytoskeleton and membrane remodelling, to the formation of pseudopod and phagosome. Fc gamma receptors are classified into three classes: FCGRI, FCGRII and FCGRIII. Each class of these FCGRs consists of several individual isoforms. Among all these isoforms FCGRI, FCGRIIA and FCGRIIIA, are able to mediate phagocytosis (Joshi et al. 2006, Garcia Garcia    Rosales 2002, Nimmerjahn    Ravetch 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway187">
 <bp:pathwayOrder rdf:resource="#PathwayStep1220" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1221" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1037" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1038" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1035" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1036" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1034" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1039" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1220" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FCGR activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-linking of FCGRs with IgG coated immune complexes results in tyrosine phosphorylation of the immuno tyrosine activation motif (ITAMs) of the rececptor by membrane-bound tyrosine kinases of the SRC family. The phosphorylated ITAM tyrosines serve as docking sites for Src homology 2 (SH2) domain-containing SYK kinase. Recruitment and activation of SYK is critical for FCGR-mediated signaling in phagocytosis, but the exact role of SYK in this process is unclear. Activated SYK then transmits downstream signals leading to actin polymerization and particle internalization.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway188">
 <bp:pathwayOrder rdf:resource="#PathwayStep1231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1230" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1232" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1243" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1250" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1235" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1234" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1236" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1040" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1051" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1062" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1041" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1052" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1063" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1060" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1050" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1061" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1048" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1059" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1049" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1046" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1057" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1047" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1058" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1044" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1055" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1045" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1056" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1042" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1053" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1043" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1054" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1227" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of actin dynamics for phagocytic cup formation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The actin cytoskeleton is fundamental for phagocytosis and members of the Rho family GTPases RAC and CDC42 are involved in actin cytoskeletal regulation leading to pseudopod extension. Active RAC and CDC42 exert their action through the members of WASP family proteins (WASP/N-WASP/WAVE) and ARP2/3 complex. Actin filaments move from the bottom toward the top of the phagocytic cup during pseudopod extension.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence5">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep112">
 <bp:stepProcess rdf:resource="#Pathway25" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway189">
 <bp:pathwayOrder rdf:resource="#PathwayStep1253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1252" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1255" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1254" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1260" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1261" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1068" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1069" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1066" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1067" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1064" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1075" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1065" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1073" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1074" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1071" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1072" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1070" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1252" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Role of phospholipids in phagocytosis</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipases play an integral role in phagocytosis by generating essential second messengers. An early step in phagocytic signaling is the association of PIP2 and IP3 with the phagocytic cup. These are formed by the activity of phosphoinositol kinases and phospholipases. PI3K is has been shown to accumulate at phagocytic cups and converts PI (4,5)P2 to PI (3,4,5)P3. These phosphoinositides are capable of binding and increasing the activity of proteins that regulate the actin cytoskeleton. Phospholipases are lipid modifying enzymes that produce lipid mediators such as diacylglycerol (DAG), arachidonic acid (AA) and IP3. Phopsholipases PLA, PLC and PLD have been shown to be involved in antibody (IgG) mediated phagocytosis. The PLC product IP3 stimulates release of calcium from the endoplasmic reticulum. This Ca+2 concentration increase is greatest in the cytoplasm surrounding the phagocytic cup. Calcium is involved in the various stages of phagosome formation, including phagocytic ingestion and phagosome maturation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence6">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep113">
 <bp:stepProcess rdf:resource="#Pathway26" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence3">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction89" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence4">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction90" />
 <bp:stepProcess rdf:resource="#Catalysis48" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence2">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep110">
 <bp:stepProcess rdf:resource="#BiochemicalReaction87" />
 <bp:stepProcess rdf:resource="#Catalysis47" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction88" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence98">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence99">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence96">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence97">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence94">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep127">
 <bp:stepProcess rdf:resource="#Catalysis56" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction99" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence95">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep128">
 <bp:stepProcess rdf:resource="#Catalysis57" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction100" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence92">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep129">
 <bp:stepProcess rdf:resource="#BiochemicalReaction101" />
 <bp:stepProcess rdf:resource="#Catalysis58" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence93">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway150">
 <bp:pathwayOrder rdf:resource="#PathwayStep857" />
 <bp:pathwayOrder rdf:resource="#PathwayStep858" />
 <bp:pathwayOrder rdf:resource="#PathwayStep859" />
 <bp:pathwayOrder rdf:resource="#PathwayStep854" />
 <bp:pathwayOrder rdf:resource="#PathwayStep855" />
 <bp:pathwayOrder rdf:resource="#PathwayStep856" />
 <bp:pathwayOrder rdf:resource="#PathwayStep860" />
 <bp:pathwayOrder rdf:resource="#PathwayStep861" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction705" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction707" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction706" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction709" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction708" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction710" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction712" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction711" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence854" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway151">
 <bp:pathwayOrder rdf:resource="#PathwayStep875" />
 <bp:pathwayOrder rdf:resource="#PathwayStep871" />
 <bp:pathwayOrder rdf:resource="#PathwayStep872" />
 <bp:pathwayOrder rdf:resource="#PathwayStep873" />
 <bp:pathwayOrder rdf:resource="#PathwayStep874" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction721" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction723" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction722" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction725" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction724" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence871" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway152">
 <bp:pathwayOrder rdf:resource="#PathwayStep879" />
 <bp:pathwayOrder rdf:resource="#PathwayStep886" />
 <bp:pathwayOrder rdf:resource="#PathwayStep887" />
 <bp:pathwayOrder rdf:resource="#PathwayStep888" />
 <bp:pathwayOrder rdf:resource="#PathwayStep878" />
 <bp:pathwayOrder rdf:resource="#PathwayStep889" />
 <bp:pathwayOrder rdf:resource="#PathwayStep882" />
 <bp:pathwayOrder rdf:resource="#PathwayStep883" />
 <bp:pathwayOrder rdf:resource="#PathwayStep884" />
 <bp:pathwayOrder rdf:resource="#PathwayStep885" />
 <bp:pathwayOrder rdf:resource="#PathwayStep890" />
 <bp:pathwayOrder rdf:resource="#PathwayStep880" />
 <bp:pathwayOrder rdf:resource="#PathwayStep881" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction727" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction738" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction737" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction729" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction728" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction739" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction730" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction732" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction731" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction734" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction733" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction736" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction735" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence878" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TLR by endogenous ligand</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Diverse molecules of host-cell origin may serve as endogenous ligands of Toll-like receptors (TLRs) (Erridge C 2010; Piccinini AM    Midwood KS 2010). These molecules are known as damage-associated molecular patterns (DAMPs). DAMPs are immunologically silent in healthy tissues but become active upon tissue damage during both infectious and sterile insult. DAMPs are released from necrotic cells or secreted from activated cells in response to tissue damage to mediate tissue repair by promoting inflammatory responses. However, DAMPs have also been implicated in the pathogenesis of many inflammatory and autoimmune diseases, including rheumatoid arthritis (RA), cancer, and atherosclerosis. The mechanism underlying the switch from DAMPs that initiate controlled tissue repair, to those that mediate chronic, uncontrolled inflammation is still unclear. Recent evidence suggests that an abnormal increase in protein citrullination is involved in disease pathophysiology (Anzilotti C et al. 2010; Sanchez-Pernaute O et al. 2013; Sokolove J et al. 2011; Sharma P et al. 2012). Citrullination is a post-translational modification event mediated by peptidyl-arginine deaminase enzymes which catalyze the deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway153">
 <bp:pathwayOrder rdf:resource="#PathwayStep968" />
 <bp:pathwayOrder rdf:resource="#PathwayStep941" />
 <bp:pathwayOrder rdf:resource="#PathwayStep898" />
 <bp:pathwayOrder rdf:resource="#PathwayStep892" />
 <bp:pathwayComponent rdf:resource="#Pathway162" />
 <bp:pathwayComponent rdf:resource="#Pathway154" />
 <bp:pathwayComponent rdf:resource="#Pathway155" />
 <bp:pathwayComponent rdf:resource="#Pathway156" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence892" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In the complement cascade, a panel of soluble molecules rapidly and effectively senses a danger or damage and triggers reactions to provide a response that discriminates among foreign intruders, cellular debris, healthy and altered host cells (Ricklin D et al. 2010). Complement proteins circulate in the blood stream in functionally inactive states. When triggered the complement cascade generates enzymatically active molecules (such as C3/C5 convertases) and biological effectors: opsonins (C3b, C3d and C4b), anaphylatoxins (C3a and C5a), and C5b, which initiates assembly of the lytic membrane attack complex (MAC). Three branches lead to complement activation: the classical, lectin and alternative pathways (Kang YH et al. 2009; Ricklin D et al. 2010). The classical pathway is initiated by C1 complex binding to immune complexes, pentraxins or other targets such as apoptotic cells leading to cleavage of C4 and C2 components and formation of the classical C3 convertase, C4bC2a. The lectin pathway is activated by binding of mannan-binding lectin (MBL) to repetitive carbohydrate residues, or by binding of ficolins to carbohydrate or acetylated groups on target surfaces. MBL and ficolins interact with MBL-associated serine proteases (MASP) leading to cleavage of C4 and C2 and formation of the classical C3 convertase, C4bC2a. The alternative pathway is spontaneously activated by the hydrolysis of the internal thioester group of C3 to give C3(H2O). Alternative pathway activation involves interaction of C3(H2O) and/or previously generated C3b with factor B, which is cleaved by factor D to generate the alternative C3 convertases C3(H2O)Bb and/or C3bBb. All three pathways merge at the proteolytic cleavage of component C3 by C3 convertases to form opsonin C3b and anaphylatoxin C3a. C3b covalently binds to glycoproteins scattered across the target cell surface. This is followed by an amplification reaction that generates additional C3 convertases and deposits more C3b at the local site. C3b can also bind to C3 convertases switching them to C5 convertases, which mediate C5 cleavage leading to MAC formation. Thus, the activation of the complement system leads to several important outcomes:  opsonization of target cells to enhance phagocytosis, lysis of target cells via membrane attack complex (MAC) assembly on the cell surface, production of anaphylatoxins C3a/C5a involved in the host inflammatory response, C5a-mediated leukocyte chemotaxis, and clearance of antibody-antigen complexes. The complement system is able to distinguish between pathological and physiological challenges, i.e. the outcomes of complement activation are predetermined by the trigger and are tightly tuned by a combination of initiation events with several regulatory mechanisms. These regulatory mechanisms use soluble (e.g., C4BP, CFI and CFH) and membrane-bound regulators (e.g., CR1, CD46(MCP), CD55(DAF) and CD59) and are coordinated by complement receptors such as CR1, CR2, etc. In response to microbial infection complement activation results in flagging microorganisms with opsonins for facilitated phagocytosis, formation of MAC on cells such as Gram-negative bacteria leading to cell lysis, and release of C3a and C5a to stimulate downstream immune responses and to attract leukocytes. Most pathogens can be eliminated by these complement-mediated host responses, though some pathogenic microorganisms have developed ways of avoiding complement recognition or blocking host complement attack resulting in greater virulence (Lambris JD et al. 2008; Serruto D et al. 2010). All three complement pathways (classical, lectin and alternative) have been implicated in clearance of dying cells (Mevorach D et al. 1998; Ogden CA et al. 2001; Gullstrand B et al.2009; Kemper C et al. 2008). Altered surfaces of apoptotic cells are recognized by complement proteins leading to opsonization and subsequent phagocytosis. In contrast to pathogens, apoptotic cells are believed to induce only a limited complement activation by allowing opsonization of altered surfaces but restricting the terminal pathway of MAC formation (Gershov D et al. 2000; Braunschweig A and Jozsi M 2011). Thus, opsonization facilitates clearance of dying cells and cell debris without triggering danger signals and further inflammatory responses (Fraser DA et al. 2007, 2009; Benoit ME et al. 2012). C1q-mediated complement activation by apoptotic cells has been shown in a variety of human cells: keratinocytes, human umbilical vein endothelial cells (HUVEC), Jurkat T lymphoblastoid cells, lung adenocarcinoma cells (Korb LC and Ahearn JM 1997; Mold C and Morris CA 2001; Navratil JS et al. 2001; Nauta AJ et al. 2004). In addition to C1q the opsonization of apoptotic Jurkat T cells with MBL also facilitated clearance of these cells by both dendritic cells (DC) and macrophages (Nauta AJ et al. 2004). Also C3b, iC3b and C4b deposition on apoptotic cells as a consequence of activation of the complement cascade may promote complement-mediated phagocytosis. C1q, MBL and cleavage fragments of C3/C4 can bind to several receptors expressed on macrophages (e.g. cC1qR (calreticulin), CR1, CR3, CR4) suggesting a potential clearance mechanism through this interaction (Mevorach D et al. 1998; Ogden CA et al. 2001). Apoptosis is also associated with an altered expression of complement regulators on the surface of apoptotic cells. CD46 (MCP) bound to the plasma membrane of a healthy cell protects it from complement-mediated attack by preventing deposition of C3b and C4b, and reduced expression of CD46 on dying cells may lead to enhanced opsonization (Elward K et al. 2005). Upregulation of CD55 (DAF) and CD59 on apoptotic cell surfaces may protect damaged cells against complement mediated lysis (Pedersen ED et al. 2007; Iborra A et al. 2003; Hensel F et al. 2001). In addition, fluid-phase complement regulators such as C4BP, CFH may also inhibit lysis of apoptotic cells by limiting complement activation (Trouw LA et al 2007; Braunschweig A and Jozsi M. 2011). Complement facilitates the clearance of immune complexes (IC) from the circulation (Chevalier J and Kazatchkine MD 1989; Nielsen CH et al. 1997). Erythrocytes bear clusters of complement receptor 1 (CR1 or CD35), which serves as an immune adherence receptor for C3 and/or C4 fragments deposited on IC that are shuttled to liver and spleen, where IC are transferred and processed by tissue macrophages through an Fc receptor-mediated process. Complement proteins are always present in the blood and a small percentage spontaneously activate. Inappropriate activation leads to host cell damage, so on healthy human cells any complement activation or amplification is strictly regulated by surface-bound regulators that accelerate decay of the convertases (CR1, CD55), act as a cofactor for the factor I (CFI)-mediated degradation of C3b and C4b (CR1, CD46), or prevent the formation of MAC (CD59). Soluble regulators such as C4BP, CFH and FHL1 recognize self surface pattern-like glycosaminoglycans and further impair activation. Complement components interact with other biological systems. Upon microbial infection complement acts in cooperation with Toll-like receptors (TLRs) to amplify innate host defense. Anaphylatoxin C5a binds C5a receptor (C5aR) resulting in a synergistic enhancement of the TLR and C5aR-mediated proinflammatory cytokine response to infection. This interplay is negatively modulated by co-ligation of TLR and the second C5a receptor, C5L2, suggesting the existence of complex immunomodulatory interactions (Kohl J 2006; Hajishengallis G and Lambris JD 2010). In addition to C5aR and C5L2, complement receptor 3 (CR3) facilitates TLR2 or TLR4 signaling pathways by promoting a recruitment of their sorting adaptor TIRAP (MAL) to the receptor complex (van Bruggen R et al. 2007; Kagan JC and Medzhitov R 2006). Complement may activate platelets or facilitate biochemical and morphological changes in the endothelium potentiating coagulation and contributing to homeostasis in response to injury (Oikonomopoulou K et al. 2012). The interplay of complement and coagulation also involves cleavage of C3 and C5 convertases by coagulation proteases, generating biologically active anaphylatoxins (Amara U et al. 2010). Complement is believed to link the innate response to both humoral and cell-mediated immunity (Toapanta FR and Ross TM 2006; Mongini PK et al. 1997). The majority of published data is based on experiments using mouse as a model organism. Further characterization of the influence of complement on B or T cell activation is required for the human system, since differences between murine models and the human system are not yet fully determined. Complement is also involved in regulation of mobilization and homing of hematopoietic stem/progenitor cells (HSPCs) from bone marrow to the circulation and peripheral tissue in order to accommodate blood cell replenishment (Reca R et al. 2006). Thus, the complement system orchestrates the host defense by sensing a danger signal and transmitting it into specific cellular responses while extensively communicating with associated biological pathways ranging from immunity and inflammation to homeostasis and development. Originally the larger fragment of Complement Factor 2 (C2) was designated C2a. However, complement scientists decided that the smaller of all C fragments should be designated with an &apos;a&apos;, the larger with a &apos;b&apos;, changing the nomenclature for C2. Recent literature may use the updated nomenclature and refer to the larger C2 fragment as C2b, and refer to the classical C3 convertase as C4bC2b. Throughout this pathway Reactome adheres to the original convention to agree with the current (Sep 2013) Uniprot names for C2 fragments. The complement cascade pathway is organised into the following sections: initial triggering, activation of C3 and C5, terminal pathway and regulation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway154">
 <bp:pathwayOrder rdf:resource="#PathwayStep897" />
 <bp:pathwayOrder rdf:resource="#PathwayStep893" />
 <bp:pathwayOrder rdf:resource="#PathwayStep894" />
 <bp:pathwayOrder rdf:resource="#PathwayStep895" />
 <bp:pathwayOrder rdf:resource="#PathwayStep896" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction741" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction740" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction743" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction742" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction744" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence893" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Terminal pathway of complement</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">After cleavage of C5, C5b undergoes conformational changes and exposes a binding site for C6. C5b6 binds C7 resulting in the exposure of membrane binding sites and incorporation into target membranes. The membrane-bound C5b-7 complex can then bind C8. C5b-8 acts as a polymerizing agent for C9. The first C9 bound to C5b-8 undergoes major structural changes enabling formation of an elongated molecule and allows binding of additional C9 molecules and insertion of C9 cylinders into the target membrane. The number of C9 molecules varies from 1-12 in the membrane, although polymers containing up to fifteen C9 molecules are also possible.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway155">
 <bp:pathwayOrder rdf:resource="#PathwayStep901" />
 <bp:pathwayOrder rdf:resource="#PathwayStep923" />
 <bp:pathwayOrder rdf:resource="#PathwayStep902" />
 <bp:pathwayOrder rdf:resource="#PathwayStep924" />
 <bp:pathwayOrder rdf:resource="#PathwayStep903" />
 <bp:pathwayOrder rdf:resource="#PathwayStep925" />
 <bp:pathwayOrder rdf:resource="#PathwayStep904" />
 <bp:pathwayOrder rdf:resource="#PathwayStep926" />
 <bp:pathwayOrder rdf:resource="#PathwayStep920" />
 <bp:pathwayOrder rdf:resource="#PathwayStep921" />
 <bp:pathwayOrder rdf:resource="#PathwayStep900" />
 <bp:pathwayOrder rdf:resource="#PathwayStep922" />
 <bp:pathwayOrder rdf:resource="#PathwayStep909" />
 <bp:pathwayOrder rdf:resource="#PathwayStep905" />
 <bp:pathwayOrder rdf:resource="#PathwayStep927" />
 <bp:pathwayOrder rdf:resource="#PathwayStep906" />
 <bp:pathwayOrder rdf:resource="#PathwayStep928" />
 <bp:pathwayOrder rdf:resource="#PathwayStep907" />
 <bp:pathwayOrder rdf:resource="#PathwayStep929" />
 <bp:pathwayOrder rdf:resource="#PathwayStep908" />
 <bp:pathwayOrder rdf:resource="#PathwayStep940" />
 <bp:pathwayOrder rdf:resource="#PathwayStep912" />
 <bp:pathwayOrder rdf:resource="#PathwayStep934" />
 <bp:pathwayOrder rdf:resource="#PathwayStep913" />
 <bp:pathwayOrder rdf:resource="#PathwayStep935" />
 <bp:pathwayOrder rdf:resource="#PathwayStep914" />
 <bp:pathwayOrder rdf:resource="#PathwayStep936" />
 <bp:pathwayOrder rdf:resource="#PathwayStep915" />
 <bp:pathwayOrder rdf:resource="#PathwayStep937" />
 <bp:pathwayOrder rdf:resource="#PathwayStep930" />
 <bp:pathwayOrder rdf:resource="#PathwayStep931" />
 <bp:pathwayOrder rdf:resource="#PathwayStep899" />
 <bp:pathwayOrder rdf:resource="#PathwayStep910" />
 <bp:pathwayOrder rdf:resource="#PathwayStep932" />
 <bp:pathwayOrder rdf:resource="#PathwayStep911" />
 <bp:pathwayOrder rdf:resource="#PathwayStep933" />
 <bp:pathwayOrder rdf:resource="#PathwayStep916" />
 <bp:pathwayOrder rdf:resource="#PathwayStep938" />
 <bp:pathwayOrder rdf:resource="#PathwayStep917" />
 <bp:pathwayOrder rdf:resource="#PathwayStep939" />
 <bp:pathwayOrder rdf:resource="#PathwayStep918" />
 <bp:pathwayOrder rdf:resource="#PathwayStep919" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction749" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction748" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction763" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction785" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction762" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction784" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction765" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction764" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction786" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction745" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction767" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction766" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction747" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction769" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction746" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction768" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction770" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction750" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction772" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction771" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction759" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction752" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction774" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction751" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction773" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction754" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction776" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction753" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction775" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction756" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction778" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction755" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction777" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction758" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction757" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction779" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction781" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction780" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction761" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction783" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction782" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence899" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of Complement cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Two inherent features of complement activation make its regulation very important:  1. There is an inherent positive feedback loop because the product of C3 activation forms part of an enzyme that causes more C3 activation. 2. There is continuous low-level activation of the alternative pathway (see Spontaneous hydrolysis of C3 thioester).  Complement cascade activation is regulated by a family of related proteins termed the regulators of complement activation (RCA). These are expressed on healthy host cells. Most pathogens do not express RCA proteins on their surface, but many have found ways to evade the complement system by stably binding the RCA that circulates in human plasma (Lambris et al. 2008); trapping RCA is by far the most widely employed strategy for avoiding the complement response. RCA recruitment is common in bacteria such as E. coli and streptococci (Kraiczy    Wurzner 2006) and has also been described for viruses, fungi and  parasites. RCA deposition and the complement system also have an important role in tissue homeostasis, clearing dead cells and debris, and preventing damage from oxidative stress (Weismann et al. 2011).  RCA proteins control complement activation in two different ways; by promoting the irreversible dissociation (decay acceleration) of complement convertases and by acting as cofactors for Complement factor I (CFI)-mediated cleavage of C3b and C4b. Decay accelerating factor (DAF, CD55), Complement factor H (FH), Membrane Cofactor Protein (MCP) and Complement receptor 1 (CR1) are composed of arrays of tandem globular domains termed CCPs (complement control protein repeats) or SCRs (short consensus repeats). CR1, MCP and FH are cofactors for the CFI-mediated cleavage of C3b, generating iC3b. CR1 and MCP are also cofactors for C4b cleavage.  C4BP is an additional cofactor for the CFI-mediated cleavage of C4b.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep123">
 <bp:stepProcess rdf:resource="#Catalysis54" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction97" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway156">
 <bp:pathwayOrder rdf:resource="#PathwayStep956" />
 <bp:pathwayOrder rdf:resource="#PathwayStep942" />
 <bp:pathwayOrder rdf:resource="#PathwayStep953" />
 <bp:pathwayOrder rdf:resource="#PathwayStep943" />
 <bp:pathwayOrder rdf:resource="#PathwayStep954" />
 <bp:pathwayOrder rdf:resource="#PathwayStep955" />
 <bp:pathwayComponent rdf:resource="#Pathway157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction787" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction798" />
 <bp:pathwayComponent rdf:resource="#Pathway158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction797" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction799" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence942" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Initial triggering of complement</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement activation is due to a cascade of proteolytic steps, performed by serine protease domains in some of the components. Three different pathways of activation are distinguished triggered by target-bound antibody (the classical pathway); microbial polysaccharide structures (the lectin pathway); or recognition of other &quot;foreign&quot; surface structures (the alternative pathway) by C3b. All three merge in the pivotal activation of C3 and, subsequently, of C5 by highly specific enzymatic complexes, the so-called C3/C5 convertases. A complement system with three C3 activation pathways and a common lytic pathway is found only in jawed vertebrates.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep124">
 <bp:stepProcess rdf:resource="#Pathway28" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway157">
 <bp:pathwayOrder rdf:resource="#PathwayStep945" />
 <bp:pathwayOrder rdf:resource="#PathwayStep946" />
 <bp:pathwayOrder rdf:resource="#PathwayStep947" />
 <bp:pathwayOrder rdf:resource="#PathwayStep948" />
 <bp:pathwayOrder rdf:resource="#PathwayStep952" />
 <bp:pathwayOrder rdf:resource="#PathwayStep944" />
 <bp:pathwayOrder rdf:resource="#PathwayStep950" />
 <bp:pathwayOrder rdf:resource="#PathwayStep951" />
 <bp:pathwayOrder rdf:resource="#PathwayStep949" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction790" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction792" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction791" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction794" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction793" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction796" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction795" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction789" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction788" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence944" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alternative complement activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The proteins participating in alternative pathway activation are C3 (and C3b), the factors B, D, and properdin. In the first place, alternative pathway activation is a positive feedback mechanism to increase C3b. When C3b binds covalently to sugars on a cell surface, it can become protected. Then Factor B binds to C3b. In the presence of Factor D, bound Factor B is cleaved to Ba and Bb. Bb contains the active site for a C3 convertase. Properdin then binds to C3bBb to stabilize the C3bBb convertase on cell surface leading to cleavage of C3. Finally, a C3bBb3b complex forms and this is a C5 convertase.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep125">
 <bp:stepProcess rdf:resource="#Catalysis55" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction98" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway158">
 <bp:pathwayOrder rdf:resource="#PathwayStep957" />
 <bp:pathwayOrder rdf:resource="#PathwayStep960" />
 <bp:pathwayComponent rdf:resource="#Pathway160" />
 <bp:pathwayComponent rdf:resource="#Pathway159" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence957" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Creation of C4 and C2 activators</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Two pathways lead to a complex capable of activating C4 and C2.  The classical pathway is triggered by activation of the C1-complex, which consists of hexameric molecule C1q and a tetramer comprising two C1r and two C1s serine proteinases. This occurs when C1q binds to IgM or IgG complexed with antigens, a single IgM can initiate the pathway while multiple IgGs are needed, or when C1q binds directly to the surface of the pathogen. Binding leads to conformational changes in C1q, activating the serine protease activity of C1r, which then cleaves C1s, another serine protease. The C1r:C1s component is now capable of splitting C4 and C2 to produce the classical C3-convertase C4b2a. C1r and C1s are additionally controlled by C1-inhibitor.(Kerr MA 1980) The lectin pathway is similar in operation but has different components.  Mannose-binding lectin (MBL) or ficolins (L-ficolin, M-ficolin and H-ficolin) initiate the lectin pathway cascade by binding to specific carbohydrate patterns on pathogenic cell surfaces. MBL and ficolins circulate in plasma in complexes with homodimers of MBL-associated serine proteases (MASP) (Fujita et al. 2004; Hajela et al. 2002). Upon binding of human lectin (MBL or ficolins) to the target surface the complex of lectin:MASP undergoes conformational changes, which results in the activation of MASPs by cleavage (Matsushita M et al. 2000; Fujita et al. 2004). Activated MASPs become capable of C4 and C2 cleavage, giving rise to the same C3 convertase C4b:C2a as the classical pathway. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep126">
 <bp:stepProcess rdf:resource="#Pathway29" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway159">
 <bp:pathwayOrder rdf:resource="#PathwayStep958" />
 <bp:pathwayOrder rdf:resource="#PathwayStep959" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction800" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction801" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence958" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Classical antibody-mediated complement activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C1, the first component of complement is a complex containing three protein species, C1q, C1r, and C1s. C1q is assembled from six identical subunits each of which consists of three homologous chains (A, B, and C). These chains form a globular domain at the C-terminus, followed by the &quot;neck&quot; and a coil in the &quot;stalk.&quot; The six subunits are held together by the collagenous stalk parts (giving rise to the comparison of C1q with a &quot;bunch of six tulips&quot;). The stalks also interact with the [C1s:C1r:C1r:C1s] tetramer assembled in a linear chain. Binding of an antigen to an antibody of the IgM or IgG class induces a conformational change in the Fc domain of the antibody that allows it to bind to the C1q component of C1. C1 activation requires interaction with two separate Fc domains, so pentavalent IgM antibody is far more efficient at complement activation than IgG antibody. Antibody binding results in a conformational change in the C1r component of the C1 complex and a proteolytic cleavage of C1r, activating it. Active C1r then cleaves and activates the C1s component of the C1 complex (Muller-Eberhard 1988).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep120">
 <bp:stepProcess rdf:resource="#Catalysis51" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction94" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep121">
 <bp:stepProcess rdf:resource="#Catalysis52" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction95" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction96" />
 <bp:stepProcess rdf:resource="#Catalysis53" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence87">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence88">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence85">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence86">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence83">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep138">
 <bp:stepProcess rdf:resource="#Catalysis65" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction109" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence84">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep139">
 <bp:stepProcess rdf:resource="#BiochemicalReaction110" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence81">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence82">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence89">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway160">
 <bp:pathwayOrder rdf:resource="#PathwayStep967" />
 <bp:pathwayOrder rdf:resource="#PathwayStep966" />
 <bp:pathwayOrder rdf:resource="#PathwayStep961" />
 <bp:pathwayOrder rdf:resource="#PathwayStep962" />
 <bp:pathwayComponent rdf:resource="#Pathway161" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction806" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction807" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction802" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence961" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lectin pathway of complement activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the lectin pathway (LP) is initiated by Mannose-binding lectin (MBL), the hetero-complex CL-LK formed from COLEC11 (Collectin liver 1, CL-L1) and COLEC10 (Collectin kidney 1, CL-K1), and the ficolins (FCN1, FCN2, FCN3). All are Ca-dependent (C-type) lectins that initiate the complement cascade after binding to specific carbohydrate patterns on the target cell surface. All form trimers and larger oligomers (Jensen et al. 2005, Dommett et al. 2006, Garlatti et al. 2010). MBL and ficolins circulate in plasma as complexes with homodimers of MBL-associated serine proteases (MASP) (Fujita et al. 2004, Hajela et al. 2002). MASP1, MASP2 and MASP3 have all been reported to mediate complement activation. Upon binding of human lectin to the target surface, the complex of lectin:MASP undergoes conformational changes that result in MASP cleavage and activation (Matsushita M et al. 2000, Fujita et al. 2004). Active MASP2 cleaves C4 to generate C4a and C4b. C4b binds to the target cell surface via its thioester bond, then binds circulating C2 (Law and Dodds 1997). Bound C2 is cleaved by MASP2 to yield the C3 convertase C4b:C2a. The active form of MASP1 was reported to cleave C2 in a manner similar to MASP2 (Matsushita et al. 2000, Chen    Wallis 2004). MASP1 can cleave proenzyme MASP2, leading to complement activation (Heja et al. 2012). MASP1 can also cleave fibrinogen to yield fibrinopeptide B, and activates factor XIII. MASP1 may have a role in removal of &apos;dead C3&apos;, i.e. C3(H2O) (Hajela et al. 2002). In addition to MASP1 to 3, two alternatively-slpiced forms of MASP1 (MAp44) and MASP2 (sMAP) have been implicated in complement cascade signaling (Takahashi et al. 1999, Degn et al. 2010). The functions of MASP3, sMAP and MAp44 in the lectin pathway remain to be clarified.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway161">
 <bp:pathwayOrder rdf:resource="#PathwayStep963" />
 <bp:pathwayOrder rdf:resource="#PathwayStep964" />
 <bp:pathwayOrder rdf:resource="#PathwayStep965" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction804" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction803" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction805" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence963" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolins bind to repetitive carbohydrate structures on the target cell surface</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolins are recognition molecules in the lectin pathway of complement activation. Three types of ficolin have been identified in humans: M-ficolin (ficolin-1, FCN1), L-ficolin (ficolin-2, FCN2) and H-ficolin (ficolin-3, FCN3). FCN2 and 3 circulate in blood plasma whereas FCN1 is locally secreted by immune response cells (Teh et al. 2000, Liu et al. 2005, Matsushita et al. 2002). Plasma ficolins circulate as complexes with MBL-associated serine proteases (MASPs). Upon binding of ficolins to carbohydrates on the target cell surface, MASPs are activated and subsequently activate the complement cascade (Matsushita et al. 2002, Gout et al. 2009). Ficolins function as trimers and larger oligomers. Ficolin peptide sequences contain an amino-terminal cysteine-rich region, a collagen-like domain, a neck region and a carboxy-terminal fibrinogen-like domain. The fibrinogen-like domain binds to pathogen- or apoptotic cell-associated molecular patterns. Different ficolins have distinct recognition specificities (Endo et al. 2007, Thiel and Gadjeva 2009, Garlatti et al. 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway162">
 <bp:pathwayOrder rdf:resource="#PathwayStep969" />
 <bp:pathwayOrder rdf:resource="#PathwayStep970" />
 <bp:pathwayOrder rdf:resource="#PathwayStep971" />
 <bp:pathwayOrder rdf:resource="#PathwayStep972" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction808" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction809" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction811" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction810" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence969" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of C3 and C5</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The 3 pathways of complement activation converge on the cleavage of C3  by C3 convertases. C3 convertase cleaves C3 into C3a and C3b - a central  step of complement activation. C3a remains in the fluid phase and acts  as an anaphylatoxin, whereas C3b can form additional C3 convertases hastening the production of C3b. Besides, C3b binds to C3 convertases to form C5 convertase, which can act as an opsonin, or is degraded into fragments which  cannot form an active convertase.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway163">
 <bp:pathwayOrder rdf:resource="#PathwayStep978" />
 <bp:pathwayOrder rdf:resource="#PathwayStep979" />
 <bp:pathwayOrder rdf:resource="#PathwayStep974" />
 <bp:pathwayOrder rdf:resource="#PathwayStep975" />
 <bp:pathwayOrder rdf:resource="#PathwayStep976" />
 <bp:pathwayOrder rdf:resource="#PathwayStep977" />
 <bp:pathwayOrder rdf:resource="#PathwayStep981" />
 <bp:pathwayOrder rdf:resource="#PathwayStep982" />
 <bp:pathwayOrder rdf:resource="#PathwayStep983" />
 <bp:pathwayOrder rdf:resource="#PathwayStep980" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction815" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction814" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction817" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction816" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction819" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction818" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction820" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction821" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction813" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction812" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence974" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neutrophil degranulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Neutrophils are the most abundant leukocytes (white blood cells), indispensable in defending the body against invading microorganisms. In response to infection, neutrophils leave the circulation and migrate towards the inflammatory focus. They contain several subsets of granules that are mobilized to fuse with the cell membrane or phagosomal membrane, resulting in the exocytosis or exposure of membrane proteins. Traditionally, neutrophil granule constituents are described as antimicrobial or proteolytic, but granules also introduce membrane proteins to the cell surface, changing how the neutrophil responds to its environment (Borregaard et al. 2007). Primed neutrophils actively secrete cytokines and other inflammatory mediators and can present antigens via MHC II, stimulating T-cells (Wright et al. 2010).  Granules form during neutrophil differentiation. Granule subtypes can be distinguished by their content but overlap in structure and composition. The differences are believed to be a consequence of changing protein expression and differential timing of granule formation during the terminal processes of neutrophil differentiation, rather than sorting (Le Cabec et al. 1996).    The classical granule subsets are Azurophil or primary granules (AG), secondary granules (SG) and gelatinase granules (GG). Neutrophils also contain exocytosable storage cell organelles, storage vesicles (SV), formed by endocytosis they contain many cell-surface markers and extracellular, plasma proteins (Borregaard et al. 1992). Ficolin-1-rich granules (FG) are like GGs highly exocytosable but gelatinase-poor (Rorvig et al. 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway164">
 <bp:pathwayOrder rdf:resource="#PathwayStep985" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1004" />
 <bp:pathwayComponent rdf:resource="#Pathway165" />
 <bp:pathwayComponent rdf:resource="#Pathway166" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence985" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The innate immune system is the first line of defense against invading microorganisms, a broad specificity response characterized by the recruitment and activation of phagocytes and the release of anti-bacterial peptides. The receptors involved recognize conserved molecules present in microbes called pathogen-associated molecular patterns (PAMPs), and/or molecules that are produced as a result of tissue injury, the damage associated molecular pattern molecules (DAMPs). PAMPs are essential to the pathogen and therefore unlikely to vary. Examples are lipopolysaccharide (LPS), peptidoglycans (PGNs) and viral RNA. DAMPs include intracellular proteins, such as heat-shock proteins and extracellular matrix proteins released by tissue injury, such as hyaluronan fragments. Non-protein DAMPs include ATP, uric acid, heparin sulfate and dsDNA. The receptors for these factors are referred to collectively as pathogen- or pattern-recognition receptors (PRRs). The best studied of these are the membrane-associated Toll-like receptor family. Less well studied but more numerous are the intracellular nucleotide-binding domain, leucine rich repeat containing receptors (NLRs) also called nucleotide binding oligomerization domain (NOD)-like receptors, a family with over 20 members in humans and over 30 in mice. These recognise PAMPs/DAMPs from phagocytosed microorganisms or from intracellular infections (Kobayashi et al. 2003, Proell et al. 2008, Wilmanski et al. 2008). Some NLRs are involved in process unrelated to pathogen detection such as tissue homeostasis, apoptosis, graft-versus-host disease and early development (Kufer    Sansonetti 2011).    Structurally NLRs can be subdivided into the caspase-recruitment domain (CARD)-containing NLRCs (NODs) and the pyrin domain (PYD)-containing NLRPs (NALPs), plus outliers including ice protease (caspase-1) activating factor (IPAF) (Martinon    Tschopp, 2005). In practical terms, NLRs can be divided into the relatively well characterized NOD1/2 which signal via RIP2 primarily to NFkappaB, and the remainder, some of which participate in macromolecular structures called Inflammasomes that activate caspases. Mutations in several members of the NLR protein family have been linked to inflammatory diseases, suggesting these molecules play important roles in maintaining host-pathogen interactions and inflammatory responses.   Most NLRs have a tripartite structure consisting of a variable amino-terminal domain, a central nucleotide-binding oligomerization domain (NOD or NACHT) that is believed to mediate the formation of self oligomers, and a carboxy-terminal leucine-rich repeat (LRR) that detects PAMPs/DAMPs. In most cases the amino-terminal domain includes protein-interaction modules, such as CARD or PYD, some harbour baculovirus inhibitor repeat (BIR) or other domains. For most characterised NLRs these domains have been attributed to downstream signaling  Under resting conditions, NLRs are thought to be present  in an autorepressed form, with the LRR folded back onto the NACHT domain preventing oligomerization. Accessory proteins may help maintain the inactive state. PAMP/DAMP exposure is thought to triggers conformational changes that expose the NACHT domain enabling oligomerization and recruitment of effectors, though it should be noted that due to the lack of availability of structural data, the mechanistic details of NLR activation remain largely elusive.  New terminology for NOD-like receptors was adopted by the Human Genome Organization (HUGO) in 2008 to standardize the nomenclature of NLRs. The acronym NLR, once standing for NOD-like receptor, now is an abbreviation of &apos;nucleotide-binding domain, leucine-rich repeat containing&apos; protein. The term NOD-like receptor is officially outdated and replaced by NLRC where the C refers to the CARD domain. However the official gene symbols for NOD1 and NOD2 still contain NOD and this general term is still widely used.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway165">
 <bp:pathwayOrder rdf:resource="#PathwayStep989" />
 <bp:pathwayOrder rdf:resource="#PathwayStep996" />
 <bp:pathwayOrder rdf:resource="#PathwayStep986" />
 <bp:pathwayOrder rdf:resource="#PathwayStep997" />
 <bp:pathwayOrder rdf:resource="#PathwayStep987" />
 <bp:pathwayOrder rdf:resource="#PathwayStep998" />
 <bp:pathwayOrder rdf:resource="#PathwayStep988" />
 <bp:pathwayOrder rdf:resource="#PathwayStep999" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1000" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1002" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1001" />
 <bp:pathwayOrder rdf:resource="#PathwayStep992" />
 <bp:pathwayOrder rdf:resource="#PathwayStep993" />
 <bp:pathwayOrder rdf:resource="#PathwayStep994" />
 <bp:pathwayOrder rdf:resource="#PathwayStep995" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1003" />
 <bp:pathwayOrder rdf:resource="#PathwayStep990" />
 <bp:pathwayOrder rdf:resource="#PathwayStep991" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction826" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction837" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction825" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction836" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction828" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction839" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction827" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction838" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction829" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction831" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction830" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction822" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction833" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction832" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction824" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction835" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction823" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction834" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence986" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOD1/2 Signaling Pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOD1 is ubiquitously expressed, while NOD2 expression is restricted to monocytes, macrophages, dendritic cells, and intestinal Paneth cells (Inohara et al. 2005). NOD1 and NOD2 activation induces transcription of immune response genes, predominantly mediated by the proinflammatory transcriptional factor NFkappaB but also by AP-1 and Elk-1 (Inohara et al. 2005). NFkappaB translocates to the nucleus following release from IkappaB proteins. NOD1 and NOD2 signaling involves an interaction between their caspase-recruitment domain (CARD) and the CARD of the kinase RIPK2 (RIP2/RICK). This leads to the activation of the NFkappaB pathway and MAPK pathways (Windheim et al. 2007). Activated NODs oligomerize via their NACHT domains, inducing physical proximity of RIP2 proteins that is believed to trigger their K63-linked polyubiquitination, facilitating recruitment of the TAK1 complex. RIP2 also recruits NEMO, bringing the TAK1 and IKK complexes into proximity, leading to NF-kappaB activation and activation of MAPK signaling. Recent studies have demonstrated that K63-linked regulatory ubiquitination of RIP2 is essential for the recruitment of TAK1 (Hasegawa et al. 2008, Hitosumatsu et al. 2008). As observed for toll-like receptor (TLR) signaling, ubiquitination can be removed by the deubiquitinating enzyme A20, thereby dampening NOD1/NOD2-induced NF-kappaB activation. NOD1 and NOD2 both induce K63-linked ubiquitination of RIP2, but NOD2-signaling appears to preferentially utilize the E3 ligase TRAF6, while TRAF2 and TRAF5 were shown to be important for NOD1-mediated signaling. In both cases, activation of NF-kappaB results in the upregulated transcription and production of inflammatory mediators.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway166">
 <bp:pathwayOrder rdf:resource="#PathwayStep1010" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1034" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1015" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1005" />
 <bp:pathwayComponent rdf:resource="#Pathway170" />
 <bp:pathwayComponent rdf:resource="#Pathway167" />
 <bp:pathwayComponent rdf:resource="#Pathway168" />
 <bp:pathwayComponent rdf:resource="#Pathway169" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1005" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inflammasomes</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In contrast to NOD1/2 some NLRPs function as large macromolecular complexes called &apos;Inflammasomes&apos;. These multiprotein platforms control activation of the cysteinyl aspartate protease caspase-1 and thereby the subsequent cleavage of pro-interleukin 1B (pro-IL1B) into the active proinflammatory cytokine IL1B. Activation of caspase-1 is essential for production of IL1B and IL18, which respectively bind and activate the IL1 receptor (IL1R) and IL18 receptor (IL18R) complexes. IL1R and IL18R activate NFkappaB and other signaling cascades.  As the activation of inflammasomes leads to caspase-1 activation, inflammasomes can be considered an upstream step of the IL1R and IL18R signaling cascades, linking intracellular pathogen sensing to immune response pathways mediated by Toll-Like Receptors (TLRs). Monocytes and macrophages do not express pro-IL1B until stimulated, typically by TLRs (Franchi et al. 2009). The resulting pro-IL1B is not converted to IL1B unless a second stimulus activates an inflammasome. This requirement for two distinct stimuli allows tight regulation of IL1B/IL18 production, necessary because excessive IL-1B production is associated with numerous inflammatory diseases such as  gout and rheumatoid arthritis (Masters et al. 2009).  There are at least four subtypes of the inflammasome, characterized by the NLRP. In addition the protein AIM2 can form an inflammasome. All activate caspase-1. NLRP1 (NALP1), NLRP3 (Cryopyrin, NALP3), IPAF (CARD12, NLRC4) and AIM2 inflammasomes all have clear physiological roles in vivo. NLRP2, NLRP6, NLRP7, NLRP10 and NLRP12 have been demonstrated to modulate caspase-1 activity in vitro but the significance of this is unclear (Mariathasan and Monack, 2007).  NLRP3 and AIM2 bind the protein &apos;apoptosis-associated speck-like protein containing a CARD&apos; (ASC, also called PYCARD), via a PYD-PYD domain interaction. This in turn recruits procaspase-1 through a CARD-CARD interaction. NLRP1 and IPAF contain CARD domains and can bind procaspase-1 directly, though both are stimulated by ASC. Oligomerization of NLRPs is believed to bring procaspases into close proximity, leading to &apos;induced proximity&apos; auto-activation (Boatright et al. 2003). This leads to formation of the active caspase tetramer. NLRPs are generally considered to be cytoplasmic proteins, but there is evidence for cytoplasmic-nuclear shuttling of the family member CIITA (LeibundGut-Landmann et al. 2004) and tissue/cell dependent NALP1 expression in the nucleus of neurons and lymphocytes (Kummer et al. 2007); the significance of this remains unclear. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence90">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep134">
 <bp:stepProcess rdf:resource="#Pathway30" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway167">
 <bp:pathwayOrder rdf:resource="#PathwayStep1008" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1007" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1009" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1006" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction840" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction842" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction841" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction843" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1006" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The AIM2 inflammasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AIM2 is a member of the PYHIN or HIN200 family. It has a C-terminal HIN domain which can bind double-stranded DNA (dsDNA) and a PYD domain that can bind ASC via a PYD-PYD interaction. In cells expressing procaspase-1, The interaction of AIM2 with ASC leads to recruitment of procaspase-1  forming the ASC pyroptosome which induces pyroptotic cell death by generating active caspase-1. Data from AIM2 deficient mice indicates that the AIM2 inflammasome is a nonredundant sensor for dsDNA that regulates the caspase-1-dependent maturation of IL-1beta and IL-18 (Rathinam et al. 2010, Hornung    Latz, 2009).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence91">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction106" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway168">
 <bp:pathwayOrder rdf:resource="#PathwayStep1011" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1013" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1012" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1014" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction847" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction844" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction846" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction845" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1011" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The NLRP1 inflammasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP1 is activated by MDP (Faustin et al. 2007). The NLRP1 inflammasome was the first to be characterized. It was described as a complex containing NALP1, ASC, caspase-1 and caspase-5 (Martinon et al. 2002). Unlike NLRP3, NLRP1 has a C-terminal extension containing a CARD domain, which has been reported to interact directly with procaspase-1, obviating a requirement for ASC (Faustin et al. 2007), though ASC was found to augment the interaction. Mouse NLRP1 has no PYD domain and would therefore not be expected to interact directly with procaspase-1. Like the NLRP3 inflammasome, K+ efflux appears to be essential for caspase-1 activation (Wickliffe et al. 2008). Ribonucleoside triphosphates (NTPs) are required for NALP1-mediated caspase-1 activation with ATP being the most efficient, Mg2+ was also required (Faustin et al. 2007). The human NLRP1 gene has 3 paralogues in mouse that are highly polymorphic. Differences between mouse strains underlie susceptibility to anthrax lethal toxin (Boyden    Dietrich 2006). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep136">
 <bp:stepProcess rdf:resource="#Catalysis63" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction107" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway169">
 <bp:pathwayOrder rdf:resource="#PathwayStep1022" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1033" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1021" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1032" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1024" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1023" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1020" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1031" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1030" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1019" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1018" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1029" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1026" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1025" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1017" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1028" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1016" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1027" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction848" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction859" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction858" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction849" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction851" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction862" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction850" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction861" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction853" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction864" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction852" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction863" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction855" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction854" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction865" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction857" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction856" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction860" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1016" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The NLRP3 inflammasome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The NLRP3 (Cryopyrin) inflammasome is currently the best characterized. It consists of NLRP3, ASC (PYCARD) and procaspase-1; CARD8 (Cardinal) is also suggested to be a component. It is activated by a number of pathogens and bacterial toxins as well as diverse PAMPs, danger-associated molecular patterns (DAMPS) such as hyaluronan and uric acid, and exogenous irritants such as silica and asbestos (see Table S1 Schroder    Tschopp, 2010).  Mutations in NLRP3 which lead to constitutive activation are linked to the human diseases Muckle-Wells syndrome, familial cold autoinflammatory syndrome and NOMID (Ting et al. 2006), characterized by skin rashes and other symptoms associated with generalized inflammation. The cause of these symptoms is uncontrolled IL-1 beta production. Multiple studies have shown that activation of the NLRP3 inflammasome by particulate activators (e.g. Hornung et al. 2008) requires phagocytosis, but this is not required for the response to ATP, which is mediated by the P2X7 receptor (Kahlenberg    Dubyak, 2004) and appears to involve the pannexin membrane channel (Pellegrin    Suprenenant 2006). Direct binding of activators to NLRP3 has not been demonstrated and the exact process of activation is unclear, though it is speculated to involve changes in conformation that free the NACHT domain for oligomerization (Inohara    Nunez 2001, 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep137">
 <bp:stepProcess rdf:resource="#Catalysis64" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction108" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction102" />
 <bp:stepProcess rdf:resource="#Catalysis59" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep131">
 <bp:stepProcess rdf:resource="#BiochemicalReaction103" />
 <bp:stepProcess rdf:resource="#Catalysis60" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep132">
 <bp:stepProcess rdf:resource="#Catalysis61" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep133">
 <bp:stepProcess rdf:resource="#Catalysis62" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction105" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence76">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence77">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence74">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence75">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence72">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence73">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence70">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence71">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence78">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence79">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway130">
 <bp:pathwayOrder rdf:resource="#PathwayStep738" />
 <bp:pathwayOrder rdf:resource="#PathwayStep749" />
 <bp:pathwayOrder rdf:resource="#PathwayStep744" />
 <bp:pathwayComponent rdf:resource="#Pathway131" />
 <bp:pathwayComponent rdf:resource="#Pathway132" />
 <bp:pathwayComponent rdf:resource="#Pathway133" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence738" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1351">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway131">
 <bp:pathwayOrder rdf:resource="#PathwayStep739" />
 <bp:pathwayOrder rdf:resource="#PathwayStep743" />
 <bp:pathwayOrder rdf:resource="#PathwayStep740" />
 <bp:pathwayOrder rdf:resource="#PathwayStep741" />
 <bp:pathwayOrder rdf:resource="#PathwayStep742" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction609" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction611" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction610" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction613" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction612" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence739" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1350">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway132">
 <bp:pathwayOrder rdf:resource="#PathwayStep747" />
 <bp:pathwayOrder rdf:resource="#PathwayStep748" />
 <bp:pathwayOrder rdf:resource="#PathwayStep745" />
 <bp:pathwayOrder rdf:resource="#PathwayStep746" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction617" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction616" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction615" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction614" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence745" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1353">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway133">
 <bp:pathwayOrder rdf:resource="#PathwayStep758" />
 <bp:pathwayOrder rdf:resource="#PathwayStep754" />
 <bp:pathwayOrder rdf:resource="#PathwayStep755" />
 <bp:pathwayOrder rdf:resource="#PathwayStep756" />
 <bp:pathwayOrder rdf:resource="#PathwayStep757" />
 <bp:pathwayOrder rdf:resource="#PathwayStep750" />
 <bp:pathwayOrder rdf:resource="#PathwayStep751" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction618" />
 <bp:pathwayComponent rdf:resource="#Pathway134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction622" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction621" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction624" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction623" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction625" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence750" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1352">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway134">
 <bp:pathwayOrder rdf:resource="#PathwayStep752" />
 <bp:pathwayOrder rdf:resource="#PathwayStep753" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction619" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction620" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence752" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1355">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence80">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway135">
 <bp:pathwayOrder rdf:resource="#PathwayStep765" />
 <bp:pathwayOrder rdf:resource="#PathwayStep766" />
 <bp:pathwayOrder rdf:resource="#PathwayStep767" />
 <bp:pathwayOrder rdf:resource="#PathwayStep761" />
 <bp:pathwayOrder rdf:resource="#PathwayStep762" />
 <bp:pathwayOrder rdf:resource="#PathwayStep763" />
 <bp:pathwayOrder rdf:resource="#PathwayStep764" />
 <bp:pathwayOrder rdf:resource="#PathwayStep760" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction628" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction627" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction629" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction631" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction630" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction633" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction632" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction626" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence760" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1354">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway136">
 <bp:pathwayOrder rdf:resource="#PathwayStep777" />
 <bp:pathwayOrder rdf:resource="#PathwayStep778" />
 <bp:pathwayOrder rdf:resource="#PathwayStep779" />
 <bp:pathwayOrder rdf:resource="#PathwayStep780" />
 <bp:pathwayOrder rdf:resource="#PathwayStep781" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction642" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction644" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction643" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction646" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction645" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence777" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1357">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway137">
 <bp:pathwayOrder rdf:resource="#PathwayStep876" />
 <bp:pathwayOrder rdf:resource="#PathwayStep784" />
 <bp:pathwayOrder rdf:resource="#PathwayStep785" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction726" />
 <bp:pathwayComponent rdf:resource="#Pathway138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction648" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence784" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor TLR1:TLR2 Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR1 is expressed by monocytes. TLR1 and TLR2 cotranslationally form heterodimeric complexes on the cell surface and in the cytosol. The TLR2:TLR1 complex recognizes Neisserial PorB and Mycobacterial triacylated lipoproteins and peptides, amongst others, triggering up-regulation of nuclear factor-kappaB production and apoptotic cascades. Such cooperation between TLR1 and TLR2 on the cell surface of normal human peripheral blood mononuclear cells, for instance, leads to the activation of pro-inflammatory cytokine secretion (Sandor et al. 2003).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1356">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway138">
 <bp:pathwayOrder rdf:resource="#PathwayStep813" />
 <bp:pathwayOrder rdf:resource="#PathwayStep868" />
 <bp:pathwayOrder rdf:resource="#PathwayStep814" />
 <bp:pathwayOrder rdf:resource="#PathwayStep869" />
 <bp:pathwayOrder rdf:resource="#PathwayStep815" />
 <bp:pathwayOrder rdf:resource="#PathwayStep816" />
 <bp:pathwayOrder rdf:resource="#PathwayStep787" />
 <bp:pathwayOrder rdf:resource="#PathwayStep820" />
 <bp:pathwayOrder rdf:resource="#PathwayStep864" />
 <bp:pathwayOrder rdf:resource="#PathwayStep865" />
 <bp:pathwayOrder rdf:resource="#PathwayStep811" />
 <bp:pathwayOrder rdf:resource="#PathwayStep866" />
 <bp:pathwayOrder rdf:resource="#PathwayStep812" />
 <bp:pathwayOrder rdf:resource="#PathwayStep867" />
 <bp:pathwayOrder rdf:resource="#PathwayStep817" />
 <bp:pathwayOrder rdf:resource="#PathwayStep818" />
 <bp:pathwayOrder rdf:resource="#PathwayStep819" />
 <bp:pathwayOrder rdf:resource="#PathwayStep862" />
 <bp:pathwayOrder rdf:resource="#PathwayStep786" />
 <bp:pathwayOrder rdf:resource="#PathwayStep863" />
 <bp:pathwayOrder rdf:resource="#PathwayStep792" />
 <bp:pathwayOrder rdf:resource="#PathwayStep870" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction716" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction649" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction715" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction718" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction717" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction719" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction675" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction674" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction677" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction676" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction720" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction679" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction678" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction714" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction713" />
 <bp:pathwayComponent rdf:resource="#Pathway140" />
 <bp:pathwayComponent rdf:resource="#Pathway151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction671" />
 <bp:pathwayComponent rdf:resource="#Pathway142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction673" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction672" />
 <bp:pathwayComponent rdf:resource="#Pathway139" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence786" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88:MAL(TIRAP) cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The first known downstream component of TLR4 and TLR2 signaling is the adaptor MyD88. Another adapter MyD88-adaptor-like (Mal; also known as TIR-domain-containing adaptor protein or TIRAP) has also been described for TLR4 and TLR2 signaling. MyD88 comprises an N-terminal Death Domain (DD) and a C-terminal TIR, whereas Mal lacks the DD. The TIR homotypic interactions bring adapters into contact with the activated TLRs, whereas the DD modules recruit serine/threonine kinases such as interleukin-1-receptor-associated kinase (IRAK). Recruitment of these protein kinases is accompanied by phosphorylation, which in turn results in the interaction of IRAKs with TNF-receptor-associated factor 6 (TRAF6). The oligomerization of TRAF6 activates TAK1, a member of the MAP3-kinase family, and this leads to the activation of the IkB kinases. These kinases, in turn, phosphorylate IkB, leading to its proteolytic degradation and the translocation of NF-kB to the nucleus. Concomitantly, members of the activator protein-1 (AP-1) transcription factor family, Jun and Fos, are activated, and both AP-1 transcription factors and NF-kB are required for cytokine production, which in turn produces downstream inflammatory effects.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1359">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway139">
 <bp:pathwayOrder rdf:resource="#PathwayStep788" />
 <bp:pathwayOrder rdf:resource="#PathwayStep789" />
 <bp:pathwayOrder rdf:resource="#PathwayStep790" />
 <bp:pathwayOrder rdf:resource="#PathwayStep791" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction651" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction650" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction653" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction652" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence788" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1358">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence65">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence66">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence63">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence64">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence61">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence62">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence60">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence69">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence67">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence68">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1360">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway140">
 <bp:pathwayOrder rdf:resource="#PathwayStep810" />
 <bp:pathwayOrder rdf:resource="#PathwayStep794" />
 <bp:pathwayOrder rdf:resource="#PathwayStep795" />
 <bp:pathwayOrder rdf:resource="#PathwayStep807" />
 <bp:pathwayOrder rdf:resource="#PathwayStep808" />
 <bp:pathwayOrder rdf:resource="#PathwayStep793" />
 <bp:pathwayOrder rdf:resource="#PathwayStep809" />
 <bp:pathwayComponent rdf:resource="#Pathway141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction670" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction655" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction654" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction668" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction667" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction669" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence793" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway141">
 <bp:pathwayOrder rdf:resource="#PathwayStep802" />
 <bp:pathwayOrder rdf:resource="#PathwayStep803" />
 <bp:pathwayOrder rdf:resource="#PathwayStep804" />
 <bp:pathwayOrder rdf:resource="#PathwayStep805" />
 <bp:pathwayOrder rdf:resource="#PathwayStep798" />
 <bp:pathwayOrder rdf:resource="#PathwayStep799" />
 <bp:pathwayOrder rdf:resource="#PathwayStep800" />
 <bp:pathwayOrder rdf:resource="#PathwayStep801" />
 <bp:pathwayOrder rdf:resource="#PathwayStep796" />
 <bp:pathwayOrder rdf:resource="#PathwayStep797" />
 <bp:pathwayOrder rdf:resource="#PathwayStep806" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction660" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction662" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction661" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction664" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction663" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction666" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction665" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction657" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction656" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction659" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction658" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence796" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1362">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway142">
 <bp:pathwayOrder rdf:resource="#PathwayStep825" />
 <bp:pathwayOrder rdf:resource="#PathwayStep831" />
 <bp:pathwayOrder rdf:resource="#PathwayStep853" />
 <bp:pathwayOrder rdf:resource="#PathwayStep821" />
 <bp:pathwayComponent rdf:resource="#Pathway150" />
 <bp:pathwayComponent rdf:resource="#Pathway143" />
 <bp:pathwayComponent rdf:resource="#Pathway144" />
 <bp:pathwayComponent rdf:resource="#Pathway145" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence821" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1361">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway143">
 <bp:pathwayOrder rdf:resource="#PathwayStep824" />
 <bp:pathwayOrder rdf:resource="#PathwayStep822" />
 <bp:pathwayOrder rdf:resource="#PathwayStep823" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction680" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction682" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction681" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence822" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1364">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway144">
 <bp:pathwayOrder rdf:resource="#PathwayStep826" />
 <bp:pathwayOrder rdf:resource="#PathwayStep827" />
 <bp:pathwayOrder rdf:resource="#PathwayStep830" />
 <bp:pathwayOrder rdf:resource="#PathwayStep828" />
 <bp:pathwayOrder rdf:resource="#PathwayStep829" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction684" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction683" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction686" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction685" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction687" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence826" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1363">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway145">
 <bp:pathwayOrder rdf:resource="#PathwayStep838" />
 <bp:pathwayOrder rdf:resource="#PathwayStep832" />
 <bp:pathwayOrder rdf:resource="#PathwayStep843" />
 <bp:pathwayComponent rdf:resource="#Pathway146" />
 <bp:pathwayComponent rdf:resource="#Pathway147" />
 <bp:pathwayComponent rdf:resource="#Pathway148" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence832" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1366">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway146">
 <bp:pathwayOrder rdf:resource="#PathwayStep835" />
 <bp:pathwayOrder rdf:resource="#PathwayStep836" />
 <bp:pathwayOrder rdf:resource="#PathwayStep837" />
 <bp:pathwayOrder rdf:resource="#PathwayStep833" />
 <bp:pathwayOrder rdf:resource="#PathwayStep834" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction691" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction690" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction692" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction688" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction689" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence833" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1365">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway147">
 <bp:pathwayOrder rdf:resource="#PathwayStep842" />
 <bp:pathwayOrder rdf:resource="#PathwayStep840" />
 <bp:pathwayOrder rdf:resource="#PathwayStep841" />
 <bp:pathwayOrder rdf:resource="#PathwayStep839" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction693" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction695" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction696" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence839" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1368">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway148">
 <bp:pathwayOrder rdf:resource="#PathwayStep848" />
 <bp:pathwayOrder rdf:resource="#PathwayStep849" />
 <bp:pathwayOrder rdf:resource="#PathwayStep844" />
 <bp:pathwayOrder rdf:resource="#PathwayStep845" />
 <bp:pathwayOrder rdf:resource="#PathwayStep850" />
 <bp:pathwayOrder rdf:resource="#PathwayStep851" />
 <bp:pathwayOrder rdf:resource="#PathwayStep852" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction704" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction697" />
 <bp:pathwayComponent rdf:resource="#Pathway149" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction701" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction700" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction703" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction702" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence844" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1367">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway149">
 <bp:pathwayOrder rdf:resource="#PathwayStep846" />
 <bp:pathwayOrder rdf:resource="#PathwayStep847" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction699" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction698" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence846" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1369">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence54">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway109">
 <bp:pathwayOrder rdf:resource="#PathwayStep626" />
 <bp:pathwayOrder rdf:resource="#PathwayStep627" />
 <bp:pathwayOrder rdf:resource="#PathwayStep628" />
 <bp:pathwayOrder rdf:resource="#PathwayStep611" />
 <bp:pathwayOrder rdf:resource="#PathwayStep612" />
 <bp:pathwayOrder rdf:resource="#PathwayStep613" />
 <bp:pathwayOrder rdf:resource="#PathwayStep625" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction518" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction517" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction519" />
 <bp:pathwayComponent rdf:resource="#Pathway110" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction503" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction516" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction504" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence611" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence55">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence52">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence53">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence50">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence51">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence58">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence59">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence56">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence57">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1371">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1370">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1373">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1372">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway110">
 <bp:pathwayOrder rdf:resource="#PathwayStep615" />
 <bp:pathwayOrder rdf:resource="#PathwayStep616" />
 <bp:pathwayOrder rdf:resource="#PathwayStep617" />
 <bp:pathwayOrder rdf:resource="#PathwayStep618" />
 <bp:pathwayOrder rdf:resource="#PathwayStep622" />
 <bp:pathwayOrder rdf:resource="#PathwayStep623" />
 <bp:pathwayOrder rdf:resource="#PathwayStep624" />
 <bp:pathwayOrder rdf:resource="#PathwayStep614" />
 <bp:pathwayOrder rdf:resource="#PathwayStep620" />
 <bp:pathwayOrder rdf:resource="#PathwayStep621" />
 <bp:pathwayOrder rdf:resource="#PathwayStep619" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction507" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction506" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction509" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction508" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction510" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction512" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction511" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction514" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction513" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction505" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction515" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence614" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1375">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway111">
 <bp:pathwayOrder rdf:resource="#PathwayStep639" />
 <bp:pathwayOrder rdf:resource="#PathwayStep645" />
 <bp:pathwayOrder rdf:resource="#PathwayStep667" />
 <bp:pathwayOrder rdf:resource="#PathwayStep635" />
 <bp:pathwayComponent rdf:resource="#Pathway112" />
 <bp:pathwayComponent rdf:resource="#Pathway113" />
 <bp:pathwayComponent rdf:resource="#Pathway114" />
 <bp:pathwayComponent rdf:resource="#Pathway119" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence635" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1374">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway112">
 <bp:pathwayOrder rdf:resource="#PathwayStep637" />
 <bp:pathwayOrder rdf:resource="#PathwayStep638" />
 <bp:pathwayOrder rdf:resource="#PathwayStep636" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction525" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction527" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction526" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence636" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1377">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway113">
 <bp:pathwayOrder rdf:resource="#PathwayStep644" />
 <bp:pathwayOrder rdf:resource="#PathwayStep640" />
 <bp:pathwayOrder rdf:resource="#PathwayStep641" />
 <bp:pathwayOrder rdf:resource="#PathwayStep642" />
 <bp:pathwayOrder rdf:resource="#PathwayStep643" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction529" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction528" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction530" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction532" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction531" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence640" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1376">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway114">
 <bp:pathwayOrder rdf:resource="#PathwayStep646" />
 <bp:pathwayOrder rdf:resource="#PathwayStep657" />
 <bp:pathwayOrder rdf:resource="#PathwayStep652" />
 <bp:pathwayComponent rdf:resource="#Pathway115" />
 <bp:pathwayComponent rdf:resource="#Pathway116" />
 <bp:pathwayComponent rdf:resource="#Pathway117" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence646" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1379">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway115">
 <bp:pathwayOrder rdf:resource="#PathwayStep648" />
 <bp:pathwayOrder rdf:resource="#PathwayStep649" />
 <bp:pathwayOrder rdf:resource="#PathwayStep647" />
 <bp:pathwayOrder rdf:resource="#PathwayStep651" />
 <bp:pathwayOrder rdf:resource="#PathwayStep650" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction534" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction536" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction535" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction537" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence647" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1378">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway116">
 <bp:pathwayOrder rdf:resource="#PathwayStep655" />
 <bp:pathwayOrder rdf:resource="#PathwayStep656" />
 <bp:pathwayOrder rdf:resource="#PathwayStep653" />
 <bp:pathwayOrder rdf:resource="#PathwayStep654" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction539" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction541" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction538" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence653" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway117">
 <bp:pathwayOrder rdf:resource="#PathwayStep659" />
 <bp:pathwayOrder rdf:resource="#PathwayStep666" />
 <bp:pathwayOrder rdf:resource="#PathwayStep658" />
 <bp:pathwayOrder rdf:resource="#PathwayStep662" />
 <bp:pathwayOrder rdf:resource="#PathwayStep663" />
 <bp:pathwayOrder rdf:resource="#PathwayStep664" />
 <bp:pathwayOrder rdf:resource="#PathwayStep665" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction542" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction545" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction547" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction546" />
 <bp:pathwayComponent rdf:resource="#Pathway118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction549" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction548" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence658" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway118">
 <bp:pathwayOrder rdf:resource="#PathwayStep660" />
 <bp:pathwayOrder rdf:resource="#PathwayStep661" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction543" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction544" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence660" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway119">
 <bp:pathwayOrder rdf:resource="#PathwayStep668" />
 <bp:pathwayOrder rdf:resource="#PathwayStep669" />
 <bp:pathwayOrder rdf:resource="#PathwayStep673" />
 <bp:pathwayOrder rdf:resource="#PathwayStep674" />
 <bp:pathwayOrder rdf:resource="#PathwayStep675" />
 <bp:pathwayOrder rdf:resource="#PathwayStep670" />
 <bp:pathwayOrder rdf:resource="#PathwayStep671" />
 <bp:pathwayOrder rdf:resource="#PathwayStep672" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction550" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction552" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction551" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction554" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction553" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction556" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction555" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction557" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence668" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence43">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence44">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence41">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence42">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence40">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence49">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence47">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence48">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence45">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence46">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1380">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1382">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1381">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1384">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway120">
 <bp:pathwayOrder rdf:resource="#PathwayStep684" />
 <bp:pathwayOrder rdf:resource="#PathwayStep685" />
 <bp:pathwayOrder rdf:resource="#PathwayStep681" />
 <bp:pathwayOrder rdf:resource="#PathwayStep682" />
 <bp:pathwayOrder rdf:resource="#PathwayStep683" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction563" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction562" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction565" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction564" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction566" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence681" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1383">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway121">
 <bp:pathwayOrder rdf:resource="#PathwayStep689" />
 <bp:pathwayOrder rdf:resource="#PathwayStep783" />
 <bp:pathwayComponent rdf:resource="#Pathway122" />
 <bp:pathwayComponent rdf:resource="#Pathway137" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence689" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 2 (TLR2) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR2 is involved in recognition of peptidoglycan from gram-positive bacteria, bacterial lipoproteins, mycoplasma lipoprotein and mycobacterial products. It is quite possible that recognition of at least some other TLR2 ligands may be assisted by additional accessory proteins, particularly in association with TLR1 or TLR6. TLR2 is expressed constitutively on macrophages, dendritic cells, and B cells, and can be induced in some other cell types, including epithelial cells. TLR1 and TLR6, on the other hand, are expressed almost ubiquitously (Muzio et al. 2000). TLR2 may be a sensor and inductor of specific defense processes, including oxidative stress and cellular necrosis initially spurred by microbial compounds.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1386">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway122">
 <bp:pathwayOrder rdf:resource="#PathwayStep690" />
 <bp:pathwayOrder rdf:resource="#PathwayStep691" />
 <bp:pathwayOrder rdf:resource="#PathwayStep782" />
 <bp:pathwayComponent rdf:resource="#Pathway123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction569" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction647" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence690" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor TLR6:TLR2 Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR2 and TLR4 recognize different bacterial cell wall components. While TLR4 is trained onto Gram-negative lipopolysaccharide components, TLR2 - in combination with TLR6 - plays a major role in recognizing peptidoglycan wall products from Gram-positive bacteria, as well as Mycobacterial diacylated lipopeptides. In particular, TLR6 appears to participate in discriminating the subtle differences between dipalmitoyl and tripalmitoyl cysteinyl residues (Okusawa et al. 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1385">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway123">
 <bp:pathwayOrder rdf:resource="#PathwayStep725" />
 <bp:pathwayOrder rdf:resource="#PathwayStep769" />
 <bp:pathwayOrder rdf:resource="#PathwayStep726" />
 <bp:pathwayOrder rdf:resource="#PathwayStep717" />
 <bp:pathwayOrder rdf:resource="#PathwayStep721" />
 <bp:pathwayOrder rdf:resource="#PathwayStep776" />
 <bp:pathwayOrder rdf:resource="#PathwayStep722" />
 <bp:pathwayOrder rdf:resource="#PathwayStep723" />
 <bp:pathwayOrder rdf:resource="#PathwayStep724" />
 <bp:pathwayOrder rdf:resource="#PathwayStep768" />
 <bp:pathwayOrder rdf:resource="#PathwayStep718" />
 <bp:pathwayOrder rdf:resource="#PathwayStep719" />
 <bp:pathwayOrder rdf:resource="#PathwayStep772" />
 <bp:pathwayOrder rdf:resource="#PathwayStep773" />
 <bp:pathwayOrder rdf:resource="#PathwayStep774" />
 <bp:pathwayOrder rdf:resource="#PathwayStep698" />
 <bp:pathwayOrder rdf:resource="#PathwayStep720" />
 <bp:pathwayOrder rdf:resource="#PathwayStep775" />
 <bp:pathwayOrder rdf:resource="#PathwayStep692" />
 <bp:pathwayOrder rdf:resource="#PathwayStep693" />
 <bp:pathwayOrder rdf:resource="#PathwayStep770" />
 <bp:pathwayOrder rdf:resource="#PathwayStep771" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction639" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction638" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction598" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction597" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction641" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction600" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction599" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction635" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction634" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction637" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction636" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction570" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction592" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction594" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction593" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction596" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction640" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction595" />
 <bp:pathwayComponent rdf:resource="#Pathway124" />
 <bp:pathwayComponent rdf:resource="#Pathway125" />
 <bp:pathwayComponent rdf:resource="#Pathway136" />
 <bp:pathwayComponent rdf:resource="#Pathway127" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence692" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88:MAL(TIRAP) cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The first known downstream component of TLR4 and TLR2 signaling is the adaptor MyD88. Another adapter MyD88-adaptor-like (Mal; also known as TIR-domain-containing adaptor protein or TIRAP) has also been described for TLR4 and TLR2 signaling. MyD88 comprises an N-terminal Death Domain (DD) and a C-terminal TIR, whereas Mal lacks the DD. The TIR homotypic interactions bring adapters into contact with the activated TLRs, whereas the DD modules recruit serine/threonine kinases such as interleukin-1-receptor-associated kinase (IRAK). Recruitment of these protein kinases is accompanied by phosphorylation, which in turn results in the interaction of IRAKs with TNF-receptor-associated factor 6 (TRAF6). The oligomerization of TRAF6 activates TAK1, a member of the MAP3-kinase family, and this leads to the activation of the IkB kinases. These kinases, in turn, phosphorylate IkB, leading to its proteolytic degradation and the translocation of NF-kB to the nucleus. Concomitantly, members of the activator protein-1 (AP-1) transcription factor family, Jun and Fos, are activated, and both AP-1 transcription factors and NF-kB are required for cytokine production, which in turn produces downstream inflammatory effects.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1388">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway124">
 <bp:pathwayOrder rdf:resource="#PathwayStep695" />
 <bp:pathwayOrder rdf:resource="#PathwayStep696" />
 <bp:pathwayOrder rdf:resource="#PathwayStep697" />
 <bp:pathwayOrder rdf:resource="#PathwayStep694" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction572" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction571" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction574" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction573" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence694" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1387">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway125">
 <bp:pathwayOrder rdf:resource="#PathwayStep714" />
 <bp:pathwayOrder rdf:resource="#PathwayStep715" />
 <bp:pathwayOrder rdf:resource="#PathwayStep716" />
 <bp:pathwayOrder rdf:resource="#PathwayStep699" />
 <bp:pathwayOrder rdf:resource="#PathwayStep700" />
 <bp:pathwayOrder rdf:resource="#PathwayStep701" />
 <bp:pathwayOrder rdf:resource="#PathwayStep713" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction590" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction591" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction576" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction575" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction589" />
 <bp:pathwayComponent rdf:resource="#Pathway126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction588" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence699" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway126">
 <bp:pathwayOrder rdf:resource="#PathwayStep703" />
 <bp:pathwayOrder rdf:resource="#PathwayStep704" />
 <bp:pathwayOrder rdf:resource="#PathwayStep705" />
 <bp:pathwayOrder rdf:resource="#PathwayStep706" />
 <bp:pathwayOrder rdf:resource="#PathwayStep710" />
 <bp:pathwayOrder rdf:resource="#PathwayStep711" />
 <bp:pathwayOrder rdf:resource="#PathwayStep712" />
 <bp:pathwayOrder rdf:resource="#PathwayStep702" />
 <bp:pathwayOrder rdf:resource="#PathwayStep707" />
 <bp:pathwayOrder rdf:resource="#PathwayStep708" />
 <bp:pathwayOrder rdf:resource="#PathwayStep709" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction581" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction580" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction583" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction582" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction585" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction584" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction587" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction586" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction578" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction577" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction579" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence702" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence1389">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway127">
 <bp:pathwayOrder rdf:resource="#PathwayStep737" />
 <bp:pathwayOrder rdf:resource="#PathwayStep759" />
 <bp:pathwayOrder rdf:resource="#PathwayStep727" />
 <bp:pathwayOrder rdf:resource="#PathwayStep731" />
 <bp:pathwayComponent rdf:resource="#Pathway130" />
 <bp:pathwayComponent rdf:resource="#Pathway135" />
 <bp:pathwayComponent rdf:resource="#Pathway128" />
 <bp:pathwayComponent rdf:resource="#Pathway129" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence727" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway128">
 <bp:pathwayOrder rdf:resource="#PathwayStep728" />
 <bp:pathwayOrder rdf:resource="#PathwayStep730" />
 <bp:pathwayOrder rdf:resource="#PathwayStep729" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction602" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction601" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction603" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence728" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway129">
 <bp:pathwayOrder rdf:resource="#PathwayStep736" />
 <bp:pathwayOrder rdf:resource="#PathwayStep732" />
 <bp:pathwayOrder rdf:resource="#PathwayStep733" />
 <bp:pathwayOrder rdf:resource="#PathwayStep734" />
 <bp:pathwayOrder rdf:resource="#PathwayStep735" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction606" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction605" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction608" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction607" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction604" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence732" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction763">
 <bp:evidence rdf:resource="#Evidence918" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H binds host cell surface markers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction762">
 <bp:evidence rdf:resource="#Evidence917" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor I inactivates Factor H-boundC3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction765">
 <bp:evidence rdf:resource="#Evidence920" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H binds to C3bBb</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction764">
 <bp:evidence rdf:resource="#Evidence919" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of soluble VTN:C5b-C9 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction767">
 <bp:evidence rdf:resource="#Evidence922" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b binding protein binds C4bC2a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction766">
 <bp:evidence rdf:resource="#Evidence921" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD55 (DAF) promotes C3bBb/C4bC2a dissociation</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction769">
 <bp:evidence rdf:resource="#Evidence924" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Clusterin binds C5b-C7, C8, C9</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction768">
 <bp:evidence rdf:resource="#Evidence923" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C3a receptor binds anaphylatoxin C3a</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep181">
 <bp:stepProcess rdf:resource="#BiochemicalReaction147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep182">
 <bp:stepProcess rdf:resource="#BiochemicalReaction148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep183">
 <bp:stepProcess rdf:resource="#Pathway36" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep184">
 <bp:stepProcess rdf:resource="#BiochemicalReaction149" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction770">
 <bp:evidence rdf:resource="#Evidence925" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I binds to extracellular Factor H:C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction772">
 <bp:evidence rdf:resource="#Evidence927" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor I inactivates plasma Factor H-bound C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction146" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction771">
 <bp:evidence rdf:resource="#Evidence926" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5a receptor binds C5a anaphylatoxin</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep189">
 <bp:stepProcess rdf:resource="#Catalysis77" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction154" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep185">
 <bp:stepProcess rdf:resource="#BiochemicalReaction150" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep186">
 <bp:stepProcess rdf:resource="#Catalysis76" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction151" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep187">
 <bp:stepProcess rdf:resource="#BiochemicalReaction152" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep188">
 <bp:stepProcess rdf:resource="#BiochemicalReaction153" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction759">
 <bp:evidence rdf:resource="#Evidence914" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Displacement of C2a/Bb by CR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction752">
 <bp:evidence rdf:resource="#Evidence907" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor I cleaves iC3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction751">
 <bp:evidence rdf:resource="#Evidence906" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I inactivates C4BP-bound C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction754">
 <bp:evidence rdf:resource="#Evidence909" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CR2 binds C3d, C3dg, iC3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction753">
 <bp:evidence rdf:resource="#Evidence908" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I binds to MCP, CR1:C4b, C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction756">
 <bp:evidence rdf:resource="#Evidence911" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CPN, CPB2 cleave C3a, C5a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction755">
 <bp:evidence rdf:resource="#Evidence910" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H binds to C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction758">
 <bp:evidence rdf:resource="#Evidence913" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD55 (DAF) binds C3bBb, C4bC2a</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction757">
 <bp:evidence rdf:resource="#Evidence912" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CR1 binds C3bBb/C4bC2a</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep193">
 <bp:stepProcess rdf:resource="#Catalysis78" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep194">
 <bp:stepProcess rdf:resource="#BiochemicalReaction158" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep195">
 <bp:stepProcess rdf:resource="#Pathway38" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep190">
 <bp:stepProcess rdf:resource="#Pathway37" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction761">
 <bp:evidence rdf:resource="#Evidence916" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I binds C4BP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep191">
 <bp:stepProcess rdf:resource="#BiochemicalReaction155" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction760">
 <bp:evidence rdf:resource="#Evidence915" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C4b-binding protein binds C4b</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep196">
 <bp:stepProcess rdf:resource="#BiochemicalReaction159" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep197">
 <bp:stepProcess rdf:resource="#BiochemicalReaction160" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep198">
 <bp:stepProcess rdf:resource="#BiochemicalReaction161" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep199">
 <bp:stepProcess rdf:resource="#Pathway39" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction749">
 <bp:evidence rdf:resource="#Evidence904" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antigen:IgG:C1Q:2xActivated C1R:SERPING1:2xActivated C1S:SERPING1 dissociates</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction748">
 <bp:evidence rdf:resource="#Evidence903" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5AR2 binds anaphylatoxins and thier desArginated derivatives</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction741">
 <bp:evidence rdf:resource="#Evidence895" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C7 binds C5b:C6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction740">
 <bp:evidence rdf:resource="#Evidence894" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C9 binds C5b:C6:C7:C8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction743">
 <bp:evidence rdf:resource="#Evidence897" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5b:C6:C7 translocates to the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction742">
 <bp:evidence rdf:resource="#Evidence896" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5b binds C6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction745">
 <bp:evidence rdf:resource="#Evidence900" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Complement factor I binds to membrane-associated Factor H:C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction744">
 <bp:evidence rdf:resource="#Evidence898" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C8 binds C5b:C6:C7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction747">
 <bp:evidence rdf:resource="#Evidence902" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CR2:C3d,C3dg,iC3b binds CD19:CD81</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction746">
 <bp:evidence rdf:resource="#Evidence901" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor I inactivates MCP/CR1-bound C4b/C3b</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction750">
 <bp:evidence rdf:resource="#Evidence905" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Factor H displaces Bb</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction738">
 <bp:evidence rdf:resource="#Evidence890" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGB1 release from cells</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction737">
 <bp:evidence rdf:resource="#Evidence889" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">oxPL binds CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction739">
 <bp:evidence rdf:resource="#Evidence891" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFTPA/SFTPD binds TLR2:TLR1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction730">
 <bp:evidence rdf:resource="#Evidence882" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">oxLDL:CD36 binds TLR4:TLR6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction732">
 <bp:evidence rdf:resource="#Evidence884" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">G or G analog binds C-ter TLR7 dimer</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction731">
 <bp:evidence rdf:resource="#Evidence883" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SFTPA/SFTPD binds TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction734">
 <bp:evidence rdf:resource="#Evidence886" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A1 binds TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction733">
 <bp:evidence rdf:resource="#Evidence885" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGB1 binds TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction736">
 <bp:evidence rdf:resource="#Evidence888" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">oxPL binds LBP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction735">
 <bp:evidence rdf:resource="#Evidence887" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleaved fibrinogen products bind TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction727">
 <bp:evidence rdf:resource="#Evidence879" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGB1 binds LPS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction726">
 <bp:evidence rdf:resource="#Evidence877" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR1/2 ligand binds to CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction729">
 <bp:evidence rdf:resource="#Evidence881" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGB1 binds LTP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction728">
 <bp:evidence rdf:resource="#Evidence880" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S100A8:S100A9 binds TLR4:LY96</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction118" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction721">
 <bp:evidence rdf:resource="#Evidence872" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction720">
 <bp:evidence rdf:resource="#Evidence870" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to p-IRAK2  </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction723">
 <bp:evidence rdf:resource="#Evidence874" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction722">
 <bp:evidence rdf:resource="#Evidence873" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction725">
 <bp:evidence rdf:resource="#Evidence876" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction724">
 <bp:evidence rdf:resource="#Evidence875" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep140">
 <bp:stepProcess rdf:resource="#Catalysis66" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction111" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep145">
 <bp:stepProcess rdf:resource="#BiochemicalReaction115" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep146">
 <bp:stepProcess rdf:resource="#Pathway32" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction116" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep148">
 <bp:stepProcess rdf:resource="#Catalysis67" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction117" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction112" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep142">
 <bp:stepProcess rdf:resource="#BiochemicalReaction113" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep143">
 <bp:stepProcess rdf:resource="#Pathway31" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep144">
 <bp:stepProcess rdf:resource="#BiochemicalReaction114" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction716">
 <bp:evidence rdf:resource="#Evidence866" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction715">
 <bp:evidence rdf:resource="#Evidence865" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction718">
 <bp:evidence rdf:resource="#Evidence868" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction717">
 <bp:evidence rdf:resource="#Evidence867" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:TIRAP:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction719">
 <bp:evidence rdf:resource="#Evidence869" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with TIRAP:activated TLR2/4</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction710">
 <bp:evidence rdf:resource="#Evidence860" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction712">
 <bp:evidence rdf:resource="#Evidence862" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction711">
 <bp:evidence rdf:resource="#Evidence861" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction714">
 <bp:evidence rdf:resource="#Evidence864" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of p-IRAK2:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction713">
 <bp:evidence rdf:resource="#Evidence863" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4:TIRAP interacts with BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction119" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep151">
 <bp:stepProcess rdf:resource="#Catalysis68" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep156">
 <bp:stepProcess rdf:resource="#BiochemicalReaction125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep157">
 <bp:stepProcess rdf:resource="#BiochemicalReaction126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep158">
 <bp:stepProcess rdf:resource="#Catalysis70" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep159">
 <bp:stepProcess rdf:resource="#BiochemicalReaction128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep152">
 <bp:stepProcess rdf:resource="#BiochemicalReaction121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep153">
 <bp:stepProcess rdf:resource="#BiochemicalReaction122" />
 <bp:stepProcess rdf:resource="#Catalysis69" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep154">
 <bp:stepProcess rdf:resource="#BiochemicalReaction123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep155">
 <bp:stepProcess rdf:resource="#BiochemicalReaction124" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence291">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction705">
 <bp:evidence rdf:resource="#Evidence855" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence290">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction704">
 <bp:evidence rdf:resource="#Evidence853" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction707">
 <bp:evidence rdf:resource="#Evidence857" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction706">
 <bp:evidence rdf:resource="#Evidence856" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence295">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction709">
 <bp:evidence rdf:resource="#Evidence859" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence294">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction708">
 <bp:evidence rdf:resource="#Evidence858" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence293">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence292">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence299">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence298">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence297">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence296">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction701">
 <bp:evidence rdf:resource="#Evidence850" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction700">
 <bp:evidence rdf:resource="#Evidence849" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction703">
 <bp:evidence rdf:resource="#Evidence852" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway190">
 <bp:pathwayOrder rdf:resource="#PathwayStep1266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1265" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1267" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1079" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1077" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1078" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1076" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1265" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Advanced glycosylation endproduct receptor signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Advanced Glycosylation End- product-specific Receptor (AGER) also known as Receptor for Advanced Glycation End-products (RAGE) is a multi-ligand membrane receptor belonging to the immunoglobulin superfamily. It is considered to be a Pattern Recognition Receptor (Liliensiek et al. 2004). It recognizes a large variety of modified proteins known as advanced glycation/glycosylation endproducts (AGEs), a heterogenous group of structures that are generated by the Maillard reaction, a consequence of long-term incubation of proteins with glucose (Ikeda et al. 1996). Their accumulation is associated with diabetes, atherosclerosis, renal failure and ageing (Schmidt et al. 1999). The most prevalent class of AGE in vivo are N(6)-carboxymethyllysine (NECML) adducts (Kislinger et al. 1991). In addition to AGEs, AGER is a signal transduction receptor for amyloid-beta peptide (Ab) (Yan et al. 1996), mediating Ab neurotoxicity and promoting Ab influx into the brain. AGER also responds to the proinflammatory S100/calgranulins (Hofmann et al. 1999) and High mobility group protein B1 (HMGB1/Amphoterin/DEF), a protein linked to neurite outgrowth and cellular motility (Hori et al. 1995).  The major inflammatory pathway stimulated by AGER activation is NFkappaB. Though the signaling cascade is unclear, several pieces of experimental data suggest that activation of AGER leads to sustained activation and upregulation of NFkappaB, measured as NFkappaB translocation to the nucleus, and increased levels of de novo synthesized NFkappaB (Bierhaus et al. 2001). As this is clearly an indirect effect it is represented here as positive regulation of NFkappaB translocation to the nucleus. AGER can bind ERK1/2 and thereby activate the MAPK and JNK cascades (Bierhaus et al. 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction702">
 <bp:evidence rdf:resource="#Evidence851" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway191">
 <bp:pathwayOrder rdf:resource="#PathwayStep1270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1295" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1283" />
 <bp:pathwayComponent rdf:resource="#Pathway192" />
 <bp:pathwayComponent rdf:resource="#Pathway193" />
 <bp:pathwayComponent rdf:resource="#Pathway194" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1270" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-type lectin receptors (CLRs)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pathogen recognition is central to the induction of T cell differentiation. Groups of pathogens share similar structures known as pathogen-associated molecular patterns (PAMPs), which are recognised by pattern recognition receptors (PRRs) expressed on dendritic cells (DCs) to induce cytokine expression. PRRs include archetypical Toll-like receptors (TLRs) and non-TLRs such as retinoic acid-inducible gene I (RIG-I)-like receptors, C-type lectin receptors (CLRs) and intracellular nucleotide-binding domain and leucine-rich-repeat-containing family (NLRs). PRR recognition of PAMPs can lead to the activation of intracellular signalling pathways that elicit innate responses against pathogens and direct the development of adaptive immunity. CLRs comprises a large family of receptors which bind carbohydrates, through one or more carbohydrate recognition domains (CRDs), or which possess structurally similar C-type lectin-like domains (CTLDs) which do not necessarily recognise carbohydrate ligands. Some CLRs can induce signalling pathways that directly activate nuclear factor-kB (NF-kB), whereas other CLRs affect signalling by Toll-like receptors. These signalling pathways trigger cellular responses, including phagocytosis, DC maturation, chemotaxis, the respiratory burst, inflammasome activation, and cytokine production.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway192">
 <bp:pathwayOrder rdf:resource="#PathwayStep1275" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1276" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1279" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1088" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1089" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1086" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1087" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1084" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1085" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1082" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1083" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1080" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1091" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1081" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1090" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1271" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dectin-2 family</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dendritic cell-associated C-type lectin-2 (Dectin-2) family of C-type lectin receptors (CLRs) includes Dectin-2 (CLEC6A), blood dendritic antigen 2 (BDCA2/CLEC4C), macrophage C-type lectin (MCL/CLEC4D), Dendritic cell immunoreceptor (DCIR/CLEC4A) and macrophage inducible C-type lectin (Mincle/CLEC4E). These receptors possesses a single extracellular conserved C-type lectin domain (CTLD) with a short cytoplasmic tail that induces intracellular signalling indirectly by binding with the FCERG (High affinity immunoglobulin epsilon receptor subunit gamma) except for DCIR that has a longer cytoplasmic tail with an integral inhibitory signalling motif (Graham    Brown. 2009, Kerschera et al. 2013). CLEC6A (Dectin-2) binds to high mannose containing pathogen-associated molecular patterns (PAMPs) expressed by fungal hyphae, and CLEC4E (mincle) binds to alpha-mannaosyl PAMPs on fungal, mycobacterial and necrotic cell ligands. Both signaling pathways lead to Toll-like receptor (TLR)-independent production of cytokines such as tumor necrosis factor (TNF) and interleukin 6 (IL6). Similarities with Dectin-1 (CLC7A) signaling pathway suggests that both these CLRs couple SYK activation to NF-kB activation using a complex involving CARD9, BCL10 and MALT1 (Geijtenbeek    Gringhuis 2009). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep160">
 <bp:stepProcess rdf:resource="#Catalysis71" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction129" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway193">
 <bp:pathwayOrder rdf:resource="#PathwayStep1286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1287" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1293" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1294" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1099" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1097" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1098" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1095" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1096" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1093" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1094" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1092" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1284" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 (DC-SIGN) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD209 (also called as DC-SIGN (DC-specific intracellular adhesion molecule-3-grabbing non-integrin)) is a type II transmembrane C-type lectin receptor preferentially expressed on dendritic cells (DCs). CD209 functions as a pattern recognition receptor (PRR) that recognises several microorganisms and pathogens, contributing to generation of pathogen-tailored immune responses (Gringhuis    Geijtenbeek 2010, den Dunnen et al. 2009, Svajger et al. 2010). CD209 interacts with different mannose-expressing pathogens such as Mycobacterium tuberculosis and HIV-1 (Gringhuis et al. 2007, Geijtenbeek et al. 2000a). It also acts as an adhesion receptor that interacts with ICAM2 (intracellular adhesion molecule-2) on endothelial cells and ICAM3 on T cells (Geijtenbeek et al. 2000b,c).  CD209 functions not only as an independent PRR, but is also implicated in the modulation of Toll-like receptor (TLR) signaling at the level of the transcription factor NF-kB (Gringhuis et al. 2009). CLEC7A (Dectin-1) and CD209 (DC-SIGN) signalling modulates Toll-like receptor (TLR) signalling through the kinase RAF1 that is independent of the SYK pathway but integrated with it at the level of NF-kB activation. The activation of RAF1 by CLEC7A or CD209 does not lead to activation of extracellular signal-regulated kinase 1 (ERK1)/2 or Mitogen-activated protein kinase kinase 1 (MEK1)/2 but leads to the phosphorylation and subsequent acetylation of RELA (p65). RELA phosphorylated on S276 not only positively regulates the activity of p65 through acetylation of p65, but also represses RELB activity by sequestering active RELB into inactive p65-RELB dimers that do not bind DNA (Gringhuis et al. 2007, Svajger et al. 2010, Jacque et al. 2005). RAF1-dependent signaling pathway is crucial in dectin-1 mediated immunity as it modulates both the canonical (promoting p65 phosphorylation and acetylation) and non-canonical (forming inactive p65-RELB dimers) NK-kB activation.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep161">
 <bp:stepProcess rdf:resource="#BiochemicalReaction130" />
 <bp:stepProcess rdf:resource="#Catalysis72" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway194">
 <bp:pathwayOrder rdf:resource="#PathwayStep1319" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1330" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1296" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1331" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1317" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1339" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1333" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1314" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1313" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1340" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1343" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1320" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1342" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1326" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1329" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1306" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1328" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1323" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1322" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1145" />
 <bp:pathwayComponent rdf:resource="#Pathway195" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1146" />
 <bp:pathwayComponent rdf:resource="#Pathway196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1122" />
 <bp:pathwayComponent rdf:resource="#Pathway197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1129" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1128" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1130" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1119" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A (Dectin-1) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A (also known as Dectin-1) is a pattern-recognition receptor (PRR) expressed by myeloid cells (macrophages, dendritic cells and neutrophils) that detects pathogens by binding to beta-1,3-glucans in fungal cell walls and triggers direct innate immune responses to fungal and bacterial infections. CLEC7A belongs to thetype-II C-type lectin receptor (CLR) family that can mediate its own intracellular signaling. Upon binding particulate beta-1,3-glucans, CLEC7A mediates intracellular signalling through its cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM)-like motif (Brown 2006). CLEC7A signaling can induce the production of various cytokines and chemokines, including tumour-necrosis factor (TNF), CXC-chemokine ligand 2 (CXCL2, also known as MIP2), interleukin-1beta (IL-1b), IL-2, IL-10 and IL-12 (Brown et al. 2003), it also triggers phagocytosis and stimulates the production of reactive oxygen species (ROS), thus contributing to microbial killing (Gantner et al. 2003, Herre et al. 2004, Underhill et al. 2005, Goodridge at al. 2011, Reid et al. 2009). These cellular responses mediated by CLEC7A rely on both Syk-dependent and Syk-independent signaling cascades. The pathways leading to the Syk-dependent activation of NF-kB can be categorised into both canonical and non-canonical routes (Gringhuis et al. 2009). Activation of the canonical NF-kB pathway is essential for innate immunity, whereas activation of the non-canonical pathway is involved in lymphoid organ development and adaptive immunity (Plato et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep162">
 <bp:stepProcess rdf:resource="#Pathway33" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway195">
 <bp:pathwayOrder rdf:resource="#PathwayStep1297" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1298" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1300" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1103" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1110" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1108" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1106" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dectin-1 mediated noncanonical NF-kB signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In addition to the activation of canonical NF-kB subunits, activation of SYK pathway by Dectin-1 leads to the induction of the non-canonical NF-kB pathway, which mediates the nuclear translocation of RELB-p52 dimers through the successive activation of NF-kB-inducing kinase (NIK) and IkB kinase-alpha (IKKa) (Geijtenbeek    Gringhuis 2009, Gringhuis et al. 2009). Noncanonical activity tends to build more slowly and remain sustained several hours longer than does the activation of canonical NF-kB. The noncanonical NF-kB pathway is characterized by the post-translational processing of NFKB2 (Nuclear factor NF-kappa-B) p100 subunit to the mature p52 subunit. This subsequently leads to nuclear translocation of p52:RELB (Transcription factor RelB) complexes to induce cytokine expression of some genes (C-C motif chemokine 17 (CCL17) and CCL22) and transcriptional repression of others (IL12B) (Gringhuis et al. 2009, Geijtenbeek    Gringhuis 2009, Plato et al. 2013). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway196">
 <bp:pathwayOrder rdf:resource="#PathwayStep1310" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1309" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1308" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1113" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1117" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1307" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A (Dectin-1) induces NFAT activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A (Dectin-1) signals through the classic calcineurin/NFAT pathway through Syk activation phospholipase C-gamma 2 (PLCG2) leading to increased soluble IP3 (inositol trisphosphate). IP3 is able to bind endoplasmic Ca2+ channels, resulting in an influx of Ca2+ into the cytoplasm. This increase in calcium concentration induces calcineurin activation and consequently, dephosphorylation of NFAT and its translocation into the nucleus, triggering gene transcription and extracellular release of Interleukin-2 (Plato et al. 2013, Goodridge et al. 2007, Mourao-Sa et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway197">
 <bp:pathwayOrder rdf:resource="#PathwayStep1337" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1140" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1139" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1334" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CLEC7A/inflammasome pathway</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Antifungal immunity through the induction of T-helper 17 cells (TH17) responses requires the production of mature, active interleukin-1beta (IL1B). CLEC7A (dectin-1) through the SYK route induces activation of NF-kB and transcription of the gene encoding pro-IL1B via the CARD9-BCL10-MALT1 complex as well as the formation and activation of a MALT1-caspase-8-ASC complex that mediated the processing of pro-IL1B. The inactive precursor pro-IL1B has to be processed into mature bioactive form of IL1B and is usually mediated by inflammatory cysteine protease caspase-1. Gringhuis et al. showed that CLEC7A mediated processing of IL1B occurs through two distinct mechanisms: CLEC7A triggering induced a primary noncanonical caspase-8 inflammasome for pro-IL1B processing that was independent of caspase-1 activity, whereas some fungi triggered a second additional mechanism that required activation of the NLRP3/caspase 1 inflammasome. Unlike the canonical caspase-1 inflammasome, CLEC7A mediated noncanonical caspase-8-dependent inflammasome is independent of pathogen internalization. CLEC7A/inflammasome pathway enables the host immune system to mount a protective TH17 response against fungi and bacterial infection (Gringhuis et al. 2012, Cheng et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway198">
 <bp:pathwayOrder rdf:resource="#PathwayStep1385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1384" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1407" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1406" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1345" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1400" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1399" />
 <bp:pathwayComponent rdf:resource="#Pathway208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1199" />
 <bp:pathwayComponent rdf:resource="#Pathway199" />
 <bp:pathwayComponent rdf:resource="#Pathway201" />
 <bp:pathwayComponent rdf:resource="#Pathway202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1193" />
 <bp:pathwayComponent rdf:resource="#Pathway205" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1345" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cytosolic sensors of pathogen-associated DNA </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Presence of pathogen-associated DNA in cytosol induces type I IFN production. Several intracellular receptors have been implicated to some degree. These include DNA-dependent activator of interferon (IFN)-regulatory factors (DAI) (also called Z-DNA-binding protein 1, ZBP1), absent in melanoma 2 (AIM2), RNA polymerase III (Pol III), IFN-inducible protein IFI16, leucine-rich repeat flightless interacting protein-1 (LRRFIP1), DEAH-box helicases (DHX9 and DHX36), DEAD-box helicase DDX41, meiotic recombination 11 homolog A (MRE11), DNA-dependent protein kinase (DNA-PK), cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). Detection of cytosolic DNA requires multiple and possibly redundant sensors leading to activation of the transcription factor NF-kappaB and TBK1-mediated phosphorylation of the transcription factor IRF3. Cytosolic DNA also activates caspase-1-dependent maturation of the pro-inflammatory cytokines interleukin IL-1beta and IL-18. This pathway is mediated by AIM2.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway199">
 <bp:pathwayOrder rdf:resource="#PathwayStep1352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1351" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1348" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1150" />
 <bp:pathwayComponent rdf:resource="#Pathway200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1149" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1346" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of innate immune responses to cytosolic DNA</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Innate immune responses are coordinated and regulated to provide an efficient first line of defense against pathogens and at the same time to prevent host self-damage. Here we present some regulatory events involved in the detection of cytosolic nucleic acids.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep167">
 <bp:stepProcess rdf:resource="#BiochemicalReaction134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep168">
 <bp:stepProcess rdf:resource="#BiochemicalReaction135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep169">
 <bp:stepProcess rdf:resource="#BiochemicalReaction136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep163">
 <bp:stepProcess rdf:resource="#BiochemicalReaction131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep165">
 <bp:stepProcess rdf:resource="#BiochemicalReaction133" />
 <bp:stepProcess rdf:resource="#Catalysis73" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep166">
 <bp:stepProcess rdf:resource="#Pathway34" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence280">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence284">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence283">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence282">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence281">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence288">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence287">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence286">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence285">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence289">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep170">
 <bp:stepProcess rdf:resource="#Catalysis74" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction138" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep172">
 <bp:stepProcess rdf:resource="#BiochemicalReaction139" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep173">
 <bp:stepProcess rdf:resource="#BiochemicalReaction140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep178">
 <bp:stepProcess rdf:resource="#Pathway35" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction141" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep175">
 <bp:stepProcess rdf:resource="#BiochemicalReaction142" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep176">
 <bp:stepProcess rdf:resource="#BiochemicalReaction143" />
 <bp:stepProcess rdf:resource="#Catalysis75" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction144" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence390">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep901">
 <bp:stepProcess rdf:resource="#BiochemicalReaction747" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep902">
 <bp:stepProcess rdf:resource="#BiochemicalReaction748" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep903">
 <bp:stepProcess rdf:resource="#BiochemicalReaction749" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep904">
 <bp:stepProcess rdf:resource="#BiochemicalReaction750" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence394">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence393">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence392">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence391">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep900">
 <bp:stepProcess rdf:resource="#Catalysis360" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction746" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence398">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep909">
 <bp:stepProcess rdf:resource="#BiochemicalReaction755" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence397">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence396">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence395">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep905">
 <bp:stepProcess rdf:resource="#BiochemicalReaction751" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep906">
 <bp:stepProcess rdf:resource="#BiochemicalReaction752" />
 <bp:stepProcess rdf:resource="#Catalysis361" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep907">
 <bp:stepProcess rdf:resource="#BiochemicalReaction753" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence399">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep908">
 <bp:stepProcess rdf:resource="#BiochemicalReaction754" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep912">
 <bp:stepProcess rdf:resource="#BiochemicalReaction758" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep913">
 <bp:stepProcess rdf:resource="#BiochemicalReaction759" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep914">
 <bp:stepProcess rdf:resource="#BiochemicalReaction760" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep915">
 <bp:stepProcess rdf:resource="#BiochemicalReaction761" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence383">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence382">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence381">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep910">
 <bp:stepProcess rdf:resource="#BiochemicalReaction756" />
 <bp:stepProcess rdf:resource="#Catalysis362" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence380">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep911">
 <bp:stepProcess rdf:resource="#BiochemicalReaction757" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence387">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence386">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence385">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence384">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep916">
 <bp:stepProcess rdf:resource="#BiochemicalReaction762" />
 <bp:stepProcess rdf:resource="#Catalysis363" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep917">
 <bp:stepProcess rdf:resource="#BiochemicalReaction763" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence389">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep918">
 <bp:stepProcess rdf:resource="#BiochemicalReaction764" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence388">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep919">
 <bp:stepProcess rdf:resource="#BiochemicalReaction765" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep923">
 <bp:stepProcess rdf:resource="#BiochemicalReaction769" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep924">
 <bp:stepProcess rdf:resource="#BiochemicalReaction770" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep925">
 <bp:stepProcess rdf:resource="#BiochemicalReaction771" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep926">
 <bp:stepProcess rdf:resource="#BiochemicalReaction772" />
 <bp:stepProcess rdf:resource="#Catalysis364" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence372">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence371">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep920">
 <bp:stepProcess rdf:resource="#BiochemicalReaction766" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence370">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep921">
 <bp:stepProcess rdf:resource="#BiochemicalReaction767" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep922">
 <bp:stepProcess rdf:resource="#BiochemicalReaction768" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence376">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence375">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence374">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence373">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep927">
 <bp:stepProcess rdf:resource="#BiochemicalReaction773" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence379">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep928">
 <bp:stepProcess rdf:resource="#BiochemicalReaction774" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence378">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep929">
 <bp:stepProcess rdf:resource="#BiochemicalReaction775" />
 <bp:stepProcess rdf:resource="#Catalysis365" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence377">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep934">
 <bp:stepProcess rdf:resource="#BiochemicalReaction780" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1506">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep935">
 <bp:stepProcess rdf:resource="#BiochemicalReaction781" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1505">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep936">
 <bp:stepProcess rdf:resource="#BiochemicalReaction782" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1508">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep937">
 <bp:stepProcess rdf:resource="#BiochemicalReaction783" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1507">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence361">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep930">
 <bp:stepProcess rdf:resource="#BiochemicalReaction776" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence360">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep931">
 <bp:stepProcess rdf:resource="#BiochemicalReaction777" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1509">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep932">
 <bp:stepProcess rdf:resource="#BiochemicalReaction778" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep933">
 <bp:stepProcess rdf:resource="#BiochemicalReaction779" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence365">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence364">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence363">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence362">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence369">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep938">
 <bp:stepProcess rdf:resource="#BiochemicalReaction784" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence368">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep939">
 <bp:stepProcess rdf:resource="#BiochemicalReaction785" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence367">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence366">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1500">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1502">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1501">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1504">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1503">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence350">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence354">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence353">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence352">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence351">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence358">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence357">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence356">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence355">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence359">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence343">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence342">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence341">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence340">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence347">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence346">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence345">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence344">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence349">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence348">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence332">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence331">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence330">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence336">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence335">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence334">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence333">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence339">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence338">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence337">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence321">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction895">
 <bp:evidence rdf:resource="#Evidence1068" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p-T,4S-IRF3:p-T,4S-IRF3:CREBBP, EP300 binds promoters of Interferon-beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence320">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction894">
 <bp:evidence rdf:resource="#Evidence1067" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of interferon-beta</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction897">
 <bp:evidence rdf:resource="#Evidence1071" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of MEKK1 with TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction896">
 <bp:evidence rdf:resource="#Evidence1070" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKK Complex phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence325">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction899">
 <bp:evidence rdf:resource="#Evidence1073" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of IKK by MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence324">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction898">
 <bp:evidence rdf:resource="#Evidence1072" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence323">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence322">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence329">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence328">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence327">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence326">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis67">
 <bp:controlled rdf:resource="#BiochemicalReaction117" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep989">
 <bp:stepProcess rdf:resource="#BiochemicalReaction825" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway208">
 <bp:pathwayOrder rdf:resource="#PathwayStep1404" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1403" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1405" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1402" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1195" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1401" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DEx/H-box helicases activate type I IFN and inflammatory cytokines production </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DHX36 and DHX9 are aspartate-glutamate-any amino acid aspartate/histidine (DExD/H) box helicase (DHX) proteins that localize in the cytosol. The DHX RNA helicases family includes a large number of proteins that are implicated in RNA metabolism. Members of this family, RIG-1 and MDA5, have been shown to sense a non-self RNA leading to type I IFN production. RNA helicases DHX36 and DHX9 were found to trigger host responses to non-self DNA in MyD88-dependent manner. DHX36 sensed CpG class A, while DHX9 sensed CpG class B. Both DHX36 and DHX9 were critical for antiviral immune responses in viral DNA-stimulated human plasmacytoid dendritic cells (pDC) (Kim T et al. 2010).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis68">
 <bp:controlled rdf:resource="#BiochemicalReaction120" />
</bp:Catalysis>

<bp:Pathway rdf:ID="Pathway209">
 <bp:pathwayOrder rdf:resource="#PathwayStep1419" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1418" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1409" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1440" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1442" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1441" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1415" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1437" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1414" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1417" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1439" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1416" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1438" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1411" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1410" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1413" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1233" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1201" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1232" />
 <bp:pathwayComponent rdf:resource="#Pathway210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1230" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1228" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1207" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1205" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1409" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAP12 interactions</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DNAX activation protein of 12kDa (DAP12) is an immunoreceptor tyrosine-based activation motif (ITAM)-bearing adapter molecule that transduces activating signals in natural killer (NK) and myeloid cells. It mediates signalling for multiple cell-surface receptors expressed by these cells, associating with receptor chains through complementary charged transmembrane amino acids that form a salt-bridge in the context of the hydrophobic lipid bilayer (Lanier et al. 1998). DAP12 homodimers associate with a variety of receptors expressed by macrophages, monocytes and myeloid cells including TREM2, Siglec H and SIRP-beta, as well as activating KIR, LY49 and the NKG2C proteins expressed by NK cells. DAP12 is expressed at the cell surface, with most of the protein lying on the cytoplasmic side of the membrane (Turnbull    Colonna 2007, Tessarz    Cerwenka 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis65">
 <bp:controlled rdf:resource="#BiochemicalReaction109" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis66">
 <bp:controlled rdf:resource="#BiochemicalReaction111" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis63">
 <bp:controlled rdf:resource="#BiochemicalReaction107" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep985">
 <bp:stepProcess rdf:resource="#Pathway165" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis64">
 <bp:controlled rdf:resource="#BiochemicalReaction108" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep986">
 <bp:stepProcess rdf:resource="#BiochemicalReaction822" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis61">
 <bp:controlled rdf:resource="#BiochemicalReaction104" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep987">
 <bp:stepProcess rdf:resource="#BiochemicalReaction823" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis62">
 <bp:controlled rdf:resource="#BiochemicalReaction105" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep988">
 <bp:stepProcess rdf:resource="#Catalysis376" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction824" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction93">
 <bp:evidence rdf:resource="#Evidence119" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence310">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction92">
 <bp:evidence rdf:resource="#Evidence118" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction95">
 <bp:evidence rdf:resource="#Evidence122" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction94">
 <bp:evidence rdf:resource="#Evidence121" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence314">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence313">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction91">
 <bp:evidence rdf:resource="#Evidence117" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis69">
 <bp:controlled rdf:resource="#BiochemicalReaction122" />
</bp:Catalysis>

<bp:Evidence rdf:ID="Evidence312">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction90">
 <bp:evidence rdf:resource="#Evidence116" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence311">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence318">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence317">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence316">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence315">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction97">
 <bp:evidence rdf:resource="#Evidence124" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction96">
 <bp:evidence rdf:resource="#Evidence123" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction99">
 <bp:evidence rdf:resource="#Evidence128" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction98">
 <bp:evidence rdf:resource="#Evidence126" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence319">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway210">
 <bp:pathwayOrder rdf:resource="#PathwayStep1429" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1420" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1431" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1430" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1426" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1425" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1436" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1428" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1427" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1422" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1433" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1421" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1432" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1424" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1435" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1423" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1434" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1224" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1222" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1212" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1218" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1215" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1216" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1227" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1420" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DAP12 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In response to receptor ligation, the tyrosine residues in DAP12&apos;s immunoreceptor tyrosine-based activation motif (ITAM) are phosphorylated by Src family kinases. These phosphotyrosines form the docking site for the protein tyrosine kinase SYK in myeloid cells and SYK and ZAP70 in NK cells. DAP12-bound SYK autophosphorylates and phosphorylates the scaffolding molecule LAT, recruiting the proximal signaling molecules phosphatidylinositol-3-OH kinase (PI3K), phospholipase-C gamma (PLC-gamma), GADS (GRB2-related adapter downstream of SHC), SLP76 (SH2 domain-containing leukocyte protein of 76 kDa), GRB2:SOS (Growth factor receptor-bound protein 2:Son of sevenless homolog 1) and VAV. All of these intermediate signalling molecules result in the recruitment and activation of kinases AKT, CBL (Casitas B-lineage lymphoma) and ERK (extracellular signal-regulated kinase), and rearrangement of the actin cytoskeleton (actin polymerization) finally leading to cellular activation. PLC-gamma generates the secondary messengers diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (InsP3), leading to activation of protein kinase C (PKC) and calcium mobilization, respectively (Turnbull    Colonna 2007, Klesney-Tait et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep981">
 <bp:stepProcess rdf:resource="#BiochemicalReaction819" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway211">
 <bp:pathwayOrder rdf:resource="#PathwayStep1453" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1452" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1480" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1492" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1444" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1455" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1477" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1454" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1457" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1479" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1456" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1478" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1244" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1245" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1267" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1241" />
 <bp:pathwayComponent rdf:resource="#Pathway212" />
 <bp:pathwayComponent rdf:resource="#Pathway213" />
 <bp:pathwayComponent rdf:resource="#Pathway214" />
 <bp:pathwayComponent rdf:resource="#Pathway215" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1444" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Fc epsilon receptor (FCERI) signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mast cells (MC) are distributed in tissues throughout the human body and have long been recognized as key cells of type I hypersensitivity reactions. They also play important roles in inflammatory and immediate allergic reactions. Activation through FCERI-bound antigen-specific IgE causes release of potent inflammatory mediators, such as histamine, proteases, chemotactic factors, cytokines and metabolites of arachidonic acid that act on the vasculature, smooth muscle, connective tissue, mucous glands and inflammatory cells (Borish    Joseph 1992, Amin 2012, Metcalfe et al. 1993). FCERI is a multimeric cell-surface receptor that binds the Fc fragment of IgE with high affinity. On mast cells and basophils FCERI exists as a tetrameric complex consisting of one alpha-chain, one beta-chain, and two disulfide-bonded gamma-chains, and on dendritic cells, Langerhans cells, macrophages, and eosinophils it exists as a trimeric complex with one alpha-chain and two disulfide-bonded gamma-chains (Wu 2011, Kraft    Kinet 2007). FCERI signaling in mast cells includes a network of signaling molecules and adaptor proteins. These molecules coordinate ultimately leading to effects on degranulation, eicosanoid production, and cytokine and chemokine production and cell migration and adhesion, growth and survival. The first step in FCERI signaling is the phosphorylation of the tyrosine residues in the ITAM of both the beta and the gamma subunits of the FCERI by LYN, which is bound to the FCERI beta-chain. The phosphorylated ITAM then recruits the protein tyrosine kinase SYK (spleen tyrosine kinase) which then phosphorylates the adaptor protein LAT. Phosphorylated LAT (linker for activation of T cells) acts as a scaffolding protein and recruits other cytosolic adaptor molecules GRB2 (growth-factor-receptor-bound protein 2), GADS (GRB2-related adaptor protein), SHC (SRC homology 2 (SH2)-domain-containing transforming protein C) and SLP76 (SH2-domain-containing leukocyte protein of 76 kDa), as well as the exchange factors and adaptor molecules VAV and SOS (son of sevenless homologue), and the signalling enzyme phospholipase C gamma1 (PLC-gamma1). Tyrosoine phosphorylation of enzymes and adaptors, including VAV, SHC GRB2 and SOS stimulate small GTPases such as RAC, RAS and RAF. These pathways lead to activation of the ERK, JNK and p38 MAP kinases, histamine release and cytokine production. FCERI activation also triggers the phosphorylation of PLC-gamma which upon membrane localisation hydrolyse PIP2 to form IP3 and 1,2-diacylglycerol (DAG) - second messengers that release Ca2+ from internal stores and activate PKC, respectively. Degranulation or histamine release follows the activation of PLC-gamma and protein kinase C (PKC) and the increased mobilization of calcium (Ca2+). Receptor aggregation also results in the phosphorylation of adaptor protein NTAL/LAT2 which then recruits GAB2. PI3K associates with phosphorylated GAB2 and catalyses the formation of PIP3 in the membrane, which attracts many PH domain proteins like BTK, PLC-gamma, AKT and PDK. PI3K mediated activation of AKT then regulate the mast cell proliferation, development and survival (Gu et al. 2001).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Catalysis rdf:ID="Catalysis60">
 <bp:controlled rdf:resource="#BiochemicalReaction103" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep982">
 <bp:stepProcess rdf:resource="#BiochemicalReaction820" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway212">
 <bp:pathwayOrder rdf:resource="#PathwayStep1451" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1450" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1448" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1447" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1449" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1446" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1240" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1239" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1238" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1445" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Role of LAT2/NTAL/LAB on calcium mobilization</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The lipid raft resident adaptor molecules LAT1 and Non-T cell activation linker (NTAL), also known as linker for activation of B cells (LAB)/LAT2 are known participants in the regulation of mast cell calcium responses. Both LAT and NTAL are expressed and phosphorylated following engagement of FCERI on mast cells. NTAL is functionally and topographically different from LAT. There is a considerable debate on the role of NTAL in mast cell. Depending on the circumstances, NTAL appears to have a dual role as positive and negative regulator of MC responses elicited via FCERI. Studies conducted in bone marrow-derived mast cells (BMMCs) of mice lacking NTAL displayed enhanced FCERI-mediated tyrosine phosphorylation of several substrates, calcium response, degranulation, and cytokine production. This indicated that NTAL negatively regulates FCERI-mediated degranulation. However, in mice lacking both LAT and NTAL showed severe block in FCERI-mediated signaling than BMMCs deficient in LAT alone, suggesting that NTAL also shares a redundant function with LAT to play a positive role (Draberova et al. 2007, Orr    McVicar. 2011, Zhu et al. 2004, Volna et al. 2004). The major steps in NTAL mediated Ca+2 influx involves  NTAL--&gt; GAB2--&gt; PI3K</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep983">
 <bp:stepProcess rdf:resource="#BiochemicalReaction821" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway213">
 <bp:pathwayOrder rdf:resource="#PathwayStep1462" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1473" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1461" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1472" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1464" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1475" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1463" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1474" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1460" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1471" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1470" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1459" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1458" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1469" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1466" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1465" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1476" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1468" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1467" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1250" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1258" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1256" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1263" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1249" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1458" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FCERI mediated NF-kB activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The increase in intracellular Ca+2 in conjunction with DAG also activates PKC and RasGRP, which inturn contributes to cytokine production by mast cells (Kambayashi et al. 2007). Activation of the FCERI engages CARMA1, BCL10 and MALT1 complex to activate NF-kB through PKC-theta (Klemm et al. 2006, Chen et al. 2007). FCERI stimulation leads to phosphorylation, and degradation of IkB which allows the release and nuclear translocation of the NF-kB proteins. Activation of the NF-kB transcription factors then results in the synthesis of several cytokines. NF-kB activation by FCERI is critical for proinflammatory cytokine production during mast cell activation and is crucial for allergic inflammatory diseases (Klemm et al. 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep984">
 <bp:stepProcess rdf:resource="#Pathway164" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway214">
 <bp:pathwayOrder rdf:resource="#PathwayStep1484" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1483" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1486" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1485" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1491" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1490" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1482" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1481" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1488" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1487" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1489" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1268" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1269" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1277" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1272" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1270" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1481" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FCERI mediated Ca+2 mobilization</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Increase of intracellular calcium in mast cells is most crucial for mast cell degranulation. Elevation of intracellular calcium is achieved by activation of PLC-gamma. Mast cells express both PLC-gamma1 and PLC-gamma2 isoforms and activation of these enzymes leads to conversion of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol triphosphate (IP3) and diacylglycerol (DAG). The production of IP3 leads to mobilization of intracellular Ca+2, which later results in a sustained Ca+2 flux response that is maintained by an influx of extracellular Ca+2. In addition to degranulation, an increase in intracellular calcium concentration also activates the Ca2+/calmodulin-dependent serine phosphatase calcineurin. Calcineurin dephosphorylates the nuclear factor for T cell activation (NFAT) which exposes nuclear-localization signal sequence triggering translocation of the dephosphorylated NFAT-CaN complex to the nucleus. Once in the nucleus, NFAT regulates the transcription of several cytokine genes (Kambayashi et al. 2007, Hoth    Penner 1992, Ebinu et al. 2000, Siraganian et al).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway215">
 <bp:pathwayOrder rdf:resource="#PathwayStep1507" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1506" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1509" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1508" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1495" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1494" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1497" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1496" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1493" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1503" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1502" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1505" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1504" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1499" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1510" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1498" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1501" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1512" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1500" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1511" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1294" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1291" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1290" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1288" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1295" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1296" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1493" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FCERI mediated MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of the LAT signaling complex leads to activation of MAPK and production of cytokines. The sequence of events that leads from LAT to cytokine production has not been as clearly defined as the sequence that leads to degranulation. However, the pathways that lead to cytokine production require the guanine-nucleotide-exchange factors SOS and VAV that regulate GDP-GTP exchange of RAS. After its activation, RAS positively regulates the RAF-dependent pathway that leads to phosphorylation and, in part, activation of the mitogen-activated protein kinases (MAPKs) extracellular-signal-regulated kinase 1 (ERK1) and  ERK2 (Gilfillan    Tkaczyk 2006).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep980">
 <bp:stepProcess rdf:resource="#BiochemicalReaction818" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis78">
 <bp:controlled rdf:resource="#BiochemicalReaction157" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis79">
 <bp:controlled rdf:resource="#BiochemicalReaction165" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis76">
 <bp:controlled rdf:resource="#BiochemicalReaction151" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis77">
 <bp:controlled rdf:resource="#BiochemicalReaction154" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis74">
 <bp:controlled rdf:resource="#BiochemicalReaction137" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep996">
 <bp:stepProcess rdf:resource="#Catalysis377" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction832" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis75">
 <bp:controlled rdf:resource="#BiochemicalReaction143" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep997">
 <bp:stepProcess rdf:resource="#Catalysis378" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction833" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis72">
 <bp:controlled rdf:resource="#BiochemicalReaction130" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep998">
 <bp:stepProcess rdf:resource="#BiochemicalReaction834" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis73">
 <bp:controlled rdf:resource="#BiochemicalReaction133" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep999">
 <bp:stepProcess rdf:resource="#BiochemicalReaction835" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence303">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence302">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence301">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence300">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence307">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence306">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence305">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence304">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence309">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence308">
</bp:Evidence>

<bp:Catalysis rdf:ID="Catalysis70">
 <bp:controlled rdf:resource="#BiochemicalReaction127" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep992">
 <bp:stepProcess rdf:resource="#BiochemicalReaction828" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis71">
 <bp:controlled rdf:resource="#BiochemicalReaction129" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep993">
 <bp:stepProcess rdf:resource="#BiochemicalReaction829" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep994">
 <bp:stepProcess rdf:resource="#BiochemicalReaction830" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep995">
 <bp:stepProcess rdf:resource="#BiochemicalReaction831" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep990">
 <bp:stepProcess rdf:resource="#BiochemicalReaction826" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep991">
 <bp:stepProcess rdf:resource="#BiochemicalReaction827" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis45">
 <bp:controlled rdf:resource="#BiochemicalReaction85" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis46">
 <bp:controlled rdf:resource="#BiochemicalReaction86" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis43">
 <bp:controlled rdf:resource="#BiochemicalReaction82" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis44">
 <bp:controlled rdf:resource="#BiochemicalReaction83" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis41">
 <bp:controlled rdf:resource="#BiochemicalReaction77" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis42">
 <bp:controlled rdf:resource="#BiochemicalReaction78" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis40">
 <bp:controlled rdf:resource="#BiochemicalReaction76" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction71">
 <bp:evidence rdf:resource="#Evidence88" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation within the complex activated TLR:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction70">
 <bp:evidence rdf:resource="#Evidence87" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with the activated TLR receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction73">
 <bp:evidence rdf:resource="#Evidence90" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomerl:activated TLR5 or 10 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction72">
 <bp:evidence rdf:resource="#Evidence89" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis49">
 <bp:controlled rdf:resource="#BiochemicalReaction91" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis47">
 <bp:controlled rdf:resource="#BiochemicalReaction87" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis48">
 <bp:controlled rdf:resource="#BiochemicalReaction90" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction79">
 <bp:evidence rdf:resource="#Evidence97" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1 or p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction78">
 <bp:evidence rdf:resource="#Evidence96" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction75">
 <bp:evidence rdf:resource="#Evidence93" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction74">
 <bp:evidence rdf:resource="#Evidence92" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction77">
 <bp:evidence rdf:resource="#Evidence95" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction76">
 <bp:evidence rdf:resource="#Evidence94" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis56">
 <bp:controlled rdf:resource="#BiochemicalReaction99" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis57">
 <bp:controlled rdf:resource="#BiochemicalReaction100" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis54">
 <bp:controlled rdf:resource="#BiochemicalReaction97" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis55">
 <bp:controlled rdf:resource="#BiochemicalReaction98" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis52">
 <bp:controlled rdf:resource="#BiochemicalReaction95" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis53">
 <bp:controlled rdf:resource="#BiochemicalReaction96" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis50">
 <bp:controlled rdf:resource="#BiochemicalReaction92" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis51">
 <bp:controlled rdf:resource="#BiochemicalReaction94" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction82">
 <bp:evidence rdf:resource="#Evidence105" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction81">
 <bp:evidence rdf:resource="#Evidence104" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction84">
 <bp:evidence rdf:resource="#Evidence108" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction83">
 <bp:evidence rdf:resource="#Evidence106" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction80">
 <bp:evidence rdf:resource="#Evidence100" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SARM binds TICAM1:TRAM:TLR4:LY96:LPS:CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis58">
 <bp:controlled rdf:resource="#BiochemicalReaction101" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis59">
 <bp:controlled rdf:resource="#BiochemicalReaction102" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction89">
 <bp:evidence rdf:resource="#Evidence115" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction86">
 <bp:evidence rdf:resource="#Evidence110" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction85">
 <bp:evidence rdf:resource="#Evidence109" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction88">
 <bp:evidence rdf:resource="#Evidence112" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction87">
 <bp:evidence rdf:resource="#Evidence111" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway200">
 <bp:pathwayOrder rdf:resource="#PathwayStep1354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1155" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1353" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation by TREX1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Three prime repair exonuclease 1 (TREX1) is a DNase type III enzyme, which targets and digests unpaired nucleotides on ssDNA and dsDNA ends through a 3&apos;to 5&apos; exonuclease activity (Perrino FW et al. 1994; de Silva U et al. 2007; Lehtinen DA et al. 2008; Fye JM et al 2011). TREX1 is an endoplasmic reticulum (ER)-associated protein, which is anchored to ER membrane via the C-terminal transmembrane domain (Chowdhury D et al. 2006; Richards A et al. 2007; Stetson DB et al. 2009). TREX1 has been implicated in innate immune responses against self (damaged or retrotransposons-derived DNA) and retroviral-derived DNA (Stetson DB et al. 2009; Yan N et al. 2010; Hasan M et al. 2012). TREX1 deficiency in human and mouse cells led to accumulation of cytosolic DNA which resulted in a continual activation of cytosolic DNA-sensors. In addition, cells lacking TREX1 function were less susceptible to infection with different types of RNA viruses (Yan N et al. 2010; Hasan M et al. 2012).Thus, the physiological role of the exonuclease TREX1 is to digest cytosolic host DNA to avoid autoimmunity. Loss-of-function mutations in the gene encoding human TREX1 are associated with several autoimmune diseases (Aicardi-Goutieres syndrome (AGS), familial chilblain lupus (FCL), systemic lupus erythematosus (SLE)) that result in increased levels of interferon and circulating antibodies to DNA (Crow YJ et al. 2006; Rice G et al. 2007; Lee-Kirsch MA et al. 2007). During infection with human immunodeficiency virus (HIV) or other RNA viruses, TREX1 activity may inhibit the innate immune responses by processing viral DNA generated during reverse transcription (Yan N et al. 2010; Hasan M et al. 2012). It&apos;s not yet known whether TREX1 is also involved in regulation of host responses to DNA viruses. Detection of nucleic acids is known to launch signaling cascades leading to induction of type I interferons, which in turn orchestrate an immune response that involves the expression of hundreds of interferon-stimulated genes (ISGs). It is interesting to note that interferon(IFN)-independent activation of a subset of ISGs was detected in mouse and human cells lacking functional TREX1 (Hasan M et al. 2012).  Hasan et al. have also observed that TREX1-deficiency resulted in an increased lysosomal compartment. Trex1 was found to control mTORC1 activity in mouse embryonic fibroblasts (MEF), which in turn negatively regulates translocation of transcription factor EB (TFEB) to the nucleus thereby controlling lysosomal biogenesis (Hasan M et al. 2012; Roczniak-Ferguson A et al. 2012). The authors linked the altered lysosomal compartment to innate immune responses by suggesting that lysosomal biogenesis (regulated by TFEB and mTORC1)  acted upstream of IFN-independent ISG expression (regulated by IRF3 and IRF7) (Hasan M et al. 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway201">
 <bp:pathwayOrder rdf:resource="#PathwayStep1361" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1360" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1359" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1159" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1157" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1161" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1160" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1357" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1) can bind exogenous double-stranded RNA and double-stranded DNA (Wilson SA et al. 1998; Yang P et al. 2010). LRRFIP1 was shown to mediate Listeria monocytogenes- and vesicular stomatitis virus (VSV)-induced IFN-beta production in mouse primary macrophages by regulating beta-catenin activity. Beta-catenin possibly functions as a transcriptional cofactor of IRF3 to initiate Ifnb1 transcription (Yang P et al. 2010). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway202">
 <bp:pathwayOrder rdf:resource="#PathwayStep1363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1373" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1364" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1375" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1381" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1382" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1366" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1162" />
 <bp:pathwayComponent rdf:resource="#Pathway203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1171" />
 <bp:pathwayComponent rdf:resource="#Pathway204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1180" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1363" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING mediated induction of host immune responses</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STING (stimulator of IFN genes; also known as MITA/ERIS/MPYS/TMEM173) is an endoplasmic reticulum (ER) resident, which is required for effective type I IFN production in response to nucleic acids. Indeed, select pathogen-derived DNA or RNA were shown to activate STING in human and mouse cells (Ishikawa H and Barber GN 2008; Ishikawa H et al. 2009; Sun W et al. 2009; Prantner D et al. 2010). Importantly, in vitro studies have shown that STING is essential for Mycobacterium tuberculosis (Manzanillo PS et al. 2012), Plasmodium falciparum (Sharma S et al. 2011) and human immunodeficiency virus (HIV) induced type I IFN production [Yan N et al 2010]. Mycobacterium tuberculosis, plasmodium falciparum and HIV are three deadliest pathogens, which kill millions of people each year worldwide. STING has been also implicated in type I IFN response which was stimulated by fusion of viral and target-cell membrane in a manner independent of DNA, RNA and viral capsid  [Holm CK et al 2012]. Under steady state conditions, STING is positioned at the translocon complex within the ER membrane. However upon stimulation with intracellular DNA it translocates from ER to perinuclear vesicles via the Golgi by mechanisms that remain unclear (Ishikawa H and Barber GN 2008; Sun W et al. 2009; Ishikawa H et al. 2009; Saitoh T et al. 2009). Mouse Sting trafficking in dsDNA-stimulated mouse embryonic fibroblasts (MEF) cells was found to depend on autophagy-related gene 9a (Atg9a) (Saitoh T et al. 2009). STING was reported to function as a signaling adaptor or coreceptor in response to cytosolic dsDNA (Unterholzner L et al. 2010; Zhang Z et al. 2011). STING was also shown to function as a direct DNA sensor to induce the innate immune response in human telomerase fibroblasts (hTERT-BJ1) and murine embryonic fibroblasts (MEFs) (Abe T et al. 2013). Additionally, STING is thought to function as a direct sensor of cyclic dinucleotides. STING was shown to interact directly with c-di-GMP in human embryonic kidney HEK293T cell lysates (Burdette DL et al. 2011). Once STING is stimulated, its C-terminus serves as a signaling scaffold to recruit IRF3 and TBK1, which leads to TBK1-dependent phosphorylation of IRF3 (Tanaka Y and Chen ZJ 2012). Mouse, but not human STING, can also bind vascular disrupting agents 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and the antiviral small molecule 10-carboxymethyl-9-acridanone (CMA) to induce type I IFN production, suggesting a species-specific drug effect on the STING-mediated host response (Conlon J et al. 2013; Cavlar T et al. 2013).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway203">
 <bp:pathwayOrder rdf:resource="#PathwayStep1370" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1372" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1371" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1368" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1167" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1168" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1166" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1170" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1367" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">STAT6-mediated induction of chemokines</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Signal transducer and activator of transcription 6 (STAT6) may function as a signaling molecule and as a transcription factor. The canonical activation of STAT6 in IL4 and IL13 signaling pathways is mediated by the tyrosine kinases JAK (Hebenstreit D et al. 2006). Virus-induced STAT6 activation was found to be cytokine- and JAK-independent (Chen H et al. 2011). Infection of human cells with RNA or DNA viruses resulted in an interaction of STAT6 with STING. The kinase TBK1 was shown to phosphorylate STAT6, which in turn induced STAT6 dimerization and translocation to the nucleus, leading to induction of chemokines CCL2, CCL20, and CCL26 in IFN-independent manner (Chen H et al. 2011). RNA virus infection triggers STAT6 activation through STING, TBK1 and adaptor protein MAVS interaction (Chen H et al. 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway204">
 <bp:pathwayOrder rdf:resource="#PathwayStep1376" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1377" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1174" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1173" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1376" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3-mediated induction of type I IFN</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TANK-binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3) are central regulators of type-I interferon induction during bacterial or viral infection. TBK1 was found to form complexes with distinct scaffolding proteins that appeared to target TBK1 to different subcellular compartments [Hemmi H et al 2004; Oganesyan G et al 2006; Chariot A et al 2002; Huang J et al 2005]. STING interacted with both TBK1 and IRF3. Once STING is stimulated, its C-terminus served as a signaling scaffold to recruit IRF3 anhd TBK1, which led to TBK1-dependent phosphorylation of IRF3. Phosphorylation of IRF3 promoted its dimerization and translocation to the nucleus, where it triggered the transcription of interferon stimulated genes (ISGs) (Tanaka Y and Chen ZJ 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway205">
 <bp:pathwayOrder rdf:resource="#PathwayStep1386" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1394" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1188" />
 <bp:pathwayComponent rdf:resource="#Pathway206" />
 <bp:pathwayComponent rdf:resource="#Pathway207" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1386" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ZBP1(DAI) mediated induction of type I IFNs</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Z-DNA-binding protein-1 (ZBP1), also known as, DNA-dependent activator of IFN-regulatory factors (DAI) was reported to initiate innate immune responses in murine L929 cells upon stimulation by multiple types of exogenously added DNA (Takaoka A et al 2007). Human cytomegalovirus (HCMV) was shown to stimulate ZBP1-mediated induction of IRF3 in human foreskin (DeFilippis VR et al 2010). ZBP1 was also implicated in activation of NF-kappaB pathways in human embryonic kidney HEK293T cells (Kaiser WJ et al 2008, Rebsamen M et al 2009). However, the role and importance ofZBP1 as dsDNA sensor remain controversial, since knocking down ZBP1 expression in other human or murine cell types by siRNA had very little effect on cellular responses to cytosolic DNA, suggesting the presence of alternative pathway (Wang ZC et al 2008, Lippmann J et al 2008). Tissue-specific expression of human ZBP1 also suggests that ZBP1 may function in cell-type specific way (Rothenburg S et al 2002). </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway206">
 <bp:pathwayOrder rdf:resource="#PathwayStep1387" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1392" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1391" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1390" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1389" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1182" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1387" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRF3 mediated activation of type 1 IFN</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interferon regulatory factors (IRF) IRF-3 and IRF-7 are the major modulators of IFN gene expression in response to pathogenic molecules. The relative contribution of IRF3 and IRF7 depends on the signaling pathway that is activated. Type I IFN production in cytosolic DNA-sensing pathway is mediated predominantly by IRF3 and partially by IRF7, since DNA-stimulated IFN-beta and IFN-alpha4 mRNA induction was strongly inhibited in IRF3-deficient mouse embryonic fibroblasts (MEFs), while remained normal (IFN-beta) or reduced (IFN-alpha4) in IRF7-deficient MEFs (Takaoke A et al 2007).  IRF3 activation in response to B-DNA stimulation occurs via its co-recruitment with serine/threonine kinase TANK-binding kinase 1 (TBK1) or inducible IkB kinase (IKKi/IKKepsilon) to the C-terminal region of DAI.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway207">
 <bp:pathwayOrder rdf:resource="#PathwayStep1396" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1395" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1398" />
 <bp:pathwayOrder rdf:resource="#PathwayStep1397" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction1191" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence1395" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP-mediated NFkB activation via ZBP1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Overexpression of human or murine ZBP1 (DAI) in human embryonic kidney 293T cells (HEK293T) activated NF-kB-dependent promoter in a dose-dependent manner. Two RHIM-contaning kinases RIP1 and RIP3 are implicated in ZBP1-induced NFkB activation (Rebsamen M et al 2009; Kaiser WJ et al 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep945">
 <bp:stepProcess rdf:resource="#BiochemicalReaction789" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep946">
 <bp:stepProcess rdf:resource="#BiochemicalReaction790" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep947">
 <bp:stepProcess rdf:resource="#BiochemicalReaction791" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep948">
 <bp:stepProcess rdf:resource="#BiochemicalReaction792" />
 <bp:stepProcess rdf:resource="#Catalysis366" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep941">
 <bp:stepProcess rdf:resource="#Pathway156" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep942">
 <bp:stepProcess rdf:resource="#BiochemicalReaction787" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep943">
 <bp:stepProcess rdf:resource="#Pathway157" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep944">
 <bp:stepProcess rdf:resource="#BiochemicalReaction788" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction51">
 <bp:evidence rdf:resource="#Evidence65" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction50">
 <bp:evidence rdf:resource="#Evidence64" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep949">
 <bp:stepProcess rdf:resource="#BiochemicalReaction793" />
 <bp:stepProcess rdf:resource="#Catalysis367" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction57">
 <bp:evidence rdf:resource="#Evidence73" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction56">
 <bp:evidence rdf:resource="#Evidence72" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction59">
 <bp:evidence rdf:resource="#Evidence75" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction58">
 <bp:evidence rdf:resource="#Evidence74" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction53">
 <bp:evidence rdf:resource="#Evidence67" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction52">
 <bp:evidence rdf:resource="#Evidence66" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction55">
 <bp:evidence rdf:resource="#Evidence71" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction54">
 <bp:evidence rdf:resource="#Evidence69" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence1511">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep940">
 <bp:stepProcess rdf:resource="#BiochemicalReaction786" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1510">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1513">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1512">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep956">
 <bp:stepProcess rdf:resource="#Pathway158" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep957">
 <bp:stepProcess rdf:resource="#Pathway159" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep958">
 <bp:stepProcess rdf:resource="#BiochemicalReaction800" />
 <bp:stepProcess rdf:resource="#Catalysis372" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep959">
 <bp:stepProcess rdf:resource="#Catalysis373" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction801" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep952">
 <bp:stepProcess rdf:resource="#Catalysis369" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction796" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep953">
 <bp:stepProcess rdf:resource="#Catalysis370" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction797" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep954">
 <bp:stepProcess rdf:resource="#BiochemicalReaction798" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep955">
 <bp:stepProcess rdf:resource="#BiochemicalReaction799" />
 <bp:stepProcess rdf:resource="#Catalysis371" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction60">
 <bp:evidence rdf:resource="#Evidence76" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction62">
 <bp:evidence rdf:resource="#Evidence79" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction61">
 <bp:evidence rdf:resource="#Evidence77" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction68">
 <bp:evidence rdf:resource="#Evidence85" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction67">
 <bp:evidence rdf:resource="#Evidence84" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction69">
 <bp:evidence rdf:resource="#Evidence86" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction64">
 <bp:evidence rdf:resource="#Evidence81" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction63">
 <bp:evidence rdf:resource="#Evidence80" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction66">
 <bp:evidence rdf:resource="#Evidence83" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction65">
 <bp:evidence rdf:resource="#Evidence82" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep950">
 <bp:stepProcess rdf:resource="#BiochemicalReaction794" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep951">
 <bp:stepProcess rdf:resource="#Catalysis368" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction795" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis89">
 <bp:controlled rdf:resource="#BiochemicalReaction189" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep967">
 <bp:stepProcess rdf:resource="#BiochemicalReaction807" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep968">
 <bp:stepProcess rdf:resource="#Pathway162" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis87">
 <bp:controlled rdf:resource="#BiochemicalReaction185" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep969">
 <bp:stepProcess rdf:resource="#BiochemicalReaction808" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis88">
 <bp:controlled rdf:resource="#BiochemicalReaction188" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis85">
 <bp:controlled rdf:resource="#BiochemicalReaction182" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep963">
 <bp:stepProcess rdf:resource="#BiochemicalReaction803" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis86">
 <bp:controlled rdf:resource="#BiochemicalReaction183" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep964">
 <bp:stepProcess rdf:resource="#BiochemicalReaction804" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis83">
 <bp:controlled rdf:resource="#BiochemicalReaction175" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep965">
 <bp:stepProcess rdf:resource="#BiochemicalReaction805" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis84">
 <bp:controlled rdf:resource="#BiochemicalReaction180" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep966">
 <bp:stepProcess rdf:resource="#BiochemicalReaction806" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction35">
 <bp:evidence rdf:resource="#Evidence43" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1099">
 <bp:stepProcess rdf:resource="#Catalysis398" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction923" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction34">
 <bp:evidence rdf:resource="#Evidence42" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 or IRAK2:TRAF6-oligomer from the activated TLR5 or 10:oligo-Myd88:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1098">
 <bp:stepProcess rdf:resource="#BiochemicalReaction922" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction37">
 <bp:evidence rdf:resource="#Evidence47" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction36">
 <bp:evidence rdf:resource="#Evidence44" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to MyD88 bound to the activated TLR5 or 10 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction31">
 <bp:evidence rdf:resource="#Evidence39" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1095">
 <bp:stepProcess rdf:resource="#BiochemicalReaction920" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction30">
 <bp:evidence rdf:resource="#Evidence38" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1094">
 <bp:stepProcess rdf:resource="#BiochemicalReaction919" />
 <bp:stepProcess rdf:resource="#Catalysis397" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction33">
 <bp:evidence rdf:resource="#Evidence41" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1097">
 <bp:stepProcess rdf:resource="#BiochemicalReaction921" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction32">
 <bp:evidence rdf:resource="#Evidence40" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1096">
 <bp:stepProcess rdf:resource="#Pathway177" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis81">
 <bp:controlled rdf:resource="#BiochemicalReaction170" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis82">
 <bp:controlled rdf:resource="#BiochemicalReaction173" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep960">
 <bp:stepProcess rdf:resource="#Pathway160" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep961">
 <bp:stepProcess rdf:resource="#BiochemicalReaction802" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis80">
 <bp:controlled rdf:resource="#BiochemicalReaction166" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep962">
 <bp:stepProcess rdf:resource="#Pathway161" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction39">
 <bp:evidence rdf:resource="#Evidence49" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction38">
 <bp:evidence rdf:resource="#Evidence48" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep978">
 <bp:stepProcess rdf:resource="#BiochemicalReaction816" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep979">
 <bp:stepProcess rdf:resource="#BiochemicalReaction817" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis98">
 <bp:controlled rdf:resource="#BiochemicalReaction202" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis99">
 <bp:controlled rdf:resource="#BiochemicalReaction203" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis96">
 <bp:controlled rdf:resource="#BiochemicalReaction198" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep974">
 <bp:stepProcess rdf:resource="#BiochemicalReaction812" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis97">
 <bp:controlled rdf:resource="#BiochemicalReaction199" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep975">
 <bp:stepProcess rdf:resource="#BiochemicalReaction813" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis94">
 <bp:controlled rdf:resource="#BiochemicalReaction195" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep976">
 <bp:stepProcess rdf:resource="#BiochemicalReaction814" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis95">
 <bp:controlled rdf:resource="#BiochemicalReaction197" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep977">
 <bp:stepProcess rdf:resource="#BiochemicalReaction815" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1091">
 <bp:stepProcess rdf:resource="#BiochemicalReaction916" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1090">
 <bp:stepProcess rdf:resource="#BiochemicalReaction915" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction40">
 <bp:evidence rdf:resource="#Evidence51" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1093">
 <bp:stepProcess rdf:resource="#BiochemicalReaction918" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1092">
 <bp:stepProcess rdf:resource="#BiochemicalReaction917" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction46">
 <bp:evidence rdf:resource="#Evidence59" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1088">
 <bp:stepProcess rdf:resource="#BiochemicalReaction913" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction45">
 <bp:evidence rdf:resource="#Evidence58" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1087">
 <bp:stepProcess rdf:resource="#BiochemicalReaction912" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction48">
 <bp:evidence rdf:resource="#Evidence61" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction47">
 <bp:evidence rdf:resource="#Evidence60" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1089">
 <bp:stepProcess rdf:resource="#BiochemicalReaction914" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction42">
 <bp:evidence rdf:resource="#Evidence53" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1084">
 <bp:stepProcess rdf:resource="#BiochemicalReaction909" />
 <bp:stepProcess rdf:resource="#Catalysis396" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction41">
 <bp:evidence rdf:resource="#Evidence52" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1083">
 <bp:stepProcess rdf:resource="#BiochemicalReaction908" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction44">
 <bp:evidence rdf:resource="#Evidence55" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1086">
 <bp:stepProcess rdf:resource="#BiochemicalReaction911" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction43">
 <bp:evidence rdf:resource="#Evidence54" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1085">
 <bp:stepProcess rdf:resource="#BiochemicalReaction910" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis92">
 <bp:controlled rdf:resource="#BiochemicalReaction192" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep970">
 <bp:stepProcess rdf:resource="#BiochemicalReaction809" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis93">
 <bp:controlled rdf:resource="#BiochemicalReaction194" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep971">
 <bp:stepProcess rdf:resource="#BiochemicalReaction810" />
 <bp:stepProcess rdf:resource="#Catalysis374" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis90">
 <bp:controlled rdf:resource="#BiochemicalReaction190" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep972">
 <bp:stepProcess rdf:resource="#Catalysis375" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction811" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis91">
 <bp:controlled rdf:resource="#BiochemicalReaction191" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep973">
 <bp:stepProcess rdf:resource="#Pathway163" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction49">
 <bp:evidence rdf:resource="#Evidence62" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction804">
 <bp:evidence rdf:resource="#Evidence965" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolin-1 binds to molecular patterns on the target cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction803">
 <bp:evidence rdf:resource="#Evidence964" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolin-3 binds to molecular patterns on the target cell surface </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction806">
 <bp:evidence rdf:resource="#Evidence967" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of MASPs</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction805">
 <bp:evidence rdf:resource="#Evidence966" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ficolin-2 binds to molecular patterns on the target cell surface </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction808">
 <bp:evidence rdf:resource="#Evidence970" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C5 binds C5 inhibitors</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction807">
 <bp:evidence rdf:resource="#Evidence968" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MBL binds to repetitive carbohydrate structures on the surfaces of viruses, bacteria, fungi, and protozoa</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction809">
 <bp:evidence rdf:resource="#Evidence971" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of classic pathway C5 convertase</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1080">
 <bp:stepProcess rdf:resource="#Pathway176" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1082">
 <bp:stepProcess rdf:resource="#BiochemicalReaction907" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1081">
 <bp:stepProcess rdf:resource="#BiochemicalReaction906" />
 <bp:stepProcess rdf:resource="#Catalysis395" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction800">
 <bp:evidence rdf:resource="#Evidence959" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of C1s</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction802">
 <bp:evidence rdf:resource="#Evidence962" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CL-LK binds carbohydrates on target cell surface</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction801">
 <bp:evidence rdf:resource="#Evidence960" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of C1r</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1077">
 <bp:stepProcess rdf:resource="#BiochemicalReaction903" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1076">
 <bp:stepProcess rdf:resource="#BiochemicalReaction902" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1079">
 <bp:stepProcess rdf:resource="#BiochemicalReaction905" />
 <bp:stepProcess rdf:resource="#Catalysis394" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1078">
 <bp:stepProcess rdf:resource="#BiochemicalReaction904" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1073">
 <bp:stepProcess rdf:resource="#BiochemicalReaction900" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1072">
 <bp:stepProcess rdf:resource="#BiochemicalReaction899" />
 <bp:stepProcess rdf:resource="#Catalysis393" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1075">
 <bp:stepProcess rdf:resource="#BiochemicalReaction901" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1074">
 <bp:stepProcess rdf:resource="#Pathway175" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1071">
 <bp:stepProcess rdf:resource="#BiochemicalReaction898" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1070">
 <bp:stepProcess rdf:resource="#BiochemicalReaction897" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1066">
 <bp:stepProcess rdf:resource="#BiochemicalReaction894" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1065">
 <bp:stepProcess rdf:resource="#BiochemicalReaction893" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1068">
 <bp:stepProcess rdf:resource="#Pathway174" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1067">
 <bp:stepProcess rdf:resource="#BiochemicalReaction895" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1062">
 <bp:stepProcess rdf:resource="#Catalysis391" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction890" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1061">
 <bp:stepProcess rdf:resource="#Catalysis390" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction889" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1064">
 <bp:stepProcess rdf:resource="#BiochemicalReaction892" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1063">
 <bp:stepProcess rdf:resource="#BiochemicalReaction891" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1069">
 <bp:stepProcess rdf:resource="#Catalysis392" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction896" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1060">
 <bp:stepProcess rdf:resource="#BiochemicalReaction888" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1055">
 <bp:stepProcess rdf:resource="#BiochemicalReaction884" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1054">
 <bp:stepProcess rdf:resource="#BiochemicalReaction883" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1057">
 <bp:stepProcess rdf:resource="#BiochemicalReaction885" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1056">
 <bp:stepProcess rdf:resource="#Pathway173" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1051">
 <bp:stepProcess rdf:resource="#BiochemicalReaction880" />
 <bp:stepProcess rdf:resource="#Catalysis389" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1050">
 <bp:stepProcess rdf:resource="#BiochemicalReaction879" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1053">
 <bp:stepProcess rdf:resource="#BiochemicalReaction882" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1052">
 <bp:stepProcess rdf:resource="#BiochemicalReaction881" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1059">
 <bp:stepProcess rdf:resource="#BiochemicalReaction887" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1058">
 <bp:stepProcess rdf:resource="#BiochemicalReaction886" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1044">
 <bp:stepProcess rdf:resource="#BiochemicalReaction873" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1043">
 <bp:stepProcess rdf:resource="#BiochemicalReaction872" />
 <bp:stepProcess rdf:resource="#Catalysis385" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1046">
 <bp:stepProcess rdf:resource="#BiochemicalReaction875" />
 <bp:stepProcess rdf:resource="#Catalysis386" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1045">
 <bp:stepProcess rdf:resource="#BiochemicalReaction874" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1040">
 <bp:stepProcess rdf:resource="#BiochemicalReaction870" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1042">
 <bp:stepProcess rdf:resource="#BiochemicalReaction871" />
 <bp:stepProcess rdf:resource="#Catalysis384" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1041">
 <bp:stepProcess rdf:resource="#Pathway172" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1048">
 <bp:stepProcess rdf:resource="#BiochemicalReaction877" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1047">
 <bp:stepProcess rdf:resource="#Catalysis387" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction876" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1049">
 <bp:stepProcess rdf:resource="#Catalysis388" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction878" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis23">
 <bp:controlled rdf:resource="#BiochemicalReaction51" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis24">
 <bp:controlled rdf:resource="#BiochemicalReaction52" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis21">
 <bp:controlled rdf:resource="#BiochemicalReaction48" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis22">
 <bp:controlled rdf:resource="#BiochemicalReaction50" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis20">
 <bp:controlled rdf:resource="#BiochemicalReaction47" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis29">
 <bp:controlled rdf:resource="#BiochemicalReaction57" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis27">
 <bp:controlled rdf:resource="#BiochemicalReaction55" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis28">
 <bp:controlled rdf:resource="#BiochemicalReaction56" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis25">
 <bp:controlled rdf:resource="#BiochemicalReaction53" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis26">
 <bp:controlled rdf:resource="#BiochemicalReaction54" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1033">
 <bp:stepProcess rdf:resource="#BiochemicalReaction865" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1032">
 <bp:stepProcess rdf:resource="#BiochemicalReaction864" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1035">
 <bp:stepProcess rdf:resource="#BiochemicalReaction866" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1470">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1034">
 <bp:stepProcess rdf:resource="#Pathway170" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1472">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1471">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1031">
 <bp:stepProcess rdf:resource="#BiochemicalReaction863" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1474">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1030">
 <bp:stepProcess rdf:resource="#BiochemicalReaction862" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1473">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1476">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1475">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1478">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1477">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1037">
 <bp:stepProcess rdf:resource="#Pathway171" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1036">
 <bp:stepProcess rdf:resource="#BiochemicalReaction867" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1479">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1039">
 <bp:stepProcess rdf:resource="#BiochemicalReaction869" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1038">
 <bp:stepProcess rdf:resource="#BiochemicalReaction868" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis34">
 <bp:controlled rdf:resource="#BiochemicalReaction63" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis35">
 <bp:controlled rdf:resource="#BiochemicalReaction64" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis32">
 <bp:controlled rdf:resource="#BiochemicalReaction60" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis33">
 <bp:controlled rdf:resource="#BiochemicalReaction61" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis30">
 <bp:controlled rdf:resource="#BiochemicalReaction58" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis31">
 <bp:controlled rdf:resource="#BiochemicalReaction59" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis38">
 <bp:controlled rdf:resource="#BiochemicalReaction71" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis39">
 <bp:controlled rdf:resource="#BiochemicalReaction73" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis36">
 <bp:controlled rdf:resource="#BiochemicalReaction65" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis37">
 <bp:controlled rdf:resource="#BiochemicalReaction67" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1022">
 <bp:stepProcess rdf:resource="#BiochemicalReaction854" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1021">
 <bp:stepProcess rdf:resource="#BiochemicalReaction853" />
 <bp:stepProcess rdf:resource="#Catalysis383" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1024">
 <bp:stepProcess rdf:resource="#BiochemicalReaction856" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1481">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1023">
 <bp:stepProcess rdf:resource="#BiochemicalReaction855" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1480">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1483">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1482">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1020">
 <bp:stepProcess rdf:resource="#BiochemicalReaction852" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1485">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1484">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1487">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1029">
 <bp:stepProcess rdf:resource="#BiochemicalReaction861" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1486">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1489">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1488">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1026">
 <bp:stepProcess rdf:resource="#BiochemicalReaction858" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1025">
 <bp:stepProcess rdf:resource="#BiochemicalReaction857" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1028">
 <bp:stepProcess rdf:resource="#BiochemicalReaction860" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1027">
 <bp:stepProcess rdf:resource="#BiochemicalReaction859" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1011">
 <bp:stepProcess rdf:resource="#BiochemicalReaction844" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1490">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1010">
 <bp:stepProcess rdf:resource="#Pathway168" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1013">
 <bp:stepProcess rdf:resource="#BiochemicalReaction846" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1492">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1012">
 <bp:stepProcess rdf:resource="#BiochemicalReaction845" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1491">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1494">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1493">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1496">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1495">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1019">
 <bp:stepProcess rdf:resource="#BiochemicalReaction851" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1498">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1018">
 <bp:stepProcess rdf:resource="#BiochemicalReaction850" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence1497">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence1499">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1015">
 <bp:stepProcess rdf:resource="#Pathway169" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1014">
 <bp:stepProcess rdf:resource="#BiochemicalReaction847" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1017">
 <bp:stepProcess rdf:resource="#BiochemicalReaction849" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1016">
 <bp:stepProcess rdf:resource="#BiochemicalReaction848" />
</bp:PathwayStep>

<bp:Catalysis rdf:ID="Catalysis12">
 <bp:controlled rdf:resource="#BiochemicalReaction33" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis13">
 <bp:controlled rdf:resource="#BiochemicalReaction35" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis10">
 <bp:controlled rdf:resource="#BiochemicalReaction30" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis11">
 <bp:controlled rdf:resource="#BiochemicalReaction31" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis18">
 <bp:controlled rdf:resource="#BiochemicalReaction43" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis19">
 <bp:controlled rdf:resource="#BiochemicalReaction46" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis16">
 <bp:controlled rdf:resource="#BiochemicalReaction41" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis17">
 <bp:controlled rdf:resource="#BiochemicalReaction42" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis14">
 <bp:controlled rdf:resource="#BiochemicalReaction38" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis15">
 <bp:controlled rdf:resource="#BiochemicalReaction39" />
</bp:Catalysis>

<bp:PathwayStep rdf:ID="PathwayStep1000">
 <bp:stepProcess rdf:resource="#BiochemicalReaction836" />
 <bp:stepProcess rdf:resource="#Catalysis379" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1002">
 <bp:stepProcess rdf:resource="#Catalysis381" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction838" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1001">
 <bp:stepProcess rdf:resource="#BiochemicalReaction837" />
 <bp:stepProcess rdf:resource="#Catalysis380" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1008">
 <bp:stepProcess rdf:resource="#BiochemicalReaction842" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1007">
 <bp:stepProcess rdf:resource="#BiochemicalReaction841" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1009">
 <bp:stepProcess rdf:resource="#BiochemicalReaction843" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1004">
 <bp:stepProcess rdf:resource="#Pathway166" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1003">
 <bp:stepProcess rdf:resource="#BiochemicalReaction839" />
 <bp:stepProcess rdf:resource="#Catalysis382" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1006">
 <bp:stepProcess rdf:resource="#BiochemicalReaction840" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1005">
 <bp:stepProcess rdf:resource="#Pathway167" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction884">
 <bp:evidence rdf:resource="#Evidence1056" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAVS binds TOMM70</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction883">
 <bp:evidence rdf:resource="#Evidence1055" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ISGylation of DDX58</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction886">
 <bp:evidence rdf:resource="#Evidence1059" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1/IKK epsilon complex interacts with MAVS bound TRAF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction885">
 <bp:evidence rdf:resource="#Evidence1058" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of phosphorylated IRF3,IRF7 dimers into nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction888">
 <bp:evidence rdf:resource="#Evidence1061" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of TRAF3 to MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction887">
 <bp:evidence rdf:resource="#Evidence1060" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREBBP, EP300 binds p-T,4S-IRF3:p-T,4S-IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction889">
 <bp:evidence rdf:resource="#Evidence1062" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1, IKBKE are autophosphorylated at Ser172</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction891">
 <bp:evidence rdf:resource="#Evidence1064" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dimerization of Phospho IRF3 or phospho IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction890">
 <bp:evidence rdf:resource="#Evidence1063" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation and release of IRF3/IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction893">
 <bp:evidence rdf:resource="#Evidence1066" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TBK1 or IKBKE forms homodimers</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction892">
 <bp:evidence rdf:resource="#Evidence1065" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of IRF3,IRF7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction873">
 <bp:evidence rdf:resource="#Evidence1045" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PCBP2 with MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction872">
 <bp:evidence rdf:resource="#Evidence1044" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYLD mediated deubiquitination of DDX58 (RIG-I)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction875">
 <bp:evidence rdf:resource="#Evidence1047" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Recruitment of ITCH and K48 ubiquitination of MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction874">
 <bp:evidence rdf:resource="#Evidence1046" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 interacts with DDX58/IFIH1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction877">
 <bp:evidence rdf:resource="#Evidence1049" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Interaction of PIN1 with p-IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction876">
 <bp:evidence rdf:resource="#Evidence1048" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNF125 mediated ubiquitination of DDX58, IFIH1 and MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction879">
 <bp:evidence rdf:resource="#Evidence1051" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Inhibition of DDX58/IFIH1 signaling by ATG5:ATG12:MAVS</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction878">
 <bp:evidence rdf:resource="#Evidence1050" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">OTUD5 deubiquitinates TRAF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction880">
 <bp:evidence rdf:resource="#Evidence1052" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Negative regulation of DDX58/IFIH1 signaling by RNF216</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction882">
 <bp:evidence rdf:resource="#Evidence1054" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 inhibits MAVS-DDX58 interaction</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction881">
 <bp:evidence rdf:resource="#Evidence1053" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAX1BP1:A20 inhibit TBK1/IKKi K63-polyubiquitination</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction869">
 <bp:evidence rdf:resource="#Evidence1040" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HSP90 binds TBK1 and IRF3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction862">
 <bp:evidence rdf:resource="#Evidence1031" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PSTPIP1 binds Pyrin</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis520">
 <bp:controlled rdf:resource="#BiochemicalReaction1298" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction861">
 <bp:evidence rdf:resource="#Evidence1030" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ATP binds to P2X7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction864">
 <bp:evidence rdf:resource="#Evidence1033" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pyrin binds ASC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction863">
 <bp:evidence rdf:resource="#Evidence1032" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROS oxidize thioredoxin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction866">
 <bp:evidence rdf:resource="#Evidence1036" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IPAF is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction865">
 <bp:evidence rdf:resource="#Evidence1034" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXNIP is released from oxidized thioredoxin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction868">
 <bp:evidence rdf:resource="#Evidence1039" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">viral dsRNA binds IFIH1:TKFC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction867">
 <bp:evidence rdf:resource="#Evidence1037" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IPAF binds procaspase-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis517">
 <bp:controlled rdf:resource="#BiochemicalReaction1292" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis518">
 <bp:controlled rdf:resource="#BiochemicalReaction1295" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis515">
 <bp:controlled rdf:resource="#BiochemicalReaction1287" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis516">
 <bp:controlled rdf:resource="#BiochemicalReaction1289" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis513">
 <bp:controlled rdf:resource="#BiochemicalReaction1285" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis514">
 <bp:controlled rdf:resource="#BiochemicalReaction1286" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction871">
 <bp:evidence rdf:resource="#Evidence1043" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PIN1 mediated IRF3 degradation</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis511">
 <bp:controlled rdf:resource="#BiochemicalReaction1281" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction870">
 <bp:evidence rdf:resource="#Evidence1041" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">viral dsRNA binds DDX58</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis512">
 <bp:controlled rdf:resource="#BiochemicalReaction1283" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis519">
 <bp:controlled rdf:resource="#BiochemicalReaction1296" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction859">
 <bp:evidence rdf:resource="#Evidence1028" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP3 activation by elicitor proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction858">
 <bp:evidence rdf:resource="#Evidence1027" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXNIP binds NLRP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction851">
 <bp:evidence rdf:resource="#Evidence1020" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2X7 forms oligomeric non-selective cation channels</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction850">
 <bp:evidence rdf:resource="#Evidence1019" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SGT1 binds HSP90</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis510">
 <bp:controlled rdf:resource="#BiochemicalReaction1280" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction853">
 <bp:evidence rdf:resource="#Evidence1022" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2X7 mediates loss of intracellular K+</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction852">
 <bp:evidence rdf:resource="#Evidence1021" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TXNIP binds reduced thioredoxin</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction855">
 <bp:evidence rdf:resource="#Evidence1024" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP3 activation by small molecules</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction854">
 <bp:evidence rdf:resource="#Evidence1023" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP3 recruits PYCARD (ASC) via a PYD-PYD interaction</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction857">
 <bp:evidence rdf:resource="#Evidence1026" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Expression of NLRP3 gene</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction856">
 <bp:evidence rdf:resource="#Evidence1025" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SGT1:HSP90 binds inactive NLRP3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis506">
 <bp:controlled rdf:resource="#BiochemicalReaction1272" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis507">
 <bp:controlled rdf:resource="#BiochemicalReaction1273" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis504">
 <bp:controlled rdf:resource="#BiochemicalReaction1270" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis505">
 <bp:controlled rdf:resource="#BiochemicalReaction1271" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis502">
 <bp:controlled rdf:resource="#BiochemicalReaction1265" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis503">
 <bp:controlled rdf:resource="#BiochemicalReaction1267" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction860">
 <bp:evidence rdf:resource="#Evidence1029" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP3 oligomerizes via NACHT domains</bp:displayName>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:ID="Catalysis500">
 <bp:controlled rdf:resource="#BiochemicalReaction1256" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis501">
 <bp:controlled rdf:resource="#BiochemicalReaction1261" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis508">
 <bp:controlled rdf:resource="#BiochemicalReaction1277" />
</bp:Catalysis>

<bp:Catalysis rdf:ID="Catalysis509">
 <bp:controlled rdf:resource="#BiochemicalReaction1278" />
</bp:Catalysis>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction848">
 <bp:evidence rdf:resource="#Evidence1017" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P2X7 mediates membrane pores that include pannexin-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction847">
 <bp:evidence rdf:resource="#Evidence1015" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP1 senses MDP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction849">
 <bp:evidence rdf:resource="#Evidence1018" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PYCARD recruits procaspase-1 via CARD</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction840">
 <bp:evidence rdf:resource="#Evidence1007" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AIM2 binds dsDNA</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction842">
 <bp:evidence rdf:resource="#Evidence1009" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AIM2 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction841">
 <bp:evidence rdf:resource="#Evidence1008" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">dsDNA:AIM2:ASC cluster binds procaspase-1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction844">
 <bp:evidence rdf:resource="#Evidence1012" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Bcl-2 and Bcl-XL bind NLRP1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction843">
 <bp:evidence rdf:resource="#Evidence1010" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">dsDNA:AIM2 clusters bind ASC</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction846">
 <bp:evidence rdf:resource="#Evidence1014" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRP1 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction845">
 <bp:evidence rdf:resource="#Evidence1013" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDP:NLRP1 binds ATP</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction837">
 <bp:evidence rdf:resource="#Evidence1002" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TNFAIP3 (A20) deubiquitinates RIP2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction836">
 <bp:evidence rdf:resource="#Evidence1001" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP2 is K63 polyubiquitinated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction839">
 <bp:evidence rdf:resource="#Evidence1004" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1 phosphorylates MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction838">
 <bp:evidence rdf:resource="#Evidence1003" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP2 induces K63-linked ubiquitination of NEMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction831">
 <bp:evidence rdf:resource="#Evidence996" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NOD1 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction830">
 <bp:evidence rdf:resource="#Evidence995" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">iE-DAP elicits a NOD1 response</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction833">
 <bp:evidence rdf:resource="#Evidence998" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CYLD deubiquitinates NEMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction832">
 <bp:evidence rdf:resource="#Evidence997" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of p38 MAPK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction835">
 <bp:evidence rdf:resource="#Evidence1000" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1 is activated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction834">
 <bp:evidence rdf:resource="#Evidence999" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RIP2 binds NEMO</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction826">
 <bp:evidence rdf:resource="#Evidence991" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NOD oligomer recruites RIP2 (RICK)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction825">
 <bp:evidence rdf:resource="#Evidence990" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CARD9 binds RIP2 (and NOD2)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction828">
 <bp:evidence rdf:resource="#Evidence993" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">AAMP binds NOD2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction827">
 <bp:evidence rdf:resource="#Evidence992" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated NOD2 oligomerizes</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction829">
 <bp:evidence rdf:resource="#Evidence994" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">K63 polyubiquitinated RIP2 associates with the TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction820">
 <bp:evidence rdf:resource="#Evidence983" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of specific granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction822">
 <bp:evidence rdf:resource="#Evidence987" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MDP elicits a NOD2 response</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction821">
 <bp:evidence rdf:resource="#Evidence984" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of secretory granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction824">
 <bp:evidence rdf:resource="#Evidence989" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction823">
 <bp:evidence rdf:resource="#Evidence988" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NOD1 induced apoptosis is mediated by RIP2 and CARD8</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction815">
 <bp:evidence rdf:resource="#Evidence978" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of secretory granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction814">
 <bp:evidence rdf:resource="#Evidence977" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of tertiary granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction817">
 <bp:evidence rdf:resource="#Evidence980" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of azurophil granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction816">
 <bp:evidence rdf:resource="#Evidence979" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of specific granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction819">
 <bp:evidence rdf:resource="#Evidence982" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of azurophil granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction818">
 <bp:evidence rdf:resource="#Evidence981" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of ficolin-rich granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction811">
 <bp:evidence rdf:resource="#Evidence973" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of C5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction810">
 <bp:evidence rdf:resource="#Evidence972" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cleavage of C3 by C3 convertases</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction813">
 <bp:evidence rdf:resource="#Evidence976" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of ficolin-rich granule membrane proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction812">
 <bp:evidence rdf:resource="#Evidence975" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Exocytosis of tertiary granule lumen proteins</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction598">
 <bp:evidence rdf:resource="#Evidence724" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:TIRAP:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction597">
 <bp:evidence rdf:resource="#Evidence723" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction599">
 <bp:evidence rdf:resource="#Evidence725" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep802">
 <bp:stepProcess rdf:resource="#BiochemicalReaction662" />
 <bp:stepProcess rdf:resource="#Catalysis323" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep803">
 <bp:stepProcess rdf:resource="#BiochemicalReaction663" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep804">
 <bp:stepProcess rdf:resource="#BiochemicalReaction664" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep805">
 <bp:stepProcess rdf:resource="#BiochemicalReaction665" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep800">
 <bp:stepProcess rdf:resource="#BiochemicalReaction660" />
 <bp:stepProcess rdf:resource="#Catalysis322" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep801">
 <bp:stepProcess rdf:resource="#BiochemicalReaction661" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction587">
 <bp:evidence rdf:resource="#Evidence713" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction586">
 <bp:evidence rdf:resource="#Evidence712" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction589">
 <bp:evidence rdf:resource="#Evidence715" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction588">
 <bp:evidence rdf:resource="#Evidence714" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep806">
 <bp:stepProcess rdf:resource="#BiochemicalReaction666" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep807">
 <bp:stepProcess rdf:resource="#Catalysis324" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction667" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep808">
 <bp:stepProcess rdf:resource="#BiochemicalReaction668" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep809">
 <bp:stepProcess rdf:resource="#Catalysis325" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction669" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction590">
 <bp:evidence rdf:resource="#Evidence716" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction592">
 <bp:evidence rdf:resource="#Evidence718" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4 interacts with MAL (TIRAP)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction591">
 <bp:evidence rdf:resource="#Evidence717" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction594">
 <bp:evidence rdf:resource="#Evidence720" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP binds PIP2-rich regions in the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction593">
 <bp:evidence rdf:resource="#Evidence719" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:Mal</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction596">
 <bp:evidence rdf:resource="#Evidence722" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP is phosphorylated by BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction595">
 <bp:evidence rdf:resource="#Evidence721" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 or IRAK2 binds to the activated IRAK4 :activated TLR:MyD88:TIRAP complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep813">
 <bp:stepProcess rdf:resource="#BiochemicalReaction673" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep814">
 <bp:stepProcess rdf:resource="#BiochemicalReaction674" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep815">
 <bp:stepProcess rdf:resource="#Catalysis328" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction675" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep816">
 <bp:stepProcess rdf:resource="#Catalysis329" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction676" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep810">
 <bp:stepProcess rdf:resource="#Catalysis326" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction670" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep811">
 <bp:stepProcess rdf:resource="#BiochemicalReaction671" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep812">
 <bp:stepProcess rdf:resource="#Catalysis327" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction672" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction576">
 <bp:evidence rdf:resource="#Evidence701" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction575">
 <bp:evidence rdf:resource="#Evidence700" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction578">
 <bp:evidence rdf:resource="#Evidence704" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction577">
 <bp:evidence rdf:resource="#Evidence703" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep817">
 <bp:stepProcess rdf:resource="#BiochemicalReaction677" />
 <bp:stepProcess rdf:resource="#Catalysis330" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction579">
 <bp:evidence rdf:resource="#Evidence705" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep818">
 <bp:stepProcess rdf:resource="#Catalysis331" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction678" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep819">
 <bp:stepProcess rdf:resource="#Catalysis332" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction679" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction581">
 <bp:evidence rdf:resource="#Evidence707" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction580">
 <bp:evidence rdf:resource="#Evidence706" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction583">
 <bp:evidence rdf:resource="#Evidence709" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction582">
 <bp:evidence rdf:resource="#Evidence708" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction585">
 <bp:evidence rdf:resource="#Evidence711" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction584">
 <bp:evidence rdf:resource="#Evidence710" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction565">
 <bp:evidence rdf:resource="#Evidence685" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction564">
 <bp:evidence rdf:resource="#Evidence684" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction567">
 <bp:evidence rdf:resource="#Evidence687" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1 or p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction566">
 <bp:evidence rdf:resource="#Evidence686" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction569">
 <bp:evidence rdf:resource="#Evidence691" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR6:TLR2 is recruited to ligand:CD14:CD36</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction568">
 <bp:evidence rdf:resource="#Evidence688" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ligand binds to TLR10</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction570">
 <bp:evidence rdf:resource="#Evidence693" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR receptor:TIRAP:MyD88 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction572">
 <bp:evidence rdf:resource="#Evidence696" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction571">
 <bp:evidence rdf:resource="#Evidence695" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction574">
 <bp:evidence rdf:resource="#Evidence698" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction573">
 <bp:evidence rdf:resource="#Evidence697" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction554">
 <bp:evidence rdf:resource="#Evidence673" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction553">
 <bp:evidence rdf:resource="#Evidence672" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction556">
 <bp:evidence rdf:resource="#Evidence675" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction555">
 <bp:evidence rdf:resource="#Evidence674" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction558">
 <bp:evidence rdf:resource="#Evidence677" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with the activated TLR receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction557">
 <bp:evidence rdf:resource="#Evidence676" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction559">
 <bp:evidence rdf:resource="#Evidence678" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation within the complex activated TLR:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction561">
 <bp:evidence rdf:resource="#Evidence680" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomerl:activated TLR5 or 10 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction560">
 <bp:evidence rdf:resource="#Evidence679" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction563">
 <bp:evidence rdf:resource="#Evidence683" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction562">
 <bp:evidence rdf:resource="#Evidence682" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction543">
 <bp:evidence rdf:resource="#Evidence661" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction542">
 <bp:evidence rdf:resource="#Evidence659" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction545">
 <bp:evidence rdf:resource="#Evidence663" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction544">
 <bp:evidence rdf:resource="#Evidence662" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction547">
 <bp:evidence rdf:resource="#Evidence665" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction546">
 <bp:evidence rdf:resource="#Evidence664" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction549">
 <bp:evidence rdf:resource="#Evidence667" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction548">
 <bp:evidence rdf:resource="#Evidence666" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction550">
 <bp:evidence rdf:resource="#Evidence669" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction552">
 <bp:evidence rdf:resource="#Evidence671" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction551">
 <bp:evidence rdf:resource="#Evidence670" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction539">
 <bp:evidence rdf:resource="#Evidence655" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction532">
 <bp:evidence rdf:resource="#Evidence645" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction531">
 <bp:evidence rdf:resource="#Evidence644" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction534">
 <bp:evidence rdf:resource="#Evidence649" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction533">
 <bp:evidence rdf:resource="#Evidence648" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction536">
 <bp:evidence rdf:resource="#Evidence651" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction535">
 <bp:evidence rdf:resource="#Evidence650" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction538">
 <bp:evidence rdf:resource="#Evidence654" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction537">
 <bp:evidence rdf:resource="#Evidence652" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction541">
 <bp:evidence rdf:resource="#Evidence657" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction540">
 <bp:evidence rdf:resource="#Evidence656" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep868">
 <bp:stepProcess rdf:resource="#BiochemicalReaction719" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep869">
 <bp:stepProcess rdf:resource="#BiochemicalReaction720" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway79">
 <bp:pathwayOrder rdf:resource="#PathwayStep439" />
 <bp:pathwayOrder rdf:resource="#PathwayStep435" />
 <bp:pathwayOrder rdf:resource="#PathwayStep436" />
 <bp:pathwayOrder rdf:resource="#PathwayStep437" />
 <bp:pathwayOrder rdf:resource="#PathwayStep438" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction361" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction360" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction358" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction357" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction359" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence435" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway77">
 <bp:pathwayOrder rdf:resource="#PathwayStep428" />
 <bp:pathwayOrder rdf:resource="#PathwayStep429" />
 <bp:pathwayOrder rdf:resource="#PathwayStep431" />
 <bp:pathwayOrder rdf:resource="#PathwayStep432" />
 <bp:pathwayOrder rdf:resource="#PathwayStep430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction352" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction354" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction356" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction355" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence428" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep864">
 <bp:stepProcess rdf:resource="#BiochemicalReaction715" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway78">
 <bp:pathwayOrder rdf:resource="#PathwayStep434" />
 <bp:pathwayOrder rdf:resource="#PathwayStep445" />
 <bp:pathwayOrder rdf:resource="#PathwayStep440" />
 <bp:pathwayComponent rdf:resource="#Pathway79" />
 <bp:pathwayComponent rdf:resource="#Pathway80" />
 <bp:pathwayComponent rdf:resource="#Pathway81" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence434" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep865">
 <bp:stepProcess rdf:resource="#BiochemicalReaction716" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway75">
 <bp:pathwayOrder rdf:resource="#PathwayStep427" />
 <bp:pathwayOrder rdf:resource="#PathwayStep433" />
 <bp:pathwayOrder rdf:resource="#PathwayStep455" />
 <bp:pathwayOrder rdf:resource="#PathwayStep423" />
 <bp:pathwayComponent rdf:resource="#Pathway77" />
 <bp:pathwayComponent rdf:resource="#Pathway78" />
 <bp:pathwayComponent rdf:resource="#Pathway76" />
 <bp:pathwayComponent rdf:resource="#Pathway83" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence423" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep866">
 <bp:stepProcess rdf:resource="#BiochemicalReaction717" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway76">
 <bp:pathwayOrder rdf:resource="#PathwayStep424" />
 <bp:pathwayOrder rdf:resource="#PathwayStep425" />
 <bp:pathwayOrder rdf:resource="#PathwayStep426" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction350" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction351" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction349" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence424" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep867">
 <bp:stepProcess rdf:resource="#BiochemicalReaction718" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway73">
 <bp:pathwayOrder rdf:resource="#PathwayStep413" />
 <bp:pathwayOrder rdf:resource="#PathwayStep414" />
 <bp:pathwayOrder rdf:resource="#PathwayStep415" />
 <bp:pathwayOrder rdf:resource="#PathwayStep411" />
 <bp:pathwayOrder rdf:resource="#PathwayStep412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction341" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction340" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction343" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction339" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence411" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In plasmacytoid dendritic cell induction of type I IFNs critically depends on IFN regulatory factor 7 in TLR7 and 9 signaling (Honda et al 2005). IRF-7, but not IRF3, interacts with MyD88, TRAF6, and IRAKs and translocates to the nucleus upon phosphorylation (Kawai et al 2004; Uematsu et al 2005).  TLR7/8 signaling was shown to induce IRF5 activation along with IRF7 [Schoenemeyer et al 2005], while IRF8 [Tsujimura H et al 2004] and IRF1 were reported to be implicated in TLR9 signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway74">
 <bp:pathwayOrder rdf:resource="#PathwayStep490" />
 <bp:pathwayOrder rdf:resource="#PathwayStep464" />
 <bp:pathwayOrder rdf:resource="#PathwayStep465" />
 <bp:pathwayOrder rdf:resource="#PathwayStep422" />
 <bp:pathwayOrder rdf:resource="#PathwayStep484" />
 <bp:pathwayOrder rdf:resource="#PathwayStep495" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction382" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction409" />
 <bp:pathwayComponent rdf:resource="#Pathway75" />
 <bp:pathwayComponent rdf:resource="#Pathway86" />
 <bp:pathwayComponent rdf:resource="#Pathway87" />
 <bp:pathwayComponent rdf:resource="#Pathway84" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence422" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediates NFkB activation via canonical phosphorylation of IKK complex by TAK1. TRAF6 and TAK1 also regulate MAPK cascades leading to the activation of AP-1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway71">
 <bp:pathwayOrder rdf:resource="#PathwayStep398" />
 <bp:pathwayOrder rdf:resource="#PathwayStep399" />
 <bp:pathwayOrder rdf:resource="#PathwayStep394" />
 <bp:pathwayOrder rdf:resource="#PathwayStep395" />
 <bp:pathwayOrder rdf:resource="#PathwayStep396" />
 <bp:pathwayOrder rdf:resource="#PathwayStep397" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction325" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction324" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction327" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction326" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction329" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction328" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence394" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC15A4:TASL-dependent IRF5 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This Reactome module describes the Toll-like receptor 7 (TLR7), TLR8, or TLR9 &#8211; induced activation of interferon regulatory factor 5 (IRF5) via the SLC15A4:TASL axis.  Solute carrier family 15, member 4 (SLC15A4, also known as PHT1) is a proton-coupled L-histidine/oligopeptide transporter. In addition to its function as a transporter, SLC15A4 regulates TLR7-9 signaling pathways in late endosomes/lysosomes (Heinz LX. et al., 2020; Kobayashi T et al., 2021). SLC15A4 acts as a signaling scaffold, recruiting the protein TLR adaptor interacting with SLC15A4 on the lysosome (TASL) to the cytosolic surface of endolysosomes (Heinz LX. et al., 2020; Custodio TF et al., 2023; Chen X et al., 2023). Upon activation of endosomal TLR signaling, TASL undergoes phosphorylation and recruits IRF5 to its pLxIS motif (Heinz LX. et al., 2020). The SLC15A4:TASL complex facilitates IRF5 phosphorylation by IKBKB (IKK&#946;) and subsequent IRF5 homodimerization downstream of TLR7-TLR9 (Heinz LX. et al., 2020; Zhang H et al., 2023; Chen X et al., 2023; Boeszoermeny A et al., 2023). Once activated, IRF5 translocates to the nucleus to induce the transcription of genes encoding type I interferons (IFNs) and pro-inflammatory cytokines. Hyperactivation of the SLC15A4:TASL:IRF5 pathway, often caused by the detection of endogenous nucleic acids, leads to increased production of type I IFNs and is associated with pathogenesis of inflammatory diseases such as systemic lupus erythematosus (SLE) (Odhams CA et al., 2019; Heinz LX. et al., 2020; Kobayashi T et al., 2021). .</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway72">
 <bp:pathwayOrder rdf:resource="#PathwayStep406" />
 <bp:pathwayOrder rdf:resource="#PathwayStep417" />
 <bp:pathwayOrder rdf:resource="#PathwayStep407" />
 <bp:pathwayOrder rdf:resource="#PathwayStep418" />
 <bp:pathwayOrder rdf:resource="#PathwayStep408" />
 <bp:pathwayOrder rdf:resource="#PathwayStep419" />
 <bp:pathwayOrder rdf:resource="#PathwayStep409" />
 <bp:pathwayOrder rdf:resource="#PathwayStep405" />
 <bp:pathwayOrder rdf:resource="#PathwayStep416" />
 <bp:pathwayOrder rdf:resource="#PathwayStep420" />
 <bp:pathwayOrder rdf:resource="#PathwayStep410" />
 <bp:pathwayOrder rdf:resource="#PathwayStep421" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction334" />
 <bp:pathwayComponent rdf:resource="#Pathway73" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction345" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction344" />
 <bp:pathwayComponent rdf:resource="#Pathway74" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction336" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction347" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction335" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction346" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction338" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction337" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction348" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence405" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 dependent cascade initiated on endosome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Upon binding of their ligands, TLR7/8 and TLR9 recruit a cytoplasmic adaptor MyD88 and IRAKs, downstream of which the signaling pathways are divided to induce either inflammatory cytokines or type I IFNs.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway70">
 <bp:pathwayOrder rdf:resource="#PathwayStep393" />
 <bp:pathwayOrder rdf:resource="#PathwayStep402" />
 <bp:pathwayOrder rdf:resource="#PathwayStep403" />
 <bp:pathwayOrder rdf:resource="#PathwayStep404" />
 <bp:pathwayOrder rdf:resource="#PathwayStep400" />
 <bp:pathwayOrder rdf:resource="#PathwayStep401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction330" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction332" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction333" />
 <bp:pathwayComponent rdf:resource="#Pathway71" />
 <bp:pathwayComponent rdf:resource="#Pathway72" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence393" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 7/8 (TLR7/8) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RNA can serve as a danger signal, both in its double-stranded form as well as single-stranded RNA (ssRNA). Toll like receptor 7 (TLR7) and TLR8 are endosomal receptors that sense ssRNA oligonucleotides containing guanosine (G)- and uridine (U)-rich sequences from RNA viruses (Jurk M et al. 2002; Heil F et al. 2004; Diebold SS et al. 2004; Li Y et al. 2013; reviewed in Lester SN    Li K 2014). TLR7 is primarily expressed in plasmacytoid dendritic cells (pDCs) and, to some extent, in B cells, monocytes and macrophages, whereas TLR8 is mostly expressed in monocytes, macrophages and myeloid DCs. Upon engagement of ssRNAs in endosomes, TLR7/8 initiate the myeloid differentiation factor 88 (MyD88)-dependent pathway, culminating in synthesis of type I and type III IFNs and proinflammatory mediators via activation of IFN regulatory factors (IRF7, IRF5) and NF-kappaB, respectively, depending on the cell type (Takaoka A et al., 2005; Heinz LX et al., 2020; reviewed in Lester SN    Li K 2014). TLR7 and TLR8 are able to detect GU-rich ssRNA sequences from the viral genomes of influenza, human immunodeficiency virus-1 (HIV-1), vesicular stomatitis virus (VSV), coxsackie B virus, coronavirus and flaviviruses (hepatitis C virus, HCV and West Nile virus, WNV; reviewed in Lester SN    Li K 2014). Specifically, GU-rich ssRNA oligonucleotides derived from HIV-1, for example, stimulate dendritic cells (DC) and macrophages to secrete interferon-alpha and proinflammatory, as well as regulatory, cytokines (Heil F et al. 2004). This has been found to be mediated by TLR7, as well as TLR8. Similarly, severe acute respiratory syndrome-associated coronavirus type 1 (SARS-CoV-1) GU-rich ssRNAs had powerful immunostimulatory activities in mononuclear phagocytes to induce considerable level of pro-inflammatory cytokine TNF-a, IL-6 and IL-12 release via the TLR7 and TLR8 (Li Y et al. 2013). Further, mice deficient in either Tlr7 or the TLR adaptor protein Myd88 demonstrated reduced responses to in vivo infection with VSV (Lund JM et al. 2004),  mouse-adapted SARS-CoV-1 (Sheahan et al. 2008; Totura et al., 2015). Upon Middle East respiratory syndrome-related coronavirus (MERS-CoV) infection, lack of MyD88 signaling resulted in delayed viral clearance and increased lung pathology in mice (Zhao et al. 2014). Consistently, another study showed that Tlr7-/- mice have reduced IFN expression compared with wild-type mice (Channappanavar et al. 2019). In addition, loss of function TLR7 variants identified in the patients with SARS-CoV-2 (COVID-19) resulted in defective upregulation of type I IFN&#8211;related genes in the TLR7 pathway (Figure 3) in response to the TLR7 agonist imiquimod as compared with controls (Van der Made CI et al. 2020). Separate studies showed that synthetic imidazoquinoline compounds (e.g. imiquimod and R-848, low-molecular-weight immune response modifiers that can induce the synthesis of interferon-alpha) also exert their effects in a MyD88-dependent fashion through TLR7 or TLR8 (Hemmi H et al. 2002; Jurk M et al. 2002; Diebold SS et al. 2004). Some viruses utilize multiple strategies to evade antiviral innate immune signaling, as is seen with influenza or SARS coronaviruses. TLR7-mediated innate immunity, for example, was associated with the negative regulation through removing Lys63-linked polyubiquitin chains of TRAF3/TRAF6 by papin-like protease (PLpro) catalytic domain of nsp3 from SARS-CoV-1 (Li SW et al. 2016). Thus, TLR7 and TLR8 play a critical role in sensing of viral ssRNA in the endosome.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep860">
 <bp:stepProcess rdf:resource="#BiochemicalReaction711" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep861">
 <bp:stepProcess rdf:resource="#BiochemicalReaction712" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep862">
 <bp:stepProcess rdf:resource="#BiochemicalReaction713" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep863">
 <bp:stepProcess rdf:resource="#BiochemicalReaction714" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep879">
 <bp:stepProcess rdf:resource="#BiochemicalReaction728" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway88">
 <bp:pathwayOrder rdf:resource="#PathwayStep505" />
 <bp:pathwayOrder rdf:resource="#PathwayStep506" />
 <bp:pathwayOrder rdf:resource="#PathwayStep507" />
 <bp:pathwayOrder rdf:resource="#PathwayStep508" />
 <bp:pathwayOrder rdf:resource="#PathwayStep497" />
 <bp:pathwayOrder rdf:resource="#PathwayStep498" />
 <bp:pathwayOrder rdf:resource="#PathwayStep509" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction419" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction418" />
 <bp:pathwayComponent rdf:resource="#Pathway89" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction420" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction410" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction417" />
 <bp:pathwayComponent rdf:resource="#Pathway90" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence497" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 9 (TLR9) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CpG DNA is an unusual Pathogen-Associated Molecular Pattern (PAMP). Cytosine methylation exists in mammalian but not bacterial cells, and most (but not all) CpG in the mammalian genome is methylated. Therefore, unmethylated CpG DNA may signal the presence of microbial infection. Evidence of CpG recognition by TLR9 was demonstrated both in human and  mouse, and this type of signaling requires its internalization into late endosomal/lysosomal compartments. TLR9 has been reported to be able to discern different types of CpG motifs, and therefore that it presumably recognizes CpG DNA directly. It appears that over evolutionary periods, TLR9 molecules expressed by different species have diverged. This has led to differences in the precise sequence motif (CpG dinucleotide plus flanking regions) that optimally stimulate the innate immune system of different animals.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep875">
 <bp:stepProcess rdf:resource="#Catalysis359" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction725" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway89">
 <bp:pathwayOrder rdf:resource="#PathwayStep501" />
 <bp:pathwayOrder rdf:resource="#PathwayStep502" />
 <bp:pathwayOrder rdf:resource="#PathwayStep503" />
 <bp:pathwayOrder rdf:resource="#PathwayStep504" />
 <bp:pathwayOrder rdf:resource="#PathwayStep499" />
 <bp:pathwayOrder rdf:resource="#PathwayStep500" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction411" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction413" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction412" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction415" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction414" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction416" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence499" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SLC15A4:TASL-dependent IRF5 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">This Reactome module describes the Toll-like receptor 7 (TLR7), TLR8, or TLR9 &#8211; induced activation of interferon regulatory factor 5 (IRF5) via the SLC15A4:TASL axis.  Solute carrier family 15, member 4 (SLC15A4, also known as PHT1) is a proton-coupled L-histidine/oligopeptide transporter. In addition to its function as a transporter, SLC15A4 regulates TLR7-9 signaling pathways in late endosomes/lysosomes (Heinz LX. et al., 2020; Kobayashi T et al., 2021). SLC15A4 acts as a signaling scaffold, recruiting the protein TLR adaptor interacting with SLC15A4 on the lysosome (TASL) to the cytosolic surface of endolysosomes (Heinz LX. et al., 2020; Custodio TF et al., 2023; Chen X et al., 2023). Upon activation of endosomal TLR signaling, TASL undergoes phosphorylation and recruits IRF5 to its pLxIS motif (Heinz LX. et al., 2020). The SLC15A4:TASL complex facilitates IRF5 phosphorylation by IKBKB (IKK&#946;) and subsequent IRF5 homodimerization downstream of TLR7-TLR9 (Heinz LX. et al., 2020; Zhang H et al., 2023; Chen X et al., 2023; Boeszoermeny A et al., 2023). Once activated, IRF5 translocates to the nucleus to induce the transcription of genes encoding type I interferons (IFNs) and pro-inflammatory cytokines. Hyperactivation of the SLC15A4:TASL:IRF5 pathway, often caused by the detection of endogenous nucleic acids, leads to increased production of type I IFNs and is associated with pathogenesis of inflammatory diseases such as systemic lupus erythematosus (SLE) (Odhams CA et al., 2019; Heinz LX. et al., 2020; Kobayashi T et al., 2021). .</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep876">
 <bp:stepProcess rdf:resource="#BiochemicalReaction726" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway86">
 <bp:pathwayOrder rdf:resource="#PathwayStep486" />
 <bp:pathwayOrder rdf:resource="#PathwayStep487" />
 <bp:pathwayOrder rdf:resource="#PathwayStep488" />
 <bp:pathwayOrder rdf:resource="#PathwayStep489" />
 <bp:pathwayOrder rdf:resource="#PathwayStep485" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction400" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction402" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction401" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction404" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction403" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence485" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep877">
 <bp:stepProcess rdf:resource="#Pathway152" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway87">
 <bp:pathwayOrder rdf:resource="#PathwayStep491" />
 <bp:pathwayOrder rdf:resource="#PathwayStep492" />
 <bp:pathwayOrder rdf:resource="#PathwayStep493" />
 <bp:pathwayOrder rdf:resource="#PathwayStep494" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction408" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction407" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction406" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction405" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence491" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep878">
 <bp:stepProcess rdf:resource="#BiochemicalReaction727" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway84">
 <bp:pathwayOrder rdf:resource="#PathwayStep480" />
 <bp:pathwayOrder rdf:resource="#PathwayStep481" />
 <bp:pathwayOrder rdf:resource="#PathwayStep468" />
 <bp:pathwayOrder rdf:resource="#PathwayStep466" />
 <bp:pathwayOrder rdf:resource="#PathwayStep467" />
 <bp:pathwayOrder rdf:resource="#PathwayStep482" />
 <bp:pathwayOrder rdf:resource="#PathwayStep483" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction383" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction396" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction384" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction398" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction397" />
 <bp:pathwayComponent rdf:resource="#Pathway85" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction399" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence466" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway85">
 <bp:pathwayOrder rdf:resource="#PathwayStep470" />
 <bp:pathwayOrder rdf:resource="#PathwayStep479" />
 <bp:pathwayOrder rdf:resource="#PathwayStep469" />
 <bp:pathwayOrder rdf:resource="#PathwayStep475" />
 <bp:pathwayOrder rdf:resource="#PathwayStep476" />
 <bp:pathwayOrder rdf:resource="#PathwayStep477" />
 <bp:pathwayOrder rdf:resource="#PathwayStep478" />
 <bp:pathwayOrder rdf:resource="#PathwayStep471" />
 <bp:pathwayOrder rdf:resource="#PathwayStep472" />
 <bp:pathwayOrder rdf:resource="#PathwayStep473" />
 <bp:pathwayOrder rdf:resource="#PathwayStep474" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction392" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction391" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction394" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction393" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction385" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction395" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction387" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction388" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction390" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence469" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway82">
 <bp:pathwayOrder rdf:resource="#PathwayStep448" />
 <bp:pathwayOrder rdf:resource="#PathwayStep449" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction367" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction368" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence448" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway83">
 <bp:pathwayOrder rdf:resource="#PathwayStep457" />
 <bp:pathwayOrder rdf:resource="#PathwayStep458" />
 <bp:pathwayOrder rdf:resource="#PathwayStep459" />
 <bp:pathwayOrder rdf:resource="#PathwayStep456" />
 <bp:pathwayOrder rdf:resource="#PathwayStep460" />
 <bp:pathwayOrder rdf:resource="#PathwayStep461" />
 <bp:pathwayOrder rdf:resource="#PathwayStep462" />
 <bp:pathwayOrder rdf:resource="#PathwayStep463" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction381" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction380" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction374" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction376" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction375" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction378" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction377" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction379" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence456" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway80">
 <bp:pathwayOrder rdf:resource="#PathwayStep442" />
 <bp:pathwayOrder rdf:resource="#PathwayStep443" />
 <bp:pathwayOrder rdf:resource="#PathwayStep444" />
 <bp:pathwayOrder rdf:resource="#PathwayStep441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction363" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction362" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction365" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction364" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence441" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway81">
 <bp:pathwayOrder rdf:resource="#PathwayStep446" />
 <bp:pathwayOrder rdf:resource="#PathwayStep447" />
 <bp:pathwayOrder rdf:resource="#PathwayStep453" />
 <bp:pathwayOrder rdf:resource="#PathwayStep454" />
 <bp:pathwayOrder rdf:resource="#PathwayStep450" />
 <bp:pathwayOrder rdf:resource="#PathwayStep451" />
 <bp:pathwayOrder rdf:resource="#PathwayStep452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction370" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction372" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction371" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction373" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction366" />
 <bp:pathwayComponent rdf:resource="#Pathway82" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction369" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence446" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep871">
 <bp:stepProcess rdf:resource="#BiochemicalReaction721" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep872">
 <bp:stepProcess rdf:resource="#BiochemicalReaction722" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep873">
 <bp:stepProcess rdf:resource="#Catalysis357" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction723" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep874">
 <bp:stepProcess rdf:resource="#Catalysis358" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction724" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep870">
 <bp:stepProcess rdf:resource="#Pathway151" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway99">
 <bp:pathwayOrder rdf:resource="#PathwayStep556" />
 <bp:pathwayOrder rdf:resource="#PathwayStep557" />
 <bp:pathwayOrder rdf:resource="#PathwayStep558" />
 <bp:pathwayOrder rdf:resource="#PathwayStep559" />
 <bp:pathwayOrder rdf:resource="#PathwayStep552" />
 <bp:pathwayOrder rdf:resource="#PathwayStep555" />
 <bp:pathwayOrder rdf:resource="#PathwayStep551" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction460" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction453" />
 <bp:pathwayComponent rdf:resource="#Pathway100" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction457" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction456" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction459" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction458" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence551" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep886">
 <bp:stepProcess rdf:resource="#BiochemicalReaction735" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep887">
 <bp:stepProcess rdf:resource="#BiochemicalReaction736" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway97">
 <bp:pathwayOrder rdf:resource="#PathwayStep541" />
 <bp:pathwayOrder rdf:resource="#PathwayStep542" />
 <bp:pathwayOrder rdf:resource="#PathwayStep543" />
 <bp:pathwayOrder rdf:resource="#PathwayStep544" />
 <bp:pathwayOrder rdf:resource="#PathwayStep540" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction444" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction446" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction445" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction448" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction447" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence540" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep888">
 <bp:stepProcess rdf:resource="#BiochemicalReaction737" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway98">
 <bp:pathwayOrder rdf:resource="#PathwayStep549" />
 <bp:pathwayOrder rdf:resource="#PathwayStep546" />
 <bp:pathwayOrder rdf:resource="#PathwayStep547" />
 <bp:pathwayOrder rdf:resource="#PathwayStep548" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction451" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction450" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction452" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction449" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence546" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep889">
 <bp:stepProcess rdf:resource="#BiochemicalReaction738" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway95">
 <bp:pathwayOrder rdf:resource="#PathwayStep534" />
 <bp:pathwayOrder rdf:resource="#PathwayStep535" />
 <bp:pathwayOrder rdf:resource="#PathwayStep536" />
 <bp:pathwayOrder rdf:resource="#PathwayStep537" />
 <bp:pathwayOrder rdf:resource="#PathwayStep533" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction440" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction442" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction441" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction443" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction439" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence533" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence893">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway96">
 <bp:pathwayOrder rdf:resource="#PathwayStep539" />
 <bp:pathwayOrder rdf:resource="#PathwayStep545" />
 <bp:pathwayOrder rdf:resource="#PathwayStep550" />
 <bp:pathwayComponent rdf:resource="#Pathway99" />
 <bp:pathwayComponent rdf:resource="#Pathway97" />
 <bp:pathwayComponent rdf:resource="#Pathway98" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence539" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence892">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway93">
 <bp:pathwayOrder rdf:resource="#PathwayStep538" />
 <bp:pathwayOrder rdf:resource="#PathwayStep528" />
 <bp:pathwayOrder rdf:resource="#PathwayStep532" />
 <bp:pathwayOrder rdf:resource="#PathwayStep560" />
 <bp:pathwayComponent rdf:resource="#Pathway95" />
 <bp:pathwayComponent rdf:resource="#Pathway101" />
 <bp:pathwayComponent rdf:resource="#Pathway96" />
 <bp:pathwayComponent rdf:resource="#Pathway94" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence528" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence891">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway94">
 <bp:pathwayOrder rdf:resource="#PathwayStep529" />
 <bp:pathwayOrder rdf:resource="#PathwayStep530" />
 <bp:pathwayOrder rdf:resource="#PathwayStep531" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction437" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction436" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction438" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence529" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence890">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway91">
 <bp:pathwayOrder rdf:resource="#PathwayStep516" />
 <bp:pathwayOrder rdf:resource="#PathwayStep517" />
 <bp:pathwayOrder rdf:resource="#PathwayStep518" />
 <bp:pathwayOrder rdf:resource="#PathwayStep519" />
 <bp:pathwayOrder rdf:resource="#PathwayStep520" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction429" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction430" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction426" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction428" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction427" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence516" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In plasmacytoid dendritic cell induction of type I IFNs critically depends on IFN regulatory factor 7 in TLR7 and 9 signaling (Honda et al 2005). IRF-7, but not IRF3, interacts with MyD88, TRAF6, and IRAKs and translocates to the nucleus upon phosphorylation (Kawai et al 2004; Uematsu et al 2005).  TLR7/8 signaling was shown to induce IRF5 activation along with IRF7 [Schoenemeyer et al 2005], while IRF8 [Tsujimura H et al 2004] and IRF1 were reported to be implicated in TLR9 signaling.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence897">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway92">
 <bp:pathwayOrder rdf:resource="#PathwayStep527" />
 <bp:pathwayOrder rdf:resource="#PathwayStep589" />
 <bp:pathwayOrder rdf:resource="#PathwayStep600" />
 <bp:pathwayOrder rdf:resource="#PathwayStep569" />
 <bp:pathwayOrder rdf:resource="#PathwayStep570" />
 <bp:pathwayOrder rdf:resource="#PathwayStep595" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction496" />
 <bp:pathwayComponent rdf:resource="#Pathway102" />
 <bp:pathwayComponent rdf:resource="#Pathway93" />
 <bp:pathwayComponent rdf:resource="#Pathway104" />
 <bp:pathwayComponent rdf:resource="#Pathway105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction469" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence527" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 mediates NFkB activation via canonical phosphorylation of IKK complex by TAK1. TRAF6 and TAK1 also regulate MAPK cascades leading to the activation of AP-1.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence896">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence895">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway90">
 <bp:pathwayOrder rdf:resource="#PathwayStep512" />
 <bp:pathwayOrder rdf:resource="#PathwayStep523" />
 <bp:pathwayOrder rdf:resource="#PathwayStep513" />
 <bp:pathwayOrder rdf:resource="#PathwayStep524" />
 <bp:pathwayOrder rdf:resource="#PathwayStep514" />
 <bp:pathwayOrder rdf:resource="#PathwayStep525" />
 <bp:pathwayOrder rdf:resource="#PathwayStep515" />
 <bp:pathwayOrder rdf:resource="#PathwayStep526" />
 <bp:pathwayOrder rdf:resource="#PathwayStep510" />
 <bp:pathwayOrder rdf:resource="#PathwayStep521" />
 <bp:pathwayOrder rdf:resource="#PathwayStep511" />
 <bp:pathwayOrder rdf:resource="#PathwayStep522" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction431" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction422" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction433" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction421" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction432" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction424" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction435" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction423" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction434" />
 <bp:pathwayComponent rdf:resource="#Pathway91" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction425" />
 <bp:pathwayComponent rdf:resource="#Pathway92" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence510" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 dependent cascade initiated on endosome</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Upon binding of their ligands, TLR7/8 and TLR9 recruit a cytoplasmic adaptor MyD88 and IRAKs, downstream of which the signaling pathways are divided to induce either inflammatory cytokines or type I IFNs.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence894">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence899">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence898">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep882">
 <bp:stepProcess rdf:resource="#BiochemicalReaction731" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep883">
 <bp:stepProcess rdf:resource="#BiochemicalReaction732" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep884">
 <bp:stepProcess rdf:resource="#BiochemicalReaction733" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep885">
 <bp:stepProcess rdf:resource="#BiochemicalReaction734" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep880">
 <bp:stepProcess rdf:resource="#BiochemicalReaction729" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep881">
 <bp:stepProcess rdf:resource="#BiochemicalReaction730" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep897">
 <bp:stepProcess rdf:resource="#BiochemicalReaction744" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep898">
 <bp:stepProcess rdf:resource="#Pathway155" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep899">
 <bp:stepProcess rdf:resource="#BiochemicalReaction745" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence882">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence881">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence880">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence886">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence885">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence884">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence883">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence889">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence888">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence887">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep893">
 <bp:stepProcess rdf:resource="#BiochemicalReaction740" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep894">
 <bp:stepProcess rdf:resource="#BiochemicalReaction741" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep895">
 <bp:stepProcess rdf:resource="#BiochemicalReaction742" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep896">
 <bp:stepProcess rdf:resource="#BiochemicalReaction743" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep890">
 <bp:stepProcess rdf:resource="#BiochemicalReaction739" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep891">
 <bp:stepProcess rdf:resource="#Pathway153" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep892">
 <bp:stepProcess rdf:resource="#Pathway154" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep824">
 <bp:stepProcess rdf:resource="#BiochemicalReaction682" />
 <bp:stepProcess rdf:resource="#Catalysis334" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep825">
 <bp:stepProcess rdf:resource="#Pathway144" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep826">
 <bp:stepProcess rdf:resource="#BiochemicalReaction683" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep827">
 <bp:stepProcess rdf:resource="#BiochemicalReaction684" />
 <bp:stepProcess rdf:resource="#Catalysis335" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep820">
 <bp:stepProcess rdf:resource="#Pathway142" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep821">
 <bp:stepProcess rdf:resource="#Pathway143" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep822">
 <bp:stepProcess rdf:resource="#BiochemicalReaction680" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep823">
 <bp:stepProcess rdf:resource="#BiochemicalReaction681" />
 <bp:stepProcess rdf:resource="#Catalysis333" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence871">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence870">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep828">
 <bp:stepProcess rdf:resource="#Catalysis336" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction685" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence875">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep829">
 <bp:stepProcess rdf:resource="#Catalysis337" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction686" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence874">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence873">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence872">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence879">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence878">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence877">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence876">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep835">
 <bp:stepProcess rdf:resource="#Catalysis339" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction690" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep836">
 <bp:stepProcess rdf:resource="#BiochemicalReaction691" />
 <bp:stepProcess rdf:resource="#Catalysis340" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep837">
 <bp:stepProcess rdf:resource="#BiochemicalReaction692" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep838">
 <bp:stepProcess rdf:resource="#Pathway147" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep831">
 <bp:stepProcess rdf:resource="#Pathway145" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep832">
 <bp:stepProcess rdf:resource="#Pathway146" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep833">
 <bp:stepProcess rdf:resource="#BiochemicalReaction688" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep834">
 <bp:stepProcess rdf:resource="#Catalysis338" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction689" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence860">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep839">
 <bp:stepProcess rdf:resource="#BiochemicalReaction693" />
 <bp:stepProcess rdf:resource="#Catalysis341" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence864">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence863">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence862">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence861">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence868">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence867">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence866">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence865">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence869">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep830">
 <bp:stepProcess rdf:resource="#BiochemicalReaction687" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep846">
 <bp:stepProcess rdf:resource="#Catalysis346" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction698" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep847">
 <bp:stepProcess rdf:resource="#Catalysis347" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction699" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep848">
 <bp:stepProcess rdf:resource="#Catalysis348" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction700" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep849">
 <bp:stepProcess rdf:resource="#Catalysis349" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction701" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep842">
 <bp:stepProcess rdf:resource="#Catalysis344" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction696" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep843">
 <bp:stepProcess rdf:resource="#Pathway148" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep844">
 <bp:stepProcess rdf:resource="#BiochemicalReaction697" />
 <bp:stepProcess rdf:resource="#Catalysis345" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep845">
 <bp:stepProcess rdf:resource="#Pathway149" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence853">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence852">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence851">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence850">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence857">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence856">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence855">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence854">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence859">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence858">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep840">
 <bp:stepProcess rdf:resource="#BiochemicalReaction694" />
 <bp:stepProcess rdf:resource="#Catalysis342" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep841">
 <bp:stepProcess rdf:resource="#BiochemicalReaction695" />
 <bp:stepProcess rdf:resource="#Catalysis343" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep857">
 <bp:stepProcess rdf:resource="#BiochemicalReaction708" />
 <bp:stepProcess rdf:resource="#Catalysis355" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep858">
 <bp:stepProcess rdf:resource="#BiochemicalReaction709" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep859">
 <bp:stepProcess rdf:resource="#Catalysis356" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction710" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep853">
 <bp:stepProcess rdf:resource="#Pathway150" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep854">
 <bp:stepProcess rdf:resource="#BiochemicalReaction705" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep855">
 <bp:stepProcess rdf:resource="#BiochemicalReaction706" />
 <bp:stepProcess rdf:resource="#Catalysis353" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep856">
 <bp:stepProcess rdf:resource="#BiochemicalReaction707" />
 <bp:stepProcess rdf:resource="#Catalysis354" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence842">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence841">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence840">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence846">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence845">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence844">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence843">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence849">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence848">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence847">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep850">
 <bp:stepProcess rdf:resource="#BiochemicalReaction702" />
 <bp:stepProcess rdf:resource="#Catalysis350" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep851">
 <bp:stepProcess rdf:resource="#Catalysis351" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction703" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep852">
 <bp:stepProcess rdf:resource="#BiochemicalReaction704" />
 <bp:stepProcess rdf:resource="#Catalysis352" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence952">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence951">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence950">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction13">
 <bp:evidence rdf:resource="#Evidence19" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1/or IRAK2 binds to the activated IRAK4 :oligo MyD88:activated TLR5 or 10 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence956">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1198">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1015" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction12">
 <bp:evidence rdf:resource="#Evidence18" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence955">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1197">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1014" />
 <bp:stepProcess rdf:resource="#Catalysis415" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction15">
 <bp:evidence rdf:resource="#Evidence22" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence954">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction14">
 <bp:evidence rdf:resource="#Evidence20" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation within the complex p-IRAK4:oligo MyD88:activated TLR</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence953">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1199">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1016" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1194">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1011" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence959">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1193">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1010" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction11">
 <bp:evidence rdf:resource="#Evidence17" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence958">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1196">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1013" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction10">
 <bp:evidence rdf:resource="#Evidence16" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence957">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1195">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1012" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction17">
 <bp:evidence rdf:resource="#Evidence25" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction16">
 <bp:evidence rdf:resource="#Evidence23" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction19">
 <bp:evidence rdf:resource="#Evidence27" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction18">
 <bp:evidence rdf:resource="#Evidence26" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1190">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1008" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1192">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1009" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1191">
 <bp:stepProcess rdf:resource="#Pathway184" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence941">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence940">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction24">
 <bp:evidence rdf:resource="#Evidence32" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence945">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1187">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1005" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction23">
 <bp:evidence rdf:resource="#Evidence31" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence944">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1186">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1004" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction26">
 <bp:evidence rdf:resource="#Evidence34" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence943">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1189">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1007" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction25">
 <bp:evidence rdf:resource="#Evidence33" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence942">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1188">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1006" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction20">
 <bp:evidence rdf:resource="#Evidence28" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence949">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1183">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1001" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence948">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1182">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1000" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction22">
 <bp:evidence rdf:resource="#Evidence30" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence947">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1185">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1003" />
 <bp:stepProcess rdf:resource="#Catalysis414" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction21">
 <bp:evidence rdf:resource="#Evidence29" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence946">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1184">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1002" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction28">
 <bp:evidence rdf:resource="#Evidence36" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction27">
 <bp:evidence rdf:resource="#Evidence35" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction29">
 <bp:evidence rdf:resource="#Evidence37" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:Pathway rdf:ID="Pathway15">
 <bp:pathwayOrder rdf:resource="#PathwayStep74" />
 <bp:pathwayOrder rdf:resource="#PathwayStep73" />
 <bp:pathwayOrder rdf:resource="#PathwayStep72" />
 <bp:pathwayOrder rdf:resource="#PathwayStep76" />
 <bp:pathwayOrder rdf:resource="#PathwayStep75" />
 <bp:pathwayOrder rdf:resource="#PathwayStep69" />
 <bp:pathwayOrder rdf:resource="#PathwayStep68" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction57" />
 <bp:pathwayComponent rdf:resource="#Pathway16" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction59" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction58" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction54" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction60" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction61" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence68" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway16">
 <bp:pathwayOrder rdf:resource="#PathwayStep71" />
 <bp:pathwayOrder rdf:resource="#PathwayStep70" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction56" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction55" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence70" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway13">
 <bp:pathwayOrder rdf:resource="#PathwayStep61" />
 <bp:pathwayOrder rdf:resource="#PathwayStep60" />
 <bp:pathwayOrder rdf:resource="#PathwayStep59" />
 <bp:pathwayOrder rdf:resource="#PathwayStep58" />
 <bp:pathwayOrder rdf:resource="#PathwayStep57" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction46" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction45" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction48" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction47" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction49" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence57" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway14">
 <bp:pathwayOrder rdf:resource="#PathwayStep63" />
 <bp:pathwayOrder rdf:resource="#PathwayStep66" />
 <bp:pathwayOrder rdf:resource="#PathwayStep65" />
 <bp:pathwayOrder rdf:resource="#PathwayStep64" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction53" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction52" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction51" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction50" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence63" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway11">
 <bp:pathwayOrder rdf:resource="#PathwayStep52" />
 <bp:pathwayOrder rdf:resource="#PathwayStep51" />
 <bp:pathwayOrder rdf:resource="#PathwayStep50" />
 <bp:pathwayOrder rdf:resource="#PathwayStep54" />
 <bp:pathwayOrder rdf:resource="#PathwayStep53" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction42" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction41" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction44" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction43" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction40" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence50" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway12">
 <bp:pathwayOrder rdf:resource="#PathwayStep62" />
 <bp:pathwayOrder rdf:resource="#PathwayStep56" />
 <bp:pathwayOrder rdf:resource="#PathwayStep67" />
 <bp:pathwayComponent rdf:resource="#Pathway15" />
 <bp:pathwayComponent rdf:resource="#Pathway13" />
 <bp:pathwayComponent rdf:resource="#Pathway14" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence56" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway10">
 <bp:pathwayOrder rdf:resource="#PathwayStep48" />
 <bp:pathwayOrder rdf:resource="#PathwayStep47" />
 <bp:pathwayOrder rdf:resource="#PathwayStep46" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction37" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction39" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction38" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence46" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1181">
 <bp:stepProcess rdf:resource="#BiochemicalReaction999" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1180">
 <bp:stepProcess rdf:resource="#BiochemicalReaction998" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence930">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence934">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1176">
 <bp:stepProcess rdf:resource="#BiochemicalReaction994" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence933">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1175">
 <bp:stepProcess rdf:resource="#BiochemicalReaction993" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence932">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1178">
 <bp:stepProcess rdf:resource="#BiochemicalReaction996" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence931">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1177">
 <bp:stepProcess rdf:resource="#BiochemicalReaction995" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence938">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1172">
 <bp:stepProcess rdf:resource="#BiochemicalReaction990" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence937">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1171">
 <bp:stepProcess rdf:resource="#BiochemicalReaction989" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence936">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1174">
 <bp:stepProcess rdf:resource="#BiochemicalReaction992" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence935">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1173">
 <bp:stepProcess rdf:resource="#BiochemicalReaction991" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence939">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1179">
 <bp:stepProcess rdf:resource="#BiochemicalReaction997" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway26">
 <bp:pathwayOrder rdf:resource="#PathwayStep116" />
 <bp:pathwayOrder rdf:resource="#PathwayStep117" />
 <bp:pathwayOrder rdf:resource="#PathwayStep118" />
 <bp:pathwayOrder rdf:resource="#PathwayStep114" />
 <bp:pathwayOrder rdf:resource="#PathwayStep115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction89" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction93" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction92" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction91" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction90" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence114" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway27">
 <bp:pathwayOrder rdf:resource="#PathwayStep123" />
 <bp:pathwayOrder rdf:resource="#PathwayStep120" />
 <bp:pathwayOrder rdf:resource="#PathwayStep121" />
 <bp:pathwayOrder rdf:resource="#PathwayStep122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction97" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction96" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction95" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction94" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence120" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway24">
 <bp:pathwayOrder rdf:resource="#PathwayStep109" />
 <bp:pathwayOrder rdf:resource="#PathwayStep107" />
 <bp:pathwayOrder rdf:resource="#PathwayStep108" />
 <bp:pathwayOrder rdf:resource="#PathwayStep110" />
 <bp:pathwayOrder rdf:resource="#PathwayStep111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction86" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction85" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction88" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction87" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction84" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence107" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway25">
 <bp:pathwayOrder rdf:resource="#PathwayStep119" />
 <bp:pathwayOrder rdf:resource="#PathwayStep113" />
 <bp:pathwayOrder rdf:resource="#PathwayStep124" />
 <bp:pathwayComponent rdf:resource="#Pathway26" />
 <bp:pathwayComponent rdf:resource="#Pathway27" />
 <bp:pathwayComponent rdf:resource="#Pathway28" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence113" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway22">
 <bp:pathwayOrder rdf:resource="#PathwayStep106" />
 <bp:pathwayOrder rdf:resource="#PathwayStep112" />
 <bp:pathwayOrder rdf:resource="#PathwayStep134" />
 <bp:pathwayOrder rdf:resource="#PathwayStep102" />
 <bp:pathwayComponent rdf:resource="#Pathway24" />
 <bp:pathwayComponent rdf:resource="#Pathway25" />
 <bp:pathwayComponent rdf:resource="#Pathway23" />
 <bp:pathwayComponent rdf:resource="#Pathway30" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence102" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway23">
 <bp:pathwayOrder rdf:resource="#PathwayStep105" />
 <bp:pathwayOrder rdf:resource="#PathwayStep103" />
 <bp:pathwayOrder rdf:resource="#PathwayStep104" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction82" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction81" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction83" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence103" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway20">
 <bp:pathwayOrder rdf:resource="#PathwayStep194" />
 <bp:pathwayOrder rdf:resource="#PathwayStep99" />
 <bp:pathwayOrder rdf:resource="#PathwayStep100" />
 <bp:pathwayComponent rdf:resource="#Pathway21" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction158" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction80" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence99" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88-independent TLR4 cascade </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The MyD88-independent signaling pathway is shared by TLR3 and TLR4 cascades. TIR-domain-containing adapter-inducing interferon-beta (TRIF or TICAM1) is a key adapter molecule in transducing signals from TLR3 and TLR4 in a MyD88-independent manner (Yamamoto M et al. 2003a). TRIF is recruited to the ligand-stimulated TLR3 or 4 complex via its TIR domain. TLR3 directly binds TRIF (Oshiumi H et al 2003). In contrast, the TLR4-mediated signaling pathway requires two adapter molecules, TRAM (TRIF-related adapter molecule or TICAM2) and TRIF. TRAM(TICAM2) is thought to bridge the activated TLR4 complex and TRIF (Yamamoto M et al. 2003b, Tanimura N et al. 2008, Kagan LC et al. 2008). TRIF recruitment to the TLR complex stimulates distinct pathways leading to the production of type I interferons (IFNs) and pro-inflammatory cytokines and to the induction of programmed cell death.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway21">
 <bp:pathwayOrder rdf:resource="#PathwayStep183" />
 <bp:pathwayOrder rdf:resource="#PathwayStep162" />
 <bp:pathwayOrder rdf:resource="#PathwayStep190" />
 <bp:pathwayOrder rdf:resource="#PathwayStep101" />
 <bp:pathwayOrder rdf:resource="#PathwayStep143" />
 <bp:pathwayOrder rdf:resource="#PathwayStep166" />
 <bp:pathwayComponent rdf:resource="#Pathway37" />
 <bp:pathwayComponent rdf:resource="#Pathway36" />
 <bp:pathwayComponent rdf:resource="#Pathway22" />
 <bp:pathwayComponent rdf:resource="#Pathway33" />
 <bp:pathwayComponent rdf:resource="#Pathway34" />
 <bp:pathwayComponent rdf:resource="#Pathway31" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence101" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIF (TICAM1)-mediated TLR4 signaling </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIF (TICAM1) was shown to induce IRF3/7 and NF-kappa-B activation as well as apoptosis through distinct intracellular signaling pathways (Yamamoto M et al., 2003; Fitzgerald KA et al., 2003; Han KJ et al., 2004; Kaiser WJ    Offermann MK 2005).  TRIF consists of an N-terminal domain (NTD) (1-153), an intermediate disordered proline-rich region, a TIR domain, and a C-terminal region (Mahita J    Sowdhamin R 2017). The disordered proline-rich region between NTD domain and the TIR domain of TICAM1 contains binding sites for TRAF (TNF receptor associated factor) family proteins, which, in turn, recruit protein kinases to promote activation of IRF3 and/or NF-kappa-B (Sato S et al., 2003; Fitzgerald KA et al., 2003). The C-terminal region of TICAM1 (TRIF) can recruit receptor-interacting serine/threonine-protein kinase 1 (RIPK1), and this event is followed by the activation of the IKK complex or the induction of programmed cell death (Han KJ et al., 2004; Kaiser WJ    Offermann MK 2005).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1170">
 <bp:stepProcess rdf:resource="#BiochemicalReaction988" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence923">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1165">
 <bp:stepProcess rdf:resource="#BiochemicalReaction984" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence922">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1164">
 <bp:stepProcess rdf:resource="#BiochemicalReaction983" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence921">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1167">
 <bp:stepProcess rdf:resource="#Catalysis412" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction985" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence920">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1166">
 <bp:stepProcess rdf:resource="#Pathway183" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence927">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1161">
 <bp:stepProcess rdf:resource="#BiochemicalReaction980" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence926">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1160">
 <bp:stepProcess rdf:resource="#BiochemicalReaction979" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence925">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1163">
 <bp:stepProcess rdf:resource="#BiochemicalReaction982" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence924">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1162">
 <bp:stepProcess rdf:resource="#BiochemicalReaction981" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence929">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence928">
</bp:Evidence>

<bp:Pathway rdf:ID="Pathway19">
 <bp:pathwayOrder rdf:resource="#PathwayStep291" />
 <bp:pathwayOrder rdf:resource="#PathwayStep292" />
 <bp:pathwayOrder rdf:resource="#PathwayStep293" />
 <bp:pathwayOrder rdf:resource="#PathwayStep195" />
 <bp:pathwayOrder rdf:resource="#PathwayStep294" />
 <bp:pathwayOrder rdf:resource="#PathwayStep98" />
 <bp:pathwayOrder rdf:resource="#PathwayStep290" />
 <bp:pathwayOrder rdf:resource="#PathwayStep198" />
 <bp:pathwayOrder rdf:resource="#PathwayStep199" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction161" />
 <bp:pathwayComponent rdf:resource="#Pathway38" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction240" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction242" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction241" />
 <bp:pathwayComponent rdf:resource="#Pathway20" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction239" />
 <bp:pathwayComponent rdf:resource="#Pathway39" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence98" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 4 (TLR4) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR4 is unique among the TLR family in its ability to recruit four adapters to activate two distinct signaling pathways. One pathway is activated by the pair of the adapters  Mal or TIRAP (Toll/interleukin-1-receptor (TIR)-domain-containing adapter protein) and MyD88, which leads to the NFkB activation and the induction of pro-inflammatory cytokines. The second pathway is activated by the adapters TRIF (TIR-domain-containing adapter protein inducing interferon-beta) and TRAM (TRIF-related adapter molecule). The combined use of TRIF and TRAM adapters is specific for TLR4 signaling pathway and leads to the induction of type I interferons  and delayed activation of NFkB. The previous model of TLR4 signaling pathway described the simultaneous activation of these two signaling pathways at the plasma membrane, however the later studies suggested that upon activation TLR4 first induces TIRAP-MyD88 signaling at the plasma membrane and is then endocytosed and activates TRAM-TRIF signaling from the early endosome [Kagan JC et al 2008; Tanimura N et al 2008; Zanoni I et al 2011].
Toll-like Receptor 4 is a microbe associated molecular pattern receptor well known for it&apos;s sensitivity to bacterial lipopolysaccharides (LPS). LPS is assembled within diverse Gram-negative bacteria, many of which are human or plant pathogens. It is a component of the outer membrane of Gram-negative bacteria and consists of lipid A, a core polysaccharide and an O-polysaccharide of variable length (often more than 50 monosaccharide units). LPS is a potent activator of the innate immune response in humans, causing reactions including fever, headache, nausea, diarrhoea, changes in leukocyte and platelet counts, disseminated intravascular coagulation, multiorgan failure, shock and death. All these reactions are induced by cytokines and other endogenous mediators which are produced after interaction of LPS with the humoral and cellular targets of the host. In macrophages and dendritic cells, LPS-mediated activation of TLR4 triggers the biosynthesis of diverse mediators of inflammation, such as TNF-alpha and IL6, and activates the production of co-stimulatory molecules required for the adaptive immune response. In mononuclear and endothelial cells, LPS also stimulates tissue factor production. These events are desirable for clearing local infections, but when these various mediators and clotting factors are overproduced, they can damage small blood vessels and precipitate shock accompanied by disseminated intravascular coagulation and multiple organ failure.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1169">
 <bp:stepProcess rdf:resource="#BiochemicalReaction987" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1168">
 <bp:stepProcess rdf:resource="#Catalysis413" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction986" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway17">
 <bp:pathwayOrder rdf:resource="#PathwayStep85" />
 <bp:pathwayOrder rdf:resource="#PathwayStep84" />
 <bp:pathwayOrder rdf:resource="#PathwayStep83" />
 <bp:pathwayOrder rdf:resource="#PathwayStep82" />
 <bp:pathwayOrder rdf:resource="#PathwayStep78" />
 <bp:pathwayOrder rdf:resource="#PathwayStep79" />
 <bp:pathwayOrder rdf:resource="#PathwayStep81" />
 <bp:pathwayOrder rdf:resource="#PathwayStep80" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction68" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction67" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction69" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction64" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction63" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction66" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction65" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction62" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence78" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway18">
 <bp:pathwayOrder rdf:resource="#PathwayStep95" />
 <bp:pathwayOrder rdf:resource="#PathwayStep94" />
 <bp:pathwayOrder rdf:resource="#PathwayStep93" />
 <bp:pathwayOrder rdf:resource="#PathwayStep92" />
 <bp:pathwayOrder rdf:resource="#PathwayStep91" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction78" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction75" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction74" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction77" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction76" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence91" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway37">
 <bp:pathwayOrder rdf:resource="#PathwayStep192" />
 <bp:pathwayOrder rdf:resource="#PathwayStep193" />
 <bp:pathwayOrder rdf:resource="#PathwayStep191" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction156" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction157" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence191" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKK complex recruitment mediated by RIP1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor-interacting protein 1 (RIP1) mediates the activation of proinflammatory cytokines via intermediate induction of IKK complex in NFkB pathways [Ea et al. 2006]. Poly(I-C) treatment stimulated the recruitment of RIP1, TRAF6, and TAK1 to the TLR3 receptor complex in human embryonic kidney HEK293 transfected with FLAG-tagged TLR3 [Cusson-Hermance et al. 2005]. RIP1 was shown to be dispensable for TRIF-dependent activation of IRF3, which occurs in a TRIF/TBK1/IKKi-dependent manner [Cusson-Hermance et al. 2005, Sato et al. 2003]</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway38">
 <bp:pathwayOrder rdf:resource="#PathwayStep196" />
 <bp:pathwayOrder rdf:resource="#PathwayStep197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction160" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction159" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence196" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Transfer of LPS from LBP carrier to CD14</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LBP delivers LPS from bacteria (or bacterial membrane fragments) to CD14 on the surfaces of phagocytes, where it is recognised by the MD2:TLR4 complex . Thus, LBP is an opsonin and CD14 is an opsonic receptor for complexes of LPS (or LPS-containing particles such as bacteria) and LBP. CD14 exists as two isoforms. CD14 can be either secreted into the extracellular compartment, or it can be anchored to the plasma membrane via its GPI module.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway35">
 <bp:pathwayOrder rdf:resource="#PathwayStep181" />
 <bp:pathwayOrder rdf:resource="#PathwayStep180" />
 <bp:pathwayOrder rdf:resource="#PathwayStep179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction145" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction147" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction146" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence179" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TBK1, IKK&#949; (IKBKE)-mediated activation of IRF3, IRF7 </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Production of type I IFN genes in response to Toll-like receptor 3 (TLR3) and TLR4 ligands is mediated by TANK-binding kinase 1 (TBK1) or I-kappa-B kinase epsilon (IKK&#949;, IKBKE), which phosphorylate IFN regulatory factor 3 (IRF3) and IRF7. The activity of TBK1 and/or IRF3, IRF7 is regulated by multiple mechanisms including post-translational modifications, protein-protein interactions, and protein degradation (Zhao W et al., 2013; Runde AP et al., 2022).  This Reactome module describes regulation of TBK1, IKK&#949; activity by K63-linked ubiquitination of TBK1 and IKK&#949;, and TBK1 interaction with OPTN.  .</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway36">
 <bp:pathwayOrder rdf:resource="#PathwayStep184" />
 <bp:pathwayOrder rdf:resource="#PathwayStep189" />
 <bp:pathwayOrder rdf:resource="#PathwayStep185" />
 <bp:pathwayOrder rdf:resource="#PathwayStep186" />
 <bp:pathwayOrder rdf:resource="#PathwayStep187" />
 <bp:pathwayOrder rdf:resource="#PathwayStep188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction150" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction152" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction151" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction154" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction153" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction149" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence184" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6-mediated induction of TAK1 complex within TLR4 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In human, together with ubiquitin-conjugating E2-type enzymes UBC13 and UEV1A (also known as UBE2V1), TRAF6 catalyses Lys63-linked ubiquitination. It is believed that auto polyubiquitination  and oligomerization of TRAF6 is followed by binding the ubiquitin receptors of TAB2 or TAB3 (TAK1 binding protein 2 and 3), which stimulates phosphorylation and activation of TGF beta-activated kinase 1(TAK1). TAK1 phosphorylates IKK alpha and IKK beta, which in turn phosphorylate NF-kB inhibitors - IkB  and eventually results in IkB degradation and NF-kB translocation to the nucleus. Also TAK1 mediates JNK and p38 MAP kinases activation by phosphorylating MKK4/7 and MKK3/6 respectivly resulting in the activation of many transcription factors.  The role of TRAF6 is somewhat controversial and probably cell type specific. TRAF6 autoubiquitination was found to be dispensable for TRAF6 function to activate TAK1 pathway. These findings are consistent with the new mechanism of TRAF6-mediated NF-kB activation that was suggested by Xia et al. (2009). TRAF6 generates unanchored Lys63-linked polyubiquitin chains that bind to the regulatory subunits of TAK1 (TAB2 or TAB3) and IKK(NEMO), leading to the activation of the kinases.  Xia et al. (2009) demonstrated in vitro that unlike polyubiquitin chains covalently attached to TRAF6 or IRAK, TAB2 and NEMO-associated ubiquitin chains were found to be unanchored and susceptible to N-terminal ubiquitin cleavage. Only K63-linked polyubiquitin chains, but not monomeric ubiquitin, activated TAK1 in a dose-dependent manner. Optimal activation of the IKK complex was achieved using ubiquitin polymers containing both K48 and K63 linkages. Furthermore, the authors proposed that the TAK1 complexes might be brougt in close proximity by binding several TAB2/3 to a single polyubiquitin chain to facilitate TAK1 kinase trans-phosphorylation. Alternativly, the possibility that polyUb binding promotes allosteric activation of TAK1 complex should  be considered (Walsh et al 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway33">
 <bp:pathwayOrder rdf:resource="#PathwayStep163" />
 <bp:pathwayOrder rdf:resource="#PathwayStep164" />
 <bp:pathwayOrder rdf:resource="#PathwayStep165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction132" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction131" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction133" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence163" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRIF-mediated programmed cell death</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR3 and -4 trigger TRIF-dependent programmed cell death in various human and mouse cells (Kalai M et al. 2002; Han KJ et al. 2004; Kaiser WJ and Offermann MK 2005; Estornes Y et al. 2012; He S et al. 2011). Apoptosis is a prevalent form of programmed cell death and is mediated by the activation of a set of caspases. In addition to apoptosis, TLR3/TLR4 activation induces RIP3-dependent necroptosis. These two programmed cell-death pathways may suppress each other. When the caspase activity is impaired or inhibited, certain cell types switch the apoptotic death program to necroptosis in response to various stimuli (TNF, Fas, viral infection and other stress stimuli) (Kalai M et al. 2002; Weber A et al. 2010; Feoktistova M et al. 2011, Tenev et al 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep787">
 <bp:stepProcess rdf:resource="#Pathway139" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway34">
 <bp:pathwayOrder rdf:resource="#PathwayStep170" />
 <bp:pathwayOrder rdf:resource="#PathwayStep171" />
 <bp:pathwayOrder rdf:resource="#PathwayStep182" />
 <bp:pathwayOrder rdf:resource="#PathwayStep172" />
 <bp:pathwayOrder rdf:resource="#PathwayStep173" />
 <bp:pathwayOrder rdf:resource="#PathwayStep167" />
 <bp:pathwayOrder rdf:resource="#PathwayStep178" />
 <bp:pathwayOrder rdf:resource="#PathwayStep168" />
 <bp:pathwayOrder rdf:resource="#PathwayStep169" />
 <bp:pathwayOrder rdf:resource="#PathwayStep174" />
 <bp:pathwayOrder rdf:resource="#PathwayStep175" />
 <bp:pathwayOrder rdf:resource="#PathwayStep176" />
 <bp:pathwayOrder rdf:resource="#PathwayStep177" />
 <bp:pathwayComponent rdf:resource="#Pathway35" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction136" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction135" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction138" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction137" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction148" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction139" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction141" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction140" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction143" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction134" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction144" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence167" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of IRF3, IRF7 mediated by TBK1, IKK&#949; (IKBKE)</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cell stimulation with viral double-stranded (ds) RNA and bacterial lipopolysaccharide (LPS) activate Toll-like receptors 3 (TLR3) and TLR4, respectively, triggering the activation the activation of two IKK-related serine/threonine kinases, TANK-binding kinase 1 (TBK1) and I&#954;B kinase &#949; (IKK&#949;, IKBKE) which directly phosphorylate interferon regulatory factor 3 (IRF3) and IRF7 promoting their dimerization and translocation into the nucleus. Although both kinases show structural and functional similarities, it seems that TBK1 and IKBKE differ in their regulation of downstream signaling events of TLR3/TLR4.  IRF3 activation and interferon &#946; (IFN&#946;) production by poly(I:C), a synthetic analog of dsRNA, are decreased in TBK1-deficient mouse fibroblasts, whereas normal activation was observed in the IKBKE-deficient fibroblasts. However, in double-deficient mouse fibroblasts, the activation of IRF3 is completely abolished, suggesting a partially redundant functions of TBK1 and IKK&#949; (IKBKE) (Hemmi H et al., 2004).  The poly(I:C)-induced phosphorylation of TBK1 and IRF3 was abolished in TRIF (TICAM1)-knockout human keratinocyte HACAT cells (Bakshi S et al., 2017). TICAM1 is utilized as an adaptor protein by TLR3 and TLR4 (Yamamoto M et al., 2003).  TLR3 recruits and activates PI3 kinase (PI3K), which activates the downstream kinase, Akt, leading to full phosphorylation and activation of IRF3 (Sarkar SN et al., 2004). When PI3K is not recruited to TLR3 or its activity is blocked, IRF3 is only partially phosphorylated and fails to bind the promoter of the target gene (Sarkar SN et al., 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep788">
 <bp:stepProcess rdf:resource="#BiochemicalReaction650" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway31">
 <bp:pathwayOrder rdf:resource="#PathwayStep160" />
 <bp:pathwayOrder rdf:resource="#PathwayStep161" />
 <bp:pathwayOrder rdf:resource="#PathwayStep145" />
 <bp:pathwayOrder rdf:resource="#PathwayStep146" />
 <bp:pathwayOrder rdf:resource="#PathwayStep158" />
 <bp:pathwayOrder rdf:resource="#PathwayStep159" />
 <bp:pathwayOrder rdf:resource="#PathwayStep144" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction130" />
 <bp:pathwayComponent rdf:resource="#Pathway32" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction114" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction127" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction115" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction129" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction128" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence144" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep789">
 <bp:stepProcess rdf:resource="#BiochemicalReaction651" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway32">
 <bp:pathwayOrder rdf:resource="#PathwayStep150" />
 <bp:pathwayOrder rdf:resource="#PathwayStep151" />
 <bp:pathwayOrder rdf:resource="#PathwayStep149" />
 <bp:pathwayOrder rdf:resource="#PathwayStep156" />
 <bp:pathwayOrder rdf:resource="#PathwayStep157" />
 <bp:pathwayOrder rdf:resource="#PathwayStep147" />
 <bp:pathwayOrder rdf:resource="#PathwayStep148" />
 <bp:pathwayOrder rdf:resource="#PathwayStep152" />
 <bp:pathwayOrder rdf:resource="#PathwayStep153" />
 <bp:pathwayOrder rdf:resource="#PathwayStep154" />
 <bp:pathwayOrder rdf:resource="#PathwayStep155" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction121" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction120" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction123" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction122" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction125" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction124" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction116" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction126" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction118" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction117" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction119" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence147" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway30">
 <bp:pathwayOrder rdf:resource="#PathwayStep140" />
 <bp:pathwayOrder rdf:resource="#PathwayStep138" />
 <bp:pathwayOrder rdf:resource="#PathwayStep139" />
 <bp:pathwayOrder rdf:resource="#PathwayStep135" />
 <bp:pathwayOrder rdf:resource="#PathwayStep136" />
 <bp:pathwayOrder rdf:resource="#PathwayStep137" />
 <bp:pathwayOrder rdf:resource="#PathwayStep141" />
 <bp:pathwayOrder rdf:resource="#PathwayStep142" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction110" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction112" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction111" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction113" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction107" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction106" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction109" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction108" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence135" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence912">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1154">
 <bp:stepProcess rdf:resource="#Pathway180" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence911">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1153">
 <bp:stepProcess rdf:resource="#BiochemicalReaction975" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence910">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1156">
 <bp:stepProcess rdf:resource="#Catalysis411" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction977" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1155">
 <bp:stepProcess rdf:resource="#BiochemicalReaction976" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence916">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1150">
 <bp:stepProcess rdf:resource="#BiochemicalReaction972" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence915">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence914">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1152">
 <bp:stepProcess rdf:resource="#BiochemicalReaction974" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence913">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1151">
 <bp:stepProcess rdf:resource="#BiochemicalReaction973" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep783">
 <bp:stepProcess rdf:resource="#Pathway137" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep784">
 <bp:stepProcess rdf:resource="#BiochemicalReaction648" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence919">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep785">
 <bp:stepProcess rdf:resource="#Pathway138" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence918">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep786">
 <bp:stepProcess rdf:resource="#BiochemicalReaction649" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence917">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1158">
 <bp:stepProcess rdf:resource="#BiochemicalReaction978" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep780">
 <bp:stepProcess rdf:resource="#Catalysis317" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction645" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1157">
 <bp:stepProcess rdf:resource="#Pathway181" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway28">
 <bp:pathwayOrder rdf:resource="#PathwayStep129" />
 <bp:pathwayOrder rdf:resource="#PathwayStep125" />
 <bp:pathwayOrder rdf:resource="#PathwayStep126" />
 <bp:pathwayOrder rdf:resource="#PathwayStep130" />
 <bp:pathwayOrder rdf:resource="#PathwayStep131" />
 <bp:pathwayOrder rdf:resource="#PathwayStep132" />
 <bp:pathwayOrder rdf:resource="#PathwayStep133" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction101" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction98" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction103" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction102" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction105" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction104" />
 <bp:pathwayComponent rdf:resource="#Pathway29" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence125" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep781">
 <bp:stepProcess rdf:resource="#Catalysis318" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction646" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway29">
 <bp:pathwayOrder rdf:resource="#PathwayStep127" />
 <bp:pathwayOrder rdf:resource="#PathwayStep128" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction99" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction100" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence127" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep782">
 <bp:stepProcess rdf:resource="#BiochemicalReaction647" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1159">
 <bp:stepProcess rdf:resource="#Pathway182" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway48">
 <bp:pathwayOrder rdf:resource="#PathwayStep255" />
 <bp:pathwayOrder rdf:resource="#PathwayStep256" />
 <bp:pathwayOrder rdf:resource="#PathwayStep253" />
 <bp:pathwayOrder rdf:resource="#PathwayStep254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction209" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction206" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction208" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction207" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence253" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway49">
 <bp:pathwayOrder rdf:resource="#PathwayStep259" />
 <bp:pathwayOrder rdf:resource="#PathwayStep266" />
 <bp:pathwayOrder rdf:resource="#PathwayStep258" />
 <bp:pathwayOrder rdf:resource="#PathwayStep262" />
 <bp:pathwayOrder rdf:resource="#PathwayStep263" />
 <bp:pathwayOrder rdf:resource="#PathwayStep264" />
 <bp:pathwayOrder rdf:resource="#PathwayStep265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction213" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction215" />
 <bp:pathwayComponent rdf:resource="#Pathway50" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction214" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction217" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction216" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence258" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway46">
 <bp:pathwayOrder rdf:resource="#PathwayStep246" />
 <bp:pathwayOrder rdf:resource="#PathwayStep257" />
 <bp:pathwayOrder rdf:resource="#PathwayStep252" />
 <bp:pathwayComponent rdf:resource="#Pathway48" />
 <bp:pathwayComponent rdf:resource="#Pathway49" />
 <bp:pathwayComponent rdf:resource="#Pathway47" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence246" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway47">
 <bp:pathwayOrder rdf:resource="#PathwayStep250" />
 <bp:pathwayOrder rdf:resource="#PathwayStep248" />
 <bp:pathwayOrder rdf:resource="#PathwayStep249" />
 <bp:pathwayOrder rdf:resource="#PathwayStep247" />
 <bp:pathwayOrder rdf:resource="#PathwayStep251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction202" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction201" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction204" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction205" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence247" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway44">
 <bp:pathwayOrder rdf:resource="#PathwayStep237" />
 <bp:pathwayOrder rdf:resource="#PathwayStep238" />
 <bp:pathwayOrder rdf:resource="#PathwayStep236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction194" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction193" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction195" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence236" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep798">
 <bp:stepProcess rdf:resource="#BiochemicalReaction658" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway45">
 <bp:pathwayOrder rdf:resource="#PathwayStep244" />
 <bp:pathwayOrder rdf:resource="#PathwayStep240" />
 <bp:pathwayOrder rdf:resource="#PathwayStep241" />
 <bp:pathwayOrder rdf:resource="#PathwayStep242" />
 <bp:pathwayOrder rdf:resource="#PathwayStep243" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction196" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction198" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction197" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction200" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction199" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence240" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep799">
 <bp:stepProcess rdf:resource="#BiochemicalReaction659" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway42">
 <bp:pathwayOrder rdf:resource="#PathwayStep219" />
 <bp:pathwayOrder rdf:resource="#PathwayStep215" />
 <bp:pathwayOrder rdf:resource="#PathwayStep216" />
 <bp:pathwayOrder rdf:resource="#PathwayStep217" />
 <bp:pathwayOrder rdf:resource="#PathwayStep218" />
 <bp:pathwayOrder rdf:resource="#PathwayStep211" />
 <bp:pathwayOrder rdf:resource="#PathwayStep212" />
 <bp:pathwayOrder rdf:resource="#PathwayStep213" />
 <bp:pathwayOrder rdf:resource="#PathwayStep214" />
 <bp:pathwayOrder rdf:resource="#PathwayStep220" />
 <bp:pathwayOrder rdf:resource="#PathwayStep210" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction172" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction171" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction174" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction173" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction176" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction175" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction178" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction177" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction169" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction179" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction170" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence210" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway43">
 <bp:pathwayOrder rdf:resource="#PathwayStep239" />
 <bp:pathwayOrder rdf:resource="#PathwayStep245" />
 <bp:pathwayOrder rdf:resource="#PathwayStep267" />
 <bp:pathwayOrder rdf:resource="#PathwayStep235" />
 <bp:pathwayComponent rdf:resource="#Pathway46" />
 <bp:pathwayComponent rdf:resource="#Pathway44" />
 <bp:pathwayComponent rdf:resource="#Pathway45" />
 <bp:pathwayComponent rdf:resource="#Pathway51" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence235" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway40">
 <bp:pathwayOrder rdf:resource="#PathwayStep204" />
 <bp:pathwayOrder rdf:resource="#PathwayStep205" />
 <bp:pathwayOrder rdf:resource="#PathwayStep202" />
 <bp:pathwayOrder rdf:resource="#PathwayStep203" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction163" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction165" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction164" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction166" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence202" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 recruits IKK complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The role of IRAK1 kinase activity in the activation of NF-kappa-B by IL-1/TLR  is still uncertain. It has been shown that a kinase-dead IRAK1 mutants can still activate NF-kappa-B. Furthermore, stimulation of IRAK1-deficient I1A 293 cells with LMP1 (latent membrane protein 1- a known viral activator of NF-kappa-B) leads to TRAF6 polyubiquitination and IKKbeta activation [Song et al 2006]. On the other hand, IRAK1 enhances p65 Ser536 phosphorylation [Song et al 2006] and p65 binding to the promoter of NF-kappa-B dependent target genes [Liu G et al 2008].  IRAK1 has also been shown to be itself Lys63-polyubiquitinated (probably by Pellino proteins, which have E3 ligase activity). Mutation of the ubiquitination sites on IRAK1 prevented interaction with the NEMO subunit of IKK complex and subsequent IL-1/TLR-induced NF-kappa-B activation [Conze et al 2008]. These data suggest that kinase activity of IRAK1 is not essential for its ability to activate NF-kappa-B, while its Lys63-polyubuquitination allows IRAK1 to bind NEMO thus facilitating association of TRAF6 and TAK1 complex with IKK complex followed by induction of NF-kappa-B.   Upon IL-1/TLR stimulation IRAK1 protein can undergo covalent modifications including phosphorylation [Kollewe et al 2004], ubiquitination [Conze DB et al 2008] and sumoylation [Huang et al 2004]. Depending upon the nature of its modification, IRAK1 may perform distinct functions including activation of IRF5/7 [Uematsu et al 2005, Schoenemeyer et al 2005], NF-kappa-B [Song et al 2006], and Stat1/3 [Huang et al 2004, Nguyen et al 2003].</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway41">
 <bp:pathwayOrder rdf:resource="#PathwayStep208" />
 <bp:pathwayOrder rdf:resource="#PathwayStep209" />
 <bp:pathwayOrder rdf:resource="#PathwayStep207" />
 <bp:pathwayOrder rdf:resource="#PathwayStep222" />
 <bp:pathwayOrder rdf:resource="#PathwayStep223" />
 <bp:pathwayOrder rdf:resource="#PathwayStep224" />
 <bp:pathwayOrder rdf:resource="#PathwayStep221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction183" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction182" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction167" />
 <bp:pathwayComponent rdf:resource="#Pathway42" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction168" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction181" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction180" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence207" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Evidence rdf:ID="Evidence901">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1143">
 <bp:stepProcess rdf:resource="#BiochemicalReaction965" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence900">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1142">
 <bp:stepProcess rdf:resource="#Catalysis408" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction964" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1145">
 <bp:stepProcess rdf:resource="#BiochemicalReaction967" />
 <bp:stepProcess rdf:resource="#Catalysis409" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1144">
 <bp:stepProcess rdf:resource="#BiochemicalReaction966" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence905">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence904">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence903">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1141">
 <bp:stepProcess rdf:resource="#BiochemicalReaction963" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence902">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep1140">
 <bp:stepProcess rdf:resource="#BiochemicalReaction962" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep794">
 <bp:stepProcess rdf:resource="#BiochemicalReaction655" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence909">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep795">
 <bp:stepProcess rdf:resource="#Pathway141" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence908">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep796">
 <bp:stepProcess rdf:resource="#BiochemicalReaction656" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence907">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep797">
 <bp:stepProcess rdf:resource="#Catalysis321" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction657" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence906">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep790">
 <bp:stepProcess rdf:resource="#Catalysis319" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction652" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1147">
 <bp:stepProcess rdf:resource="#BiochemicalReaction969" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep791">
 <bp:stepProcess rdf:resource="#BiochemicalReaction653" />
 <bp:stepProcess rdf:resource="#Catalysis320" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1146">
 <bp:stepProcess rdf:resource="#BiochemicalReaction968" />
 <bp:stepProcess rdf:resource="#Catalysis410" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway39">
 <bp:pathwayOrder rdf:resource="#PathwayStep226" />
 <bp:pathwayOrder rdf:resource="#PathwayStep227" />
 <bp:pathwayOrder rdf:resource="#PathwayStep206" />
 <bp:pathwayOrder rdf:resource="#PathwayStep228" />
 <bp:pathwayOrder rdf:resource="#PathwayStep229" />
 <bp:pathwayOrder rdf:resource="#PathwayStep280" />
 <bp:pathwayOrder rdf:resource="#PathwayStep281" />
 <bp:pathwayOrder rdf:resource="#PathwayStep282" />
 <bp:pathwayOrder rdf:resource="#PathwayStep283" />
 <bp:pathwayOrder rdf:resource="#PathwayStep200" />
 <bp:pathwayOrder rdf:resource="#PathwayStep233" />
 <bp:pathwayOrder rdf:resource="#PathwayStep277" />
 <bp:pathwayOrder rdf:resource="#PathwayStep201" />
 <bp:pathwayOrder rdf:resource="#PathwayStep234" />
 <bp:pathwayOrder rdf:resource="#PathwayStep278" />
 <bp:pathwayOrder rdf:resource="#PathwayStep279" />
 <bp:pathwayOrder rdf:resource="#PathwayStep225" />
 <bp:pathwayOrder rdf:resource="#PathwayStep284" />
 <bp:pathwayOrder rdf:resource="#PathwayStep230" />
 <bp:pathwayOrder rdf:resource="#PathwayStep231" />
 <bp:pathwayOrder rdf:resource="#PathwayStep232" />
 <bp:pathwayOrder rdf:resource="#PathwayStep276" />
 <bp:pathwayComponent rdf:resource="#Pathway43" />
 <bp:pathwayComponent rdf:resource="#Pathway40" />
 <bp:pathwayComponent rdf:resource="#Pathway41" />
 <bp:pathwayComponent rdf:resource="#Pathway52" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction226" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction228" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction227" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction229" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction185" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction162" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction184" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction187" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction231" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction186" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction230" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction189" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction233" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction188" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction232" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction190" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction192" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction191" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence200" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88:MAL(TIRAP) cascade initiated on plasma membrane</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The first known downstream component of TLR4 and TLR2 signaling is the adaptor MyD88. Another adapter MyD88-adaptor-like (Mal; also known as TIR-domain-containing adaptor protein or TIRAP) has also been described for TLR4 and TLR2 signaling. MyD88 comprises an N-terminal Death Domain (DD) and a C-terminal TIR, whereas Mal lacks the DD. The TIR homotypic interactions bring adapters into contact with the activated TLRs, whereas the DD modules recruit serine/threonine kinases such as interleukin-1-receptor-associated kinase (IRAK). Recruitment of these protein kinases is accompanied by phosphorylation, which in turn results in the interaction of IRAKs with TNF-receptor-associated factor 6 (TRAF6). The oligomerization of TRAF6 activates TAK1, a member of the MAP3-kinase family, and this leads to the activation of the IkB kinases. These kinases, in turn, phosphorylate IkB, leading to its proteolytic degradation and the translocation of NF-kB to the nucleus. Concomitantly, members of the activator protein-1 (AP-1) transcription factor family, Jun and Fos, are activated, and both AP-1 transcription factors and NF-kB are required for cytokine production, which in turn produces downstream inflammatory effects.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep792">
 <bp:stepProcess rdf:resource="#Pathway140" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1149">
 <bp:stepProcess rdf:resource="#BiochemicalReaction971" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep793">
 <bp:stepProcess rdf:resource="#BiochemicalReaction654" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1148">
 <bp:stepProcess rdf:resource="#BiochemicalReaction970" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway59">
 <bp:pathwayOrder rdf:resource="#PathwayStep318" />
 <bp:pathwayOrder rdf:resource="#PathwayStep315" />
 <bp:pathwayOrder rdf:resource="#PathwayStep316" />
 <bp:pathwayOrder rdf:resource="#PathwayStep317" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction260" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction257" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction259" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction258" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence315" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CREB phosphorylation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nerve growth factor (NGF) activates multiple signalling pathways that mediate the phosphorylation of CREB at the critical regulatory site, serine 133. CREB phosphorylation at serine 133 is a crucial event in neurotrophin signalling, being mediated by ERK/RSK, ERK/MSK1 and p38/MAPKAPK2 pathways. Several kinases, such as MSK1, RSK1/2/3 (MAPKAPK1A/B/C), and MAPKAPK2, are able to directly phosphorylate CREB at S133. MSK1 is also able to activate ATF (Cyclic-AMP-dependent transcription factor). However, the NGF-induced CREB phosphorylation appears to correlate better with activation of MSK1 rather than RSK1/2/3, or MAPKAPK2. In retrograde signalling, activation of CREB occurs within 20 minutes after neurotrophin stimulation of distal axons.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway57">
 <bp:pathwayOrder rdf:resource="#PathwayStep308" />
 <bp:pathwayOrder rdf:resource="#PathwayStep319" />
 <bp:pathwayOrder rdf:resource="#PathwayStep314" />
 <bp:pathwayComponent rdf:resource="#Pathway59" />
 <bp:pathwayComponent rdf:resource="#Pathway58" />
 <bp:pathwayComponent rdf:resource="#Pathway60" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence308" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPK targets/ Nuclear events mediated by MAP kinases</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.   The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and  also AP-1 components c-Jun and c-Fos.  Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.  Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).  JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK.  Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway58">
 <bp:pathwayOrder rdf:resource="#PathwayStep309" />
 <bp:pathwayOrder rdf:resource="#PathwayStep310" />
 <bp:pathwayOrder rdf:resource="#PathwayStep311" />
 <bp:pathwayOrder rdf:resource="#PathwayStep312" />
 <bp:pathwayOrder rdf:resource="#PathwayStep313" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction253" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction252" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction255" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction254" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction256" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence309" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activation of the AP-1 family of transcription factors</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activator protein-1 (AP-1) is a collective term referring to a group of transcription factors that bind to promoters of target genes in a sequence-specific manner. AP-1 family consists of hetero- and homodimers of bZIP (basic region leucine zipper) proteins, mainly of Jun-Jun, Jun-Fos or Jun-ATF.  AP-1 members are involved in the regulation of a number of cellular processes including cell growth, proliferation, survival, apoptosis, differentiation, cell migration. The ability of a single transcription factor to determine a cell fate critically depends on the relative abundance of AP-1 subunits, the composition of AP-1 dimers, the quality of stimulus, the cell type, the co-factor assembly.   AP-1 activity is regulated on multiple levels; transcriptional, translational and post-translational control mechanisms contribute to the balanced production of AP-1 proteins and their functions. Briefly, regulation occurs through:  effects on jun, fos, atf gene transcription and mRNA turnover.  AP-1 protein members turnover.  post-translational modifications of AP-1 proteins that modulate their transactivation potential (effect of protein kinases or phosphatases). interactions with other transcription factors that can either induce or interfere with AP-1 activity. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway55">
 <bp:pathwayOrder rdf:resource="#PathwayStep299" />
 <bp:pathwayOrder rdf:resource="#PathwayStep300" />
 <bp:pathwayOrder rdf:resource="#PathwayStep298" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction244" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction246" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction245" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence298" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">C-Jun NH2 terminal kinases (JNKs) are an evolutionarily conserved family of serine/threonine protein kinases, that belong to mitogen activated protein kinase family (MAPKs - also known as stress-activated protein kinases, SAPKs). The JNK pathway is activated by heat shock, or inflammatory cytokines, or UV radiation.  The JNKs are encoded by at least three genes: JNK1/SAPK-gamma, JNK2/SAPK-alpha and JNK3/ SAPK-beta. The first two are ubiquitously expressed, whereas the JNK3 protein is found mainly in brain and to a lesser extent in heart and testes. As a result of alternative gene splicing all cells express distinct active forms of JNK from 46 to 55 kDa in size. Sequence alignment of these different products shows homologies of &gt;80%. In spite of this similarity, the multiple JNK isoforms differ in their ability to bind and phosphorylate different target proteins, thus leading to the distinctive cellular processes: induction of apoptosis, or enhancment of cell survival, or proliferation. Activation of JNKs is mediated by activated TAK1 which phosphorylates two dual specificity enzymes MKK4 (MAPK kinase 4) and MKK7(MAPK kinase 7).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway56">
 <bp:pathwayOrder rdf:resource="#PathwayStep303" />
 <bp:pathwayOrder rdf:resource="#PathwayStep304" />
 <bp:pathwayOrder rdf:resource="#PathwayStep305" />
 <bp:pathwayOrder rdf:resource="#PathwayStep306" />
 <bp:pathwayOrder rdf:resource="#PathwayStep302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction251" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction250" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction248" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction247" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction249" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence302" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated TAK1 mediates p38 MAPK activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38 mitogen-activated protein kinase (MAPK) belongs to a highly conserved family of serine/threonine protein kinases.  The p38 MAPK-dependent signaling cascade is activated by pro-inflammatory or stressful stimuli such as ultraviolet radiation, oxidative injury, heat shock, cytokines, and other pro-inflammatory stimuli. p38 MAPK exists as four isoforms (alpha, beta, gamma, and delta). Of these, p38alpha and p38beta are ubiquitously expressed while p38gamma and p38delta are differentially expressed depending on tissue type. Each isoform is activated by upstream kinases including MAP kinase kinases (MKK) 3, 4, and 6, which in turn are phosphorylated by activated  TAK1 at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops. Once p38 MAPK is phosphorylated it activates numerous downstream substrates, including MAPK-activated protein kinase-2  and 3 (MAPKAPK-2 or 3) and mitogen and stress-activated kinase-1/2 (MSK1/2). MAPKAPK-2/3 and MSK1/2 function to phosphorylate heat shock protein 27 (HSP27) and cAMP-response element binding protein transcriptional factor, respectively. Other transcription factors, including activating transcription factor 2, Elk, CHOP/GADD153, and myocyte enhancer factor 2, are known to be regulated by these kinases. </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway53">
 <bp:pathwayOrder rdf:resource="#PathwayStep380" />
 <bp:pathwayOrder rdf:resource="#PathwayStep391" />
 <bp:pathwayOrder rdf:resource="#PathwayStep358" />
 <bp:pathwayOrder rdf:resource="#PathwayStep359" />
 <bp:pathwayOrder rdf:resource="#PathwayStep338" />
 <bp:pathwayOrder rdf:resource="#PathwayStep339" />
 <bp:pathwayOrder rdf:resource="#PathwayStep376" />
 <bp:pathwayOrder rdf:resource="#PathwayStep387" />
 <bp:pathwayOrder rdf:resource="#PathwayStep296" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction295" />
 <bp:pathwayComponent rdf:resource="#Pathway68" />
 <bp:pathwayComponent rdf:resource="#Pathway69" />
 <bp:pathwayComponent rdf:resource="#Pathway67" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction277" />
 <bp:pathwayComponent rdf:resource="#Pathway54" />
 <bp:pathwayComponent rdf:resource="#Pathway65" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction323" />
 <bp:pathwayComponent rdf:resource="#Pathway63" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence296" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll Like Receptor 3 (TLR3) Cascade</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toll-like receptor 3 (TLR3) as was shown for mammals is expressed in various tissues and cells, including myeloid dendritic cells, macrophages, respiratory and intestinal epithelium, neurons and microglial cells to induce antiviral and inflammatory responses of the innate immunity in combating viral infections. TLR3 recognizes dsRNA in the endosome and that triggers the receptor dimerization. TLR3 recruits the adaptor TRIF (TICAM1), leading to the activation of NF-kappa-B and the production of type I interferons (IFNs). dsRNA-stimulated phosphorylation of two specific TLR3 tyrosine residues (Tyr759 and Tyr858) is essential for initiating TLR3 signaling pathways.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway54">
 <bp:pathwayOrder rdf:resource="#PathwayStep307" />
 <bp:pathwayOrder rdf:resource="#PathwayStep329" />
 <bp:pathwayOrder rdf:resource="#PathwayStep301" />
 <bp:pathwayOrder rdf:resource="#PathwayStep297" />
 <bp:pathwayComponent rdf:resource="#Pathway57" />
 <bp:pathwayComponent rdf:resource="#Pathway55" />
 <bp:pathwayComponent rdf:resource="#Pathway56" />
 <bp:pathwayComponent rdf:resource="#Pathway62" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence297" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP kinase activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).  There are three major groups of MAP kinases  the extracellular signal-regulated protein kinases ERK1/2,  the p38 MAP kinase  and the c-Jun NH-terminal kinases JNK.  ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the  tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr). MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK. The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway51">
 <bp:pathwayOrder rdf:resource="#PathwayStep270" />
 <bp:pathwayOrder rdf:resource="#PathwayStep271" />
 <bp:pathwayOrder rdf:resource="#PathwayStep272" />
 <bp:pathwayOrder rdf:resource="#PathwayStep268" />
 <bp:pathwayOrder rdf:resource="#PathwayStep269" />
 <bp:pathwayOrder rdf:resource="#PathwayStep273" />
 <bp:pathwayOrder rdf:resource="#PathwayStep274" />
 <bp:pathwayOrder rdf:resource="#PathwayStep275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction220" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction222" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction221" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction224" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction223" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction225" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction219" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction218" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence268" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway52">
 <bp:pathwayOrder rdf:resource="#PathwayStep288" />
 <bp:pathwayOrder rdf:resource="#PathwayStep289" />
 <bp:pathwayOrder rdf:resource="#PathwayStep285" />
 <bp:pathwayOrder rdf:resource="#PathwayStep286" />
 <bp:pathwayOrder rdf:resource="#PathwayStep287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction235" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction234" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction237" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction236" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction238" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence285" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 mediated activation of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Although IRAK-1 was originally thought to be a key mediator of TRAF6 activation in the IL1R/TLR signaling (Dong W et al. 2006), recent studies showed that IRAK-2, but not IRAK-1, led to TRAF6 polyubiquitination (Keating SE et al 2007). IRAK-2 loss-of-function mutants, with mutated TRAF6-binding motifs, could no longer activate NF-kB and could no longer stimulate TRAF-6 ubiquitination (Keating SE et al 2007). Furthermore, the proxyvirus protein A52 - an inhibitor of all IL-1R/TLR pathways to NF-kB activation, was found to interact with both IRAK-2 and TRAF6, but not IRAK-1. Further work showed that A52 inhibits IRAK-2 functions, whereas association with TRAF6 results in A52-induced MAPK activation. The strong inhibition effect of A52 was also observed on the TLR3-NFkB axis and this observation led to the discovery that IRAK-2 is recruited to TLR3 to activate NF-kB (Keating SE et al 2007). Thus, A52 possibly inhibits MyD88-independent TLR3 pathways to NF-kB  via targeting IRAK-2 as it does for other IL-1R/TLR pathways, although it remains unclear how IRAK-2 is involved in TLR3 signaling. IRAK-2 was shown to have two TRAF6 binding motifs that are responsible for initiating TRAF6 signaling transduction (Ye H et al 2002).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway50">
 <bp:pathwayOrder rdf:resource="#PathwayStep260" />
 <bp:pathwayOrder rdf:resource="#PathwayStep261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction211" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction212" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence260" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1132">
 <bp:stepProcess rdf:resource="#Pathway179" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1131">
 <bp:stepProcess rdf:resource="#BiochemicalReaction954" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1134">
 <bp:stepProcess rdf:resource="#BiochemicalReaction956" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1133">
 <bp:stepProcess rdf:resource="#BiochemicalReaction955" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1130">
 <bp:stepProcess rdf:resource="#BiochemicalReaction953" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1139">
 <bp:stepProcess rdf:resource="#Catalysis407" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction961" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1136">
 <bp:stepProcess rdf:resource="#BiochemicalReaction958" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1135">
 <bp:stepProcess rdf:resource="#BiochemicalReaction957" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1138">
 <bp:stepProcess rdf:resource="#BiochemicalReaction960" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1137">
 <bp:stepProcess rdf:resource="#BiochemicalReaction959" />
</bp:PathwayStep>

<bp:Pathway rdf:ID="Pathway68">
 <bp:pathwayOrder rdf:resource="#PathwayStep381" />
 <bp:pathwayOrder rdf:resource="#PathwayStep382" />
 <bp:pathwayOrder rdf:resource="#PathwayStep383" />
 <bp:pathwayOrder rdf:resource="#PathwayStep384" />
 <bp:pathwayOrder rdf:resource="#PathwayStep385" />
 <bp:pathwayOrder rdf:resource="#PathwayStep386" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction319" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction314" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction316" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction315" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction318" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction317" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence381" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TICAM1,TRAF6-dependent induction of TAK1 complex</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In human, together with ubiquitin-conjugating E2-type enzymes UBC13 and UEV1A (also known as UBE2V1), TRAF6 catalyses Lys63-linked ubiquitination. It is believed that auto polyubiquitination  and oligomerization of TRAF6 is followed by binding the ubiquitin receptors of TAB2 or TAB3 (TAK1 binding protein 2 and 3), which stimulates phosphorylation and activation of TGF beta-activated kinase 1(TAK1). TAK1 phosphorylates IKK alpha and IKK beta, which in turn phosphorylate NF-kB inhibitors - IkB  and eventually results in IkB degradation and NF-kB translocation to the nucleus. Also TAK1 mediates JNK and p38 MAP kinases activation by phosphorylating MKK4/7 and MKK3/6 respectivly resulting in the activation of many transcription factors.  The role of TRAF6 is somewhat controversial and probably cell type specific. TRAF6 autoubiquitination was found to be dispensable for TRAF6 function to activate TAK1 pathway. These findings are consistent with the new mechanism of TRAF6-mediated NF-kB activation that was suggested by Xia et al. (2009). TRAF6 generates unanchored Lys63-linked polyubiquitin chains that bind to the regulatory subunits of TAK1 (TAB2 or TAB3) and IKK(NEMO), leading to the activation of the kinases.  Xia et al. (2009) demonstrated in vitro that unlike polyubiquitin chains covalently attached to TRAF6 or IRAK, TAB2 and NEMO-associated ubiquitin chains were found to be unanchored and susceptible to N-terminal ubiquitin cleavage. Only K63-linked polyubiquitin chains, but not monomeric ubiquitin, activated TAK1 in a dose-dependent manner. Optimal activation of the IKK complex was achieved using ubiquitin polymers containing both K48 and K63 linkages. Furthermore, the authors proposed that the TAK1 complexes might be brougt in close proximity by binding several TAB2/3 to a single polyubiquitin chain to facilitate TAK1 kinase trans-phosphorylation. Alternativly, the possibility that polyUb binding promotes allosteric activation of TAK1 complex should  be considered (Walsh et al 2008).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway69">
 <bp:pathwayOrder rdf:resource="#PathwayStep390" />
 <bp:pathwayOrder rdf:resource="#PathwayStep388" />
 <bp:pathwayOrder rdf:resource="#PathwayStep389" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction321" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction322" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence388" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TICAM1, RIP1-mediated IKK complex recruitment</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Receptor-interacting protein 1 (RIP1) mediates the activation of interferon-alpha/beta via intermediate activation of IKK/TBK1 or NFkB pathways.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway66">
 <bp:pathwayOrder rdf:resource="#PathwayStep370" />
 <bp:pathwayOrder rdf:resource="#PathwayStep371" />
 <bp:pathwayOrder rdf:resource="#PathwayStep372" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction305" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction307" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction306" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence370" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of TBK1, IKK&#949;-mediated activation of IRF3, IRF7 upon TLR3 ligation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Production of type I IFN genes in response to Toll-like receptor 3 (TLR3) and TLR4 ligands is mediated by TANK-binding kinase 1 (TBK1) or I-kappa-B kinase epsilon (IKK&#949;, IKBKE), which phosphorylate IFN regulatory factor 3 (IRF3) and IRF7. The activity of TBK1 and/or IRF3, IRF7 is regulated by multiple mechanisms including post-translational modifications, protein-protein interactions, and protein degradation (Zhao W et al., 2013; Runde AP et al., 2022).  This Reactome module describes regulation of TBK1, IKK&#949; activity by K63-linked ubiquitination of TBK1 and IKK&#949;, and TBK1 interaction with OPTN.  </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway67">
 <bp:pathwayOrder rdf:resource="#PathwayStep377" />
 <bp:pathwayOrder rdf:resource="#PathwayStep378" />
 <bp:pathwayOrder rdf:resource="#PathwayStep379" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction312" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction311" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction313" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence377" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR3-mediated TICAM1-dependent programmed cell death</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR3 and TLR4 trigger TRIF(TICAM1)-dependent programmed cell death in various human and mouse cells (Kalai M et al. 2002; Han KJ et al. 2004; Kaiser WJ and Offermann MK 2005; Estornes Y et al. 2012; He S et al. 2011). Apoptosis is a prevalent form of programmed cell death and is mediated by the activation of a set of caspases. In addition to apoptosis, TLR3/TLR4 activation induces RIP3-dependent necroptosis. These two programmed cell-death pathways may suppress each other. When the caspase activity is impaired or inhibited, certain cell types switch the apoptotic death program to necroptosis in response to various stimuli (TNF, Fas, viral infection and other stress stimuli) (Kalai M et al. 2002; Weber A et al. 2010; Feoktistova M et al. 2011, Tenev et al 2011).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway64">
 <bp:pathwayOrder rdf:resource="#PathwayStep347" />
 <bp:pathwayOrder rdf:resource="#PathwayStep348" />
 <bp:pathwayOrder rdf:resource="#PathwayStep349" />
 <bp:pathwayOrder rdf:resource="#PathwayStep343" />
 <bp:pathwayOrder rdf:resource="#PathwayStep344" />
 <bp:pathwayOrder rdf:resource="#PathwayStep345" />
 <bp:pathwayOrder rdf:resource="#PathwayStep346" />
 <bp:pathwayOrder rdf:resource="#PathwayStep350" />
 <bp:pathwayOrder rdf:resource="#PathwayStep351" />
 <bp:pathwayOrder rdf:resource="#PathwayStep352" />
 <bp:pathwayOrder rdf:resource="#PathwayStep353" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction282" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction281" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction284" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction283" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction286" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction285" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction288" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction287" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction289" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction280" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction290" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence343" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of NF-kappa B signaling</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear factor kappa B (NF-kappa-B, NF-&#954;B) is activated by a diverse range of stimuli including cytokines, ligands of pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) in myeloid cells, antigen-activated TCR in T-cells and by DNA damage (reviewed in Yu H et al. 2020; Zhang T et al. 2021). NF-kappa-B regulates the transcription of genes that are involved in immune and inflammatory responses, cell cycle, cell proliferation and apoptosis (Bhatt D    Ghosh S 2014; Liu T et al. 2017; Yu H et al. 2020). In unstimulated cells, NF-&#954;B is sequestered in the cytosol through interactions with a class of inhibitor proteins, called NF-&#954;B inhibitors (IkBs, such as NFKBIA or NFKBIB) (Jacobs MD    Harrison SC 1998). IkBs mask the nuclear localization signal (NLS) of NF-&#954;B preventing its nuclear translocation (Cervantes CF et al. 2011). A key event in NF-&#954;B activation involves phosphorylation of IkBs by the I&#954;B kinase (IKK) complex which consists of CHUK, IKBKB and IKBKG subunits (Isra&#235;l A 2010). The activated NF-&#954;B signaling is tightly controlled at multiple levels (Dorrington MG    Fraser IDC 2019; Prescott JA et al. 2021). Dysregulated NF-&#954;B activity can cause tissue damage associated with inflammatory diseases and is also linked to tumorigenesis (Aggarwal BB    Sung B 2011; Liu T et al.2017; Barnabei L et al. 2021). The regulation of NF-&#954;B is cell-type-, context- , and stimulus-dependent and is crucial for orchestrating specific cellular responses (Mussbacher M et al. 2019). This Reactome module describes several molecular mechanisms that regulate TLR-mediated NF-&#954;B signaling at the level of the IKK signaling complex.   </bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway65">
 <bp:pathwayOrder rdf:resource="#PathwayStep369" />
 <bp:pathwayOrder rdf:resource="#PathwayStep360" />
 <bp:pathwayOrder rdf:resource="#PathwayStep365" />
 <bp:pathwayOrder rdf:resource="#PathwayStep366" />
 <bp:pathwayOrder rdf:resource="#PathwayStep367" />
 <bp:pathwayOrder rdf:resource="#PathwayStep368" />
 <bp:pathwayOrder rdf:resource="#PathwayStep361" />
 <bp:pathwayOrder rdf:resource="#PathwayStep362" />
 <bp:pathwayOrder rdf:resource="#PathwayStep373" />
 <bp:pathwayOrder rdf:resource="#PathwayStep363" />
 <bp:pathwayOrder rdf:resource="#PathwayStep374" />
 <bp:pathwayOrder rdf:resource="#PathwayStep364" />
 <bp:pathwayOrder rdf:resource="#PathwayStep375" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction309" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction308" />
 <bp:pathwayComponent rdf:resource="#Pathway66" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction301" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction300" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction303" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction302" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction304" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction297" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction296" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction299" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction310" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction298" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence360" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TICAM1-dependent activation of IRF3/IRF7</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cell stimulation with viral double-stranded (ds) RNA and bacterial lipopolysaccharide (LPS) activate Toll-like receptors 3 (TLR3) and TLR4, respectively, triggering the activation the activation of two IKK-related serine/threonine kinases, TANK-binding kinase 1 (TBK1) and I&#954;B kinase &#949; (IKK&#949;, IKBKE) which directly phosphorylate interferon regulatory factor 3 (IRF3) and IRF7 promoting their dimerization and translocation into the nucleus. Although both kinases show structural and functional similarities, it seems that TBK1 and IKBKE differ in their regulation of downstream signaling events of TLR3/TLR4.  IRF3 activation and interferon &#946; (IFN&#946;) production by poly(I:C), a synthetic analog of dsRNA, are decreased in TBK1-deficient mouse fibroblasts, whereas normal activation was observed in the IKBKE-deficient fibroblasts. However, in double-deficient mouse fibroblasts, the activation of IRF3 is completely abolished, suggesting a partially redundant functions of TBK1 and IKK&#949; (IKBKE) (Hemmi H et al., 2004).  The poly(I:C)-induced phosphorylation of TBK1 and IRF3 was abolished in TRIF (TICAM1)-knockout human keratinocyte HACAT cells (Bakshi S et al., 2017). TICAM1 is utilized as an adaptor protein by TLR3 and TLR4 (Yamamoto M et al., 2003).  TLR3 recruits and activates PI3 kinase (PI3K), which activates the downstream kinase, Akt, leading to full phosphorylation and activation of IRF3 (Sarkar SN et al., 2004). When PI3K is not recruited to TLR3 or its activity is blocked, IRF3 is only partially phosphorylated and fails to bind the promoter of the target gene (Sarkar SN et al., 2004).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway62">
 <bp:pathwayOrder rdf:resource="#PathwayStep336" />
 <bp:pathwayOrder rdf:resource="#PathwayStep337" />
 <bp:pathwayOrder rdf:resource="#PathwayStep332" />
 <bp:pathwayOrder rdf:resource="#PathwayStep333" />
 <bp:pathwayOrder rdf:resource="#PathwayStep334" />
 <bp:pathwayOrder rdf:resource="#PathwayStep335" />
 <bp:pathwayOrder rdf:resource="#PathwayStep330" />
 <bp:pathwayOrder rdf:resource="#PathwayStep331" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction271" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction270" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction273" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction272" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction275" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction274" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction276" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction269" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence330" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 (TPL2)-dependent MAPK1/3 activation</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor progression locus-2 (TPL2, also known as COT and MAP3K8) functions as a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) in various stress-responsive signaling cascades. MAP3K8 (TPL2) mediates phosphorylation of MAP2Ks (MEK1/2) which in turn phosphorylate MAPK (ERK1/2) (Gantke T et al., 2011). In the absence of extra-cellular signals, cytosolic MAP3K8 (TPL2) is held inactive in the complex with ABIN2 (TNIP2) and NFkB p105 (NFKB1) (Beinke S et al., 2003; Waterfield MR et al., 2003; Lang V et al., 2004). This interaction stabilizes MAP3K8 (TPL2) but also prevents MAP3K8 and NFkB from activating their downstream signaling cascades by inhibiting the kinase activity of MAP3K8 and the proteolysis of NFkB precursor protein p105. Upon activation of MAP3K8 by various stimuli (such as LPS, TNF-alpha, and IL-1 beta), IKBKB phosphorylates NFkB p105 (NFKB1) at Ser927 and Ser932, which trigger p105 proteasomal degradation and releases MAP3K8 from the complex (Beinke S et al., 2003, 2004; Roget K et al., 2012). Simultaneously, MAP3K8 is activated by auto- and/or transphosphorylation (Gantke T et al. 2011; Yang HT et al. 2012). The released active MAP3K8 phosphorylates its substrates, MAP2Ks. The free MAP3K8, however, is also unstable and is targeted for proteasome-mediated degradation, thus restricting prolonged activation of MAP3K8 (TPL2) and its downstream signaling pathways (Waterfield MR et al. 2003; Cho J et al., 2005). Furthermore, partially degraded NFkB p105 (NFKB1) into p50 can dimerize with other NFkB family members to regulate the transcription of target genes. MAP3K8 activity is thought to regulate the dynamics of transcription factors that control an expression of diverse genes involved in growth, differentiation, and inflammation. Suppressing the MAP3K8 kinase activity with selective inhibitors, such as C8-chloronaphthyridine-3-carbonitrile, caused a significant reduction in TNFalpha production in LPS- and IL-1beta-induced both primary human monocytes and human blood (Hall JP et al. 2007). Similar results have been reported for mouse LPS-stimulated RAW264.7 cells (Hirata K et al. 2010). Moreover, LPS-stimulated macrophages derived from Map3k8 knockout mice secreted lower levels of pro-inflammatory cytokines such as TNFalpha, Cox2, Pge2 and CXCL1 (Dumitru CD et al. 2000; Eliopoulos AG et al. 2002). Additionally, bone marrow-derived dendritic cells (BMDCs) and macrophages from Map3k8 knockout mice showed significantly lower expression of IL-1beta in response to LPS, poly IC and LPS/MDP (Mielke et al., 2009). However, several other studies seem to contradict these findings and Map3k8 deficiency in mice has been also reported to enhance pro-inflammatory profiles. Map3k8 deficiency in LPS-stimulated macrophages was associated with an increase in nitric oxide synthase 2 (NOS2) expression (L&#243;pez-Pel&#225;ez et al., 2011). Similarly, expression of IRAK-M, whose function is to compete with IL-1R-associated kinase (IRAK) family of kinases, was decreased in Map3k8-/- macrophages while levels of TNF and IL6 were elevated (Zacharioudaki et al., 2009). Moreover, significantly higher inflammation level was observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Map3k8-/- mouse skin compared to WT skin (DeCicco-Skinner K. et al., 2011). Additionally, MAP3K8 activity is associated with NFkB inflammatory pathway. High levels of active p65 NFkB were observed in the nucleus of Map3k8 -/- mouse keratinocytes that dramatically increased within 15-30 minutes of TPA treatment. Similarly, increased p65 NFkB was observed in Map3k8-deficient BMDC both basally and after stimulation with LPS when compared to wild type controls (Mielke et al., 2009). The data opposes the findings that Map3k8-deficient mouse embryo fibroblasts and human Jurkat T cells with kinase domain-deficient protein have a reduction in NFkB activation but only when certain stimuli are administered (Lin et al., 1999; Das S et al., 2005). Thus, it is possible that whether MAP3K8 serves more of a pro-inflammatory or anti-inflammatory role may depend on cell- or tissue type and on stimuli (LPS vs. TPA, etc.) (Mielke et al., 2009; DeCicco-Skinner K. et al., 2012). MAP3K8 has been also studied in the context of carcinogenesis, however the physiological role of MAP3K8 in the etiology of human cancers is also convoluted (Vougioukalaki M et al., 2011; DeCicco-Skinner K. et al., 2012).</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway63">
 <bp:pathwayOrder rdf:resource="#PathwayStep354" />
 <bp:pathwayOrder rdf:resource="#PathwayStep355" />
 <bp:pathwayOrder rdf:resource="#PathwayStep356" />
 <bp:pathwayOrder rdf:resource="#PathwayStep357" />
 <bp:pathwayOrder rdf:resource="#PathwayStep340" />
 <bp:pathwayOrder rdf:resource="#PathwayStep341" />
 <bp:pathwayOrder rdf:resource="#PathwayStep342" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction293" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction292" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction294" />
 <bp:pathwayComponent rdf:resource="#Pathway64" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction279" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction278" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction291" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence340" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TAK1-dependent IKK and NF-kappa-B activation  </bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B is sequestered in the cytoplasm in a complex with inhibitor of NF-kappa-B (IkB). Almost all NF-kappa-B activation pathways are mediated by IkB kinase (IKK), which phosphorylates IkB resulting in dissociation of NF-kappa-B from the complex. This allows translocation of NF-kappa-B to the nucleus where it regulates gene expression.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway60">
 <bp:pathwayOrder rdf:resource="#PathwayStep325" />
 <bp:pathwayOrder rdf:resource="#PathwayStep326" />
 <bp:pathwayOrder rdf:resource="#PathwayStep327" />
 <bp:pathwayOrder rdf:resource="#PathwayStep328" />
 <bp:pathwayOrder rdf:resource="#PathwayStep321" />
 <bp:pathwayOrder rdf:resource="#PathwayStep324" />
 <bp:pathwayOrder rdf:resource="#PathwayStep320" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction261" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction264" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction266" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction265" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction268" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction267" />
 <bp:pathwayComponent rdf:resource="#Pathway61" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence320" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK targets</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK/MAPK kinases have a number of targets within the nucleus, usually transcription factors or other kinases. The best known targets, ELK1, ETS1, ATF2, MITF, MAPKAPK2, MSK1, RSK1/2/3 and MEF2 are annotated here.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:Pathway rdf:ID="Pathway61">
 <bp:pathwayOrder rdf:resource="#PathwayStep322" />
 <bp:pathwayOrder rdf:resource="#PathwayStep323" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction262" />
 <bp:pathwayComponent rdf:resource="#BiochemicalReaction263" />
 <bp:organism rdf:resource="#BioSource1" />
 <bp:evidence rdf:resource="#Evidence322" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP Kinases are inactivated by a family of protein named MAP Kinase Phosphatases (MKPs). They act through dephosphorylation of threonine and/or tyrosine residues within the signature sequence -pTXpY- located in the activation loop of MAP kinases (pT=phosphothreonine and pY=phosphotyrosine). MKPs are divided into three major categories depending on their preference for dephosphorylating; tyrosine, serine/threonine and both the tyrosine and threonine (dual specificity phoshatases or DUSPs). The tyrosine-specific MKPs include PTP-SL, STEP  and HePTP, serine/threonine-specific MKPs are PP2A and PP2C, and many DUSPs acting on MAPKs are known. Activated MAP kinases trigger activation of transcription of MKP genes. Therefore, MKPs provide a negative feedback regulatory mechanism on MAPK signaling, by inactivating MAPKs via dephosphorylation, in the cytoplasm and the nucleus. Some MKPs are more specific for ERKs, others for JNK or p38MAPK.</bp:comment>
 <bp:dataSource rdf:resource="#Provenance1" />
</bp:Pathway>

<bp:PathwayStep rdf:ID="PathwayStep1121">
 <bp:stepProcess rdf:resource="#BiochemicalReaction944" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1120">
 <bp:stepProcess rdf:resource="#BiochemicalReaction943" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1123">
 <bp:stepProcess rdf:resource="#BiochemicalReaction946" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1122">
 <bp:stepProcess rdf:resource="#BiochemicalReaction945" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1129">
 <bp:stepProcess rdf:resource="#Catalysis406" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction952" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1128">
 <bp:stepProcess rdf:resource="#Catalysis405" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction951" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1125">
 <bp:stepProcess rdf:resource="#BiochemicalReaction948" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1124">
 <bp:stepProcess rdf:resource="#BiochemicalReaction947" />
 <bp:stepProcess rdf:resource="#Catalysis404" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1127">
 <bp:stepProcess rdf:resource="#BiochemicalReaction950" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1126">
 <bp:stepProcess rdf:resource="#BiochemicalReaction949" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction529">
 <bp:evidence rdf:resource="#Evidence642" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction528">
 <bp:evidence rdf:resource="#Evidence641" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction521">
 <bp:evidence rdf:resource="#Evidence631" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction520">
 <bp:evidence rdf:resource="#Evidence630" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction523">
 <bp:evidence rdf:resource="#Evidence633" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to MyD88:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction522">
 <bp:evidence rdf:resource="#Evidence632" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 or IRAK2:TRAF6-oligomer from the activated TLR5 or 10:oligo-Myd88:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction525">
 <bp:evidence rdf:resource="#Evidence637" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction524">
 <bp:evidence rdf:resource="#Evidence634" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to MyD88 bound to the activated TLR5 or 10 receptor</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction527">
 <bp:evidence rdf:resource="#Evidence639" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction526">
 <bp:evidence rdf:resource="#Evidence638" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1110">
 <bp:stepProcess rdf:resource="#Catalysis403" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction933" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1112">
 <bp:stepProcess rdf:resource="#BiochemicalReaction935" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1111">
 <bp:stepProcess rdf:resource="#BiochemicalReaction934" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction530">
 <bp:evidence rdf:resource="#Evidence643" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1118">
 <bp:stepProcess rdf:resource="#BiochemicalReaction941" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1117">
 <bp:stepProcess rdf:resource="#BiochemicalReaction940" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1119">
 <bp:stepProcess rdf:resource="#BiochemicalReaction942" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1114">
 <bp:stepProcess rdf:resource="#BiochemicalReaction937" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1113">
 <bp:stepProcess rdf:resource="#BiochemicalReaction936" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1116">
 <bp:stepProcess rdf:resource="#BiochemicalReaction939" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1115">
 <bp:stepProcess rdf:resource="#BiochemicalReaction938" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction518">
 <bp:evidence rdf:resource="#Evidence628" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction517">
 <bp:evidence rdf:resource="#Evidence627" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction519">
 <bp:evidence rdf:resource="#Evidence629" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction510">
 <bp:evidence rdf:resource="#Evidence620" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction512">
 <bp:evidence rdf:resource="#Evidence622" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction511">
 <bp:evidence rdf:resource="#Evidence621" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction514">
 <bp:evidence rdf:resource="#Evidence624" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction513">
 <bp:evidence rdf:resource="#Evidence623" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction516">
 <bp:evidence rdf:resource="#Evidence626" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction515">
 <bp:evidence rdf:resource="#Evidence625" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1101">
 <bp:stepProcess rdf:resource="#BiochemicalReaction925" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1100">
 <bp:stepProcess rdf:resource="#BiochemicalReaction924" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1107">
 <bp:stepProcess rdf:resource="#Pathway178" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1106">
 <bp:stepProcess rdf:resource="#Catalysis401" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction930" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1109">
 <bp:stepProcess rdf:resource="#Catalysis402" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction932" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1108">
 <bp:stepProcess rdf:resource="#BiochemicalReaction931" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1103">
 <bp:stepProcess rdf:resource="#BiochemicalReaction927" />
 <bp:stepProcess rdf:resource="#Catalysis399" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1102">
 <bp:stepProcess rdf:resource="#BiochemicalReaction926" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1105">
 <bp:stepProcess rdf:resource="#BiochemicalReaction929" />
 <bp:stepProcess rdf:resource="#Catalysis400" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1104">
 <bp:stepProcess rdf:resource="#BiochemicalReaction928" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction507">
 <bp:evidence rdf:resource="#Evidence617" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction506">
 <bp:evidence rdf:resource="#Evidence616" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction509">
 <bp:evidence rdf:resource="#Evidence619" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction508">
 <bp:evidence rdf:resource="#Evidence618" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction501">
 <bp:evidence rdf:resource="#Evidence609" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1/or IRAK2 binds to the activated IRAK4 :oligo MyD88:activated TLR5 or 10 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction500">
 <bp:evidence rdf:resource="#Evidence608" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction503">
 <bp:evidence rdf:resource="#Evidence612" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction502">
 <bp:evidence rdf:resource="#Evidence610" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation within the complex p-IRAK4:oligo MyD88:activated TLR</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction505">
 <bp:evidence rdf:resource="#Evidence615" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction504">
 <bp:evidence rdf:resource="#Evidence613" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence152">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence151">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence150">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence156">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence155">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence154">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence153">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence159">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence158">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence157">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence141">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence140">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence145">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence144">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence143">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence142">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence149">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence148">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence147">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence146">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence130">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence134">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence133">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence132">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence131">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence138">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence137">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence136">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence135">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence139">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence123">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction697">
 <bp:evidence rdf:resource="#Evidence845" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence122">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction696">
 <bp:evidence rdf:resource="#Evidence843" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence121">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction699">
 <bp:evidence rdf:resource="#Evidence848" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence120">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction698">
 <bp:evidence rdf:resource="#Evidence847" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence127">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence126">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence125">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence124">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence129">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence128">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence112">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction686">
 <bp:evidence rdf:resource="#Evidence830" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence111">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction685">
 <bp:evidence rdf:resource="#Evidence829" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence110">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction688">
 <bp:evidence rdf:resource="#Evidence834" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction687">
 <bp:evidence rdf:resource="#Evidence831" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence116">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence115">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction689">
 <bp:evidence rdf:resource="#Evidence835" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence114">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence113">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence119">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence118">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction691">
 <bp:evidence rdf:resource="#Evidence837" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence117">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction690">
 <bp:evidence rdf:resource="#Evidence836" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction693">
 <bp:evidence rdf:resource="#Evidence840" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction692">
 <bp:evidence rdf:resource="#Evidence838" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction695">
 <bp:evidence rdf:resource="#Evidence842" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction694">
 <bp:evidence rdf:resource="#Evidence841" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence101">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction675">
 <bp:evidence rdf:resource="#Evidence816" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP is phosphorylated by BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence100">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction674">
 <bp:evidence rdf:resource="#Evidence815" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 or IRAK2 binds to the activated IRAK4 :activated TLR:MyD88:TIRAP complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction677">
 <bp:evidence rdf:resource="#Evidence818" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of IRAK2 bound to the activated IRAK4:MyD88 oligomer:TIRAP:activated TLR complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction676">
 <bp:evidence rdf:resource="#Evidence817" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiple IRAK1 autophosphorylation steps</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence105">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction679">
 <bp:evidence rdf:resource="#Evidence820" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence104">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction678">
 <bp:evidence rdf:resource="#Evidence819" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Second phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence103">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence102">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence109">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence108">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence107">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction680">
 <bp:evidence rdf:resource="#Evidence823" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence106">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction682">
 <bp:evidence rdf:resource="#Evidence825" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction681">
 <bp:evidence rdf:resource="#Evidence824" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction684">
 <bp:evidence rdf:resource="#Evidence828" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction683">
 <bp:evidence rdf:resource="#Evidence827" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction664">
 <bp:evidence rdf:resource="#Evidence805" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRC14 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction663">
 <bp:evidence rdf:resource="#Evidence804" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRC5 binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction666">
 <bp:evidence rdf:resource="#Evidence807" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBIP binds IKBKB and CHUK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction665">
 <bp:evidence rdf:resource="#Evidence806" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP18 binds IKBKG within IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction668">
 <bp:evidence rdf:resource="#Evidence809" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B inhibitor binds NF-kappa-B complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction667">
 <bp:evidence rdf:resource="#Evidence808" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ubiquitination of IKBKG by TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction669">
 <bp:evidence rdf:resource="#Evidence810" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 mediates phosphorylation of the IKK Complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction671">
 <bp:evidence rdf:resource="#Evidence812" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4 interacts with MAL (TIRAP)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction670">
 <bp:evidence rdf:resource="#Evidence811" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active IKBKB phosphorylates NF-kappa-B inhibitor </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction673">
 <bp:evidence rdf:resource="#Evidence814" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TIRAP binds PIP2-rich regions in the plasma membrane</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction672">
 <bp:evidence rdf:resource="#Evidence813" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">First phosphorylation of IRAK1 by IRAK4 bound to activated TLR:MyD88:Mal</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction653">
 <bp:evidence rdf:resource="#Evidence792" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK1 phosphorylates Pellino</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction652">
 <bp:evidence rdf:resource="#Evidence791" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino ubiquitinates hp-IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction655">
 <bp:evidence rdf:resource="#Evidence795" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NF-kappa-B complex is transported from cytosol to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction654">
 <bp:evidence rdf:resource="#Evidence794" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHUK, IKBKB and IKBKG form IKK complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction657">
 <bp:evidence rdf:resource="#Evidence798" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CASP8 cleaves N4BP1 at D424, D490</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction656">
 <bp:evidence rdf:resource="#Evidence797" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 binds the IKBIP gene promoter</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction659">
 <bp:evidence rdf:resource="#Evidence800" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TP53 stimulates IKBIP gene expression</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction658">
 <bp:evidence rdf:resource="#Evidence799" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NLRX1 binds CHUK:IKBKB:IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction660">
 <bp:evidence rdf:resource="#Evidence801" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">USP14 deubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction662">
 <bp:evidence rdf:resource="#Evidence803" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF2,6 ubiquitinates NLRC5</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction661">
 <bp:evidence rdf:resource="#Evidence802" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">N4BP1 binds IKBKG</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep747">
 <bp:stepProcess rdf:resource="#BiochemicalReaction616" />
 <bp:stepProcess rdf:resource="#Catalysis302" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep748">
 <bp:stepProcess rdf:resource="#BiochemicalReaction617" />
 <bp:stepProcess rdf:resource="#Catalysis303" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep749">
 <bp:stepProcess rdf:resource="#Pathway133" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep743">
 <bp:stepProcess rdf:resource="#BiochemicalReaction613" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep744">
 <bp:stepProcess rdf:resource="#Pathway132" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep745">
 <bp:stepProcess rdf:resource="#Catalysis300" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction614" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep746">
 <bp:stepProcess rdf:resource="#Catalysis301" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction615" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep740">
 <bp:stepProcess rdf:resource="#BiochemicalReaction610" />
 <bp:stepProcess rdf:resource="#Catalysis297" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep741">
 <bp:stepProcess rdf:resource="#BiochemicalReaction611" />
 <bp:stepProcess rdf:resource="#Catalysis298" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep742">
 <bp:stepProcess rdf:resource="#Catalysis299" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction612" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep758">
 <bp:stepProcess rdf:resource="#Catalysis311" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction625" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep759">
 <bp:stepProcess rdf:resource="#Pathway135" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep754">
 <bp:stepProcess rdf:resource="#Catalysis307" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction621" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep755">
 <bp:stepProcess rdf:resource="#Catalysis308" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction622" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep756">
 <bp:stepProcess rdf:resource="#Catalysis309" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction623" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep757">
 <bp:stepProcess rdf:resource="#Catalysis310" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction624" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep750">
 <bp:stepProcess rdf:resource="#BiochemicalReaction618" />
 <bp:stepProcess rdf:resource="#Catalysis304" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep751">
 <bp:stepProcess rdf:resource="#Pathway134" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep752">
 <bp:stepProcess rdf:resource="#BiochemicalReaction619" />
 <bp:stepProcess rdf:resource="#Catalysis305" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep753">
 <bp:stepProcess rdf:resource="#Catalysis306" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction620" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep769">
 <bp:stepProcess rdf:resource="#BiochemicalReaction635" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep765">
 <bp:stepProcess rdf:resource="#Catalysis315" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction631" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep766">
 <bp:stepProcess rdf:resource="#BiochemicalReaction632" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep767">
 <bp:stepProcess rdf:resource="#BiochemicalReaction633" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep768">
 <bp:stepProcess rdf:resource="#BiochemicalReaction634" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep761">
 <bp:stepProcess rdf:resource="#BiochemicalReaction627" />
 <bp:stepProcess rdf:resource="#Catalysis312" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep762">
 <bp:stepProcess rdf:resource="#BiochemicalReaction628" />
 <bp:stepProcess rdf:resource="#Catalysis313" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep763">
 <bp:stepProcess rdf:resource="#BiochemicalReaction629" />
 <bp:stepProcess rdf:resource="#Catalysis314" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep764">
 <bp:stepProcess rdf:resource="#BiochemicalReaction630" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep760">
 <bp:stepProcess rdf:resource="#BiochemicalReaction626" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep776">
 <bp:stepProcess rdf:resource="#Pathway136" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep777">
 <bp:stepProcess rdf:resource="#BiochemicalReaction642" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep778">
 <bp:stepProcess rdf:resource="#BiochemicalReaction643" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep779">
 <bp:stepProcess rdf:resource="#Catalysis316" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction644" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep772">
 <bp:stepProcess rdf:resource="#BiochemicalReaction638" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep773">
 <bp:stepProcess rdf:resource="#BiochemicalReaction639" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep774">
 <bp:stepProcess rdf:resource="#BiochemicalReaction640" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep775">
 <bp:stepProcess rdf:resource="#BiochemicalReaction641" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep770">
 <bp:stepProcess rdf:resource="#BiochemicalReaction636" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep771">
 <bp:stepProcess rdf:resource="#BiochemicalReaction637" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep703">
 <bp:stepProcess rdf:resource="#Catalysis280" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction578" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep704">
 <bp:stepProcess rdf:resource="#BiochemicalReaction579" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep705">
 <bp:stepProcess rdf:resource="#BiochemicalReaction580" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep706">
 <bp:stepProcess rdf:resource="#Catalysis281" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction581" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep700">
 <bp:stepProcess rdf:resource="#BiochemicalReaction576" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep701">
 <bp:stepProcess rdf:resource="#Pathway126" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep702">
 <bp:stepProcess rdf:resource="#BiochemicalReaction577" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence992">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence991">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence990">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep707">
 <bp:stepProcess rdf:resource="#BiochemicalReaction582" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence996">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep708">
 <bp:stepProcess rdf:resource="#Catalysis282" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction583" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence995">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep709">
 <bp:stepProcess rdf:resource="#BiochemicalReaction584" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence994">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence993">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence999">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence998">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence997">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep714">
 <bp:stepProcess rdf:resource="#BiochemicalReaction589" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep715">
 <bp:stepProcess rdf:resource="#BiochemicalReaction590" />
 <bp:stepProcess rdf:resource="#Catalysis284" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep716">
 <bp:stepProcess rdf:resource="#BiochemicalReaction591" />
 <bp:stepProcess rdf:resource="#Catalysis285" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep717">
 <bp:stepProcess rdf:resource="#BiochemicalReaction592" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep710">
 <bp:stepProcess rdf:resource="#BiochemicalReaction585" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep711">
 <bp:stepProcess rdf:resource="#BiochemicalReaction586" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep712">
 <bp:stepProcess rdf:resource="#BiochemicalReaction587" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep713">
 <bp:stepProcess rdf:resource="#BiochemicalReaction588" />
 <bp:stepProcess rdf:resource="#Catalysis283" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence981">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence980">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep718">
 <bp:stepProcess rdf:resource="#BiochemicalReaction593" />
 <bp:stepProcess rdf:resource="#Catalysis286" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence985">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep719">
 <bp:stepProcess rdf:resource="#BiochemicalReaction594" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence984">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence983">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence982">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence989">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence988">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence987">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence986">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep725">
 <bp:stepProcess rdf:resource="#Catalysis291" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction600" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep726">
 <bp:stepProcess rdf:resource="#Pathway127" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep727">
 <bp:stepProcess rdf:resource="#Pathway128" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep728">
 <bp:stepProcess rdf:resource="#BiochemicalReaction601" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep721">
 <bp:stepProcess rdf:resource="#BiochemicalReaction596" />
 <bp:stepProcess rdf:resource="#Catalysis287" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep722">
 <bp:stepProcess rdf:resource="#BiochemicalReaction597" />
 <bp:stepProcess rdf:resource="#Catalysis288" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep723">
 <bp:stepProcess rdf:resource="#BiochemicalReaction598" />
 <bp:stepProcess rdf:resource="#Catalysis289" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep724">
 <bp:stepProcess rdf:resource="#Catalysis290" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction599" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence970">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep729">
 <bp:stepProcess rdf:resource="#Catalysis292" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction602" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence974">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence973">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence972">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence971">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence978">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence977">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence976">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence975">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence979">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep720">
 <bp:stepProcess rdf:resource="#BiochemicalReaction595" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep736">
 <bp:stepProcess rdf:resource="#BiochemicalReaction608" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep737">
 <bp:stepProcess rdf:resource="#Pathway130" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep738">
 <bp:stepProcess rdf:resource="#Pathway131" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep739">
 <bp:stepProcess rdf:resource="#BiochemicalReaction609" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep732">
 <bp:stepProcess rdf:resource="#BiochemicalReaction604" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep733">
 <bp:stepProcess rdf:resource="#BiochemicalReaction605" />
 <bp:stepProcess rdf:resource="#Catalysis294" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep734">
 <bp:stepProcess rdf:resource="#BiochemicalReaction606" />
 <bp:stepProcess rdf:resource="#Catalysis295" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep735">
 <bp:stepProcess rdf:resource="#BiochemicalReaction607" />
 <bp:stepProcess rdf:resource="#Catalysis296" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence963">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence962">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence961">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence960">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence967">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence966">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence965">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence964">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence969">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence968">
</bp:Evidence>

<bp:PathwayStep rdf:ID="PathwayStep730">
 <bp:stepProcess rdf:resource="#Catalysis293" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction603" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep731">
 <bp:stepProcess rdf:resource="#Pathway129" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep8">
 <bp:stepProcess rdf:resource="#Catalysis2" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction6" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep9">
 <bp:stepProcess rdf:resource="#BiochemicalReaction7" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep6">
 <bp:stepProcess rdf:resource="#BiochemicalReaction4" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep7">
 <bp:stepProcess rdf:resource="#BiochemicalReaction5" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1">
 <bp:stepProcess rdf:resource="#Pathway2" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep4">
 <bp:stepProcess rdf:resource="#BiochemicalReaction2" />
 <bp:stepProcess rdf:resource="#Catalysis1" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep5">
 <bp:stepProcess rdf:resource="#BiochemicalReaction3" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep2">
 <bp:stepProcess rdf:resource="#Pathway3" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep3">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1" />
</bp:PathwayStep>

<bp:BioSource rdf:ID="BioSource1">
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Homo sapiens</bp:name>
</bp:BioSource>

<bp:PathwayStep rdf:ID="PathwayStep1297">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1103" />
 <bp:stepProcess rdf:resource="#Catalysis449" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1296">
 <bp:stepProcess rdf:resource="#Pathway195" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1299">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1105" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1298">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1104" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1293">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1101" />
 <bp:stepProcess rdf:resource="#Catalysis448" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1292">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1100" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1295">
 <bp:stepProcess rdf:resource="#Pathway194" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1294">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1102" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1291">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1099" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1290">
 <bp:stepProcess rdf:resource="#Catalysis447" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1098" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1286">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1094" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1285">
 <bp:stepProcess rdf:resource="#Catalysis445" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1093" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1288">
 <bp:stepProcess rdf:resource="#Catalysis446" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1096" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1287">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1095" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1282">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1091" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1281">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1090" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1284">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1092" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1283">
 <bp:stepProcess rdf:resource="#Pathway193" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1289">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1097" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep666">
 <bp:stepProcess rdf:resource="#Catalysis268" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction549" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep667">
 <bp:stepProcess rdf:resource="#Pathway119" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep668">
 <bp:stepProcess rdf:resource="#BiochemicalReaction550" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep669">
 <bp:stepProcess rdf:resource="#Catalysis269" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction551" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1280">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1089" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1275">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1084" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1274">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1083" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1277">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1086" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1276">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1085" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1271">
 <bp:stepProcess rdf:resource="#Catalysis442" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1080" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1270">
 <bp:stepProcess rdf:resource="#Pathway192" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1273">
 <bp:stepProcess rdf:resource="#Catalysis443" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1082" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1272">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1081" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep662">
 <bp:stepProcess rdf:resource="#BiochemicalReaction545" />
 <bp:stepProcess rdf:resource="#Catalysis264" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep663">
 <bp:stepProcess rdf:resource="#Catalysis265" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction546" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep664">
 <bp:stepProcess rdf:resource="#Catalysis266" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction547" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep665">
 <bp:stepProcess rdf:resource="#Catalysis267" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction548" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1279">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1088" />
 <bp:stepProcess rdf:resource="#Catalysis444" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1278">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1087" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep660">
 <bp:stepProcess rdf:resource="#BiochemicalReaction543" />
 <bp:stepProcess rdf:resource="#Catalysis262" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep661">
 <bp:stepProcess rdf:resource="#BiochemicalReaction544" />
 <bp:stepProcess rdf:resource="#Catalysis263" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep677">
 <bp:stepProcess rdf:resource="#BiochemicalReaction559" />
 <bp:stepProcess rdf:resource="#Catalysis273" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep678">
 <bp:stepProcess rdf:resource="#BiochemicalReaction560" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep679">
 <bp:stepProcess rdf:resource="#BiochemicalReaction561" />
 <bp:stepProcess rdf:resource="#Catalysis274" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1264">
 <bp:stepProcess rdf:resource="#Pathway190" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1263">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1075" />
 <bp:stepProcess rdf:resource="#Catalysis441" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1266">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1077" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1265">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1076" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1260">
 <bp:stepProcess rdf:resource="#Catalysis439" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1072" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1262">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1074" />
 <bp:stepProcess rdf:resource="#Catalysis440" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1261">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1073" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep673">
 <bp:stepProcess rdf:resource="#BiochemicalReaction555" />
 <bp:stepProcess rdf:resource="#Catalysis272" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep674">
 <bp:stepProcess rdf:resource="#BiochemicalReaction556" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep675">
 <bp:stepProcess rdf:resource="#BiochemicalReaction557" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep676">
 <bp:stepProcess rdf:resource="#BiochemicalReaction558" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1268">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1079" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep670">
 <bp:stepProcess rdf:resource="#Catalysis270" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction552" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1267">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1078" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep671">
 <bp:stepProcess rdf:resource="#Catalysis271" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction553" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep672">
 <bp:stepProcess rdf:resource="#BiochemicalReaction554" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1269">
 <bp:stepProcess rdf:resource="#Pathway191" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep688">
 <bp:stepProcess rdf:resource="#Pathway121" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep689">
 <bp:stepProcess rdf:resource="#Pathway122" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1253">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1065" />
 <bp:stepProcess rdf:resource="#Catalysis435" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1252">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1064" />
 <bp:stepProcess rdf:resource="#Catalysis434" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1255">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1067" />
 <bp:stepProcess rdf:resource="#Catalysis437" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1254">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1066" />
 <bp:stepProcess rdf:resource="#Catalysis436" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1251">
 <bp:stepProcess rdf:resource="#Pathway189" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1250">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1063" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep684">
 <bp:stepProcess rdf:resource="#BiochemicalReaction565" />
 <bp:stepProcess rdf:resource="#Catalysis276" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep685">
 <bp:stepProcess rdf:resource="#BiochemicalReaction566" />
 <bp:stepProcess rdf:resource="#Catalysis277" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep686">
 <bp:stepProcess rdf:resource="#BiochemicalReaction567" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep687">
 <bp:stepProcess rdf:resource="#BiochemicalReaction568" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep680">
 <bp:stepProcess rdf:resource="#Pathway120" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1257">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1069" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep681">
 <bp:stepProcess rdf:resource="#BiochemicalReaction562" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1256">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1068" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep682">
 <bp:stepProcess rdf:resource="#BiochemicalReaction563" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1259">
 <bp:stepProcess rdf:resource="#Catalysis438" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1071" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep683">
 <bp:stepProcess rdf:resource="#BiochemicalReaction564" />
 <bp:stepProcess rdf:resource="#Catalysis275" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1258">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1070" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep699">
 <bp:stepProcess rdf:resource="#BiochemicalReaction575" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1242">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1055" />
 <bp:stepProcess rdf:resource="#Catalysis431" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1241">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1054" />
 <bp:stepProcess rdf:resource="#Catalysis430" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1244">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1057" />
 <bp:stepProcess rdf:resource="#Catalysis432" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep690">
 <bp:stepProcess rdf:resource="#BiochemicalReaction569" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1243">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1056" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1240">
 <bp:stepProcess rdf:resource="#Catalysis429" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1053" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep695">
 <bp:stepProcess rdf:resource="#BiochemicalReaction572" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep696">
 <bp:stepProcess rdf:resource="#BiochemicalReaction573" />
 <bp:stepProcess rdf:resource="#Catalysis278" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1249">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1062" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep697">
 <bp:stepProcess rdf:resource="#BiochemicalReaction574" />
 <bp:stepProcess rdf:resource="#Catalysis279" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep698">
 <bp:stepProcess rdf:resource="#Pathway125" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep691">
 <bp:stepProcess rdf:resource="#Pathway123" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1246">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1059" />
 <bp:stepProcess rdf:resource="#Catalysis433" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep692">
 <bp:stepProcess rdf:resource="#BiochemicalReaction570" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1245">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1058" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep693">
 <bp:stepProcess rdf:resource="#Pathway124" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1248">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1061" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep694">
 <bp:stepProcess rdf:resource="#BiochemicalReaction571" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1247">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1060" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction649">
 <bp:evidence rdf:resource="#Evidence787" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 binds to the activated TLR receptor:TIRAP:MyD88 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction642">
 <bp:evidence rdf:resource="#Evidence778" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6:p-IRAK2 interacts with TAK1 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction641">
 <bp:evidence rdf:resource="#Evidence776" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to p-IRAK2  </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction644">
 <bp:evidence rdf:resource="#Evidence780" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TRAF6 synthesizes unanchored polyubiquitin chains</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction643">
 <bp:evidence rdf:resource="#Evidence779" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK2 induces TRAF6 oligomerization</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction646">
 <bp:evidence rdf:resource="#Evidence782" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto ubiquitination of oligo-TRAF6 bound to p-IRAK2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction645">
 <bp:evidence rdf:resource="#Evidence781" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction648">
 <bp:evidence rdf:resource="#Evidence785" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR1:TLR2 is recruited to ligand:CD14</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction647">
 <bp:evidence rdf:resource="#Evidence783" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TLR6/2 ligand associates with CD14 and CD36 within lipid rafts</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1231">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1044" />
 <bp:stepProcess rdf:resource="#Catalysis424" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1230">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1043" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1233">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1046" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1232">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1045" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction651">
 <bp:evidence rdf:resource="#Evidence790" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NEMO subunit of IKK complex binds to activated IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction650">
 <bp:evidence rdf:resource="#Evidence789" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pellino binds hp-IRAK1:TRAF6</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1239">
 <bp:stepProcess rdf:resource="#Catalysis428" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1052" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1238">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1051" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1235">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1048" />
 <bp:stepProcess rdf:resource="#Catalysis426" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1234">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1047" />
 <bp:stepProcess rdf:resource="#Catalysis425" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1237">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1050" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1236">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1049" />
 <bp:stepProcess rdf:resource="#Catalysis427" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction639">
 <bp:evidence rdf:resource="#Evidence774" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds to hp- IRAK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction638">
 <bp:evidence rdf:resource="#Evidence773" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 oligomerization within the complex of activated TLR:TIRAP:MyD88</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction631">
 <bp:evidence rdf:resource="#Evidence766" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates TPL2 (MAP3K8) at Ser400</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction630">
 <bp:evidence rdf:resource="#Evidence765" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">3xUb,p-S-NFkB p105:TPL2:ABIN2 dissociates due to degradation of p105</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction633">
 <bp:evidence rdf:resource="#Evidence768" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAP3K8 is phosphorylated</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction632">
 <bp:evidence rdf:resource="#Evidence767" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">NFKB p105, TPL2 (COT) and ABIN2 form a stable complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction635">
 <bp:evidence rdf:resource="#Evidence770" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of p-IRAK2:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction634">
 <bp:evidence rdf:resource="#Evidence769" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TLR2/4:TIRAP interacts with BTK</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction637">
 <bp:evidence rdf:resource="#Evidence772" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissociation of hp-IRAK1:TRAF6 from the activated TLR:oligo-Myd88:TIRAP:p-IRAK4 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction636">
 <bp:evidence rdf:resource="#Evidence771" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TRAF6 binds MEKK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1220">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1034" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1222">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1036" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1221">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1035" />
 <bp:stepProcess rdf:resource="#Catalysis420" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction640">
 <bp:evidence rdf:resource="#Evidence775" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MyD88 forms a complex with TIRAP:activated TLR2/4</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1228">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1041" />
 <bp:stepProcess rdf:resource="#Catalysis422" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1227">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1040" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1229">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1042" />
 <bp:stepProcess rdf:resource="#Catalysis423" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1224">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1038" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1223">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1037" />
 <bp:stepProcess rdf:resource="#Catalysis421" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1226">
 <bp:stepProcess rdf:resource="#Pathway188" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1225">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1039" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction628">
 <bp:evidence rdf:resource="#Evidence763" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP ubiquitinates NFKB p105 within p-S927, S932-NFkB p105:TPL2:ABIN2 </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction627">
 <bp:evidence rdf:resource="#Evidence762" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IKBKB phosphorylates NFkB p105 within the NFkB p105:TPL2:ABIN2 complex</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction629">
 <bp:evidence rdf:resource="#Evidence764" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TPL2 phosphorylates MEK1, SEK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction620">
 <bp:evidence rdf:resource="#Evidence754" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction622">
 <bp:evidence rdf:resource="#Evidence756" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2/5 activate RSK1/2/3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction621">
 <bp:evidence rdf:resource="#Evidence755" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK5 activates the transcription factor MEF2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction624">
 <bp:evidence rdf:resource="#Evidence758" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction623">
 <bp:evidence rdf:resource="#Evidence757" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERK1/2 activates ELK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction626">
 <bp:evidence rdf:resource="#Evidence761" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SCF betaTrCP1,2 binds p-NFkB p105:TPL2:ABIN2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction625">
 <bp:evidence rdf:resource="#Evidence759" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by protein phosphatase 2A</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1211">
 <bp:stepProcess rdf:resource="#Catalysis417" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1028" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1210">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1027" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1217">
 <bp:stepProcess rdf:resource="#Catalysis419" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1033" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1216">
 <bp:stepProcess rdf:resource="#Catalysis418" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1032" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1219">
 <bp:stepProcess rdf:resource="#Pathway187" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1218">
 <bp:stepProcess rdf:resource="#Pathway186" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1213">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1030" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1212">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1029" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1215">
 <bp:stepProcess rdf:resource="#Pathway185" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1214">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1031" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction617">
 <bp:evidence rdf:resource="#Evidence749" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">RSK1/2/3 phosphorylates CREB at Serine 119</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction616">
 <bp:evidence rdf:resource="#Evidence748" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates ATF1</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction619">
 <bp:evidence rdf:resource="#Evidence753" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ERKs are inactivated by dual-specific phosphatases (DUSPs)</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction618">
 <bp:evidence rdf:resource="#Evidence751" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p38MAPK phosphorylates MSK1</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1209">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1026" />
</bp:PathwayStep>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction611">
 <bp:evidence rdf:resource="#Evidence742" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MAPKs phosphorylate ATF-2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction610">
 <bp:evidence rdf:resource="#Evidence741" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated JNKs phosphorylate c-JUN</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction613">
 <bp:evidence rdf:resource="#Evidence744" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. cFOS/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction612">
 <bp:evidence rdf:resource="#Evidence743" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">c-FOS activation by phospho ERK1/2</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction615">
 <bp:evidence rdf:resource="#Evidence747" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MSK1 activates CREB</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction614">
 <bp:evidence rdf:resource="#Evidence746" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MAPKAPK2 phosphorylates CREB at Serine 133</bp:displayName>
</bp:BiochemicalReaction>

<bp:PathwayStep rdf:ID="PathwayStep1200">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1017" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1206">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1023" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1205">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1022" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1208">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1025" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1207">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1024" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1202">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1019" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1201">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1018" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1204">
 <bp:stepProcess rdf:resource="#Catalysis416" />
 <bp:stepProcess rdf:resource="#BiochemicalReaction1021" />
</bp:PathwayStep>

<bp:PathwayStep rdf:ID="PathwayStep1203">
 <bp:stepProcess rdf:resource="#BiochemicalReaction1020" />
</bp:PathwayStep>

<bp:Evidence rdf:ID="Evidence192">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction606">
 <bp:evidence rdf:resource="#Evidence735" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence191">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction605">
 <bp:evidence rdf:resource="#Evidence734" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">activated human TAK1 phosphorylates MKK3/MKK6</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence190">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction608">
 <bp:evidence rdf:resource="#Evidence737" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Nuclear export of human p38 MAPK mediated by its substrate MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction607">
 <bp:evidence rdf:resource="#Evidence736" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Active p38 MAPK phosphorylates MAPKAPK2 or 3</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence196">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence195">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction609">
 <bp:evidence rdf:resource="#Evidence740" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Formation of Activated Protein 1 (AP-1) complex. ATF2/c-JUN heterodimer. </bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence194">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence193">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence199">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence198">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction600">
 <bp:evidence rdf:resource="#Evidence726" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IRAK4 autophosphorylation in the complex with activated TLR:MyD88:TIRAP</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence197">
</bp:Evidence>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction602">
 <bp:evidence rdf:resource="#Evidence730" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated TAK1 phosphorylates MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction601">
 <bp:evidence rdf:resource="#Evidence729" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Activated human JNKs migrate to nucleoplasm</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction604">
 <bp:evidence rdf:resource="#Evidence733" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylated MKK3/MKK6 migrates to nucleus</bp:displayName>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:ID="BiochemicalReaction603">
 <bp:evidence rdf:resource="#Evidence731" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of human JNKs by activated MKK4/MKK7</bp:displayName>
</bp:BiochemicalReaction>

<bp:Evidence rdf:ID="Evidence181">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence180">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence185">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence184">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence183">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence182">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence189">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence188">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence187">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence186">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence170">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence174">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence173">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence172">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence171">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence178">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence177">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence176">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence175">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence179">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence163">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence162">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence161">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence160">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence167">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence166">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence165">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence164">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence169">
</bp:Evidence>

<bp:Evidence rdf:ID="Evidence168">
</bp:Evidence>
</rdf:RDF>